Molecular characterization of novel ADP-ribosyl cyclases from the sea urchin by Ramakrishnan, L.
1 
 
 
Molecular characterization of 
novel ADP-ribosyl cyclases 
from the sea urchin 
 
 
 
Latha Ramakrishnan 
 
 
 
A thesis submitted for the degree of 
Doctor of Philosophy 
 
 
 
 
 
Department of Cell and Developmental Biology 
University College London 
 
 
 
July 2010 
 
 
 
 2 
 
Declarations 
 
I, Latha Ramakrishnan, hereby confirm that this thesis which is approximately 43,000 
words long has been written by me and the work presented in this thesis is my own. 
Where information has been derived from other sources, I confirm that it has been duly 
acknowledged. This work has not been submitted in any previous application for a 
higher degree. 
 
The data presented in this thesis was collected through April 2007 to April 2010. 
 
 
Signature of the candidate:                                                           Date:        
 3 
 
Acknowledgements 
 
I  am  sincerely  and  earnestly  grateful  to  my  principal  investigator  Dr.  Sandip  Patel  for 
providing  excellent  supervision,  adequate  criticisms  and  necessary  pastoral  care 
throughout my  project.  I  also  thank him  for  being  a  good  friend  and  providing me  this 
opportunity to work as a part of his team.  
 
I am also extremely grateful to Dr. Leslie Dale, Dept. of Cell and Developmental Biology, 
UCL for performing all the Xenopus embryo injections and rewarding scientific discussions.  
 
I  would  like  to  take  this  opportunity  to  whole-heartedly  thank  my  colleagues  Dr.  Dev 
Churamani, Dr. George Dickinson and Mr. Rob Hooper for all their help, support, valuable 
discussions and particularly their patience for putting up with me. 
 
I thank the UCL-Bogue fellowship committee for awarding me the fellowship to enable me 
to  travel  to  USA  for  performing  endogenous  studies  with  S.purpuratus.  I  take  this 
opportunity to thank Dr. Amro Hamdoun, Scripps Institute of Oceanography, La Jolla, USA 
for  hosting  me  to  learn  new  techniques  in  his  lab  and  for  the  performing  all  the 
microinjections  in  S.  purpuratus  embryos.  Thanks  also  to  his  lab  colleagues  Dr.  Kevin 
Ulhinger and Mr. Joesph Campanale for assisting me through the embryology work. 
 
I am also hugely gratified to Prof. Victor D.Vacquier, Scripps Institute of Oceanography, 
USA for providing me with S.purpuratus embryo samples for biochemical characterizations 
and pastoral care during my stay at La Jolla.  
 
I am also appreciative of my collaborators Dr. Christophe Bosc and Dr. Marie-Jo Moutin, 
Grenoble,  France  for  all  the  valuable  advice  on  the  bio-informatics  of  SpARC1-like 
isoforms.  
 
Thanks are due to Dr. Xinjiang Cai, Duke University Medical Center, Durham, USA for his 
help and advice with phylogenetics over emails.   
 
Thanks also to my current Dept. of Cell and Developmental Biology, UCL and my Ex- Dept. 
of Physiology, UCL for providing the necessary infrastructures and also for offering me this 
opportunity to pursue a PhD program.  
 
Finally I thank my official sponsors, MRC for providing me bread and butter during my study 
period.  
 
Last but not the least I am deeply grateful to my entire family including my parents, sister 
and most importantly my husband who have been my pillar of support leading to my current 
achievements in my life and career. I hope my 3.5 year old son, who was 5 months old 
when I started my PhD would be proud of his mom one day. 
 
“When the going gets tough, the tough get going” 4 
 
Abstract 
 
Calcium signalling is ubiquitous and regulates diverse cellular processes. Cyclic ADP-
ribose  (cADPR)  and  nicotinic  acid  adenine  dinucleotide  phosphate  (NAADP)  are 
second  messengers  that  are  involved  in  calcium  release  from  the  intracellular 
organelles.  These  molecules  are  structurally  and  mechanistically  distinct  but 
synthesised by a common enzyme, ADP-ribosyl cyclase (ARC). The sea urchin has 
long  been  a  model  system  for  both  calcium  signalling  and  embryogenesis.  In  fact, 
cADPR  and  NAADP  were  both  discovered  in  the  sea  urchin.  However,  molecular 
details of ARCs and their roles during development are limited. Recently three ARC 
isoforms: SpARC1, SpARC2 and SpARC3 were identified from the sea urchin. In this 
study,  additional  novel  isoforms  including  SpARC4  were  cloned  from  S.purpuratus, 
highlighting the further expansion of ARCs in basal deuterostomes. SpARC2, SpARC3 
and SpARC4 were found to be glycoproteins tethered to the plasma membrane via a 
GPI-anchor.  SpARC2  and  SpARC4  were  multi-functional  and  able  to  produce  both 
cADPR  and  NAADP  over  a  wide  pH  range.  SpARC2  was  a  preferential  base-
exchanger  and  SpARC4  a  preferential  cyclase.  A  unique  non-canonical  active  site 
tyrosine  residue  regulated  the  cyclisation:  base-exchange  activity  ratio  of  SpARC4. 
Both SpARC2 and SpARC4 were poor hydrolases and unable to cyclise NGD, a NAD 
surrogate. A single non-conserved glycine residue in the “TLEDTL domain” of SpARC2 
was responsible for its poor hydrolase activity. All SpARC isoforms were detectable in 
S.purpuratus  egg  and  the  majority  of  ARC  activity  was  GPI-anchored.  During  the 
course of early development, SpARC isoforms were differentially expressed and the 
endogenous ARC activity also varied. Over-expression and knock-down of SpARC4 
during embryo development interfered with gastrulation. These findings provide new 
insights into the molecular mechanisms of multifunctionality of this remarkable family of 
enzymes and suggest that the expression and activities of ARCs could be fine-tuned 
for production of specific calcium messengers during embryogenesis of S.purpuratus. 5 
 
List of abbreviations  
 
 
ADPR  Adenosine diphosphate-ribose 
AG MP1  Analytical grade 1 macroporous 
ARC  ADP-ribosyl cyclase 
BLAST  Basic local alignment search tool 
cADPR  Cyclic adenosine diphosphate ribose 
cADPRP  Cyclic adenosine diphosphate ribose phosphate 
cAMP  3’-5’- cyclic adenosine monophosphate 
CD  Cluster differentiation 
cGDPR  Cyclic guanosine diphosphate-ribose 
cGMP  Cyclic guanosine mono phosphate 
CICR  Calcium-induced calcium release 
DAG  Diacyl glycerol 
DTT  Dithiotherithol 
FSW  Filtered sea water 
EDTA  Ethylenediaminetetraacetic acid 
GDPR  Guanosine diphosphate ribose 
GPCRs  G protein-coupled receptors 
GPI  Glycosylphosphatidylinositol 
HEK  Human embryonic kidney 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HPLC  High performance liquid chromatography 
IL  Interleukin 
IP3  Myo - inositol 1,4,5-triphosphate 
IP3R  IP3 receptor 
IP4 
L-Type 
Inositol 1,3 4,5-tetrakisphosphate 
“Long-lasting” type  
MASO  Morpholino antisense oligonucleotide 
mRNAs 
N-Type 
Messenger-ribonucleic acid 
“Neural”/ “Non-L” type 
NAAD  Nicotinic acid adenine dinucleotide 
NAADP  Nicotinic acid adenine dinucleotide phosphate  
NAD  Nicotinamide adenine dinucleotide  
NADP  Nicotinamide adenine dinucleotide phosphate  
NGD  Nicotinamide guanine dinucleotide 6 
 
NMDA  N-methyl,D-aspartate 
NO  Nitric oxide 
ORF 
P-Type 
Open reading frame 
“Purkinje” type 
PCR  Polymerase chain reaction 
PHYLIP  Phylogeny inference package 
PIP2  Phosphatidylinositol 4,5-bisphosphate 
PI-PLC  Phosphatidylinositol specific phospholipase C 
PLC 
PMCA 
R-Type 
Phospholipase C 
Plasma membrane Ca
2+ ATPase 
“Residual” type 
RACE  Random amplification of cDNA ends 
RNA  Ribonucleic acid 
RT-PCR  Reverse transcription polymerase chain reaction 
RyRs  Ryanodine receptors 
S1P 
SERCA 
Sphingosine-1-phosphate 
Sacro endoplasmic reticulum Ca
2+ ATPase 
SIRT1  Sirtuin (silent mating type information regulation 2, S. cerevisiae, homolog) 1 
SmNACE  Schistosoma mansoni NAD[P
+] catabolizing enzyme 
SNP  Single-nucleotide polymorphism 
SpARCs  Strongylocentrotus purpuratus ADP-ribosyl cyclase 
SPC 
SPCA 
T-Type 
Sphingosylphosphoryl choline 
Secretory pathway Ca
2+ ATPase 
“Transient” type 
TNF  Tumour necrosis factor 
TPCs  Two-pore channels 
TRP  Transient receptor potential 
UTR 
VOC 
Untranslated region 
Voltage operated channel 
WGS  Whole genome shotgun 
   
   
   
   
   
   7 
 
Table of contents 
 
Declarations ......................................................................................................  2 
Acknowledgements ..........................................................................................  3 
Abstract .............................................................................................................  4 
List of abbreviations .........................................................................................  5 
List of figures ..................................................................................................  11 
Chapter 1: Introduction ..................................................................................  13 
1.1  Calcium signalling ............................................................................................ 13 
1.2  Calcium mobilization from intracellular organelles ............................................ 15 
1.2.1  IP3 ....................................................................................................................... 15 
1.2.2  cADPR  ................................................................................................................ 17 
1.2.3  NAADP ............................................................................................................... 19 
1.2.4  Sphingolipids ...................................................................................................... 22 
1.3  Multiple interacting calcium stores  .................................................................... 23 
1.3.1  Agonist-evoked messenger production ............................................................. 25 
1.4  ADP-ribosyl cyclases ....................................................................................... 26 
1.4.1  Aplysia cyclase  ................................................................................................... 27 
1.4.2  CD38 and CD157 ............................................................................................... 27 
1.4.3  SmNACE ............................................................................................................ 28 
1.4.4  Structural features of ARCs ............................................................................... 28 
1.4.5  Heterologous expression of ARCs  ..................................................................... 30 
1.5  ARC catalysis  ................................................................................................... 30 
1.5.1  Cyclisation .......................................................................................................... 31 
1.5.2  Base-exchange .................................................................................................. 32 
1.5.3  Hydrolysis ........................................................................................................... 33 
1.5.4  Other reactions  ................................................................................................... 34 
1.5.5  pH dependence of ARC reactions ..................................................................... 35 
1.5.6  Amino acid residues critical for the activity of ARCs ......................................... 35 
1.5.7  Physiological relevance of the base-exchange reaction ................................... 37 
1.6  Localization of ARCs  ........................................................................................ 38 
1.6.1  Topology Paradox .............................................................................................. 39 
1.7  Regulation of ARC activities  ............................................................................. 41 
1.8  Physiological relevance of ARCs...................................................................... 43 
1.8.1  “Receptor-related” functions .............................................................................. 43 
1.8.2  Knock-out studies  ............................................................................................... 45 
1.8.3  Pathophysiological implications ......................................................................... 46 
1.9  Existence of novel ADP-ribosyl cyclases  .......................................................... 47 
1.10  The sea urchin as a model system for calcium signalling ............................... 49 
1.10.1  Regulation of endogenous ARC activity in the sea urchins  ............................. 50 
1.10.2  ARC(s) from the sea urchin ............................................................................. 51 8 
 
1.11  Aims  ............................................................................................................... 52 
Chapter 2: Cloning of novel ADP-ribosyl cyclases from the sea urchin  ....  53 
2.1  Introduction ...................................................................................................... 53 
2.2  Materials and Methods ..................................................................................... 55 
2.2.1  Identification of SpARC1-like isoforms .............................................................. 55 
2.2.2  Molecular cloning of SpARC1-like isoforms  ....................................................... 56 
2.2.3  Molecular cloning of SpARC4 ............................................................................ 57 
2.2.4  Sequence comparisons and phylogenetic analysis  ........................................... 59 
2.3  Results  ............................................................................................................. 59 
2.3.1  Identification of a new family of SpARC1-like isoforms ..................................... 59 
2.3.1.1  Existence of multiple copies of SpARC1 exons ................................................. 62 
2.3.1.2  Molecular cloning of SpARC1-like isoforms  ....................................................... 64 
2.3.1.3  Sequence comparisons between SpARC1-like isoforms .................................. 71 
2.3.1.4  Genomic correlates of SpARC1-like isoforms.................................................... 71 
2.3.1.5  Functional predictions for SpARC1-like isoforms............................................... 76 
2.3.2  Molecular cloning of SpARC4 ............................................................................ 77 
2.3.2.1  Sequence similarity between SpARCs .............................................................. 78 
2.3.2.2  Exonic organisation of SpARC4  ......................................................................... 79 
2.3.3  Phylogenetics of ARCs ...................................................................................... 82 
2.4  Discussion ....................................................................................................... 84 
Chapter 3: Localization and structural properties of sea urchin ADP-
ribosyl cyclases ..............................................................................................  93 
3.1  Introduction ...................................................................................................... 93 
3.2  Materials and Methods ..................................................................................... 96 
3.2.1  Structural predictions for SpARCs ..................................................................... 96 
3.2.2  Cloning of SpARCs into pCS2+ vectors ............................................................ 97 
3.2.3  In vitro transcription ............................................................................................ 98 
3.2.4  Microinjection of Xenopus laevis embryos  ....................................................... 100 
3.2.5  Transfection of HEK cells  ................................................................................. 101 
3.2.6  Western blot analysis ....................................................................................... 101 
3.2.7  Immunohistochemistry in Xenopus embryos ................................................... 102 
3.2.8  Immunocytochemistry in HEK cells.................................................................. 103 
3.2.9  Confocal microscopy  ........................................................................................ 104 
3.2.10  PI-PLC treatment of transfected HEK cells.................................................... 104 
3.2.11  Assay for secretion of C-terminal truncated SpARCs.................................... 104 
3.3  Results  ........................................................................................................... 105 
3.3.1  Topology predictions for SpARCs  .................................................................... 105 
3.3.2  Generation of expression constructs for SpARCs ........................................... 107 
3.3.3  Expression and glycosylation of SpARCs  ........................................................ 107 
3.3.4  Localization of SpARCs ................................................................................... 110 
3.3.5  Mode of membrane attachment in SpARCs .................................................... 112 
3.4  Discussion ..................................................................................................... 118 
Chapter 4:  Enzymatic activities of sea urchin ADP-ribosyl cyclases  ......  124 
4.1  Introduction .................................................................................................... 124 9 
 
4.2  Materials and Methods ................................................................................... 126 
4.2.1  Generation of expression constructs for SpARCs ........................................... 126 
4.2.2  Preparation of Xenopus embryo homogenates ............................................... 128 
4.2.3  Enzyme activity measurements ....................................................................... 129 
4.2.4  Activity measurements at different pH ............................................................. 130 
4.2.5  HPLC analysis  .................................................................................................. 130 
4.3  Results  ........................................................................................................... 131 
4.3.1  SpARCs are multifunctional ............................................................................. 131 
4.3.1.1  NAD utilisation by SpARCs .............................................................................. 131 
4.3.1.2  NADP utilisation by SpARCs............................................................................ 133 
4.3.1.3  NGD utilisation by SpARCs.............................................................................. 133 
4.3.2  Differences in catalytic activities of SpARCs ................................................... 136 
4.3.2.1  cADPR and NAADP production by SpARCs ................................................... 136 
4.3.2.2  ADPR production by SpARCs  .......................................................................... 138 
4.3.3  pH profile of SpARCs ....................................................................................... 139 
4.3.4  SpARC3 (in)activity .......................................................................................... 140 
4.4  Discussion ..................................................................................................... 143 
Chapter 5: Molecular determinants governing catalytic activities of sea 
urchin ADP-ribosyl cyclases........................................................................  149 
5.1 Introduction ..................................................................................................... 149 
5.2  Materials and Methods ................................................................................... 152 
5.2.1  Site-directed mutagenesis ............................................................................... 152 
5.2.2  Generation of SpARC4-ΔN-Myc ...................................................................... 154 
5.3  Results  ........................................................................................................... 155 
5.3.1  Determinants dictating preferential cyclase over hydrolase activity ................ 155 
5.3.1.1  Role of non-conserved “TLEDTL domain” in SpARC2 catalysis ..................... 155 
5.3.1.2  Role of Phe
238 in SpARC4 catalysis  ................................................................. 159 
5.3.2  Determinants dictating preferential cyclisation over base-exchange activity .. 161 
5.3.2.1  Role of the N-terminus in SpARC4 catalysis ................................................... 161 
5.3.2.2  Role of Phe
123 in SpARC4 catalysis  ................................................................. 165 
5.3.2.3  Role of non-canonical active site in SpARC4 catalysis ................................... 167 
5.3.2.4  Engineering a non-canonical active site in SpARC2 ....................................... 170 
5.4  Discussion ..................................................................................................... 172 
Chapter 6: Role of ADP-ribosyl cyclases in sea urchin embryogenesis .  180 
6.1  Introduction .................................................................................................... 180 
6.2  Materials and Methods ................................................................................... 184 
6.2.1  Semi-quantitative RT-PCR  ............................................................................... 184 
6.2.2  Endogenous ARC activity measurement ......................................................... 185 
6.2.3  Assay for endogenous GPI-anchored ARC activity  ......................................... 187 
6.2.4  Generation of mCherry-SpARC4 ..................................................................... 187 
6.2.5  In vitro transcription .......................................................................................... 187 
6.2.6  Design of MASO for SpARC4 .......................................................................... 187 
6.2.7  Sea urchin fertilization and microinjection ....................................................... 188 
6.2.8  Confocal Microscopy  ........................................................................................ 189 
6.3  Results  ........................................................................................................... 189 10 
 
6.3.1  Differential expression of SpARCs during early embryonic development  ....... 189 
6.3.2  Endogenous ARC activity in S.purpuratus eggs  .............................................. 192 
6.3.2.1  Endogenous cyclisation and base-exchange activities  .................................... 192 
6.3.2.2  Endogenous GPI-anchored ARC activity  ......................................................... 192 
6.3.3  Endogenous ARC activity during S.purpuratus early embryonic development195 
6.3.3.1  Cyclisation activity during early development .................................................. 195 
6.3.3.2  Base-exchange activity during early development .......................................... 195 
6.3.3.3  Switch in cyclisation: base-exchange ratio during development...................... 197 
6.3.4  Consequences of modulating SpARC expression during S.purpuratus 
embryogenesis ........................................................................................................... 197 
6.3.4.1  Localization of SpARC4-mCherry in S.purpuratus embryos  ............................ 198 
6.3.4.2  Phenotypic consequences of SpARC4 over-expression on S.purpuratus 
development  .................................................................................................................. 201 
6.3.4.3  Phenotypic consequences of SpARC4 knock-down on S.purpuratus 
development  .................................................................................................................. 203 
6.4  Discussion ..................................................................................................... 205 
Chapter 7: General Discussion and Future directions ..............................  217 
List of publications associated with this thesis  .........................................  224 
Bibliography ..................................................................................................  225 
 11 
 
List of figures 
 
Figure  Title  
1.1  Structures of cADPR and NAADP 
1.2  Targets of calcium second messengers 
1.3  Formation of cADPR and ADPR from NAD 
1.4  Structures of cADPR and cGDPR 
1.5  Formation of NAADP from NADP 
1.6  Possible ways to overcome topological conundrum of ARCs 
2.1  Sequence alignment of SpARC1 and SpARC-β 
2.2  Exonic organization of SpARC1 and SpARC-β 
2.3  Multi sequence alignment of various genomic contigs harbouring exon 1 of 
SpARC1 
2.4  Existence of multiple SpARC1-like exons 
2.5  Independent cloning of SpARC-β from ovary library of S.purpuratus 
2.6  Design of primers for RT-PCR cloning of SpARC1-like isoforms 
2.7  Nucleotide and amino acid sequence alignment of SpARC1-like isoforms  
2.8  Similarity between SpARC1-like clones 
2.9  Possible genomic correlate of clone 6 
2.10  Possible genomic correlate of clone 3 
2.11  Alternate genomic correlate of clone 3 
2.12  Four different SpARC1-like isoforms 
2.13  Percent similarity between SpARC family members 
2.14  Amino acid sequence alignment of the SpARC family 
2.15  Exonic organization of SpARC4 
2.16  Phylogenetic tree of the ADP-ribosyl cyclase family 
2.17  Peptides used for design of antibodies in SpARC-β studies 
3.1  Sub-cellular distribution of ARCs 
3.2 
3.3 
Flow-chart for heterologous expression of SpARC isoforms 
Predicted structure of SpARC isoforms 
3.4  Schematic representation of constructs used in Chapter 3 
3.5  SpARCs are glycoproteins 
3.6  Localization of SpARCs in Xenopus embryos 
3.7  Localization of SpARCs in HEK cells 
3.8  Release of SpARCs following PI-PLC treatment 12 
 
3.9  Decrease in immuno-flourescence following PI-PLC treatment 
3.10  Secretion of SpARCs lacking GPI-anchoring motif 
4.1  Schematic representation of constructs used in Chapter 4 
4.2  NAD utilisation by SpARCs 
4.3  NADP utilisation by SpARCs 
4.4  NGD utilisation by SpARCs 
4.5  SpARC2 and SpARC4 are multifunctional 
4.6  Hydrolase activity of SpARCs 
4.7  Effect of pH on catalytic activities of SpARCs 
4.8  Expression of SpARC3 mutants 
5.1  Schematic representation of constructs used in Chapter 5 
5.2  Expression of SpARC2-G126E-Myc 
5.3  Role of Glu
126 in SpARC2 catalysis 
5.4  Role of Phe
238 in controlling enzymatic activities of SpARC4 
5.5  Expression of SpARC4-∆N-Myc and SpARC4-R52/53A-Myc 
5.6  Effect of acidic basic cluster and pro-convertase consensus sequence on 
SpARC4 activity 
5.7  Role of Phe
123 in controlling SpARC4 activity 
5.8  Expression of SpARC4-Y142W-Myc and SpARC4-Y142H-Myc 
5.9  Role of the non-canonical active site in dictating cyclase:base-exchange 
activities of SpARC4 
5.10  Role of conserved active site residue Trp
103 in SpARC2 catalysis 
6.1  Embryonic developmental stages in S.purpuratus 
6.2  Design of MASO against SpARC4 
6.3  SpARCs are differentially regulated during development 
6.4  Endogenous ARC activity in S.purpuratus eggs 
6.5  Endogenous GPI-anchored base-exchange activity in S.purpuratus egg 
6.6  Endogenous ARC activity during early development of S.purpuratus 
6.7  Increase in SpARC4-mCherry expression before hatching 
6.8  Localization of SpARC4-mCherry in S.purpuratus embryo 
6.9  Over-expression of SpARC4 in S.purpuratus embryos 
6.10  SpARC4  over-expression  causes  abnormal  phenotype  in  S.purpuratus 
embryos  
6.11  Knock-down of SpARC4 expression in S.purpuratus embryo 
6.12  SpARC4-MASO generates abnormal phenotype in S.purpuratus embryos 
6.13  Predicted expression profiles for SpARC isoforms  13 
 
   
Chapter 1: Introduction 
 
1.1  Calcium signalling 
 
Calcium signalling is ubiquitous and indispensable for the regulation of a number of cell 
functions (Berridge, et al., 2000). The divalent cation calcium plays a central role in 
dictating  a  wide  array  of  cellular  activities  ranging  from  exocytosis  to  muscle 
contraction. Calcium can act as a first, second or third messenger depending on the 
site of action (Carafoli, 2002). It is intriguing that calcium can control opposing events, 
often in the same cell. For example, controlling fertilization followed by development or 
apoptosis within a same organism, long term potentiation and long term depression 
within the same synaptic connection, contraction and relaxation in the same muscle 
cell. Such is the diversity and versatility of calcium signalling (Berridge, 2005).  
 
This uniqueness is achieved by organizing the calcium signal with respect to both time 
and  space.  The  spatio-temporal  aspect  of  signalling  is  accomplished  by  deploying 
calcium  release  in  various  forms  leading  to  either  elementary  or  global  events 
(Berridge, 2005; Clapham, 2007). Quantal calcium release leading to blips and bumps 
is caused by the opening of individual channels, while puffs and sparks are due the 
opening of a cluster of channels.  In non-excitable cells, spontaneous calcium release 
leads to spikes and waves. The global events are co-ordinated by a process called 
calcium-induced calcium release (CICR), whereby channels are recruited to produce 
regenerative calcium waves and oscillations (Berridge, 1997). 
 
To achieve this highly co-ordinated pattern of signalling, the cell employs an array of 
different types of molecules to execute control of calcium  entry and exit at  various 14 
 
checkpoints. Unlike other signalling molecules, calcium is an ion and therefore cannot 
be destroyed. It is instead stored away from its site of action.  Proteins like calbindin, 
calretinin and parvalbumin act as cytosolic calcium buffers providing a “sink” for excess 
calcium  (Berridge,  et  al.,  2003).  The  cystosolic  concentrations  of  calcium  are 
maintained  at  ~100nM  under  resting  conditions.  However,  the  free  calcium 
concentration can be elevated either by influx from the extracellular sources (~1mM) or 
release from intracellular organelles. During the “ON” state of the cell, various voltage-
operated channels (VOCs) open for calcium influx into the cytosol. The N-type and 
P/Q-type channels are involved in neurotransmitter release, T-type is involved in the 
cardiac cells, while L-type/R-type channels are found in other cell types. There are also 
other types of calcium channels such as receptor-operated channels (NMDA and acetyl 
choline)  and  second  messenger-operated  channels  including  the  cyclic  nucleotide 
gated channels. Emerging in the limelight are the transient receptor potential (TRP) 
channels, with subtypes C, M, ML, N and V (Berridge, et al., 2003) and the store-
operated channels involving the ORAI proteins (Dziadek and Johnstone, 2007). During 
the “ON” phase, calcium is also released from internal stores, by the action of calcium 
second messengers, which will be discussed in section 1.2.  
 
The termination of signalling events marks the “OFF” state of the cell, whereby various 
pumps  and  exchangers  are  employed  at  different  intracellular  locations  to  remove 
calcium  from  the  cytosol,  quickly  and  efficiently.  These  include  plasma  membrane 
Ca
2+-ATPase  (PMCAs),  sacro  endoplasmic  reticulum  Ca
2+-ATPase  (SERCAs)  and 
secretory  pathway  Ca
2+-ATPase  (SPCAs).  The  Na
+/Ca
2+-exchanger,  Ca
2+  uniporter 
and H
+/Ca
2+-exchanger are also deployed for sequestering calcium (Berridge, et al., 
2000;  Berridge,  et  al.,  2003).  Needless  to  say,  alterations  to  any  of  these 
mechanisms/pathways  would  deregulate  calcium  homeostasis  leading  to  diseased 
state  and/or  cell  death.  The  focus  of  this  thesis  is  on  the  mechanisms  of  calcium 
release from intracellular stores. 15 
 
1.2  Calcium mobilization from intracellular organelles 
 
In addition to the calcium influx discussed in the previous section, changes in cytosolic 
calcium can be brought about by the action of various second messengers which are 
produced  in  response to  extra  cellular  cues  (Berridge,  et  al.,  2000).  These  second 
messengers act to release calcium from intracellular stores into the cytoplasm. The 
calcium messengers known to date are myo - inositol 1,4,5 triphosphate (IP3), cyclic 
adenosine diphosphate ribose (cADPR), nicotinic acid adenine dinucleotide phosphate 
(NAADP)  and  sphingosine-1-phosphate  (S1P).  Some  molecules  like  adenosine 
diphosphate ribose (ADPR) and PIP2 (phosphatidylinositol 4,5-bisphosphate) are also 
known to modulate calcium levels (Wu, et al., 2002; Gamper, et al., 2004), but not 
widely accepted as second messengers yet. 
 
1.2.1  IP3 
 
IP3  was  the  first  discovered  (Streb,  et  al.,  1983),  most  well  studied  and  universally 
accepted calcium second messenger. IP3 is produced at the cell surface and travels to 
the endoplasmic reticulum which is its site of action (Berridge and Irvine, 1984). IP3 is 
produced from PIP2 by the action of the enzyme PLC (phospholipase C). PLCs are 
activated through the signal transduction caused by the binding of  agonists to their 
receptors at the cell surface. DAG (diacyl glycerol) is another product of the reaction 
which in turn also acts as a second messenger to activate protein kinase C (Huang, 
1989).  
 
PLCs are of different types. The most common and the first discovered was PLC-β 
which is activated by the ʱ and βγ subunits of the G-protein coupled receptors (Taylor, 
et  al.,  1991).  PLC-γ  is  activated  and  phosphorylated  by  receptor  and  non-receptor 
tyrosine kinases (Carpenter and Ji, 1999; Wahl, et al., 1989). PLC-ε is regulated by G-16 
 
protein subunits and Ras oncoproteins (Kelley, et al., 2001; Wing, et al., 2001). PLC-δ 
is activated by an increased Ca
2+ concentration (Okada, et al., 2005). PLC-δ is the 
most recently discovered isoform known to be delivered into the egg by the sperm and 
hence important for the process of fertilization (Saunders, et al., 2003). The calcium 
transients produced in a cell, thus are largely dependent on the receptor type and the 
PLC isoform involved in the production of IP3. Hence, different cell types are able to 
execute specificity by engaging various combinations of these transducing elements. 
 
IP3 binds to the IP3R  (IP3 receptor) which is located mainly on the ER, the major store 
house of calcium (Berridge, 1993). The binding of IP3 to the cytosolic face of IP3R leads 
to a conformational change (Mignery and Südhof, 1990) and opening of the channel to 
release  calcium  from  ER  to  the  cytosol.  IP3R  was  first  purified  from  rat  cerebellar 
membranes  (Supattapone,  et  al.,  1988)  and  later  cloned  from  mouse  cerebellum 
(Furuichi,  et  al.,  1989).  The  IP3  receptors  are  composed  of  four  subunits  with  six 
transmembrane domains. Three isoforms of IP3R are present in cells that differ in their 
affinities  for  IP3.  They  assemble  either  as  homomeric  or  heteromeric  structures  to 
create functional diversity (Taylor, et al., 1999). The IP3R is regulated by calcium in a 
biphasic  manner  (Bezprozvanny,  et  al.,  1991).  Both  IP3  and  cytosolic  Ca
2+  regulate 
channel opening by direct binding. Higher calcium can also inhibit the receptor function 
probably through calmodulin (Taylor and Laude, 2002). The IP3R is phosphorylated by 
several kinases (Patel, et al., 1999). 
 
IP3 is metabolized by phosphorylation through a calcium dependent kinase, to form IP4 
(inositol  1,3,4,5-tetrakisphosphate).  IP4  is  also  thought  to  modulate  the  calcium 
homeostasis of the cell by binding to a small GTPase protein of Ras family (Cullen, 
1998). IP3 can also be rapidly metabolised by dephosphorylation to inositol (Storey, et 
al., 1984). A complete metabolic pathway and the enzymes involved in the breakdown 
pathway have been elucidated in the liver (Storey, et al., 1984).  17 
 
1.2.2  cADPR 
 
cADPR is another calcium messenger which is being studied extensively. cADPR, like 
IP3  mobilizes  calcium  from  the  endoplasmic  reticulum.  Hon  Cheung  Lee’s  lab 
discovered that nicotinamide adenine dinucleotide (NAD) released calcium in cell free 
sea urchin egg homogenate desensitized for IP3. There was a time lag in the process, 
which indicated a possible requirement for the biochemical conversion of NAD to an 
active metabolite (Clapper, et al., 1987). The molecule was later purified and identified 
as cADPR (Lee, et al., 1989) (Figure 1.1A). cADPR is formed through the cyclisation of 
NAD  by  ADP-ribosyl  cyclase  (ARC)  (Lee  and  Aarhus,  1991).  ARCs  are  versatile 
enzymes capable of carrying out multiple reactions with multiple substrates. ARCs will 
be discussed in further detail in section 1.5.  
 
cADPR targets the ryanodine receptors (RyRs) located on the endoplasmic reticulum   
(Lee, 1991; Galione, et al., 1991; Meszaros, et al., 1993). RyRs are similar to IP3R in 
terms of their structure and function. But the conductance and molecular weight of RyR 
was  approximately  twice  that  of  IP3R.  The  RyR  was  first  characterized  from  rabbit 
skeletal  muscle  (Pessah,  et  al.,  1986).  Electron  microscopic  studies  revealed  a 
quatrefoil structure with a central pore similar to that of IP3R (Lai and Meissner, 1989). 
Like IP3Rs, RyRs are also sensitive to cytosolic calcium concentrations, although they 
are both activated (1-10µM) and inhibited at higher calcium concentrations (>10µM). In 
stark contrast to the ubiquitous IP3R, RyRs were initially thought to be present mainly in 
excitable cells like muscle and neurons, although it is now known that they are present 
in many other cell types including the sea urchin eggs (Sorrentino and Volpe, 1993). 
Three  genes  encode  RyR  subtypes.  The  gene  products  seem  to  have  specific 
functions unlike the redundancy observed with IP3Rs. Type I RyRs are mainly found in 
skeletal  muscles  and  Type  II  in  cardiac  muscles  while  Type  III  is  more  widely 
distributed (Ogawa, 1994). 18 
 
RyRs  are  so-called  because  they  can  bind  ryanodine,  a  plant  alkaloid.  Low 
concentrations (<10µM) of ryanodine traps the receptor in sub-conductance state while 
higher concentrations (>100µM) leads to irreversible inhibition of the channel opening 
(Thorn, et al., 1994).  Caffine is known to activate RyR type I and II. Ruthenium red 
also inhibits RyR and blocks the action of cADPR (Galione, 1994).  cADPR is thought 
to bind to RyRs indirectly. Photoaffinity labelling studies identified two proteins of sizes 
100 kDa and 140 kDa (Walseth, et al., 1993). Later, Okamato and colleagues reported 
that cADPR was the ligand of FK506-binding protein 12.6 (Noguchi, et al., 1997). In 
fact, some reports suggest cADPR to be merely a modulator and not a messenger per 
se. Introduction of cADPR into some cells either had no immediate response (Hashii, et 
al., 2000) or elicited a response after a time lag (Cui, et al., 1999). cADPR may act by 
increasing the sensitivity of the RyRs either by coupling them with the VOCs (Empson 
and Galione, 1997) or with the SERCAs (Lukyanenko, et al., 2001).  
 
 
Figure 1.1: Structures of cADPR and NAADP 
 
Chemical structures of cyclic cADPR (A) and linear NAADP (B) messenger molecules are shown.  
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1.2.3  NAADP  
 
 
The  third  and  most  recently  discovered,  but  the  most  potent  calcium  second 
messenger is NAADP (Lee and Aarhus, 1995; Chini, et al., 1995). The first report on 
the ability of NAD to release calcium by Hon Cheung Lee also described the ability of 
NADP to release calcium from preparations desensitized to IP3 (Clapper, et al., 1987). 
Unlike the lag observed after the addition of NAD, the calcium release was almost 
instantaneous  with  NADP.  Later  studies  indicated  that  the  active  component  was 
actually  NAADP  (Figure  1.1B),  present  as  a  trace  contaminant  in  the  commercial 
preparations of NADP used. Cross-desensitization studies established that the calcium 
release evoked by NAADP was distinct from that caused by IP3 and/or cADPR (Lee 
and Aarhus, 1995). At least in vitro, NAADP is synthesised from NADP by the same 
enzyme ADP-ribosyl cyclase that produces cADPR (Aarhus, et al., 1995). The details 
of this reaction will be discussed further in section 1.5.  
 
Unlike IP3 and cADPR, NAADP released calcium from stores that were distinct from the 
endoplasmic reticulum (Genazzani and Galione, 1996). The NAADP-sensitive calcium 
stores were insensitive to the SERCA inhibitor, thapsigargin (Genazzani and Galione, 
1996;  Lee and Aarhus, 2000).  By  density gradient centrifugation of sea urchin egg 
homogenates, Lee and Aarhus showed that IP3 and cADPR, but not NAADP sensitive 
calcium  stores  co-migrated  with  the  ER  markers  (Lee  and  Aarhus,  1995).  Several 
years  later,  by  gentle  stratification  of  sea  urchin  eggs  and  the  use  of  caged 
compounds, Lee also demonstrated the functional visualization of IP3/cADPR sensitive 
Ca
2+ stores, as distinct from NAADP-sensitive Ca
2+ stores (Lee and Aarhus, 2000). 
Now, NAADP is thought to mobilize calcium from novel acidic stores (Yamasaki, et al., 
2004). Churchill et al made a break through suggesting that these acidic compartments 
were  reserve  granules  in  sea  urchins,  similar  to  endo-lysosomes  in  higher  animals 20 
 
(Churchill,  et  al.,  2002).  In  their  study,  they  used  GPN  (glycyl-phenylalanyl-
napthylamide), a substrate for cathepsin C (found exclusively in lysosomes) along with 
bafilomycin, an inhibitor of V-type ATPase, to establish that NAADP indeed mobilized 
calcium from acidic organelles. Calcium release from NAADP targeted stores are also 
sensitive to the L-type calcium channel antagonist like verapamil, diltiazem, nifedipine 
and various potassium channel blockers (Genazzani, et al., 1996b; Genazzani, et al., 
1997a). 
 
NAADP  seems  to  be  important  for  both  initiating  and  propagating  various  calcium 
signalling  events  (Patel,  et  al.,  2001).  In  stark  contrast  to  IP3  and  cADPR  release 
systems,  NAADP  mediated  calcium  release  is  insensitive  to  cytosolic  calcium 
(Genazzani and Galione, 1996) and does not promote CICR (Chini and Dousa, 1996). 
The “NAADP receptor” also possessed some unusual properties (Genazzani, et al., 
1996b; Aarhus, et al., 1996) that distinguished it from IP3R and RyRs. Even a sub-
threshold  concentration  of  NAADP  completely  inactivated  response for  a  prolonged 
period of time (Genazzani, et al., 1996b; Aarhus, et al., 1996). This rather peculiar 
characteristic of the NAADP channel would necessitate a situation whereby NAADP be 
completely  absent  in  the  un-stimulated  cells,  but  synthesized  rapidly  (probably  in 
isolated compartments) upon activation. The calcium release by NAADP was bi-phasic 
and the inactivation by low, non-activating concentrations of NAADP was an all or none 
phenomenon (Genazzani, et al., 1997b). Remarkably, the NAADP receptors from the 
sea urchin eggs underwent unusual stabilization, that was dependent on the duration of 
exposure to their ligand (Churamani, et al., 2006). 
 
The candidate organelle/receptor targeted by NAADP has been the subject of both 
study  and  controversies  throughout  the  last  decade  (Galione  and  Petersen,  2005; 
Fliegert,  et  al.,  2007;  Guse  and  Lee,  2008).  There  are  some  convincing  reports 
suggesting that NAADP releases calcium from the nuclear envelope (Gerasimenko, et 21 
 
al.,  2003a;  Gerasimenko  and  Gerasimenko,  2004)  or  the  endoplasmic  reticulum 
(Gerasimenko, et al., 2003b; Gerasimenko, et al., 2006; Steen, et al., 2007) in certain 
cell types. NAADP also appeared to target RyRs in specific cells (Mojzisova, et al., 
2001;  Hohenegger,  et al., 2002;  Langhorst,  et al., 2004)  but other studies failed to 
substantiate these findings (Copello, et al., 2001). Beck et al showed that both cADPR 
and NAADP acted in synergy with ADPR in mediating calcium influx through plasma 
membrane located TRP-M2 “chanzyme” (Beck, et al., 2006). Zhang et al reported that 
NAADP  released  calcium  via  the  activation  of  TRP-ML  channels  located  on  the 
lysosomes  (Zhang  and  Li,  2007;  Zhang,  et  al.,  2008).  However  Dong  et  al. 
demonstrated that TRP-ML was in fact an iron release channel (Dong, et al., 2008). 
 
The  breakthrough  in  the  NAADP  signalling  field  came  last  year  when  three 
independent groups provided evidence that two-pore channels (TPCs) were after all, 
the long sought after molecular target of NAADP in mammals (Calcraft, et al., 2009; 
Zong, et al., 2009; Brailoiu, et al., 2009a). Soon followed the confirmation that TPCs 
were also the NAADP-sensitive channels in sea urchins (Brailoiu, et al., 2010; Ruas, et 
al., 2010), a model system widely used in the study of calcium signalling. Brailoiu et al 
heterelogously  expressed  both  human  and  sea  urchin TPCs  and  showed  that  they 
localized  to  acidic  organelles  and  were  active  in  mediating  calcium  release  upon 
NAADP challenge (Brailoiu, et al., 2009a; Brailoiu, et al., 2010). Sea urchins have three 
isoforms of TPCs 1, 2 and 3, while humans have only TPC1 and 2, TPC3 being a 
pseudo-gene (Brailoiu, et al., 2010). A single point mutation leading to helix breaking in 
the pore forming subunit of TPC1 gene abolished the calcium release properties of the 
channel (Brailoiu, et al., 2009a). The pancreatic β-cells from the TPC2 knock-out mice 
were insensitive to NAADP challenge, suggesting that TPCs were indeed the target of 
NAADP (Calcraft, et al., 2009). The hot debate on which molecule should be accepted 
as the “actual receptor” of NAADP, continues (Guse, 2009; Galione, et al., 2009). 
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1.2.4  Sphingolipids   
 
Sphingolipids  such  as  sphingosylphosphoryl  choline  (SPC)  and  sphingosine-1-
phosphate (S1P) are metabolites involved in the modulation of calcium homeostasis. 
However they are not widely accepted as calcium messengers yet. Sphingolipids have 
gained  status  as  regulatory  molecules  involved  in  a  range  of  cellular  processes 
including  proliferation  and  apoptosis  (Young  and  Nahorski,  2002).  The  calcium 
releasing properties of sphingosine was initially deciphered by Ghosh et al (Ghosh, et 
al.,  1990).  As  with  cADPR  discovery,  an  initial  lag  in  the  release  of  calcium  was 
observed.  Again  similar  to  cADPR,  later  investigations  revealed  the  enzymatic 
conversion of sphingosine to S1P by sphingosine kinase. S1P released calcium from 
endoplasmic reticulum but was insensitive to treatment with heparin suggesting that it 
acted independent of the IP3Rs (Ghosh, et al., 1994).  
 
S1P can signal at both intra and extracellular sites. S1P has been suggested as a 
ligand of EDG receptors which are members of the G-protein coupled receptors (Lee, 
et al., 1998; Young, et al., 2000). Until recently a 20 kDa single transmembrane domain 
protein, expressed widely in many different tissues but bearing no resemblance to any 
previously identified ion channel was claimed to be the target of both SCP and S1P. It 
was referred to as “SCaMPER” (Sphingolipid Calcium Release Mediating Protein of 
Endoplasmic Reticulum). But later re-investigations confirmed that the expression of 
SCaMPER  was  insensitive  to  sphingolipid  concentrations.  Additionally,  instead  of 
modulating the calcium homeostasis, it was lethal to the cell (Schnurbus, et al., 2002). 
Thus SCaMPER is unlikely to function as a calcium channel.  
 
The  production,  site  of  action  and  molecular  targets  of  the  structurally  and 
biochemically different calcium second messengers IP3, cADPR, NAADP and S1P are 23 
 
spatio-temporally  regulated  to  generate  unique  “calcium  signatures”,  in  response to 
diverse stimuli. Figure 1.2 schematically describes the important calcium messengers 
and their site of action in cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3  Multiple interacting calcium stores   
 
The mechanistically distinct calcium second messengers IP3, cADPR and NAADP act 
on spatially segregated calcium stores in a cell. However, they can also functionally 
interact by coupling with each other to create very complex signalling patterns (Lee, 
Figure 1.2: Targets of calcium second messengers 
 
Calcium second messengers, IP3, cADPR, NAADP and S1P target distinct intracellular calcium 
storing organelles through the action on unique channels.  24 
 
2000).  Although  the  cell  employs  multiple  calcium  stores,  they  often  regulate  very 
distinct  functions.  The  specificity  and  delineation  of  the  roles  played  by  each 
messenger  has  been  studied  extensively  in  many  different  cell  types.  In  ascidian 
oocytes  cADPR  was  uniquely  responsible  for  the  cortical  granule  fusion  and 
exocytosis,  while  IP3  generated  long-lasting  calcium  oscillations.  In  addition,  pre-
treatment of the oocytes with NAADP and not cADPR inhibited the post-fertilization 
Ca
2+ oscillations (Albrieux, et al., 1998). The action of the three messengers has been 
well  described  in  pancreatic  acinar  cells  by  Cancela  et  al.  In  this  system,  calcium 
release  mediated  by  NAADP  was  accountable  for  inducing  short  and  long  lasting 
calcium oscillations and waves (Cancela, et al., 1999; Cancela, et al., 2000). This was 
possible  by  CICR  mechanism  involving  IP3  and  cADPR  sensitive  stores  (Cancela, 
2001; Cancela, et al., 2002). 
 
A “two pool mechanism” was suggested by Churchill and Galione, in case of the sea 
urchin  eggs,  whereby  the  calcium  release  initiated  by  NAADP  was  perpetuated  by 
CICR  mechanisms  involving  IP3  and  cADPR  stores  (Churchill  and  Galione,  2001). 
Similar mechanisms of action for NAADP was also observed in arterial smooth muscle 
cells (Boittin, et al., 2003). However, the mechanism of action of NAADP was very 
different in T-lymphocytes, where it appeared to act downstream of IP3/cADPR stores 
(Berg, et al., 2000). This so called “channel chatter” or “store chatter” between the 
heterotypic  receptors/stores  targeted  by  the  different  calcium  messengers  to  evoke 
differential responses in various cell types has been detailed (Patel, et al., 2001; Patel, 
2004; Churchill and Galione, 2002). Similarly, Brailiou et al. reported the recruitment of 
different calcium messengers and their specific roles in the frog neuromuscular junction 
(Brailoiu, et al., 2003), in potentiating neuronal growth of primary cell culture isolated 
from cerebral cortex of neonatal rats (Brailoiu, et al., 2005), in the differentiation of 
PC12 cells (Brailoiu, et al., 2006) and in neurons of rat medulla oblongata (Brailoiu, et 
al., 2009b). It is also important to note that varied external stimuli can be coupled to 25 
 
different  second  messengers  leading  to  both  qualitatively  and  quantitatively  unique 
“calcium signatures” (Galione and Churchill, 2002).  
 
It is intriguing that nature chose to retain all three calcium messengers to signal often in 
the same cell. This could be to maintain a (i) redundant and overlapping mechanism, 
ensuring  correct  signalling  even  if  one  system  fails  (ii)  more  localized/sub-cellular 
calcium  changes  (iii)  temporal  pattern  of  calcium  signalling  cascade  with  high 
stringency.  
 
1.3.1  Agonist-evoked messenger production 
 
Early studies on sea urchin eggs (Galione, et al., 1993) and PC12 cells (Clementi, et 
al., 1996) indicated that nitric oxide induced cADPR production through the activation 
of  cGMP  pathway.  In  pancreatic  beta cells,  glucose  stimulated  insulin  secretion  by 
increased cADPR and NAADP production (Takasawa, et al., 1993a; Masgrau, et al., 
2003).  In  pancreatic  acinar  cells,  different  agonists  recruited  different  calcium 
messengers.  Acetylcholine  exerted  its  effects  via  the  production  of  both  IP3  and 
cADPR.  However  cholecystokinin  acted  through  the  initial  recruitment  of  NAADP, 
whereas  further  amplification  of  the  calcium  signals  was  carried  out  by  cADPR 
(Cancela, et al., 1999; Cancela and Petersen, 1998; Cancela, 2001). In case of Jurkat 
T lymphocytes, ligation of T cell receptor with CD3 stimulated cADPR synthesis (Guse, 
et  al.,  1999).  In  the  same  cell  system,  NAADP  was  also  employed  as  a  second 
messenger  (Gasser,  et al., 2006a), although  in these studies,  NAADP appeared  to 
target the RyRs (Dammermann and Guse, 2005). Similarly, in vascular smooth muscle 
cells, agonist acetylcholine induced contraction via the recruitment of cADPR and RyRs 
(Kannan, et al., 1997). In another study on hepatic stellate cells, angiotensin II acted by 
evoking NAADP synthesis (Kim, et al., 2010). In more recent studies on the coronary 26 
 
arterial  myocytes,  FasL-induced  vasoconstriction  was  mediated  again  by  NAADP 
(Zhang, et al., 2010). In lymphokine-activated killer cells however, IL8 induced both 
cADPR  production  followed  by  NAADP  production  through  the  activation  of  cAMP 
pathway  (Rah,  et  al.,  2010).  Thus,  the  production  and  recruitment  of  the  calcium 
messengers, cADPR and NAADP is tightly linked to the action of specific agonists on 
particular cell types, to evoke unique physiological response. 
 
 
1.4  ADP-ribosyl cyclases 
 
The focus of this thesis is on the calcium second messengers cADPR and NAADP. 
Both cADPR and NAADP were first discovered by Hon Cheung Lee while using sea 
urchin egg homogenates as a model system to study calcium signalling (Clapper, et al., 
1987).  This  landmark  discovery  opened  up  an  era  of  the  entire  new  discipline  of 
research  on  IP3-independent  calcium  mobilization.  Structurally,  cADPR  and  NAADP 
are very distinct molecules (Figure 1.1). cADPR has a compact cyclic structure while 
NAADP  is  a  linear  molecule.  Yet,  interestingly,  both  are  synthesised  by  a  single 
common enzyme, ADP-ribosyl cyclase (Lee and Aarhus, 1991; Aarhus, et al., 1995). 
Much of the data presented in this thesis relates to ARCs. ARCs are enzymes that play 
pivotal  roles  in  maintaining  calcium  homeostasis.  ARCs  are  widely  present  from 
sponges (Zocchi, et al., 2001a) to plants (Wu, et al., 1997) and humans. ARCs are 
generally  absent  in  bacteria  although  ARC  like  activity  has  been  reported  from 
Streptococcus pyogenes (Karasawa T, 1995). ARC-like activities are also absent in the 
major  model  organisms  like  Drosophila,  C.elegans  and  S.cerevisiae  but  present  in 
Euglena,  a  unicellular  protist  (Masuda,  et  al.,  1997a).  Deciphering  the  molecular 
secrets of this rather remarkable family of enzymes is in its infancy. 27 
 
1.4.1  Aplysia cyclase 
 
 
cADPR is produced via cyclisation of the linear molecule NAD, at neutral pH, by ADP-
ribosyl cyclase (Lee, 2006a). More details of this reaction will be discussed in section 
1.5.1.  A  29  kDa,  256  residue,  soluble  enzyme  present  in  abundance  in  Aplysia 
californica ova-testis, originally purified as NADase (Glick, et al., 1991; Hellmich and 
Strumwasser, 1991), was later identified and named as ADP-ribosyl cyclase because 
of  its  cADPR  synthesizing  ability  (Lee  and  Aarhus,  1991).  Thus  a  new  class  of 
enzymes was redefined, as the conventional methods of product separation would not 
have  differentiated  between  cADPR  (formed  by  cyclisation  of  NAD)  and  ADPR  (a 
product of NAD-glycohydrolase). Before the discovery of cADPR, several enzymes with 
ADP-ribosyl cyclase activities could have been wrongly classified as NADases. 
 
Aplysia cyclase was also capable of generating NAADP by a base-exchange reaction 
when provided with NADP as a substrate, in presence of excess nicotinic acid (Aarhus, 
et  al.,  1995).  Base-exchange  reaction  is  favoured  at  acidic  pH.  The  details  of  this 
reaction will be further discussed in section 1.5.2. Therefore Aplysia cyclase is a truly 
multi-functional enzyme, capable of synthesizing both cADPR and NAADP. Although it 
is nearly two decades since the first ARC was described, few of these enzymes have 
been characterized from different organisms at the molecular level.  
 
1.4.2  CD38 and CD157  
 
Soon  after  the  identification  of  Aplysia  cyclase,  homology  searches  revealed  that 
CD38, a multi-functional type II cell surface glycoprotein expressed during lymphocyte 
differentiation  (Jackson  and  Bell,  1990)  was  actually  the  mammalian  homologue, 
sharing 24% sequence identity (States, et al., 1992). Homology searches also revealed 
that another mammalian protein, BST-1/CD157, a bone-marrow cell surface antigen, 28 
 
shared  27%  sequence  identity  with  Aplysia  Cyclase  (Hirata,  et  al.,  1994).  The 
discovery  that  CD38 and CD157  possessed  enzymatic activities  was  significant, as 
until then they were merely considered as cell surface receptors. Following this, CD38 
which was the favourite molecule of immunologists also became the favourite of the 
enzymologists/biochemists. CD38 and CD157 can catalyse both cADPR and NAADP 
production (Figures 1.3 and 1.4), albeit at different efficiencies. In addition, CD38 also 
possess  NAD  glycohydrolase  and  cADPR  hydrolase  activities  (Figure  1.3).  These 
reactions will be discussed in further details in section 1.5.3. 
 
1.4.3  SmNACE 
 
A fourth member of the cyclase family was discovered recently in a human parasitic 
worm, Schistosoma, which causes the disease schistosomasis. When NAD was used 
as a substrate, the production of cADPR via cyclisation by this enzyme was extremely 
low,  while  the  major  product  was  ADPR.  Therefore  the  enzyme  was  named  as 
SmNACE  (Schistosoma  mansoni  NAD[P
+]  catabolizing  enzyme)  (Goodrich,  et  al., 
2005). Nevertheless, SmNACE could cyclise NGD and produce NAADP through base-
exchange. SmNACE shared 21% sequence identity with human CD38. 
 
1.4.4  Structural features of ARCs 
 
The ARC family of enzymes possesses several common structural features. They all 
possess at least ten conserved cysteine residues forming five core intra-disulfide bonds 
(Lee, 2000). The formation of disulfide bonds is critical for the activity of the enzymes 
as demonstrated by Guida et al (Guida, et al., 1995). There may be additional cysteine 
residues present in some family members (like CD38), conferring additional properties 
to the enzyme. All of the ARCs known so far are glycoproteins. ARCs have a glutamate 29 
 
as their main catalytic amino acid along with two tryptophan residues at the active site 
of the enzyme (Munshi, et al., 1999). The overall topologies of Aplysia cyclase, CD38 
and CD157 are similar, except large structural changes at the N and C termini, where 
their sequences are most divergent (Liu, et al., 2005). Although the active sites are 
almost super imposable, the catalytic efficiency of CD157 is several hundred fold lower 
than  CD38  (Hussain,  et  al.,  1998).  The  reason  for  the  differences  in  the  catalytic 
activities between ARC, CD38 and CD157 remains an enigma (Lee, 2006a). Aplysia 
cyclase and CD38 also have a “TLEDTL domain” that is highly conserved (Lee, 1997). 
This domain is only modestly conserved in CD157. In SmNACE, all the ten cysteine 
residues  are  fully  conserved  while  the  TLEDTL  domain  is  partially  conserved 
(Goodrich, et al., 2005). CD38 has a single short transmembrane domain near its N-
terminus through which it is tethered to the cell surface (Jackson and Bell, 1990). On 
the other hand, CD157 and SmNACE harbour a glycophosphatidylinositol (GPI) anchor 
at their C-termini (Itoh, et al., 1994; Lee, 1997; Goodrich, et al., 2005). 
 
The crystal structures of Aplysia cyclase in the presence and absence of nicotinamide 
have been solved at 2.4 Å and were identical in all respects (Prasad, et al., 1996). 
Later, the crystallographic structure of CD157 was elucidated at 2.5 Å by Morikawa’s 
group  (Yamamoto-Katayama,  et  al.,  2002).  Owing  to  the  low  enzymatic  activity  of 
CD157,  it  could  be  co-crystallised  with  various  substrates.  Finally  a  1.9  Å,  high 
resolution  crystal  structure  of  the  much  awaited  soluble  domain  of  CD38  was 
deciphered (Liu, et al., 2005). This was achieved using an inactive mutant of CD38, to 
facilitate co-crystallisation along with substrates. All the three enzymes exist as dimers 
both in solutions and crystals. Aplysia cyclase and CD157 form head to head non-
covalent dimers (Munshi, et al., 1998), while CD38 is made of head to tail dimers. In 
Aplysia cyclase, each monomer is bean shaped and comprises two main domains: the 
N-terminal domain consisting of alpha helices and C-terminal domain made of beta 
sheets (Lee, 1997). The two domains are linked by a hinge region and form a deep 30 
 
cleft. The monomers associate with the clefts and face the interior, such that a cavity is 
formed in the center of the dimer. The dimerised enzyme also has a befitting cyclic 
structure similar to the unique structure of cADPR. 
 
1.4.5  Heterologous expression of ARCs 
 
Heterologous expression of a protein is carried-out for its over-production in a relatively 
short span of time. For enzymes, kinetics parameters such as Km and Vmax values can 
be determined with ease. Aplysia cyclase has been functionally expressed in yeast to 
produce large quantities of the recombinant enzyme (Munshi and Lee, 1997). CD38 
was first successfully expressed in mammalian cells like COS-7 cells (Howard, et al., 
1993; Takasawa, et al., 1993b). Fryxell et al have functionally expressed the soluble 
domain of CD38 in both E.coli and yeast (Fryxell, et al., 1995; Munshi, et al., 1997). 
Similarly  the  soluble  and  secreted  recombinant  version  of  CD157  was  successfully 
expressed  in  yeast  (Hussain,  et  al.,  1998).  Of  late,  a  baculo  virus,  insect  cell 
expression system has been developed for GST tagged CD38 (Khoo, et al., 2005). 
SmNACE was characterized again using a yeast expression system (Goodrich, et al., 
2005).  
 
 
1.5  ARC catalysis 
 
As previously mentioned in section 1.4.1, ADP-ribosyl cyclases are capable of carrying 
out multiple reactions. Described below are some of the well characterized reactions. 
Important among them are the formation of cADPR and NAADP.  31 
 
1.5.1  Cyclisation 
 
ARCs  convert  β-NAD  to  cADPR  by  cyclisation  to  release  nicotinamide  (Lee  and 
Aarhus, 1991) as depicted in Figure 1.3.  The ribosyl moiety is cyclised at the N-1 
position  of  the  adenine  group  (Kim,  et  al.,  1993a)  (Figure  1.4A).  The  cyclisation 
reaction occurs optimally at neutral and/or alkaline pH (Lee, 2000).  
 
 
 
 
Nicotinamide  guanine  dinucleotide  (NGD)  is  often  used  as  a  surrogate  substrate 
instead of NAD, for cyclisation reactions. The product, cyclic GDP-ribose (cGDPR) is 
Figure 1.3: Formation of cADPR and ADPR from NAD 
 
When  NAD  is  provided  as  a  substrate,  ADP-ribosyl  cyclases  can  either  carry  out  cyclisation 
reaction to produce cADPR or hydrolyse it to ADPR. Certain ARCs can in turn hydrolyse cADPR 
to ADPR. All these reactions occur predominantly at neutral pH. 
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more  stable  and  resistant  to  hydrolysis  compared  to  cADPR.  Also,  cGDPR  is 
fluorescent while GDPR is not. Hence cGDPR can be easily detected by fluorescence 
spectroscopy. This property is useful to distinguish between the activities of ARCs from 
that of common NADases (Graeff, et al., 1994). The mechanism of cyclisation of NGD 
is different to that of NAD. cGDPR is also structurally and functionally distinct from 
cADPR, although both are cyclic nucleotides. The site of cyclisation is at N-7 of the 
guanine group unlike N-1 of adenine group (Graeff, et al., 1996) as shown in Figure 
1.4. The NGD cyclisation also occurs preferentially at alkaline and/or neutral pH (Lee, 
1997). However, cGDPR does not have calcium releasing properties. 
 
 
 
 
 
1.5.2  Base-exchange 
 
As  described  in  section  1.2.3,  the  calcium  release  caused  by  NAADP  is  both 
functionally and pharmacologically discrete from that of cADPR. Yet, intriguingly, the 
Figure 1.4: Structures of cADPR and cGDPR 
 
Although both cADPR (A) and cGDPR (B) are cyclic nucleotides, they have different structures 
and site of cyclisation (N-1 in cADPR and N-7 in cGDPR).  
A  B 
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same enzyme ARC that synthesises cADPR also produces NAADP, at least in vitro. 
Base-exchange reaction occurs using the substrate NADP under acidic conditions, in 
presence  of  excess  nicotinic  acid,  where  by  the  nicotinamide  group  is  replaced  by 
nicotinic acid group (Lee, 2000), as shown in Figure 1.5. In the absence of nicotinic 
acid,  ARC cyclises NADP to 2-phospho cADPR. 2-phospho cADPR was previously 
shown to have calcium mobilizing properties (Vu, et al., 1996). 
 
 
 
 
1.5.3  Hydrolysis 
 
In  addition  to  producing  cADPR  and  NAADP,  certain  ARCs  also  exhibit  NAD 
glycohydrolase activity and cADPR hydrolase activity (Figure 1.3). In 1993, there were 
several  reports  demonstrating  the  hydrolysis  activity  of  CD38  (Zocchi,  et  al.,  1993; 
Figure 1.5: Formation of NAADP from NADP 
 
When  NADP  is  provided  as  a  substrate,  ADP-ribosyl  cyclases  can  carry  out  base-exchange 
reaction in presence of excess nicotinic acid, to produce NAADP at acidic pH. Nic=Nicotinamide; 
NA=nicotinic acid 
 
NADP  NAADP 
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Howard, et al., 1993; Takasawa, et al., 1993b; Howard, et al., 1993; Kim, et al., 1993b). 
CD38 can either convert NAD directly into ADPR or degrade cADPR into ADPR (Figure 
1.3). ADPR, the product in these reactions has been shown to modulate intracellular 
calcium levels by regulating TRP channels (Perraud, et al., 2001; Fliegert, et al., 2007). 
In Jurkat T cells, ADPR caused TRP-M2 activation, calcium influx and eventually cell 
death (Gasser, et al., 2006b). Recently the hydrolysis of NAADP to ADPRP by CD38 
was  also  described  (Graeff,  et  al.,  2006).  NADP  could  also  be  hydrolysed  to  2’-
phospho-ADPR (Moreschi, et al., 2006). SmNACE, like CD38, predominantly produces 
ADPR from NAD (Goodrich, et al., 2005). However, the hydrolase activity of Aplysia 
cyclase is minimal (Cakir-Kiefer, et al., 2000).  
 
1.5.4  Other reactions 
 
Moreschi et al have described another route for synthesis of NAADP. Human CD38 
could produce NAADP using cADPRP and nicotinic acid as substrates. cADPRP was 
detectable  in  retinoic  acid-differentiated  CD38
+  HL-60  cells,  but  absent  in  either 
undifferentiated or CD38
- cells (Moreschi, et al., 2006).  De Flora et al reported that 
both ARC and CD38 could exchange the base group of NAD with other nucleophiles to 
form dimeric ADPR, i.e. ADPR2 (De Flora A, 1997a). ADPR2 was shown to enhance 
the calcium releasing ability of sub-threshold concentrations of cADPR. In addition to 
the  above  mentioned  reactions,  ARCs  have  also  been  shown  to  produce  certain 
adenine  homo-dinucleotide  products  from  cADPR  which  affect  intracellular  calcium 
homeostasis  and  cell  proliferation  (Basile,  et  al.,  2005).  These  homo-dimers  were 
present and metabolized in normal mammalian cells. One of the isomers was involved 
in mitochondrial dysfunction and the relative concentration of various dimers influenced 
the decision between cell cycle and death (Bruzzone, et al., 2007). In a very recent 
study, these homo-dinucleotide products were shown to regulate the function of P2X7, 35 
 
a purinergic receptor (Bruzzone, et al., 2010). Some unusual substrates for the base-
exchange  reaction  have  been  identified  as  2-isoquinolines,  1,6-naphthyridines  and 
tricyclic  bases  (Preugschat,  et  al.,  2008).  The  reaction  products  were  unique 
dinucleotides.  
 
Thus, ARCs are versatile enzymes possessing multi-functionality, capable of catalyzing 
reactions  at  different  pH  conditions,  acting  on  different  substrates  to  form  various 
products, all of which are in some way involved in regulating calcium homeostasis of 
the cell.  
 
1.5.5  pH dependence of ARC reactions 
 
The reaction catalysed by ARCs is very much dependent on the pH of its environment. 
As  previously  discussed,  the  cyclisation  and  hydrolysis  reactions  are  favoured  at 
neutral/alkaline pH (Figure 1.3), while the base-exchange reaction is favoured at acidic 
pH (Figure 1.4). However, at neutral/alkaline pH, even in presence of nicotinic acid, 
NADP is cyclised to cADPRP. Similarly at acidic pH, in presence of excess nicotinic 
acid, NAAD is formed via base-exchange of NAD (Aarhus, et al., 1995). Both NAD and 
NADP  can  be  used  as  substrates  by  ARCs  with  equal  efficiencies.  However  the 
reaction preference is dependent on the pH of the medium. Therefore it is tempting to 
speculate that cADPR could be formed in organelles that are neutral while NAADP 
production could be occurring at specific acidic organelles like the endo-lysosomes.  
 
1.5.6  Amino acid residues critical for the activity of ARCs 
 
In  Apylsia  cyclase,  Glu
179  was  initially  predicted  to  be  critical  and  involved  in  the 
catalysis  as  a  part  of  the  active  site.  Site-directed  mutagenesis  of  this  glutamate 36 
 
residue to even a conservative aspartate resulted in the complete loss of all enzymatic 
activities (Munshi, et al., 1999). Additionally, two tryptophans, Trp
77 and Trp
140 were 
also established to be important for the enzyme activity. Site-directed mutagenesis of 
these residues led to the loss of both cyclisation and base-exchange activities while 
retaining some of the GDP-ribosyl cyclase activity (Munshi, et al., 1999). These two 
tryptophan residues are thought to be involved in substrate positioning, moulding the 
long NAD molecule into a folded conformation to facilitate its cyclisation. As discussed 
earlier, the fact that cGDPR is cyclised at N-7 position as opposed to N-1 in cADPR 
(Figure 1.5), could be a reason for the retention of some GDP-ribosyl cyclase activity in 
those mutants. Similarly in CD38, Glu
226 was the catalytic amino acid responsible for 
cADPR production. Like Aplysia cyclase, site-directed mutagenesis of this glutamate 
residue to a conservative substitution like aspartate resulted in the complete loss of 
CD38’s enzymatic activities (Munshi, et al., 2000). Analogous to Aplysia cyclase, the 
two tryptophan residues involved in NAD moulding were Trp
125 and Trp
189. Lee’s group 
verified  that  mutagenesis  of  these  critical  residues  led  to  a  near  complete  loss  of 
catalytic activities (Munshi, et al., 2000). Katada’s lab made several constructs with 
varying lengths of C-terminal deletions of CD38 and mapped the active site for the 
hydrolase  activity  to  residues  273  to  285  (Hoshino,  et  al.,  1997).  Site-directed 
mutagenesis of Cys
275 completely abolished the enzyme activity of CD38, suggesting it 
could  probably  be  a  catalytic  residue.  These  mutagenesis  studies  aid  in  the 
understanding of the mechanisms for multi-functionality of these remarkable enzymes. 
More examples of these studies will be discussed in Chapter 5. The structures and 
enzymology  of  ADP-ribosyl  cyclases  have  been  extensively  reviewed  over  the  last 
decade (Lee, 2000; Lee, 2006a; Schuber and Lund, 2004). 
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1.5.7  Physiological relevance of the base-exchange reaction 
 
Whether  base-exchange  is  actually  the  physiological  route  for  the  production  of 
NAADP in vivo is debatable. It has to be noted that NAADP synthesis takes place 
under  un-physiological  conditions.  Base-exchange  reaction  occurs  optimally  at  very 
acidic pH (4 to 5). In addition, the half maximal concentration of nicotinic acid required 
for this process is much higher than that occurs in the cytosol (Aarhus, et al., 1995). 
Bak et al noted that in brain microsomes, although NAADP synthesis occurred sub-
optimally at neutral pH, it was still significantly higher than the cADPR synthesis under 
same conditions (Bak, et al., 1999). Having said that, NAADP concentrations required 
for  the  activation  of calcium  release  is  very  low  (nanomolar  range)  (Aarhus,  et  al., 
1995). Thus even sub-optimal functioning of ARCs to synthesise NAADP could be of 
physiological  significance.  Initially  Chini  et  al  showed  that  the  capacity  for  NAADP 
synthesis could be co-immunoprecipitated with CD38 using an anti-CD38 antibody and 
several  tissues  from  CD38  knock-out  mice  had  no  capacity  for  NAADP  synthesis 
(Chini, et al., 2002). But later studies using CD38 knock-out mice, the same group 
demonstrated that the histamine mediated NAADP production in myometrial cells was 
independent of CD38 (Soares, et al., 2006). In contrast, again using the CD38 knock-
out  mice,  Kim  et  al  reported  that  indeed  CD38  and  base-exchange  reaction  were 
responsible for angiotensin II evoked NAADP synthesis in hepatic stellate cells (Kim, et 
al., 2010). Similarly Zhang et al showed the reduction in NAADP production in coronary 
arterial myocytes of CD38 knock-out mice (Zhang, et al., 2010). Yet again using the 
CD38 knock-out mice, Rah et al very recently demonstrated that CD38 was indeed 
involved  in  the  production  NAADP  in  lymphokine-activated  killer  cells  (Rah,  et  al., 
2010). 
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1.6  Localization of ARCs 
 
Aplysia cyclase is found in abundance in the ova-testis. Its localization mainly inside 
the cytoplasmic granules indicated it to be a soluble luminal protein (Glick, et al., 1991). 
It has also been found in Aplysia buccal ganglion (Mothet, et al., 1998). Except Aplysia 
cyclase, all other known ARCs are predominantly expressed on cell surfaces as ecto-
enzymes.  CD38  is  expressed  on  the  cell  surface  through  its  N-terminal  anchor 
sequence (Jackson and Bell, 1990). Consequently, the larger C-terminal domain which 
harbours the catalytic site is exposed to the extracellular space. On the other hand, the 
bone marrow antigen CD157 is also expressed on the cell surface, but via a C-terminal 
GPI-anchor (Itoh, et al., 1994; Lee, 1997). Similarly, SmNACE is expressed at the cell 
surface  through  a  GPI-anchoring  motif  at  its  C-terminus  (Goodrich,  et  al.,  2005). 
Although these are the conventional locations of ARCs, exceptions are also known. 
There are several reports of detection of ARC like activities in intracellular organelles 
such  as  nuclear  envelope,  mitochondria,  endosomes  etc,  which  will  be  detailed  in 
Chapter 3 (see Figure 3.1). 
 
Although  CD38  and  CD157  were  originally  identified  as  antigens  expressed  in 
differentiating B and T lymphocytes (Jackson and Bell, 1990), they are now known to 
be  more  ubiquitously  present  at  several  non-lymphoid  locations  and  tissues  (Lee, 
2006b). CD38 has been detected in tissues like brain (Yamada, et al., 1997), spleen  
(Khoo and Chang, 2002), hepatocytes (Khoo, et al., 2000), lung (Khoo and Chang, 
1998), eye  (Khoo and Chang, 1999), the islets of langherhans (Koguma, et al., 1994), 
corneal limbus (Horenstein, et al., 2009), just to name a few. Such diverse locations 
suggest that an ARC dependent signalling pathway for calcium mobilization is vital to 
most if not all cell types. 
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1.6.1  Topology Paradox 
 
ADP-ribosyl cyclases are expressed on the cell surface (or within organelles), with their 
active site actually exposed to the extra cellular space (or lumen), while ironically the 
substrates, NAD and NADP are cytosolic. The products cADPR and NAADP are also 
active on the cytosolic face of their receptors/ ion channels. Whilst cADPR binds to 
RyRs located on ER (Lee, 1991; Meszaros, et al., 1993), NAADP possibly binds to 
TPCs/TRPs  located  on  the  endo-lysosomes  (Calcraft,  et  al.,  2009;  Brailoiu,  et  al., 
2009a).  This “ecto” configuration of the enzyme results in a “Topological Paradox” (De 
Flora A., et al., 1997b) with the enzyme presented in the reverse orientation. It further 
imposes obvious questions like, how the substrates gain access to the active site of the 
enzyme or how the products are transported to the cytosol.  
 
To  overcome  this  conundrum,  researchers  have  suggested  various  theories  and 
presented data to explain the normal functioning of the enzyme at the cell surface. In 
3T3 murine fibroblast cells, cADPR could be transported through pyridine nucleoside 
transporter proteins (Guida, et al., 2002). Another study suggested that the dimerised 
CD38 enzyme itself could act as a unidirectional channel for the transport of substrate 
and products across the cell membrane (Franco, et al., 1998; Franco, et al., 2001; De 
Flora,  et  al.,  2004).  The  cADPR  thus  transported  exhibited  autocrine/paracrine 
functions, potentially acting on cells distant from the of site of enzymatic activity and 
eventually  regulating  their  functions  (De  Flora,  et  al.,  2004;  Zocchi,  et  al.,  2001b; 
Franco, et al., 2001). NAD has also been shown to be transported by connexin 43 
hemi-channels  (Bruzzone,  et  al.,  2001).  Billington  et  al  reported the  existence  of  a 
similar transport system for NAADP, in the rat basophilic cell line (Billington, et al., 
2006).  In  another  study,  externally  applied  NAADP  caused  intracellular  signalling, 
suggesting the presence of NAADP transporters on cell surface (Heidemann, et al., 
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De  Flora’s  group  demonstrated  that  CD38  underwent  extensive  but  selective 
internalization  into  non-clatharin  coated  endocytotic  vesicles  in  response  to  both 
increased external concentration of NAD and thiol compounds (Zocchi, et al., 1996). 
Thus, the enzyme activity itself could be shifted from the cell surface to the cytoplasm. 
CD38  monomers  in  the  vesicles  aggregated  to  form  channels  for  the  efflux  of  the 
cADPR into the cytoplasm. The cADPR thus released was shown to increase calcium 
release  (Zocchi,  et  al.,  1999).  CD38  reversibly  aggregated  into  catalytically  active 
dimers  or  tetramers  to  form  these  channels  that  unidirectionally  transported  the 
enzymatically formed cADPR, but not the exogenously added cADPR into the cytosol 
(Bruzzone et al 1998). Chidambaram and Chang also reported similar internalization of 
CD38 in response to externally applied NADP (Chidambaram and Chang, 1999). They 
suggested  that  the  endocytosis  of  CD38  represented  a  very  specific  pathway 
consisting of sub-cellular organelles (Funaro, et al., 1998). Another theory proposed 
that  CD38  may  function  to  regulate/scavenge  any  extracellular  NAD  released  from 
dying/ lysed cells. In this way, the availability of NAD for the functioning of certain ecto-
enzymes like ADP-ribosyl transferases would be limited, thus preventing the signals for 
apoptosis  of  the  cell  (Krebs,  et  al.,  2005).  Figure  1.6  diagrammatically  represents 
various theories suggested to overcome the topological paradox. 
 
A clear benefit of internalization of CD38 into vesicles would be that acidic conditions 
and high concentration of the substrates (like nicotinic acid), as required for the base- 
exchange reaction, could be locally provided. It is very much feasible that an acidic 
compartment like endosomal vesicle would have a pH of 5 and contain a concentrated 
source of nicotinic acid providing a “physiologically” feasible environment for NAADP 
synthesis by the base-exchange reaction. In fact,  Aplysia cyclase displaying a high 
level of base-exchange activity is found to be concentrated in granules/vesicles in the 
ova-testis (Hellmich and Strumwasser, 1991).  
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Multiple locations for a multifunctional enzyme could aid in its differential regulation with 
respect to substrate availability, pH and in particular, the need of a cell for cADPR 
and/or NAADP calcium signalling pathways.  
 
 
1.7  Regulation of ARC activities 
 
Katada’s group demonstrated that zinc ions activated the cyclase activity of CD38 while 
inversely  inhibiting  the  hydrolase  activity.  It  was  hypothesized  that  Zn
2+  caused  a 
conformational  change and  prevented  access  of  water  molecules  to  the  active  site 
such  that  cADPR  was  the  major  product  (Kukimoto,  et  al.,  1996).  Gangliosides 
Figure 1.6: Possible ways to overcome topological conundrum of ARCs 
 
ARCs are expressed with a topology that projects its active site away from the cytosol. However 
the  substrates  for  ARC  are  abundant  in  the  cytosol  and  the  products  formed  also  targets 
intracellular channels. Transport proteins for the channelling of the substrates (blue cylinders) 
and products (red cylinders) have been identified in certain cell types. The dimeric form of ARC 
can itself act as a channel to transport cADPR into the cytosol. Further, ARCs can be internalized 
into endosomes for catalysis to occur. 42 
 
inhibited both cyclase and hydrolase activities of CD38 (Hara-Yokoyama, et al., 1996). 
It was not until recently that the regulation of ARC activity by Ca
2+ itself was unravelled. 
In their interesting findings, Hao and Lee’s lab have accounted for, how calcium caused 
dramatic changes in the conformation of CD38. As exhibited in the crystal structure, in 
presence of calcium, Trp
125  moved 5Å to form hydrophobic interactions with  Trp
189, 
closing the active site pocket. Thus the active site was no longer accessible to the 
substrates, leading to the inhibition of enzymatic activity (Liu, et al., 2008).  
 
A  soluble  NADase  purified  from  bovine  brain  cytosol  has  been  suggested  to  be 
regulated by cADPR levels through allosteric modulation (Guse, 2000). It was noted 
that  a  massive  increase  in  the  hydrolysis  of  cADPR  to  ADPR  occurred,  once  a 
threshold  concentration  of  cADPR  was  reached  (Matsumura  and  Tanuma,  1998). 
Hohenegger  and  colleagues  established  that  nicotinic  acid  acted  as  an  allosteric 
regulator  of  base-exchange  reaction  catalysed  by  a  skeletal  muscle  ARC  isoform. 
Nicotinic acid could either enhance or reduce the affinity for NADP binding, depending 
on the pH of the environment (Bacher, et al., 2004). The hydrolase activity of CD38 
was inhibited by ATP, in glucose stimulated pancreatic beta cells (Takasawa, et al., 
1993b). Later it was shown that ATP bound competitively to Lys
129 to prevent binding of 
cADPR (Tohgo, et al., 1997). This lysine residue is not conserved in Aplysia cyclase. In 
pulmonary smooth muscle cells, the cyclase and hydrolase activities are regulated by 
the  redox  state  of  the  cell  i.e.,  by  the  levels  of  NADH  (Wilson,  et  al.,  2001).  In 
osteoblastic  MC3T3-E1  cells,  cellular  NAD  levels  were  proposed  to  regulate 
intracellularly expressed CD38 (Sun, et al., 2002). ADPR, the product of the hydrolase 
reaction was involved in end-product inhibition of CD38 and thus potentiated cADPR 
formation (Genazzani, et al., 1996a). As discussed in section 1.5.3, ADPR by itself also 
regulates  calcium  homeostasis  through  the  gating  of  TRP  channels.  TRPC7  is  a 
“chanzyme” that possess ADPR-pyrophosphatase activity to hydrolyse ADPR. Thus it 
is not surprising that CD38 functions by sensing the metabolic state of the cell and 43 
 
various  major  metabolites  like  ATP,  NAD/NADH  and  ADPR  influence  its  activity. 
Different exogenous second messengers like cAMP, cGMP and NO (Guse, 2000) also 
play very important roles in regulating the ARC activities in sea urchin. These will be 
dealt in greater detail in section 1.10.1.  
 
 
1.8  Physiological relevance of ARCs 
 
1.8.1  “Receptor-related” functions  
 
Before  the  discovery  of  the  enzymatic  properties  of  CD38,  its  receptor/antigenic 
activities  in  lymphocytes  were  well  known  (Jackson  and  Bell,  1990).  CD38  as  an 
antigen  covers  an  entirely  different  and  vast  branch  of  biology.  The  importance  of 
CD38 from an immunologist point of view is beyond the scope of this thesis. Hence a 
very brief mention of some important processes is outlined here. Ligation of CD38 with 
CD31 in lymphocytes led to a series of events for adhesion with different blood cells 
(Deaglio, et al., 1996). CD38-mediated signal transduction was involved in cytokine 
release (Ausiello, et al., 1995), interleukin secretion (Lande, et al., 2002) and tyrosine 
phosphorylation  of  several  intracellular  proteins  (Kirkham,  et  al.,  1994).  CD38  was 
critical for the regulation of B/T cell proliferation (Funaro, et al., 1990), regulation of 
humoral responses (Cockayne, et al., 1998), suppression of lymphopoiesis (Kumagai, 
et al., 1995) and modulation of apoptosis (Burgio, et al., 1994; Zupo, et al., 1994; Zupo, 
et  al.,  1996).  During  the  antigen  mediated  T-cell  responses,  redistribution  and 
clustering of intracellular CD38 at the immunologic synapse was observed (Munoz, et 
al., 2008). Malavasi et al envisaged that CD38 mediated signalling was controlled at 
three different levels. (1) existence of CD38 in either monomeric or dimeric forms (2) 
dynamic  organization  of  CD38  monomers  into  lipid  micro-domains  within  the  cell 44 
 
membrane (3) association of CD38 with other proteins like the CD19/CD81 complex 
(Deaglio, et al., 2007). 
 
Many workers have suggested a coupling between the enzymatic functions leading to 
increased  cytosolic  calcium  and  the  receptorial  functions  culminating  in  signal 
transduction events in CD38 (Howard, et al., 1993; Lund, et al., 1995; Mehta, et al., 
1996). Hoshino and colleagues demonstrated that the C-terminus (273-285) of CD38 
harboured  both  the  catalytic  domain  for  hydrolase  activity  as  well  as  epitopic  sites 
recognised by anti-CD38 mAbs for transmembrane signalling. This suggested a strong 
correlation  and  the  coupling  between  enzymatic  activity  and  signal  transduction  in 
CD38  (Hoshino,  et  al.,  1997).  Later  reports  conveyed  that  there  was  no  functional 
coupling  between  signal  transduction  and  enzyme  activity.  Instead,  Lund  et  al 
proposed that CD38 signalling was regulated by the conformational changes induced 
at the extracellular domain upon ligand/substrate binding, rather than the formation of 
products cADPR/ADPR (Lund, et al., 1999). In this study, the cells transfected with 
catalytically  inactive  CD38  were  still  responsive  to  ligation.  In  another  set  of 
experiments, Lund et al could delineate the receptor-mediated functions of CD38 from 
its enzyme activity.  In a murine pro-B leukemic cell line they blocked CD38 enzyme 
catalysis  with  2'-deoxy-2'-fluoro-nicotinamide  arabinoside  adenine  dinucleotide  and 
found  no  effect  of  it  on  CD38-mediated  apoptosis  (Lund,  et  al.,  2006).  Similarly 
Malavasi  et  al  in  their  later  studies  confirmed  that  CD38  was  indeed  a  pleiotropic 
molecule whose performance as a receptor was independent of its enzymatic action 
(Deaglio, et al., 2007). 
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1.8.2  Knock-out studies 
 
Having  comprehended  both  the  enzymatic  and  antigenic  functions  of  CD38,  it  is 
predictable that the knock-out of CD38 gene in an organism like mouse would have 
plieotrophic effects. CD38
-/- mice were generated by several groups. CD38 knock-out 
mice exhibited a large decrease in endogenous cADPR levels (Partida-Sanchez, et al., 
2001) in many tissues along with increased cellular NAD levels (Aksoy, et al., 2006b). 
Chini et al also observed a huge decrease in the NAADP production by base-exchange 
activity  of  the  CD38  knock-out  mice  (Chini,  et  al.,  2002).  Howard  and  colleagues 
reported an altered humoral immune response in the knock-out mouse (Cockayne, et 
al.,  1998).  In  pancreatic  β-cells  of  the  knock-out  mice,  glucose  induced  cADPR 
production, intracellular calcium increase and insulin secretion were impaired (Kato, et 
al.,  1999).  Similarly,  in  pancreatic  acinar  cells,  acetylcholine-induced  cADPR 
production was eliminated and aberrant calcium spiking was observed (Fukushi, et al., 
2001).  The  use  of  knock-out  mice  also  revealed  that  in  neutrophils,  CD38  was 
responsible  for  regulating  both  the  intra  and  extracellular  calcium  influx  during 
chemotaxis and bacterial clearance in vivo (Partida-Sanchez, et al., 2001). The same 
group also observed an impairment of the dendritic cell trafficking and T-cell activation 
in the knock-out mice (Partida-Sanchez, et al., 2004). Other effects of CD38 knock-out 
include disordered osteoclast formation, bone resorption (Sun, et al., 2003), altered 
airway responsiveness (Deshpande, et al., 2005) and aberrant signalling in the smooth 
muscle cells. CD38 was also involved in TNF-ʱ induced airway hyper-responsiveness 
(Guedes, et al., 2008).  
 
CD38 knock-down was also responsible for the inhibition of ʱ-adrenoceptor stimulated 
contraction  in  mouse  aorta.  The  knock-out  led  to  cardiac  hypertrophy  in  male  rats 
(Mitsui-Saito, et al., 2003; Takahashi, et al., 2003). Recent studies show that CD38 46 
 
controlled both oxytocin secretion and social behaviour (Higashida, et al., 2007; Jin, et 
al., 2007; Neumann, 2007; Salmina, et al., 2010). CD38-mediated intracellular calcium 
signalling was involved in the auto-regulation of oxytocin release in the hypothalamus 
and neurohypophysis of male mice thus aiding social recognition in males, independent 
of female reproduction (Lopatina, et al., 2010). In hepatic stellate cells, CD38-mediated 
signalling  played  an  important  role  in  angiotensin-II  induced  proliferation  and 
overproduction of extracellular matrix proteins (Kim, et al., 2010). Additionally, in the 
knock-out  mice,  the  bile  duct  ligation-induced  liver  fibrogenesis  and  infiltration  of 
inflammatory  cells  were  significantly  reduced.  Studies  with  knock-out  mice  also 
highlighted the role played by CD38 in the recovery of mice from traumatic brain/head 
injury through microglial responses (Levy, et al., 2009). Additionally, knock-out mice 
data  suggested  that  CD38  was  involved  in  the  regulation  of  SIRT1-mediated  NAD 
dependent deactelyation (Aksoy, et al., 2006a).  
 
Compared to CD38, there are relatively few studies on CD157 knock-out mice. This is 
possibly due to the low enzymatic activity of CD157 hindering the comparison of wild-
type  and  knock-out  samples.  However,  one  study  using  CD157  knock-out 
demonstrated an impaired local mucosal immune response when challenged with oral 
antigens (Itoh, et al., 1998).   
 
1.8.3  Pathophysiological implications  
 
CD38 expression is being used for the clinical diagnosis of leukemia and myeloma. 
CD38 is used as a negative prognostic marker for chronic lymphocytic leukemia (CLL) 
and also possibly in acute promyelocytic leukemia  patients (Morabito, et al., 2001). 
CD38 expression in CD8
+ and CD4
+ cells is also used as a prognostic tool to study the 
progression to AIDS in HIV-infected patients (Savarino, et al., 2000). cADPR and CD38 47 
 
are  implicated  in  neuro-inflammation  during  HIV-1  induced  dementia  through  the 
regulation of astrocyte calcium signalling (Banerjee, et al., 2008; Kou, et al., 2009). 
Glucose-induced insulin secretion occurs via the CD38/cADPR system and therefore 
has implications in the management of type II non-insulin-dependent diabetes mellitus 
(Kato, et al., 1999). Auto-antibody response to CD38 has been detected in patients 
with type I and type II diabetes (Mallone, et al., 2001). CD38 is also implicated in diet 
induced obesity (Barbosa, et al., 2007).  As discussed earlier, CD38 controls signalling 
in  airway  smooth  muscles  and  also  mediates  TNF-ʱ  induced  airway  hyper-
responsiveness  (Guedes,  et  al.,  2008).  This  feature  along  with  CD38’s  ability  to 
influence interleukin secretions (Lande, et al., 2002) may have clinical implications in 
the controlling asthma. CD38 also plays an important role in governing the antigen 
mediated T-cell responses during immune synapse formation (Munoz, et al., 2008), 
apart from all other immunological functions it regulates, as described in section 1.8.1. 
CD157  has  been  shown  to  be  a  risk  locus  strongly  associated  with  Parkinson’s 
disease, exhibiting population specific differences (Satake, et al., 2009). 
 
 
1.9  Existence of novel ADP-ribosyl cyclases 
   
Both cADPR and NAADP control important functions in various mammalian tissues as 
discussed in previous sections. Although the enzymatic activities were characterized in 
many of these studies, the exact molecular correlate has not been identified at the 
genetic level. In fact, there were only four reports/sequences of cloned ARCs available 
across the entire phyla until very recently (Lee and Aarhus, 1991; Howard, et al., 1993; 
Hirata,  et  al.,  1994;  Goodrich,  et  al.,  2005)  and  the  physiological  roles  of  these 
enzymes have not been rigorously explored yet.  
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There  is  mounting  evidence  now  emerging  from  various  studies  on  different 
mammalian cells and tissues, for the occurrence of novel ADP-ribosyl cyclases other 
than the known CD38 and CD157. A novel ARC type activity has been described in the 
rat kidney (Cheng, et al., 2001). The ARC activity from rat liver plasma membrane was 
inhibited greatly by Zn
2+ and Cu
2+, while from that from mitochondria was inhibited only 
to  a  lesser  extent  (Liang,  et  al.,  1999).  Similarly,  the  ADP-ribosyl  cyclase  from 
membranes  of  rat  vascular  smooth  muscle  cells  (VSMC),  unlike  CD38,  was  also 
inhibited by Zn
2+, Cu
2+ and gangliosides but was not influenced by the exposure to anti-
CD38 antibodies. (de Toledo, et al., 2000). Additionally all-trans-retinoic acid (atRA) 
stimulated only the cyclase but not hydrolase activity (Beers, et al., 1995). Additionally, 
various  reports  using  CD38  knock-out  mice  also  suggest  the  presence  of  yet 
unidentified ARC like activities (Kato, et al., 1999; Fukushi, et al., 2001; Ceni, et al., 
2003). In certain tissues like the brain of knock-out mice, Ceni et al have observed only 
40%  loss  of  ARC  activity.  The  novel  cyclase  activity  obtained  from  the  brain 
synaptosomes of CD38 knock-out mice was highly inhibited by Zn
2+ ions (Ceni, et al., 
2006). 
 
ADP-ribosyl cyclases occur not just in the animal kingdom, but also present in plants 
and protists. ARC activity has been described in Euglena, which is a unicellular protist 
(Masuda, et al., 1997b; Masuda, et al., 1997a). This is of significance from evolutionary 
point  of view,  since  Euglena is probably the most  primitive organism wherein  ARC 
activity has been described. Intriguingly, the activity was intracellular and membrane 
bound. The catalytic activity was very much like the Aplysia cyclase, since cyclisation 
but not hydrolysis was the major activity (Takenaka, et al., 1996). It is difficult to predict 
if the enzyme would bear more homology to Aplysia cyclase or to CD38, since the 
gene  has  not  been  cloned.  The  cyclase  activity  and  cADPR  levels  both  increased 
strikingly just before cell division, also correlating with DNA synthesis (Masuda, et al., 
1997a). cADPR-sensitive calcium stores (microsomes) were not only present but also 49 
 
functional in Euglena. The calcium release from the microsomes was both activated by 
caffeine  and  inhibited  by  ruthenium  red  (Masuda,  et  al.,  1997b),  indicating  the 
conservation  of  pharmacology  of  RyRs  through  evolution.  The  fact  that  cADPR  is 
involved  in  regulating  cell  cycle  from  unicellular  protists  (Masuda,  et  al.,  1997a)  to 
mammalian  cells  (Zocchi,  et  al.,  1998)  underscores  its  importance  as  an  important 
signalling molecule preserved by nature.  
 
In plants as well, cADPR regulates an array of activities. Some important functions 
governed by cADPR include abcissic acid-mediated closure of stomata (Leckie, et al., 
1998)  and  activation  of  gene  expression  (Wu,  et  al.,  1997).  cADPR  also  induced 
expression of defence genes in response to pathogenic conditions like virus infections. 
This  process  was  initiated  via  the  activation  of  the  nitric  oxide  synthase  pathway 
through cGMP and cADPR production, leading to calcium mobilization (Durner, et al., 
1998). Similar mechanisms also exist in sea urchin eggs, again emphasizing a unified 
signalling mechanism across several phyla. Therefore cloning and characterization of 
plant ADP-ribosyl cyclases would throw more light on the evolution and mechanism of 
action of these important enzymes. 
 
 
1.10  The sea urchin as a model system for calcium signalling 
   
The  sea  urchin  has  long  been  used  as  a  model  system  for  the  study  of  calcium 
signalling  in  eggs  (Lee,  1996;  Galione,  et  al.,  2000).  During  fertilization,  calcium 
signalling is an important event, which starts from a localized calcium elevation, but 
then  amplifies  into  a  calcium  wave  and  sweeps  through  the  entire  egg  to  trigger 
massive cortical exocytosis (Whitaker, 2006a). This spatially and temporally regulated 
calcium signalling is critical and leads to the formation of the fertilization envelope (to 50 
 
prevent  polyspermy)  and  also  signals  to  ensue  DNA  and  protein  synthesis  for  cell 
division  and  embryo  formation  (Parrington,  et  al.,  2007).  Urchins  therefore  must 
possess  robust  mechanisms  to  make  sure  that  the  events  from  gamete  formation 
through  fertilization  to  embryo  development  are  fool-proof  with  possibly  redundant 
mechanisms at critical checkpoints.  
 
cADPR and NAADP were both first discovered in urchin egg homogenates. (Lee 1987). 
Moreover,  NAADP  levels  were  first  measured  in  the  activated  sea  urchin  sperm 
(Billington,  et  al.,  2002)  and  established  to  rise  during  the  process  of  fertilization 
(Churchill, et al., 2003). However, the molecular nature of ARCs from the sea urchin 
remained abstract until the complete genome of this major animal model was released 
in 2006 (Sodergren, et al., 2006). 
 
1.10.1  Regulation of endogenous ARC activity in the sea urchins 
 
One of the initial studies on the sea urchin egg homogenates demonstrated that cGMP 
stimulated cADPR synthesis by the activation of ARC (Galione, et al., 1993). Later, 
Galione et al also described the role of nitric oxide in the regulation of ARC activity, 
cADPR synthesis and calcium release (Willmott, et al., 1996). Further studies, again 
with sea urchin egg homogenates by two independent groups, revealed the presence 
of two types of ARCs: soluble and membrane bound forms. Wilson et al reported that 
cADPR synthesis  was  predominant  in the soluble fraction and regulated by cGMP, 
while  NAADP  synthesis  and  cADPR  hydrolysis  activities  were  mainly  from  the 
membrane bound ARC and potentiated by cAMP (cGMP to lesser extent) (Wilson and 
Galione,  1998).  In  contrast,  Graeff  et  al  showed  that  both  the  soluble  and  the 
membrane bound cyclases could synthesise both cADPR and NAADP. The production 
of cADPR by the soluble cyclase was sensitive to cGMP. But the membrane bound 51 
 
ARC and NAADP synthesis were independent of cGMP (Graeff, et al., 1998). Thus 
there was a lack of coherence between these reports. Nevertheless, both the studies 
proved  the  existence  of  more  than  one  isoform  of  ARC  in  sea  urchins.  They  also 
suggested  differences  between  their  intra  cellular  locations,  pH  and  temperature 
optima, substrate specificity and most importantly differential regulation in response to 
cyclic nucleotides. 
 
1.10.2  ARC(s) from the sea urchin 
   
Although cADPR and NAADP were first discovered and described in sea urchins, the 
enzyme responsible for their synthesis namely ARCs had not been characterized at the 
molecular level in this important model system until recently. Patel’s lab was the first to 
clone  an  extended  family  of  these  enzymes  from  purple  urchins  and  named  them 
SpARCs  (Strongylocentrotus  purpuratus  ADP-ribosyl  cyclase),  isoforms  1,  2  and  3 
(Churamani, et al., 2007). A new expression system namely the developing Xenopus 
embryos were successfully employed for obtaining active sea urchin proteins in this 
study.  It  is  rather  surprising  to  note  that  there  are  three  isoforms  of  ARCs  in  sea 
urchins, while even in the mammals only two isoforms (CD38 and CD157) have been 
characterized until now.  
 
As  with  other  well  characterized  ARCs,  SpARCs  shared  the  following  features  in 
common. All three of them had ten core cysteine residues that probably formed five 
intra-disulfide bonds. SpARC1 and SpARC2 had  two additional cysteines that were 
conserved between them, which could potentially form another pair of disulfide bond. 
The significance of these additional cysteine residues in not known at the moment. The 
SpARCs exhibited moderate sequence similarity to each other and other members of 
the  family  (Churamani,  et  al.,  2007).  Again  as  expected  SpARC1,  SpARC2  and 52 
 
SpARC3 were more divergent towards their N and C termini. SpARC1 and SpARC2 
were  66%  similar  and  41%  similar  to  Aplysia  cyclase  respectively.  SpARC1  was 
extensively characterized at the molecular level (Churamani, et al., 2007). Later on, the 
same three isoforms of ARCs were cloned and characterized independently by another 
group.  Davis  et  al  named  the  isoforms  as  ARC-β,  ARC-ʱ  and  ARC-γ,  respectively 
(Davis, et al., 2008). Both the studies suggested that second messenger production 
could  occur  outside  of  cytosol  and  that  cellular  mechanisms  existed  for  the 
transportation of substrates/products from/to cytosol, in S.purpuratus. 
 
Calcium signalling is indispensable for the activation of sea urchins eggs and plays a 
critical  role  during  the  fertilization  process  (Parrington,  et  al.,  2007).  The  calcium 
mobilizing agents, cADPR and NAADP were both first discovered and described in the 
sea  urchins  (Clapper,  et  al.,  1987).  Therefore,  investigations  on  SpARCs,  the 
enzyme(s) responsible for calcium second messenger synthesis in sea urchins is not 
only exciting to study but of utmost importance to research.  
 
1.11  Aims 
 
 
The aims of this thesis are as follows:  
  To identify the molecular complement of ADP-ribosyl cyclase from S.purpuratus 
(Chapter 2). 
  To determine the localization of ADP-ribosyl cyclase(s) (Chapter 3).  
  To characterize the enzymatic activities of ADP-ribosyl cyclase(s) (Chapter 4). 
  To  identify  the  molecular  determinants  governing  the  catalytic  properties  of 
ADP-ribosyl cyclase(s) (Chapter 5). 
  To specify any physiological role(s) played by ADP-ribosyl cyclase(s) during the 
embryogenesis (Chapter 6). 53 
 
Chapter 2: Cloning of novel ADP-ribosyl cyclases 
from the sea urchin 
 
 
2.1  Introduction  
 
 
ADP-ribosyl cyclases are evolutionarily conserved family of enzymes that play crucial 
roles  in  maintaining  the  calcium  homeostasis  of  the  cell  (Lee,  2001).  This  family 
constitutes  proteins  from  varied  phyla  ranging  from  the  soluble  ARC  of  Aplysia  to 
surface expressed CD38 and CD157 of humans (Lee, 2000). Expansion to this group 
was  achieved  with  the  recent  identification  of  orthologs  from  the  parasitic  worm 
Schistosoma  and  three  different  isoforms  from  the  purple  urchin,  S.purpuratus 
(Goodrich, et al., 2005; Churamani, et al., 2007). Interestingly, knock down of CD38 in 
mice led to various conditions including altered immune responses, metabolic disorders 
and behavioural changes, but the animals were able to survive (Partida-Sanchez, et 
al., 2001). Therefore, it is possible that in mice, yet undiscovered ARCs (Ceni, et al., 
2006) are responsible for the compensation of the CD38 deficit. Indeed novel ARC 
activities  have  been  discovered  in  CD38  knock-out  mice  (Ceni,  et  al.,  2003).  This 
prompts efforts towards the identification of novel isoform(s) of ARC from mouse and 
also from other organisms.  
  
Aplysia cyclase, CD38 and CD157 all have remarkably similar number, structure and 
organisation of introns and exon(s) in their genes. The CD38 gene is present on the 
short arm of chromosome 4 (4p15) in Homo sapiens (Nata, et al., 1997). The CD38 
polypeptide is encoded by an 80Kb gene, 98% of that being intronic sequences. There 
are a total of eight exons. Exon 1 is the largest in size which codes for the cytoplasmic, 
transmembrane and the first 33 amino acids of the extracellular region. Also, intron 1 is 54 
 
the longest, spanning ~20Kb. The intronic sizes of the remainder of the gene are much 
more  modest  with  the  exons  2–8  spanning  only  36  Kb.  CD157  exhibiting  33% 
sequence homology with CD38 maps head-to-tail in tandem to CD38 (Ferrero, et al., 
1999). CD157 gene spans 35Kb and consists of nine exons (Muraoka, et al., 1996). 
Whilst exons 1 to 8 are similar in length and spacing to CD38, exon 9 is additional, 
encoding the GPI-anchor domain.  
 
CD38 exhibits a single-nucleotide polymorphism (SNP) located at a hot spot in the 5’ 
region  of  intron  1  (184  CpG),  responsible  for  the  presence  or  absence  of  a  PvuII 
restriction site (Ferrero, et al., 1999). In very recent studies, polymorphism in human 
CD157 has been associated with Parkinson’s disease (Satake, et al., 2009). CD38 and 
CD157 probably originated from gene duplication (Ferrero and Malavasi, 1997). Exon 4 
of  the  Aplysia  gene  is  split  into  exons  3  and  4  in  both  CD38  and  CD157  genes 
suggesting  a  common  origin.  This  division  is  also  found  in  the  murine  CD38  and 
CD157, indicating that the split occurred before humans and rodents diverged (Ferrero 
and Malavasi, 1999). CD38 and CD157 lie in tandem on the chicken genome as well, 
demonstrating that the gene duplication preceded the reptile-mammal split (Malavasi, 
et al., 2008). It has been suggested that the common ancestor of CD38 and CD157 
possibly acquired receptor functions after attaining a plasma membrane location from 
the soluble form, much later during evolution (Malavasi, et al., 2006).  
 
Sea  urchins  have  long  been  used  as  a  model  system  for  the  study  of  cell  and 
developmental  biology.  In  the  context  of  human  evolution,  the  sea  urchin,  an 
echinoderm  is  the first species  outside  the  chordate  branch  of  deuterostomia.  This 
biological niche of urchins presents a unique view of the deuterostome and bilaterian 
ancestory. Therefore, the recent sequencing of S.purpuratus genome aided in better 
understanding of the human complement of basal deuterostome genes (Sodergren, et 
al.,  2006b).  The  gene  predictions  and  annotations  revealed  that  sea  urchin  had 55 
 
approximately 23,300 genes with representatives
 of nearly all vertebrate gene families, 
including  orthologs  of  many  human  disease  associated  genes.  It  is  particularly 
interesting to note that some genes identified in
 the  sea urchin were absent in the 
chordate  lineage,  suggesting  specific  loss
  in  the  vertebrates.
  It  is  possible  that 
expansion  of  some
  gene  families  occurred  independently
  in  the  sea  urchin
  and 
vertebrates (Beane, et al., 2006).
  
 
In this Chapter, a new family of SpARC1-like isoforms and SpARC4, a novel fourth 
isoform has been cloned from S.purpuratus, highlighting the further expansion of this 
gene family in sea urchins. The phylogenetic classification of SpARCs with respect to 
ADP-ribosyl cyclases from a variety of genus is also presented.  
 
 
2.2  Materials and Methods 
 
2.2.1  Identification of SpARC1-like isoforms  
 
The SpARC1 sequence (accession number: CAM36041.2) was used to query the sea 
urchin  genome  resources  at  the  Baylor  College  of  Medicine 
(http://www.hgsc.bcm.tmc.edu/projects/seaurchin/).  This  included  whole  genome 
shotgun (WGS) contigs, traces, reference and non-reference sequences, build and ab-
initio proteins, and also the unordered fragments. This was done to retrieve all possible 
sequences in the genome that were similar to SpARC1. In cases where significant 
sequence  similarity  with  one  or  more  SpARC1  exons  was  found,  the  sequences 
upstream  were  manually  deciphered,  to  gain  insight  into  the  intronic  and/or 
untranslated regions. DNA and amino acid sequences were aligned using Multialign 
(Corpet, 1988), Clustal W (Chenna, et al., 2003) and Boxshade programs. This was 56 
 
carried  out  in  collaboration  with  Dr.  Christophe  Bosc  and  Dr.  Marie-Jo  Moutin, 
Grenoble, France. 
 
2.2.2  Molecular cloning of SpARC1-like isoforms 
 
Total RNA was isolated from the S.purpuratus embryos (58 h post-fertilization) using 
the RNeasy kit, according to manufacturer’s instructions. cDNA was synthesised from 2 
µg  of  RNA  with  Oligo-dT  primers,  in  presence  of  RNasin,  using  the  ImProm-II  kit 
(Promega)  according  to  supplier’s  directions.  Water  was  added  instead  of  reverse 
transcriptase in –RT control reactions. The RNA template and primer were denatured 
initially  at  70°C  for  5  min.  The  cDNA  synthesis  conditions  were  25°C  for  10  min, 
followed by 42°C for 60 min and 70°C for 15 min. 
 
Primers were designed based on common UTRs in the 5’ region of the identified exon 
1 sequences (SpARC1-like-5’UTR-1 + SpARC1-like-5’UTR-2) and the 3’ region of exon 
7 sequences (SpARC1-like-7
th Exon) (See: Section 2.3.1.2). Primers used in this study 
are  listed  in  Table  2.1.  A  100  µl  PCR  reaction  was  made  with  1X  Hi-fidelity  Taq 
polymerase buffer, 1 mM MgSO4, 0.2 mM dNTPs, 0.2 mM of each primer, 4 µl of the 
cDNA  template  and  0.2  U  of  Platinum  Hi-fidelity  Taq  Polymerase  enzyme.  PCR 
conditions used were initial denaturation at 94°C for 2 min, followed by 40 cycles of 30 
s denaturation at 94°C, 30 s annealing at 50°C and 1 min extension at 68°C and a final 
extension at 68°C for 5 min. 
 
The PCR product was separated on 1% agarose gel and the band of interest excised 
and gel purified using the Qiagen gel extraction kit according to guidelines provided. 
The  purified  PCR  product  was  ligated  into  TOPO-TA  vector  (Invitrogen)  and 
transformed into XL-10 gold competent cells according to standard protocols. Multiple 57 
 
colonies were screened for the presence of SpARC1-like isoform(s) and sequenced in 
both directions. 
 
  Primer name  Primer sequence (5’→3’) 
1  SpARC1-like-5’UTR-1  TTTGAGTAACTTCACTATAATCGTTCA 
2  SpARC1-like-5’UTR-2  TTTGAGTAACTTCACTGTAATCGTTTA 
3  SpARC1-like-7
th exon  TAGGGTAGTAGATATTGTATTCCAACC 
4  oligo(dT)17 adapter  GACTCGAGTCGACATCGATTTTTTTTTTTTTTTTT 
5  adapter  GACTCGAGTCGACATCG 
6  SpARC4-1F  ACAACTGTTCGGGTCTGTGG 
7  SpARC4-2F  ACCAGGAGCCTTGTAACAGC 
8  SpARC4-1R  CAACTGTCGAACGTCGGA 
9  SpARC4-3R  TCGTGAGTTCGATGTTGGTG 
10  SpARC4-2R  TGTTGGTGAAATCGGAGGAC 
11  SpARC4 6F  ATGCATTCCCTCTACGGTTTATC 
12  SpARC4 – 3’UTR-1R  AGATTCAGCCCTAAAAACACTCT 
Table 2.1: List of all primers used in this Chapter 
 
 
2.2.3  Molecular cloning of SpARC4 
 
A  BLAST  query  of  the  S.  purpuratus  genome  with  Aplysia  ADP-ribosyl  cyclase 
sequence (accession number: P29241) led to identification of SpARC1, SpARC2 and 
SpARC3  genes  (Churamani,  et  al.,  2007).  The  same  search  also  revealed  the 
presence  of  an  additional  contig  (640882)  harbouring  ~90  amino  acids  of  a  novel 
protein, with significant sequence similarity to the ARCs (Patel, Unpublished). 3’ RACE-
PCR was performed using total RNA extracted from S.purpuratus embryos (46h post 58 
 
fertilization) and cDNA synthesis carried out using oligo (dT)17 adaptor primers as per 
section 2.2.2.  PCR amplification  was conducted  from the cDNA template  using the 
adaptor and gene-specific primer, SpARC4-1F. The PCR reaction mix and conditions 
used  were  same  as  described  in  section  2.2.2,  except  35  cycles  were  used  for 
amplification. PCR products were separated on 1% agarose gel and a faint band of 
~1.5kb purified using the Qiagen gel extraction kit. The eluted products were diluted 
100 fold and used as template for a nested-PCR reaction using a second internal gene-
specific primer, SpARC4-2F, under the same conditions. A product of approximately 
850bp was amplified and sequenced. This extended the 3’ sequence to an in-frame 
stop codon plus a 441 bp of 3’ UTR. 
 
5’  RACE-PCR  was  carried  out  using  a  gene-specific  primer  SpARC4-1R.  The 
synthesised cDNA was purified with a spin column (Qiagen) and polyA tailing reaction 
was performed using terminal transferase enzyme (Promega) as per manufacturer’s 
instructions.  This polyA cDNA was subjected to PCR amplification using oligo(dT)17 
adapter primer and a second gene-specific primer, SpARC4-3R. The PCR product was 
diluted 100 times and used as a template for performing nested PCR reaction using 
adapter and a third gene-specific primer, SpARC4-2R. The 750 bp resultant product 
was sequenced. This extended the 5’ sequence to an in frame stop codon and 67 bp 5’ 
UTR.  
 
Gene-specific primers SpARC4-6F and SpARC4-3’UTR-1R were designed based on 
the sequence information obtained by RACE and were used to amplify the full length 
coding sequence plus 54 bp of 3’ UTR of SpARC4. The 1089 bp product was cloned in 
to pCR
®II-TOPO
® (Invitrogen) and sequenced in both directions. The sequence was 
deposited at EMBL under the accession number FN645665.  59 
 
2.2.4  Sequence comparisons and phylogenetic analysis  
 
Pair-wise  alignments  were  carried  with  Mac-vector  program  employing  Clustal  W 
algorithm.  Following  these,  the  percent  identity  and  similarity  were  calculated.  For 
phylogenetic studies, SpARC1 sequence was used for the nucleotide mega BLAST 
search of homologs. The resultant ARC sequences with “e values” greater than e
-11 
were  chosen,  representing  a  variety  of organisms.  Partial  and  duplicate  sequences 
were removed by manual editing. The 40 different ARC sequences were aligned using 
Clustal W nucleotide alignment program (Chenna, et al., 2003) and exported to files in 
PHYLIP  format.  Guide  trees  were  produced  using  Clustal  W  and  T-Coffee.  21 
representative ARC sequences were chosen and the final tree was constructed using 
the PHYLIP package (http://evolution.genetics.washington.edu/phylip.html). SEQBOOT 
was used to make multiple bootstrapped data sets. The base tree was generated by 
PROML (protein-maximum likelihood) algorithm using multiple (100) data sets option. 
Finally, CONSENSE was used to construct a majority rule consensus tree. The tree 
drawing programs “drawgram” and “drawtree” were used to view trees. TREEVIEW 
(http://taxonomy.zoology.gla.ac.uk/rod/treeview.html)  was  employed  for  graphical 
representation. The parameters used included “best tree” option and a “random order 
of input” and “resampling”. 
 
 
2.3  Results 
 
2.3.1  Identification of a new family of SpARC1-like isoforms 
 
SpARC1, SpARC2 and SpARC3 were first cloned in Patel’s lab (Churamani, et al., 
2007). They were subsequently cloned by an independent group and named SpARC-β, 60 
 
SpARC-ʱ and SpARC-γ, respectively (Davis, et al., 2008). SpARC1 localized to the 
lumen  of  endoplasmic  reticulum  (Churamani,  et  al.,  2007),  whilst  SpARC-β  to  the 
cortical granules of the egg  (Davis,  et  al., 2008). To gain insight  into the apparent 
discrepancy in the localization of the same protein reported by two groups, both the 
protein  sequences  were  carefully  analysed.  Amino  acid  sequence  alignment  of 
SpARC1 with SpARC-β  revealed that the proteins differed mostly at their N-termini 
(Figure 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
Therefore considering the possibility that these two proteins could actually be splice 
variants,  both  the  sequences  were  queried  against  the  S.purpuratus  genomic 
assembly.  SpARC1  and  SpARC-β  both  mapped  to  the  same  genomic  contig 
NW_001326169. This analysis suggested that SpARC1 and SpARC-β consisted of 7 
exons (Figure 2.2). The N-terminal amino acid sequences of SpARC1 and SpARC-β 
(where differences were observed) corresponded to exon 1. However, a search for an 
alternate  exon  1  in  NW_001326169  was  unsuccessful,  though  interestingly  a 
duplicated copy of exon 7 was found upstream of exon 1 but in the reverse orientation 
(Figure 2.2).  
 
SpARC1        1 MGIYTIFLYLSPILAVTVAYNNKGPGATHNITDILTGRCEEYRKCLLGEPCLPFYRNVKC 
SpARC-beta    1 MGIYTIFLYLSPMLAMTVAYINTGPGTTPNITDILTGRCEEYRKCLLGEPCLPFYRNVKC 
 
SpARC1       61 RAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTP 
SpARC-beta   61 RAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTP 
 
SpARC1      121 EFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKM 
SpARC-beta  121 EFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKM 
 
SpARC1      181 LATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEM 
SpARC-beta  181 LATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEM 
 
SpARC1      241 YAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAAS 
SpARC-beta  241 YAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAAS 
 
SpARC1      301 IVVILLQVVFAMSLSGWNTISTTL 
SpARC-beta  301 IVVILLQAVFAMSLSGWNTISTTL 
 
 
Figure 2.1: Sequence alignment of SpARC1 and SpARC-β 
 
A Clustal W alignment of the amino acid sequences of SpARC1 and SpARC-β. 61 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Subsequently,  S.purpuratus  genome  was  queried  with  just  exon  1  sequence  of 
SpARC1. Intriguingly, exon 1 mapped to various contigs with minor sequence changes. 
Figure  3A  shows  the  multi  sequence  alignment  of  three  such  contigs  (including 
NW_001326169) bearing sequences similar to exon 1 of SpARC1. It was noteworthy 
that  these  different  exon  1  sequences  had  discrete  5’  UTRs.  In  fact,  the  analysis 
revealed that contig NW_001326169 had a single nucleotide deletion that exposed an 
alternate  initiation  codon  (dotted  green  line  -  Figure  2.3A).  However,  this  alternate 
initiation codon harboured poor Kozak consensus for translation initiation. The intronic 
sequences (highlighted grey) also exhibited differences. The multi sequence alignment 
of the amino acid sequences corresponding to these contigs along with SpARC1 and 
SpARC-β  are  shown  in  Figure  2.3B.  The  analysis  highlighted  that  SpARC-β 
corresponded  to  contig  NW_001326169  better  than  SpARC1  (Figure  2.3B),  while 
SpARC1 better corresponded to contig NW_001354548. 
 
NW_001326169 
 
 
 
Figure 2.2: Exonic organization of SpARC1 and SpARC-β 
 
Mapping of SpARC1 and SpARC-β to contig NW_01326169. The red dots represent the exons. 
Grey  boxes  show  exon  number  and  corresponding  nucleotide  make-up.  Pink  box  show 
duplicated exon in the reverse direction. Scale represents 10Kb. 62 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.1.1  Existence of multiple copies of SpARC1 exons 
 
Subsequently,  a  comprehensive  analysis  of  the  genomic  assembly  individually  with 
each of the seven SpARC1 exons indicated that  they all existed in multiple copies 
(results not shown). However, intriguingly, these exons were scattered in the genome, 
and not necessarily ordered contiguously. Some exons even occurred in the reverse 
coding  strand  (see  section  2.3.1.3).  In  some  instances,  exons  were  duplicated  as 
 
 
NW_001326169  TAACTTCACTGTAATCGTTTATGTTTAGGAACGAACCAAAA-TTCGAAATGGGCATCTAC 
NW_001355038  TAACTTCACTATAATCGTTCATGTTTAGGAACGGATCAAAACTTCGAAATGGGCATCTAC 
NW_001354548  TAACTTCACTATAATCGTTCATGTTTAGGAACGGATCAAAACTTCGAAATGGGCATCTAC 
 
 
NW_001326169  ACCATATTCATCTACTTGTCACCAATGCTGGCGATGACCGTTGCCTACATCAACACAGGA 
NW_001355038  ACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACCCAGGC 
NW_001354548  ACGATATTCCTCTACTTGTCACCAATACTGGCGGTGACCGTTGCCTATAACAACCCAGGC 
 
 
NW_001326169  CCAGGGACCACGTCCAACATTACTGACATCTTAACTGGTAGATGCGAGGAATACCGGAAG 
NW_001355038  CAAGGGACCACGCACAACATTACTGACATCTTGATCGGTAGATGCGAGGAATACCGGAAG 
NW_001354548  CCAGGGACCACGCACAACATTACTGACATCTTGATCGGTAGATGCGAGGAATACCGGAAG 
 
 
NW_001326169  TGCCTCCTGGGAGAGCCATGTCTCCCGTTCTAGTAAGTTTACTTTTTCTTCCTGCCTTTT 
NW_001355038  TGCCTCCTGGGGGAGCCATGTCTCCCGTCCTAGTAAGTATAAATTTTCTTCCTAGCCTTT 
NW_001354548  TGCCTCCTGGGGGAGCCATGTCTCCCGTCCTAGTAAGTTTAAATTGTCTTCCTAGCCTTT 
 
                                                         
          .                         . 
SpARC-β       MGIYTIFLYLSPMLAMTVAYINTGPGTTPNITDILTGRCEEYRKCLLGEPCLPF 
NW_001326169  MGIYTIFIYLSPMLAMTVAYINTGPGTTSNITDILTGRCEEYRKCLLGEPCLPF 
NW_001355038  MGIYTIFLYLSPILAVTVAYNNPGQGTTHNITDILIGRCEEYRKCLLGEPCLPS 
NW_001354548  MGIYTIFLYLSPILAVTVAYNNPGPGTTHNITDILIGRCEEYRKCLLGEPCLPS 
SpARC1        MGIYTIFLYLSPILAVTVAYNNKGPGATHNITDILTGRCEEYRKCLLGEPCLPF 
                 .   .      .              . 
 
Figure 2.3: Multi sequence alignment of various genomic contigs 
harbouring exon 1 of SpARC1 
 
(A) Sequence alignment of the various genomic contigs with sequences similar to exon 1 of 
SpARC1.  The  normal  initiation  codon  is  highlighted  green.  An  alternate  initiation  codon  is 
indicated by green line. In-frame stop codons are highlighted red. The grey regions are intronic 
sequences.  (B)  Multiple  sequence  alignment  of  amino  acids  corresponding  to  exon  1  of 
SpARC1 and SpARC-β along with the translated sequences from the above genomic contigs. 
Dots  above  SpARC-β  show  differences  with  contig  NW_001326169.  Dots  below  SpARC1 
highlight differences with NW_001354548. 
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illustrated in Figure 2.2. Another example is a predicted partial protein, hmm281048 in 
the  genomic  contig  NW_001354548.  This  predicted  gene  included  amino  acid 
sequences similar to exon 3 of SpARC1, repeated twice (Figure 2.4A, highlighted cyan 
and purple). Amino acid sequences similar to exon 4 (green), exon 5 (red) and exon 6 
(blue) were also present. Sequence alignments of the amino acids coded by SpARC1 
exons with that of the predicted protein are depicted in Figure 2.4B. It indicated that 
although the sequences varied considerably, there was an absolute conservation of the 
intron-exon  boundaries.  This  region  could  potentially  code  for  alternately  spliced 
products due to the presence of two variant exon 3 sequences in tandem.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus it was now clear that novel SpARC1-like exons were present in  S.purpuratus 
genome. However, this observation was specific only to SpARC1 exons. A search of 
 
 
>lcl|hmm281048 
TMFWSGVSGTNVHLDVAQVTPDFSVLEETFPGHMANNLSWCGATDGDETGLGLNFTVCPQWSGATCP
NNTKATFWAKASKMGPNNSKTAFWNSASKMTMFWSGVKGTNVPQDIAQVTPYFNVIGETFPGYMAGN
LSWCGATDGNDTGLGLNFTVCPKGKGATCPNNTKAIFWAKASNMFATQAVDDVYVVLNAQKPGGAFS
KYSFFATEEAPNLNPDVVKNVAIYLIPNFTLPIPNEMYAETCTNGSVLYLQNFLMDMNLNVTCEENP 
 
 
 
 
SpARC1_exon3  TMFWSGVMGNNIPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKM 
hmm281048_1   TMFWSGVSGTNVHLDVAQVTPDFSVLEETFPGHMANNLSWCGATDGDETGLGLNFTVCPQWSGATCPNNTKATFWAKASKM 
hmm281048_2   TMFWSGVKGTNVPQDIAQVTPYFNVIGETFPGYMAGNLSWCGATDGNDTGLGLNFTVCPKGKGATCPNNTKAIFWAKASNM 
 
 
SpARC1_exon4  LATQAVGDVYVVLNAQRAGGAFNNGS 
hmm281048     FATQAVDDVYVVLNAQKPGGAFSKYS 
 
SpARC1_exon5  IFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEM 
hmm281048     FFATEEAPNLNPDVVKNVAIYLIPNFTLPIPNEM 
 
SpARC1_exon6  YAETCTNGSVLYLQNFLMNMNFNVTCEENP 
hmm281048     YAETCTNGSVLYLQNFLMDMNLNVTCEENP 
 
 
Figure 2.4: Existence of multiple SpARC1-like exons 
 
(A) A partial gene predicted by an automated program in the genomic contig NW_001354548 is 
shown.  Regions  similar  to  SpARC1  are  highlighted:  amino  acids  corresponding  to  exon  3 
(cyan and purple), exon 4 (green), exon 5 (red) and exon 6 (blue) of SpARC1. (B) Clustal W 
sequence alignment of the amino acids of the gene prediction, with the amino acids sequences 
corresponding to SpARC1 exons is shown. 
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the  S.purpuratus  genome  with  SpARC2  or  SpARC3  did  not  reveal  this  pattern  of 
random exon duplications (data not shown). Therefore, at this point it remained to be 
established whether these newly identified SpARC1-like exonic sequences were novel 
genes coding for SpARC1-like proteins or randomly duplicated exons and/or pseudo-
gene(s). 
 
 
2.3.1.2  Molecular cloning of SpARC1-like isoforms  
 
With the hint for the existence of SpARC1-like variants, two different approaches were 
taken for the physical cloning of these novel isoforms. Firstly, the clones obtained from 
the S.purpuratus ovary library during the initial SpARC1 cloning studies (Churamani, et 
al., 2007) were reanalysed. Additional plasmid preparations from several independent 
clones were sequenced. This analysis resulted in the retrieval of three other positive 
clones. Two of them were identical to SpARC1. However sequencing of a third clone 
that exhibited an EcoRI polymorphism revealed that it was a variant of SpARC1. The 
amino acid sequence alignment of SpARC1, SpARC-β with the new clone (Figure 2.5) 
suggested that it was in fact similar  to SpARC-β, initially  identified by Galione and 
Colleagues  (Davis,  et  al.,  2008). This  newly  identified  clone  is  hereafter  named  as 
Beta_LR (to distinguish it from SpARC-β). Thus the independent cloning of SpARC-β in 
our lab, using an entirely different approach to that of Galione’s group (Davis, et al., 
2008) supported the possibility for the existence of additional SpARC1-like isoforms.  65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In a second approach, a strategy was designed for the further cloning of additional 
SpARC1-like isoforms. Primers were designed in the common 5’ UTRs of all possible 
exon  1  sequences (Figure  2.6A)  and  in  the  common region  of  all  possible  exon  7 
sequences, prior to the stop codon (Figure 2.6B).  
 
 
 
 
 
 
 
 
SpARC1      MGIYTIFLYLSPILAVTVAYNNKGPGATHNITDILTGRCEEYRKCLLGEPCLPFYRNVKC 
SpARC-β     MGIYTIFLYLSPMLAMTVAYINTGPGTTPNITDILTGRCEEYRKCLLGEPCLPFYRNVKC 
Beta_LR     MGIYTIFLYLSPMLAMTVAYINTGPGTTPNITDILTGRCEEYRKCLLGEPCLPFYRNVKC 
 
SpARC1      RAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTP 
SpARC-β     RAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTP 
Beta_LR     RAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTP 
 
SpARC1      EFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKM 
SpARC-β     EFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKM 
Beta_LR     EFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKM 
 
SpARC1      LATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEM 
SpARC-β     LATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEM 
Beta_LR     LATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEM 
 
SpARC1      YAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAAS 
SpARC-β     YAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAAS 
Beta_LR     YAETCTNGSVLYSQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAAS 
 
SpARC1      IVVILLQVVFAMSLSGWNTISTTL 
SpARC-β     IVVILLQAVFAMSLSGWNTISTTL 
Beta_LR     IVVILLQAVFAMSLSGWNTISTTL 
 
 
Figure 2.5: Independent cloning of SpARC-β from ovary library of 
S.purpuratus 
 
Clustal  W  amino  acid  sequence  alignments  of  SpARC1  (Churamani,  et  al.,  2007),  SpARC-β 
(Davis, et al., 2008) and Beta_LR is shown. 
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Using  these  primers,  RT-PCR  was  performed  from  the  RNA  isolated  from  the 
S.purpuratus  embryos  (58  h  post-fertilization).  The  RT-PCR  product  (~1  kb)  was 
subsequently  sub-cloned  into  TOPO-TA  vector.  Several  independent  transformants 
were  analysed  and  sequenced  in  both  directions.    The  nucleotide  and  amino  acid 
alignment of 11 identified clones is depicted in Figures 2.7A and 2.7B respectively. 
Only sequences downstream of the 5’ primers were shown in the alignment in Figure 
2.7A.  This  was  to  avoid  any  potential  errors  introduced  by  the  primer  design.  The 
alignments indeed revealed the presence of variant SpARC1-like sequences. Clone 4 
and clone 6 had a deletion in the 5’ UTR (Figure 2.7A, highlighted yellow) as previously 
described for contig NW_001326169 (Figure 2.3A). Interestingly, clone 7 had a deletion 
of the complete exon 4 (Figure 2.7A, highlighted grey). This deletion would potentially 
cause a shift in the reading frame and appearance of a premature stop codon and thus 
a truncated protein (Figure 2.7B).  
 
 
 
  NW_001326169              TTTGAGTAACTTCACTGTAATCGTTTATGTTTAGGAACGAACCAAAA-TTCGAAATG 
  NW_001354548/NW_001355038 TTTGAGTAACTTCACTATAATCGTTCATGTTTAGGAACGGATCAAAACTTCGAAATG 
 
 
 
  NW_001326169           CTTCAAGCCATTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTATAA 
  AC201615/NW_001360111  CTTCAAGTCGTTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTATAG 
 
 
 
Figure 2.6: Design of primers for RT-PCR cloning of SpARC1-like 
isoforms 
 
(A) Clustal W sequence alignment of the 5’ UTRs of contigs harbouring SpARC1-like exon 1 
sequences  is  shown.  The  initiation  codon  is  highlighted  green.  Two  primers  (grey)  were 
designed  upstream  of  the variable  region.  (B)  Clustal  W  sequence alignment of the  contigs 
harbouring SpARC1-like exon 7 sequences is shown. A common primer (grey) was designed 
upstream of the stop codon (red). 
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SpARC1     ---------------ATGGGCATCTACACCATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACAAAGGACCAGGGGCCACGCACAACATTAC 
Clone14    GATCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACAAAGGACCAGGGACCACGCACAACATTAC 
Clone17    GATCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACAAAGGACCAGGGACCACGCACAACATTAC 
Clone24    GATCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACAAAGGACCAGGGACCACGCACAACATTAC 
Clone1     AATCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACCCAGGCCAAGGGACCACGTCCAACATTAC 
Beta_LR    ---------------ATGGGCATCTACACCATATTCCTCTACTTGTCACCAATGCTGGCGATGACCGTTGCCTATATCAACACAGGACCAGGGACCACGCCCAACATTAC 
Clone4     AACCAAAA-TTCGAAATGGGCATCTACACCATATTCATCTACTTGTCACCAATGCTGGCGATGACCGTTGCCTACATCAACACAGGACCAGGGACCACGTCCAACATTAC 
Clone6     AACCAAAA-TTCGAAATGGGCATCTACACCATATTCATCTACTTGTCACCAATGCTGGCGATGACCGTTGCCTACATCAACACAGGACCAGGGACCACGTCCAACATTAC 
Clone22    AGTCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACCCAGGCCCAGGGACCACGCACAACATTAC 
Clone12    AGTCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACCCAGGCCCAGGGACCACGCACAACATTAC 
Clone3     AATCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACCCAGGCCAAGGGACCACGCACAACATTAC 
Clone19    GATCCAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTATCACCAATACTAGCGGTGACCGTTGCCTATAACAACCCAGGCCAAGGGACCACGCACAACATTAC 
Clone7     AGTCAAAACTTCGAAATGGGCATCTACACGATATTCCTCTACTTGTCACCAATACTAGCGGTGACCGTTGCCTATAACAACCCAGGCCCAGGGACCACGCACAACATTAC 
 
 
SpARC1     TGACATCTTGACTGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAAGTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Clone14    TGACATCTTGACTGGTAGGTGCGAGGAATACCGGAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAATTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Clone17    TGACATCTTGACTGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAATTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Clone24    TGACATCTTGACTGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAATTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Clone1     TGACATCTTAACTGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAAGTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Beta_LR    TGACATCTTAACTGGTAGATGCGAGGAATACCGAAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAAGTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Clone4     TGACATCTTAACTGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAAGTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Clone6     TGACATCTTAACTGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGAGAGCCATGTCTCCCGTTCTATCGCAATGTCAAGTGTCGTGCAGCAGTGGAGTCGTTTTTTA 
Clone22    TGACATCTTGATCGGTAGATGCGAGGAATACCAGAAGTGCCTCCTGGGGGAGCCATGTCTCCCGTCCTATCGCAATGTCAACTGTCGTGCAGCAGTGGAGTCCTTTTTAG 
Clone12    TGACATCTTGATCGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGGGAGCCATGTCTCCCGTCCTATCGCAATGTCAACTGTCGTGCGGCAGTGGAGTCCTTTTTAG 
Clone3     TGACATCTTGATCGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGGGAGCCATGTCTCCCGTCCTATCGCAATGTCAACTGTCGTGCAGTAGTGGAGTCCTTTTTAG 
Clone19    TGACATCTTGATCGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGGGAGCCATGTCTCCCGTCCTATCGCAATGTCAACTGTCTTGCAGCAGTGGAGTCGTTTTTAG 
Clone7     TGACATCTTGATCGGTAGATGCGAGGAATACCGGAAGTGCCTCCTGGGGGAGCCATGTCTCCCGTCCTATCGCAATGTCAACTGTCGTGCAGCAGTGGAGTCCTTTTTAG 
 
 
SpARC1     AAGGCATTCGCAATATGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCCTCAACATGGTCCCACCCACCACAGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Clone14    AAGGCATTCGCAATATGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCCTCAACATGGTCCCTCCCACCACAGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Clone17    AAGGCATTCGCAATATGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCCTCAACATGGTCCCCCCCACCACAGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Clone24    AAGGCATTCGCAATATGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCCTCAACATGGTCCCTCCCACCACAGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Clone1     AAGGCATTCGCAATATGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCCTCAACATGGTCCCTCCCACCACCGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Beta_LR    AAGGCATTCGCAATATGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTTCTCAACATGGTCCCACCCACCACAGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Clone4     AAGGCATTCGCAATATGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCCTCAACATGGTCCCTCCCACCACCGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Clone6     AAGGCATTCGCAATATGGATCCATGTGCTACCCCCGACAACGCATATGATGAATTCCTCAACATGGTCCCTCCCACCACAGTTCGTGGCACGACGATGTTTTGGTCGGGT 
Clone22    GAGGCATTCGCAATGTGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCTTTGAAATGGTCCCGCCCACCACAGTTCCTAACACGACGATGTTTTGGTCGGGT 
Clone12    GAGGCATTCGCAATGTGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCTTTGAAATGGTCCCGCCCACCACAGTTCCTAACACGACGATGTTTTGGTCGGGT 
Clone3     GAGGCATTCGCAATGTGGATCCATGTTCTACCCCATACAACGCATATGATGAATTCTTTGAAATGGTCCCGCCCACCACAGTTCCTAACACGACGATGTTTTGGTCGGGT 
Clone19    GAGGCATTCGCAATGTGGATCCATGTTCTACCCCAGACAACGCATATGATGAATTCTTTGAAATGGTCCCGCCCACCACAGTTCCTAACACGACAATGTTTTGGTCGGGT 
Clone7     GAGGCATTCGCAATGTGGATCCATGTGCTACCCCAGACAACGCATATGATGAATTCTTTGAAATGGTCCCGCCCACCACAGTTCCTAACACGACGATGTTTTGGTCGGGT 
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SpARC1     GTTATGGGCAACAACATACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTTCCGGGTTACATGGCAGGTAACCTGTCCTGGTGTGGCGC 
Clone14    GTTATGGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTCCCGGGTTACATGGCCGGTAACCTGTCCTGGTGTGGCGC 
Clone17    GTTATGGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTCCCGGGTTACATGGCCGGTAACCTGTCCTGGTGTGGCGC 
Clone24    GTTATGGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTCCCGGGTTACATGGCCGGTAACCTGTCCTGGTGTGGCGC 
Clone1     GTTATGGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTCCCGGGTTACATGGCCGGTAACCTGTCCTGGTGTGGCGC 
Beta_LR    GTTATGGGCAACAACATACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTTCCGGGTTACATGGCAGGTAACCTGTCCTGGTGTGGCGC 
Clone4     GTTATGGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTCCCGGGTTACATGGCCGGTAACCTGTCCTGGTGTGGCGC 
Clone6     GTTATGGGCAACAACATACCACAGGACGTTGCTCAGGTCACCCCTGAGTTCAGTGTGCTAGAGGAGACCTTTCCGGGTTACATGGCAGGTAACCTGTCCTGGTGTGGCGC 
Clone22    GTTATCGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTAACTTCAACGTGCTCGATGAGACATTCCCGGGTTACATGACCGGTAACCTAACCTGGTGTGGCGC 
Clone12    GTTATCGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTAACTTCAACGTGCTCGATGAGACATTCCCGGGTTACATGACCGGTAACCTAACCTGGTGTGGCGC 
Clone3     GTTATCGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTAACTTCAACGTGCTCGATGAGACATTCCCGGGTTACATGACCGGTAACCTAACCTGGTGTGGCGC 
Clone19    GTTATCGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTAACTTCAACGTGCTCGATGAGACATTCCCGGGTTACATGACCGGTAACCTAACCTGGTGTGGCGC 
Clone7     GTTATCGGCACCAACGTACCACAGGACGTTGCTCAGGTCACCCCTAACTTCAACGTGCTCGATGAGACATTCCCGGGTTACATGACCGGTAACCTAACCTGGTGTGGCGC 
 
 
SpARC1     TACGGACGGTGATGGCACGGGACTCGGACTCAACTTCACCGTCTGTCCGACATGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Clone14    TACGGACGGTGATGACACGGGACTCGGACTCAACTTCACCGTCTGTCCGACATGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Clone17    TACGGACGGTGATGACACGGGACTCGGACTCAACTTCACCGTCTGTCCGACATGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Clone24    TACGGACGGTGATGACACGGGACTCGGACTCAACTTCACCGTCTGTCCGACATGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Clone1     TACGGACGGTGATGACACGGGACTCGGACTCAACTTCACCGTCTGTCCGACATGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Beta_LR    TACGGACGGTGATGGCACGGGACTCGGACTCAACTTCACCGTCTGTCCGACATGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Clone4     TACGGACGGTGATGACACGGGACTCGGACTCAACTTCACCGTCTGTCCGACATGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Clone6     TACGGACGGTGATGACACGGGACTTGGACTCAACTTCACCGTCTGTCCGACGTGGACAAGTGAAACGTGTCCCAACAATACCAAGGCGGCATTCTGGGCTAGGGCATCGA 
Clone22    TACGGACGGTGATGGCACGGGACTTGGACTCAACTTCACTGTCTGTCCTGAATGGAAAAGTGAAACATGTCCCAATAATACCAAAGTGATATTCTGGTCTAAGGCATCCA 
Clone12    TACGGACGGTGATGGCACGGGACTTGGACTCAACTTCACTGTCTGTCCTGAATGGAAAAGTGAAACATGTCCCAATAATACCAAAGTGATATTCTGGTCTAAGGCATCCA 
Clone3     TACGGACGGTGATGACACGGGACTTGGACTCAACTTCACTGTCTGTCCTGAATGGAAAAGTGAAACATGTCCCAATAATACCAAAGTGATATTCTGGTCTAAGGCATCCA 
Clone19    TACGGACGGTGATGACACGGGACTTGGACTCAACTTCACTGTCTGTCCTGAATGGAAAAGTGAAACATGTCTCAATAATACCAAAGTGATATTCTGGTCTAAGGCATCCA 
Clone7     TACGGACGGTGATGGCACGGGACTTGGACTCAACTTCACTGTCTGTCCTGAATGGAAAAGTGAAACACGTCCCAATAATACCAAAGTGATATTCTGGTCTAAGGCATCCA 
 
 
SpARC1     AGATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGAGCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCTCCTAAT 
Clone14    AGATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGAGCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCTCCTAAT 
Clone17    AGATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGAGCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCTCCTAAT 
Clone24    AGATGCTAGCAACGCAGGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGAGCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCTCCTAAT 
Clone1     AGATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGACCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCTCCTAAT 
Beta_LR    AGATGCTAGCAACGCAGGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGAGCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCACCTAAT 
Clone4     AGATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGACCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCTCCTAAT 
Clone6     AGATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTCTGAATGCGCAAAGACCTGGCGGGGCTTTCAACAATGGCAGTATATTCGCCACGATAGAAGCTCCTAAT 
Clone22    ATATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTTTGAATGCGCAAAAACCTGGCGGGGCTTTCAGCAATTATAGTTTCTTCGCCACGGAAGAAGCATCTAAT 
Clone12    ATATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTTTGAATGCGCAAAAACCTGGCGGGGCTTTCAGCAATTATAGTTTCTTCGCCACGGAAGAAGCATCTAAT 
Clone3     ATATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTTTGAATGCGCAAAAACCTGGCGGGGCATTCAGCAATTATAGTTTCTTCGCCACGGAAGAAGCACCTAAT 
Clone19    ATATGCTAGCAACGCAAGCTGTTGGTGACGTCTATGTTGTTTTGAATGCGCAAAAACCTGGCGGGGCTTTCAGCAATTATAGTTTCTTCGCCACGGAAGAAGTACCTAAT 
Clone7     ATATG-----------------------------------------------------------------------------TTTCTTCGCCACGGAAGAAGCATCTAAT 
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SpARC1     CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGAATGAGATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone14    CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGAATGAGATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone17    CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGAATGAGATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone24    CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGAATGAGATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone1     CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGAATGAGATGTATGCAGAGACGTGTACCAATGGAAGCGTTTTGTA 
Beta_LR    CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGGATGAGATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone4     CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGAATGAGATGTATGCAGAGACGTGTACCAATGGAAGCGTTTTGTA 
Clone6     CTCAACCAGGACGTGGTCACAAATGTCGCCATCTATCTCATCCCAGACTTCCAACTTGCGATTCCGAATGAGATGTATCGAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone22    CTCAACCCGGACGTGGTCACAAATGTCACCATCTATCTCATCCCAAACTTCACTCTTCCGATTCCGAATGAAATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone12    CTCAACCCGGACGTGGTCACAAATGTCACCATCTATCTCATCCCAAACTTCACTCTTCCGATTCCGAATGAAATGTATGCAGAGACGTGCACCAATGGAGGCGTTTTGTA 
Clone3     CTCAACCCGGACGTGGTCACAAATGTCACCATCTATCTCATCCCAAACTTCACTCTTCCGATTCCGAATGAAATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone19    CTCAACCCGGACGTAGTCACAAATGTCACCATCTATCTCATCCCAAACTTCACTCTTCCGATTCCGAATGAAATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
Clone7     CTCAACCCGGACGTGGTCACAAATGTCACCATCTATCTCATCCCAAACTTCACTCTTCCGATTCCGAATGAAATGTATGCAGAGACGTGCACCAATGGAAGCGTTTTGTA 
 
SpARC1     CTTGCAGAATTTCTTGATGAACATGAATTTTAATGTGACGTGTGAGGAGAACCCCAAGGAAATCATGTGGCTCCAATGTGCTCGGTTTGCAAATAGTCCATACTGTGGTC 
Clone14    CTTGCAGAATTTCTTGATGAACATGAATTTTAATGTGACGTGTGAGGAGAACCCCAAGGAAATCATGTGGCTTCAGTGTGCTCGGTTTGCAAATAGTCCATACTGTGGGC 
Clone17    CTTGCAGAATTTCTTGATGAACATGAATTTTAATGTGACGTGTGAGGAGAACCCCAGGGAAATCATGTGGCTTCAGTGTGCTCGGTTTGCAAATAGTCCATACTGTGGGC 
Clone24    CTTGCAGAATTTCTTGATGAACATGAATTTTAATGTGACGTGTGAGGAGAACCCCAAGGAAATCATGTGGCTTCAGTGTGCTCGGTTTGCAAATAATCCATACTGTGGGC 
Clone1     CTTGCAGAATTTCTTGATGAACATGAATTTCAATGTGGCATGTGAGGAGAACCCTAAGGAAATCATGTGGCTCCAGTGTGCTCGGTTTGCAAATAGTCCATACTGTGGGC 
Beta_LR    CTCGCAGAATTTCTTGATGAACATGAATTTTAATGTGACGTGTGAGGAGAACCCCAAGGAAATCATGTGGCTTCAGTGTGCTCGGTTTGCAAATAGTCCATACTGTGGGC 
Clone4     CTTGCAGAATTTCTTGATGAACATGAATTTCAATGTGACATGTGAGGAGAACCCTAAGGAAATCATGTGGCTCCAGTGTGCTCGGTTTGCAAATAGTCCATACTGTGGGC 
Clone6     CTTGCAGAATTTCTTGATGAACATGAATTTTAATGTGACATGTGAGGAGAACCCCAAGGAAATCATGTGGCTCCAGTGTGCTCGGTTTGCAAATAGTCCATACTGTGGGC 
Clone22    CTTGCGGAATTACTTGATGAACAGGAATTTTAATGTGAAATGTGAGGAGAACCCTAAGGAAATCATGTGGCTCCAGTGTGCTCGGTTTGCAGATAGTCCATACTGTGGGC 
Clone12    CTTGCGGAATTACTTGATGAACAGGAATTTTAATGTGAAATGTGAGGAGAACCCTAAGGAAATCATGTGGTTCCAGTGTGCTCGGTTTGCAGATAGTCCATACTGTGGGC 
Clone3     CTTGCGGAATTACTTGATGAACAGGAATTTTAATGTGAAATGTGAGGAGAACCCTAAGGAAATCATGTGGCTCCAGTGTGCTCGGTTTGCAGATAGTCCATACTGTGGGC 
Clone19    CTTGCGGAATTACTTGATGAACAGGAATTTTAATGTGAAATGTGAGGAGAACCCTAAGGAAATCATGTGGCTCCAGTGTGCTCGGTTTGCAGATAGTCCATACTGTGGGC 
Clone7     CTTGCGGAATTACTTGATGAACAGGAATTTTAATGTGAAATGTGAGGAGAACCCTAAGGAAATCATGTGGCTCCAGTGTGCTCGGTTTGCAGATAGTCCATACTGTGGGC 
 
SpARC1     CATACGCCAAAGGTAACCCGGTAGTGGCCGCATCAATAGTGGTTATACTGCTTCAAGTCGTTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone14    CATACGCCAAAGGTAACCTGGTAGTGGCCGCATCAATAGTGGTTATACTGCTTCAAGCCATTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone17    CATACGCCAAAGGTAACCTGGTAGTGGCCGCATCAATAGTGGTTATACTGCTTCAAGCCATTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone24    CATACGCCAAAGGTAACCTGGTAGTGGCCGCATCAATAGTGGTTATACTGCTTCAAGCCATTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone1     CATACGCCAAAGGTAACCCGGTAGTGGCCGCATCAATAGTGGTTATACTGCTTCAAGTCGTTTTCGCTATGTCTCTAAGTGGTTGGAATACAATATCTACTACCCTA 
Beta_LR    CATACGCCAAAGGTAACCCGGTAGTAGCCGCATCAATAGTGGTTATACTGCTTCAAGCCGTTTTCGCAATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone4     CATACGCCAAAGGTAACCCGGTAGTGGCCGCATCAATAGTGGTTATGCTGCTTCAAGTCGTTTTCGCTATGTCTCTAAGTGGTTGGAATACAATATCTACTACCCTA 
Clone6     CATACGCCAAAGGTACCCCGGTAGTGGCCGCATCAGTAGTGGTTATACTGCTTCAAGCCATTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone22    CATACGCCAAGGGTAACCCGGTAGTGGCTGCATCAATAGTGGTTATACTGCTTCAAGTCGTTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone12    CATACGCCAAAGGTAACCCGGTAGTGGCTGCATCAATAGTGGTTATACTGCTTCAAGTCGTTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone3     CATACGCCAAAGGTAACCCGGTAGTGGCCGCATCAATAGTGGTTATACTGCTTCAAGTCGTTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone19    CATACGCCAAAGGTAACCCGGTAGTGGCCGCATCAATAGTGGTTATACTGCTTCAAGTCGTTTTCGCTATGTCTTTCAGTGGTTGGAATACAATATCTACTACCCTA 
Clone7     CATACGCCAAAGGTAACCCGGTAGTGGCTGCATCAATAGTGGTTATACTGCTTCAAGTCGTTTTCGCTATGTCTCTCAGTGGTTGGAATACAATATCTACTACCCTA 
 
Figure 2.7A: Nucleotide sequence alignment of SpARC1-like isoforms  
Clustal W sequence alignment of the eleven TOPO-TA clones of SpARC1-like isoforms. Clone 4 and 6 have a single nucleotide deletion in 
5’UTR (highlighted yellow). Clone 7 has a deletion corresponding to complete exon 4 (highlighted grey). 70 
 
SpARC1        1 MGIYTIFLYLSPILAVTVAYNNKGPGATHNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNN 
Clone14       1 MGIYTIFLYLSPILAVTVAYNNKGPGTTHNITDILTGRCEEYRKCLLGEPCLPFYRNVNCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGTN 
Clone17       1 MGIYTIFLYLSPILAVTVAYNNKGPGTTHNITDILTGRCEEYRKCLLGEPCLPFYRNVNCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGTN 
Clone24       1 MGIYTIFLYLSPILAVTVAYNNKGPGTTHNITDILTGRCEEYRKCLLGEPCLPFYRNVNCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGTN 
Clone1        1 MGIYTIFLYLSPILAVTVAYNNPGQGTTSNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGTN 
Beta_LR       1 MGIYTIFLYLSPMLAMTVAYINTGPGTTPNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNN 
Clone4        1 MGIYTIFIYLSPMLAMTVAYINTGPGTTSNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGTN 
Clone6        1 MGIYTIFIYLSPMLAMTVAYINTGPGTTSNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNN 
Clone22       1 MGIYTIFLYLSPILAVTVAYNNPGPGTTHNITDILIGRCEEYQKCLLGEPCLPSYRNVNCRAAVESFLGGIRNVDPCATPDNAYDEFFEMVPPTTVPNTTMFWSGVIGTN  
Clone12       1 MGIYTIFLYLSPILAVTVAYNNPGPGTTHNITDILIGRCEEYRKCLLGEPCLPSYRNVNCRAAVESFLGGIRNVDPCATPDNAYDEFFEMVPPTTVPNTTMFWSGVIGTN 
Clone3        1 MGIYTIFLYLSPILAVTVAYNNPGQGTTHNITDILIGRCEEYRKCLLGEPCLPSYRNVNCRAVVESFLGGIRNVDPCSTPYNAYDEFFEMVPPTTVPNTTMFWSGVIGTN 
Clone19       1 MGIYTIFLYLSPILAVTVAYNNPGQGTTHNITDILIGRCEEYRKCLLGEPCLPSYRNVNCLAAVESFLGGIRNVDPCSTPDNAYDEFFEMVPPTTVPNTTMFWSGVIGTN 
Clone7        1 MGIYTIFLYLSPILAVTVAYNNPGPGTTHNITDILIGRCEEYRKCLLGEPCLPSYRNVNCRAAVESFLGGIRNVDPCATPDNAYDEFFEMVPPTTVPNTTMFWSGVIGTN 
SpARC1      111 IPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDV 
Clone14     111 VPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDV 
Clone17     111 VPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDV 
Clone24     111 VPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDV 
Clone1      111 VPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRPGGAFNNGSIFATIEAPNLNQDV 
Beta_LR     111 IPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAPNLNQDV 
Clone4      111 VPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRPGGAFNNGSIFATIEAPNLNQDV 
Clone6      111 IPQDVAQVTPEFSVLEETFPGYMAGNLSWCGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRPGGAFNNGSIFATIEAPNLNQDV 
Clone22     111 VPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDGTGLGLNFTVCPEWKSETCPNNTKVIFWSKASNMLATQAVGDVYVVLNAQKPGGAFSNYSFFATEEASNLNPDV  
Clone12     111 VPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDGTGLGLNFTVCPEWKSETCPNNTKVIFWSKASNMLATQAVGDVYVVLNAQKPGGAFSNYSFFATEEASNLNPDV 
Clone3      111 VPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDDTGLGLNFTVCPEWKSETCPNNTKVIFWSKASNMLATQAVGDVYVVLNAQKPGGAFSNYSFFATEEAPNLNPDV 
Clone19     111 VPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDDTGLGLNFTVCPEWKSETCLNNTKVIFWSKASNMLATQAVGDVYVVLNAQKPGGAFSNYSFFATEEVPNLNPDV 
Clone7      111 VPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDGTGLGLNFTVCPEWKSETRPNNTKVIFWSKASNMFLRHGRSI* 
 
SpARC1      221 VTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 
Clone14     221 VTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNLVVAASIVVILLQAIFAMSLSGWNTISTTL 
Clone17     221 VTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVTCEENPREIMWLQCARFANSPYCGPYAKGNLVVAASIVVILLQAIFAMSLSGWNTISTTL 
Clone24     221 VTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANNPYCGPYAKGNLVVAASIVVILLQAIFAMSLSGWNTISTTL 
Clone1      221 VTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVACEENPKEIMWLQCARFANSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 
Beta_LR     221 VTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYSQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAASIVVILLQAVFAMSLSGWNTISTTL  
Clone4      221 VTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNPVVAASIVVMLLQVVFAMSLSGWNTISTTL 
Clone6      221 VTNVAIYLIPDFQLAIPNEMYRETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGTPVVAASVVVILLQAIFAMSLSGWNTISTTL 
Clone22     221 VTNVTIYLIPNFTLPIPNEMYAETCTNGSVLYLRNYLMNRNFNVKCEENPKEIMWLQCARFADSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 
Clone12     221 VTNVTIYLIPNFTLPIPNEMYAETCTNGGVLYLRNYLMNRNFNVKCEENPKEIMWFQCARFADSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL  
Clone3      221 VTNVTIYLIPNFTLPIPNEMYAETCTNGSVLYLRNYLMNRNFNVKCEENPKEIMWLQCARFADSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 
Clone19     221 VTNVTIYLIPNFTLPIPNEMYAETCTNGSVLYLRNYLMNRNFNVKCEENPKEIMWLQCARFADSPYCGPYAKGNPVVAASIVVILLQVVFAMSFSGWNTISTTL 
 
Figure 2.7B: Amino acid sequence alignment of SpARC1-like isoforms 
Translated amino acid sequences of SpARC1-like isoforms. The highly conserved catalytic glutamate residue is highlighted green. The two tryptophan residues 
at the active site are highlighted cyan. Residues implicated in the NADase activity are highlighted grey. Clone 7 translates to a truncated protein.  71 
 
2.3.1.3  Sequence comparisons between SpARC1-like isoforms 
 
Amino acid sequence alignments of SpARC1-like isoforms with SpARC1 and SpARC-β 
indicated that they appear to segregate into 2 major groups (Figure 2.7B). The percent 
identity and similarity of the different clones (excluding truncated clone 7) is tabulated 
in Figure 2.8. Whilst clones 1, 14, 17, 24, 4, and 6 grouped with SpARC1 and Beta_LR 
(Group-I); clones 22, 12, 3 and 19 clustered together to form a distinct set (Group-II). 
The similarity within each group was higher than across the group (Figure 2.8). The 
least similar clones shared ~82% identity (or 88% similarity). Careful analysis revealed 
further  differences  in  Group-I  which  further  divided  them  into  two  subsets,  mainly 
differing in their 1
st exon. Clones 14, 17 and 24 were more similar to SpARC1, while 
Clones 4 and 6 were similar to Beta_LR (Figure 2.7B). 
 
 
2.3.1.4  Genomic correlates of SpARC1-like isoforms 
 
In  order  to  corroborate  that  the  new  clones  obtained  were  bona  fide  SpARC1-like 
isoforms  that  exist  in  S.purpuratus  genome,  and  not  an  artefact  of  PCR-cloning,  a 
representative  clone  from  each  of  the  two  groups  was  further  compared  with  the 
genomic  data.    Clone  6  was  chosen  from  Group-I.  Careful  analysis  of  clone  6 
suggested that it matched to contig NW_001326169, better than SpARC1 and Beta_LR 
(Figure 2.9) especially with respect to amino acids coded by exons 1, 6 and 7. As 
previously discussed, exon 1 of SpARC1 (or SpARC-β) did not match perfectly with 
NW_001326169 (Figure 2.3B). Therefore it is very much possible that NW_001326169 
encodes clone 6 and not SpARC1 or SpARC-β. 72 
 
  SpARC1  Clone14  Clone17  Clone24  Clone1  Beta_LR  Clone4  Clone6  Clone22  Clone12  Clone3  Clone19 
SpARC1  100  98  98  98  98  97  98  97  90  89  89  88 
Clone14  97  100  99  99  97  97  97  97  90  89  89  89 
Clone17  97  99  100  99  96  97  96  97  89  89  89  88 
Clone24  97  99  99  100  96  97  96  97  89  89  89  88 
Clone1  97  97  96  96  100  97  98  97  90  89  91  90 
Beta_LR  97  96  96  96  96  100  98  98  89  88  88  88 
Clone4  96  96  95  95  97  97  100  98  90  88  89  89 
Clone6  95  95  95  95  95  97  97  100  89  89  89  88 
Clone22  86  86  85  85  86  84  85  83  100  99  97  97 
Clone12  85  85  85  85  86  84  84  83  99  100  97  96 
Clone3  85  85  85  85  87  83  84  83  97  97  100  98 
Clone19  84  85  84  84  86  83  84  82  97  96  98  100 
 
 
Figure 2.8: Similarity between SpARC1-like clones 
 
Pair-wise  amino  acid  sequence  alignments  of  SpARC1-like  clones  with  SpARC1  and  Beta_LR  were  performed.  The  percent  identity  (cyan)  and  percent 
similarity (pink) between the members is tabulated above.  Obtained values that were beyond the known polymorphism frequencies in  S.purpuratus are 
marked red. This divides the clones into two groups: I (blue) and II (yellow).  
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Clone 3 was selected from Group-II for genomic comparison. Exons 1, 5 and 7 of clone 
3 aligned perfectly with AC201615, although exons 3 and 6 were not exact matches 
(Figure 2.10). Intriguingly AC201615 contained a single copy of exon 1, 2, 3 and 4, 
while  exons  5,  6  and  7  were  present  in  3  copies  each.  Figure  2.10  depicts  the 
alignment  of  clone  3  with  the  amino  acids  coded  by  the  best  matching  exons  of 
AC201615. The exons were not necessarily arranged in tandem while some exons (5, 
6 and 7) even occurred in the reverse direction. However, AC201615 is a working draft 
sequence made of 24 unordered fragments. 
 
An  alternate  possibility  would  be  that  clone  3  was  coded  by  NW_001356102.  This 
particular  contig  harboured  only  exons  2,  3  and  7.  Again  on  a  cautious  note, 
NW_001356102  is  a  poorly  sequenced  contig  with  many  gaps  and  unordered 
fragments. Exon 3 of clone 3 matched perfectly with this contig (Figure 2.11). It is quite 
possible that other missing exons are also present in the gap regions.  
          Exon 1 
 
SpARC1        -----------MGIYTIFLYLSPILAVTVAYNNKGPGATHNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAV 
Beta_LR       -----------MGIYTIFLYLSPMLAMTVAYINTGPGTTPNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAV 
Clone6        SFMFRNEPKFEMGIYTIFIYLSPMLAMTVAYINTGPGTTSNITDILTGRCEEYRKCLLGEPCLPFYRNVKCRAAV 
NW_001326169  SFMFRNEPKFEMGIYTIFIYLSPMLAMTVAYINTGPGTTSNITDILTGRCEEYRKCLLGEPCLPFSRNVKCRAAV 
 
SpARC1        ESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTPEFSVLEETFPGYMAGNLSW 
Beta_LR       ESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTPEFSVLEETFPGYMAGNLSW  
Clone6        ESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTPEFSVLEETFPGYMAGNLSW 
NW_001326169  ESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTPEFSVLEETFPGYMAGNLSW 
 
SpARC1        CGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAP 
Beta_LR       CGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAP  
Clone6        CGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRPGGAFNNGSIFATIEAP 
NW_001326169  CGATDGDGTGLGLNFTVCPTWTSETCPNNTKAAFWARASKMLATQAVGDVYVVLNAQRAGGAFNNGSIFATIEAP 
            Exon 6        Exon 7 
 
SpARC1        NLNQDVVTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGP 
Beta_LR       NLNQDVVTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYSQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGP  
Clone6        NLNQDVVTNVAIYLIPDFQLAIPNEMYRETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGP 
NW_001326169  NLNQDVVTNVAIYLIPDFTLPIPNEMYRETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGP 
 
SpARC1        YAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 
Beta_LR       YAKGNPVVAASIVVILLQAVFAMSLSGWNTISTTL  
Clone6        YAKGTPVVAASVVVILLQAIFAMSLSGWNTISTTL 
NW_001326169  YAKGTPVVAASIVVILLQAIFAMSLSGWNTISTTL 
 
 
Figure 2.9: Possible genomic correlate of clone 6 
 
Amino  acid  sequence  alignments  of  clone6  against  SpARC1,  Beta_LR  and  translated 
sequences from contig NW_001326169 are shown. Amino acid sequences corresponding to 
exons 1, 6 and 7 are also marked. 
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Clone 3       1 MGIYTIFLYLSPILAVTVAYNNPGQGTTHNITDILIGRCEEYRKCLLGEPCLPS 54 (exon1)  
AC201615  62997 MGIYTIFLYLSPILAVTVAYNNPGQGTTHNITDILIGRCEEYRKCLLGEPCLPS 63158 
 
 
Clone 3      56 RNVNCRAVVESFLGGIRNVDPCSTPYNAYDEFFEMVPPTTVPNT 99 (exon2) 
AC201615  82918 RNVNCRAAVESFLGGIRNVDPCSTPYNAYDEFFKMVPPTTVRNT 83055 
 
 
Clone 3     100 TMFWSGVIGTNVPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDDTGLGLNFTVCPEWKSETCPNNTKVIFWSKASNM 180(exon3)  
AC201615  64774 TMFWSGVKGTNVPQDIAQVTPYFNVIGETFPGYMAGNLSWCGATDGNDTGLGLNFTVCPKGKGATCPNNTKAIFWAKASNM 65018 
 
 
Clone 3     182 ATQAVGDVYVVLNAQKPGGAFSNY 205 (exon4) 
AC201615  68321 ATQAVGDVYVVLNAQKPGGAFSKY 68392 
 
 
Clone 3     206 SFFATEEAPNLNPDVVTNVTIYLIPNFTLPIPNEM 240 (exon5)  
AC201615  81552 SFFATEEAPNLNPDVVTNVTIYLIPNFTLPIPNEM 81448 
 
 
Clone 3     241 YAETCTNGSVLYLRNYLMNRNFNVKCEENPK 271 (exon6) 
AC201615  40357 YAETCTNGSVLYLQNFLMDMNLNVTCEENPK 40265 
 
 
Clone 3     272 EIMWLQCARFADSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 324 (exon7) 
AC201615  38652 EIMWLQCARFADSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 38490 
 
 
Figure 2.10: Possible genomic correlate of clone 3 
 
Clustal  W  sequence  alignment  of  amino  acids  corresponding  to  individual  exons  of  clone  3  against  the  corresponding  translated  sequences  from 
AC201615. 75 
 
Clone 3         56 RNVNCRAVVESFLGGIRNVDPCSTPYNAYDEFFEMVPPTTVPNT 99 (exon2)  
NW_001356102 91108 RNVNCRAAVESFLGGIRNVDPCSTPYNAYDEFFKMVPPTTVRNT 91248 
 
 
Clone 3        100 TMFWSGVIGTNVPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDDTGLGLNFTVCPEWKSETCPNNTKVIFWSKASNM 180 exon3 
NW_001356102 96778 TMFWSGVIGTNVPQDVAQVTPNFNVLDETFPGYMTGNLTWCGATDGDDTGLGLNFTVCPEWKSETCPNNTKVIFWSKASNM 97022 
 
 
Clone 3        271 EIMWLQCARFADSPYCGPYAKGNPVVAASIVVILLQVVFAMSLSGWNTISTTL 324 (exon7) 
NW_001356102 72687 EIMWLQCARFANSPYCGPYAKGNPVVAASIVVILLQAVFAMSLSGWNTISTTL 72848 
 
 
Figure 2.11: Alternate genomic correlate of clone 3 
 
Clustal  W  sequence  alignment  of  amino  acids  corresponding  to  individual  exons  of  clone3  against  the  corresponding  translated  sequences  from 
NW_001356102. 
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2.3.1.5  Functional predictions for SpARC1-like isoforms 
 
The alignment of different SpARC1-like clones (Figure 2.7B) revealed that the three 
active site amino acids (Trp
103, Trp
174, Glu
212) were conserved in all the clones. But 
intriguingly the residues adjacent to these active site amino acids differed significantly 
(sometimes a polar versus a non-polar residue). Also noticeable were the differences in 
residues implicated in cyclase and hydrolase activities (Graeff, et al., 2001). Glu
126 of 
the “TLEDTL domain” of Group-I is replaced by an Asp in Group-II clones. Similarly 
Ile
207 of Group-I is replaced by Phe in Group-II. Although this particular residue is not 
highly conserved between SpARC isoforms, it has been implicated again in controlling 
cyclase activity of Aplysia cyclase and hydrolase activity of CD38 (Graeff, et al., 2009). 
SpARC1  and  SpARC-β  have  been  shown  to  be  glycoproteins  (Churamani,  et  al., 
2007;Davis,  et  al.,  2008).  The  number  of  consensus  sites  for  potential  N-linked 
glycosylations  were  different  in  Groups  I  and  II.  For  example,  clone  3  had  nine 
consensus sites for N-linked glycosylations, compared to seven in SpARC1.  
 
In summary, it can be concluded that the 11 SpARC1-like sequences segregate into 
three different populations. Clone 6 was similar to SpARC-β. Another population with 
divergent sequences (~85% identity to SpARC1), that constituted a novel SpARC1-like 
isoform was also discovered. In addition, a novel splice variant without exon 4 was also 
identified. Figure 2.12 exhibits the differences between the amino acid sequences of 
clones from each of the three representative populations.  77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.2  Molecular cloning of SpARC4  
 
SpARC1,  SpARC2  and  SpARC3  were  identified  and  cloned  originally  by  a  BLAST 
search of the S. purpuratus genome with Aplysia cyclase sequence (Churamani, et al., 
2007). That search (by Sandip Patel, 2005) also revealed a potential fourth divergent 
isoform  encoded  by  contig  640882.  In  order  to  physically  clone  the  new  isoform, 
forward and reverse primers were designed with the sequence information gathered 
from contig 640882. However, the primers failed to amplify any product from the ovary 
or testes library of S.purpuratus that was initially used to clone SpARC1, SpARC2 and 
 
Clone6    1 MGIYTIFIYLSPMLAMTVAYINTGPGTTSNITDILTGRCEEYRKCLLGEPCLPFYRNVKC 
Clone3    1 MGIYTIFLYLSPILAVTVAYNNPGQGTTHNITDILIGRCEEYRKCLLGEPCLPSYRNVNC 
Clone7    1 MGIYTIFLYLSPILAVTVAYNNPGQGTTHNITDILIGRCEEYRKCLLGEPCLPSYRNVNC 
 
 
Clone6   61 RAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTP 
Clone3   61 RAVVESFLGGIRNVDPCSTPYNAYDEFFEMVPPTTVPNTTMFWSGVIGTNVPQDVAQVTP 
Clone7   61 RAAVESFLGGIRNVDPCATPDNAYDEFFEMVPPTTVPNTTMFWSGVIGTNVPQDVAQVTP 
 
 
Clone6  121 EFSVLEETFPGYMAGNLSWCGATDGDDTGLGLNFTVCPTWTSETCPNNTKAAFWARASKM 
Clone3  121 NFNVLDETFPGYMTGNLTWCGATDGDDTGLGLNFTVCPEWKSETCPNNTKVIFWSKASNM 
Clone7  121 NFNVLDETFPGYMTGNLTWCGATDGDGTGLGLNFTVCPEWKSETRPNNTKVIFWSKASNM 
 
 
Clone6  181 LATQAVGDVYVVLNAQRPGGAFNNGSIFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEM 
Clone3  181 LATQAVGDVYVVLNAQKPGGAFSNYSFFATEEAPNLNPDVVTNVTIYLIPNFTLPIPNEM 
Clone7  181 FLRHGRSI* 
 
 
Clone6  241 YRETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGTPVVAAS 
Clone3  241 YAETCTNGSVLYLRNYLMNRNFNVKCEENPKEIMWLQCARFADSPYCGPYAKGNPVVAAS 
Clone7   
 
Clone6  301 VVVILLQAIFAMSLSGWNTISTTL 
Clone3  301 IVVILLQVVFAMSLSGWNTISTTL 
Clone7    
 
Figure 2.12: Three different SpARC1-like isoforms 
 
Clustal  W  sequence  alignment  of  amino  acids  of  clones  6,  3  and  7  are  shown.  Highlighted 
residues show identity.  78 
 
SpARC3  (Churamani,  et  al.,  2007).  Therefore,  considering  a  possible  zygotic 
expression of the new isoform, cDNA prepared from S.purpuratus embryos were used 
for analysis by 5’ and 3’ RACE-PCR (Refer section 2.2.3 for details). This resulted in 
the successful amplification of the full length coding sequence along with 5’ and 3’ UTR 
of a new gene termed SpARC4. These data highlight the further expansion of the ARC 
family in the sea urchins. The SpARC4 open reading frame (ORF) was composed of 
1035 bp and encoded a polypeptide of 343 amino acids.  
 
 
2.3.2.1  Sequence similarity between SpARCs  
 
An alignment of SpARC4 amino acid sequence with that of SpARC1, SpARC2 and 
SpARC3  revealed  modest  similarities  between  the  family  members  (Figure  2.14). 
SpARC4  exhibited  between  24-26%  identity  and  39-42%  similarity  with  SpARC1, 
SpARC2 and SpARC3 (Figure 2.13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
  SpARC4  SpARC1  SpARC2  SpARC3 
SpARC4  100  39  42  39 
SpARC1  25  100  66  35 
SpARC2  26  52  100  38 
SpARC3  24  23  21  100 
 
 
Figure 2.13: Percent similarity between SpARC family members 
 
Tabulated above are the percent identity (cyan) and percent similarity (pink) calculated from 
pair-wise amino acid sequence alignments of the SpARC isoforms.  
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SpARC4 harboured ten core cysteine residues similar to typical ARC proteins (Figure 
2.14, yellow) along with an additional pair of cysteine residues as found in SpARC1 
and SpARC2 (Figure 2.14, purple). There was an absolute conservation of the catalytic 
glutamate residue, as in other SpARCs (Figure 2.14, green). Strikingly in SpARC4, one 
of  the  two  active  site  tryptophan  residues  (Figure  2.14,  cyan)  was  replaced  by  a 
tyrosine (Figure 2.14, red). 
 
 
 
 
2.3.2.2  Exonic organisation of SpARC4  
 
The SpARC4 gene mapped to the contig NW_001304870 as shown in Figure 2.15. 
SpARC4, like the other SpARC genes was composed of 7 exons. However, the exonic 
organization  of  SpARC4  was  strikingly  different  to  that  of  SpARC1  (Figure  2.2). 
NW_001304870  had  exons  1-7  contiguous,  although  exon  3  was  presented  in  the 
reverse  orientation.  Also  noticeable  was  the  presence  of  a  duplicated  exon  4  (in 
reverse) in between exons 2 and 3. Similarly a duplicated exon 2 (again in reverse) 
was found between exons 3 and 4 (Figure 2.15). Nucleotides 114-186 of exon 1 were 
missing in the final assembly of NW_001304870. However, the missing nucleotides 
were found in AAGJ02006063, a component of NW_001304870. Such a discrepancy 
likely reflects an error in the assembly of nucleotides, at least in this particular contig.80 
 
 
SpARC1  -----------MGIYTIFLYLSPILAVTVAYNNKG----------------------------------PGATHNITDILTGRCEEY  
SpARC2  -----------MNLLRTSLFLSSILAATVAYTLPG----------------------------------PGTTWNMTDVLLGRCVEY  
SpARC3  MPYTAYIRRRIFGVLAATIVVMTVIENASTMMTTR---------------------ATMTTLPPVLYSDNGTDIDLREIFIGRCADF 
SpARC4  -MHSLYGLSPSAPAYINKAFVLVIVAASLVVNSSGRLLPFGDTDDDDAGSRVRRADGNNMTTELPLNLGDGTTANLKAIFLGRCYD-  
 
SpARC1  RK-CLLGEPCL-PFYRNVKCRAAVESFFKGIRNMDPCATPDNAYDEFLNMVPPTTVRGTTMFWSGVMGNNIPQDVAQVTPEFSVLEE 
SpARC2  RQ-CLHGGLCF-PYYGDVNCDAAVDSFLGAIRGMDPCTASYYAYDDFFNMVPPNTKPGTTIFWTGVSGAYIPHDVAEVSQEYIVLGE 
SpARC3  KAGRVNPTVDL-NELRMKNCTHLWNLFHSTFKYREACNVTRPMYKEFVAEAAITIPSNKSAFWDGWTIYDTVHSYAKEGRRSWSLEY 
SpARC4  ---CEY---CSEEQAGLYDCSGLWDAFSSSFSYQEPCNSVPEDFDDYANMAFVPLTNDQTLFYSGMYS--MAMAIGRQSSDFTNIEL  
 
SpARC1  TFPGYMAGNLSWCGATDGDGTGLGLNFTVCPTWTSET—-CPNNTKAA--FWARASKMLATQAVGDVYVVLNAQRAGGAFNNG-SIFA  
SpARC2  TFPGYMALNLSFCGSTDPNEP-SGFNYTVCPTEDTDRAGCSNNTFAT--FWDRVSELFTRQATGEVYLVLNAQRDRGAYHLE-STFA  
SpARC3  TLMGYLINNLKFCGQEE----EPGLRYDSCP--GPDE--CGFAKGCADAFWAEASINFAKQAKGQVRVFFDSNREGGAFHNNNSYFA  
SpARC4  TMLGGLVNGITFCGMVD----APGINYDACPTF----GSCENDTQDA--FWKKSSQRFAGQASGDVTVILDGSRADGAYRPT-SFFR  
                                                      
SpARC1  TIEAPNLNQDVVTNVAIYLIPDFQLAIPNEMYAETCTNGSVLYLQNFLMNMNFNVTCEENPKEIMWLQCARFANSPYCGPYAKGNP- 
SpARC2  RVEVPALDPTKVTNVAIYLIPDFTLPTPNDKVRETCSNGTVASLRGVLTDLGLSNTCEEDPDDIMWLQCARYPDSPYCIPYSRQEPN 
SpARC3  QYELINMDPDVVENVNIYLVTELETKSG-----DNCTSPSIQELIGILKEKNIRYTCYEQPRDVLHLLCIDGNESDECILQKDALVS  
SpARC4  LQEVANLDPAKVTSLTAYVVHSLNGDVT-----EKCVTGSLLELQEDITAKRITFECIDDPSITRHVQCIQDPGHDTCLPYTDSAP-  
 
SpARC1  -------------VVAASIVVILLQVVFAMSLSGWNTISTTL  
SpARC2  ---TGGGTGGSSAIAAASMTVLFLQVVSTLLLNGCKID----  
SpARC3  PTDVALPLTTSSSSRTHNAISISFQVLIVIFVGFTHRVLHDT 
SpARC4  -----------ATFGSPTVIILTFQLVSFLSVN---------  
 
Figure 2.14: Amino acid sequence alignment of the SpARC family 
 
The amino acid sequence alignment of the four divergent SpARC isoforms is shown. Absolutely conserved and critical residues of ARCs are highlighted: ten 
cysteine residues (yellow), the catalytic glutamate residue (green), the tryptophans at the active site (cyan). Additional pair of cysteine residues in SpARC1, 
SpARC2 and SpARC4 is highlighted purple. A critical active site substitution in SpARC4 is highlighted red.  
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Figure 2.15: Exonic organization of SpARC4 
 
SpARC4 maps to NW_001304870 and comprises 7 exons. Exon 3 is presented in reverse orientation (red). Duplicated exons 4 and 2 (both in reverse) are shown 
in pink with dotted arrows. The orange box indicates that nucleotides 114-186 of exon 1 are absent in the assembly. Scale K= kilo base pairs. 82 
 
2.3.3  Phylogenetics of ARCs 
 
The  most  prominent  members  of  the  ARC  family,  human  CD38  and  CD157  are 
believed to have arisen from an ancient gene-duplication event (Ferrero and Malavasi, 
1997).  Therefore  to  provide  an  insight  into  the  evolutionary  relationship  between 
SpARCs  and  all  other  members  of  the  ARC  family,  a  comprehensive  phylogenetic 
study was carried out. Database searches identified at least 40 proteins homologous to 
SpARC1,  across  different  phyla.  Complete  amino  acid  sequence  alignments  were 
followed by phylogenetic tree construction by  protein maximum-likelihood algorithm. 
The phylogenetic analysis indicated the extensive diversification of the ARC enzymes. 
21  representative  ARC  sequences  were  further  chosen  for  analysis.  Boot-strap 
analysis  was  also  performed  to  gain  insight  into  the  probability  of  ARC  enzyme 
evolution  in  accordance  to  the  prediction  by  the  tree.  The  phylogram  broadly 
conformed to two major groups of protein families. Figure 2.16 revealed that Group-I 
clustered ARCs from a broader range of organisms, mainly the invertebrates (blue), 
while Group-II consisted of all vertebrate ARC proteins (pink). The major exception in 
Group-II  was  the  presence  of  SpARC3,  which  branched  off  separate  from  other 
SpARCs.  All  vertebrate  CD38  molecules  clustered  together  whilst  the  vertebrate 
CD157 proteins segregated further into a sub-group (yellow). SpARC1, SpARC2 and 
SpARC4 (grey) were all positioned within Group-I. SpARC1 and SpARC2 shared a 
common ancestor, as also suggested by the percent similarity between them (Figure 
2.13).  SpARC4  diverged  from  the  ancestor  protein  of  SpARC1,  SpARC2  and 
Schistosoma cyclase. The most striking grouping was that of SpARC3, which is also 
reflected by the percent similarity of SpARC3 being lowest when compared to other 
SpARCs (Figure 2.13).  83 
 
 
 
Figure 2.16: Phylogenetic tree of the ADP-ribosyl cyclase family 
 
A phylogenetic tree with 21 representative ARC sequences was constructed using SEQBOOT, 
PROML  and  CONSENSE  algorithms  of  PHYLIP  package.  Shaded  areas  (blue  and  pink) 
represent  two  main  branches  of  the  tree.  Yellow  shaded  area  represented  a  subgroup  in 
vertebrate ARC proteins. SpARC1, SpARC2, SpARC3 and SpARC4 are highlighted in grey. 
Abbreviations  used  are  detailed  on  the  next  page.  Scale  bar  indicates  10  nucleotide 
substitutions per site. Numbers on the nodes represent boot-strap values. 
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Abbreviation  Organism  Common name 
A.c  Aplysia californica  Sea slug 
G.g  Gallus gallus  Chicken 
H.m  Hydra magnipapillata  Hydra 
H.s  Homo sapiens  Human 
M.d  Monodelphis domestica  Marsupial 
M.m  Mus musculus  Mouse 
N.v  Nematostella vectensis  Sea anemone 
O.a  Ornithorhynchus anatinus  Platypus 
SmNACE  Schistosoma mansoni (NAD Catabolising Enzyme) 
 
 
Flat worm 
SpARC  Strongylocentrotus purpuratus (ADP Ribosyl Cyclase)  Sea urchin 
T.a  Trichoplax adhaerens  Placozoa 
T.n  Tetraodon nigroviridis  Pufferfish 
X.l  Xenopus laevis  Frog 
 
 
 
2.4  Discussion 
 
 
Our current knowledge of the molecular diversity of ARCs is limited. ARCs are absent 
in  yeast,  C.elegans  and  Drosophila,  but  have  been  well  characterized  from 
protostomes like Aplysia and Schistosoma (Lee and Aarhus, 1991; Goodrich, et al., 
2005). These organisms possess a single ARC gene whereas mammals possess at 
least two different isoforms, CD38 and CD157, each exhibiting both enzymatic as well 
as receptor-related functions (Lee, 2000). Sea urchins were recently shown to possess 
three different isoforms of ARC, namely SpARC1, SpARC2 and SpARC3 (Churamani, 
et  al.,  2007;  Davis,  et  al.,  2008).  In  this  study,  the  cloning  of  novel  SpARC1-like 85 
 
isoform(s)  (Figure  2.7A)  and  a  fourth  divergent  isoform,  SpARC4  (Figure  2.14), 
highlights further diversification and expansion of the family of ADP-ribosyl cyclases in 
S.purpuratus. 
 
Three  ARC  genes  were  cloned  from  S.purpuratus  by  two  independent  studies 
(Churamani, et al., 2007; Davis, et al., 2008). However, in these studies there were 
some  discrepancies  between  the  cellular  localization  of  SpARC1  and  SpARC-β. 
SpARC1 localized to the ER lumen (Churamani, et al., 2007), whilst SpARC-β was 
found in the cortical granules of the egg (Davis, et al., 2008). An amino acid sequence 
alignment revealed that the N-terminal region of the two proteins were different (Figure 
2.1).  A  possibility  that  the  two  variants  arouse  through  alternate  splicing  was 
considered.  However,  the  argument  could  not  be  substantiated  with  the  genomic 
evidences  gathered  in  this  study.  Nevertheless,  the  thorough  investigation  of  the 
S.purpuratus  genomic  sequences  revealed  the  existence  of  multiple  SpARC1-like 
exons throughout the genome (Figures 2.2,  2.3 and 2.4). These exonic sequences 
were very similar to each other and to SpARC1. The suspicion that these were errors in 
genome assembly was dismissed by the fact that the intronic sequences flanking these 
duplicated exons were also variable (Figure 2.3A). 
 
A breakthrough in sea urchin biology came with the sea urchin genome sequencing 
project. However, the large amount of heterozygosity that was present in the outbred 
animal which was sequenced, posed more challenges than solutions (Sodergren, et al., 
2006a).  A unique feature of the sea urchin genome in comparison  to other animal 
genomes is the high levels of intra-specific sequence variations or polymorphisms. As 
early as 1978, DNA melting curve experiments by Britten and colleagues suggested 
nearly  4-5%  sequence  divergence  between  the  haploid  DNA  of  two  individual  sea 
urchins  (Britten,  et  al.,  1978).  Measurements  of  sequence  variations  in  the  S. 
purpuratus genome assembly revealed at least one single nucleotide polymorphism 86 
 
(SNP) per 100 bases. This frequency  was the highest when compared to humans, 
Chimp, Arabidopsis, C.elegans and Drosophila. The differences in the S.purpuratus 
genomic sequences were also due some extent to the insertions and deletions (indels). 
The ratio of SNPs: indels was also found to vary at different loci (Britten, et al., 2003). 
The genome assembly is not perfect yet, at least in specific regions. Some examples of 
the  sequencing/assembly  error(s)  have  been  highlighted  in  Figure  2.15.  Exon  3  of 
SpARC4  was  present  in  the  reverse  orientation  in  the  genome.  Some  contigs  still 
consist of unordered fragments (Figure 2.12). Such a state of the genome together with 
high  levels  of  polymorphisms  is  problematic  for  the  identification  of  highly  similar 
genes.  
 
Considering these facts, the data suggesting the presence of multiple SpARC1-like 
exons  in  the  genome  (Figures  2.2,  2.3  and  2.4)  have  to  be  interpreted  with  great 
caution. However, the scattering of the duplicated exons in the genome was a unique 
property  of  SpARC1  gene.  Search  of  the  genome  with  the  exons  of  SpARC2  and 
SpARC3 did not exhibit similar pattern. Duplicated copies of exons 2 and 4 of SpARC4 
were however observed, but in the same genomic contig as the other exons. Since 
exon  3  of  SpARC4  is  also  presented  in  the  reverse  orientation  (Figure  2.15),  it  is 
unclear if it is an assembly error or a real duplication event. If the poor state of the 
genome was responsible for the observations with SpARC1 exons, then duplication 
events of the exons of all other SpARC isoforms should be equally prevalent. It is quite 
possible  that  SpARC1  is  the  oldest  member  of  the  SpARC  family.  Thus  the 
evolutionary pressure has possibly been relaxed for SpARC1, resulting in exons being 
shuffled  throughout  the  genome,  to  create  new  variants  of  the  gene.  S.purpuratus 
could afford such a relaxation owing to the presence several SpARC isoforms. Even if 
the shuffling results in a non-functional protein, cADPR/NAADP production could be at 
least partly compensated by the other isoforms. A functional protein on the other hand 
could lead to a positive selection. 87 
 
In this regard, the physical sequences of  SpARC1-like clones obtained by RT-PCR 
(Figures 2.5, and 2.7B) are more reliable. Again all the eleven sequences were highly 
similar  with  subtle  differences.  Hi-fidelity  Platinum  Taq  polymerase  enzyme  which 
posses proof reading ability has been used in this study. This enzyme has an error rate 
of 1 in approximately 54,000 nucleotides. A ~1 Kb fragment (SpARC1-like isoform) 
amplified  for  40  cycles  would  still  not  accumulate  significant  mutations  in  the  PCR 
product. Therefore the error introduced by PCR during cloning would be minimal and 
possibly  cannot  account  for  all  the  nucleotide  differences  observed  (Figure  2.7A). 
Hence,  the  sequence  variations  observed  in  the  eleven  SpARC1-like  clones  are 
unlikely to be cloning and/or sequencing errors. In spite of that, each of the eleven 
clones cannot be considered to be a unique SpARC1-like isoform (Figure 2.7A). Much 
of  the  variations  observed  could  be  attributed  just  to  the  heightened  levels  of 
polymorphism exhibited by sea urchins amongst their population  (Sodergren, et al., 
2006b).  Nevertheless,  the  cloning  of  SpARC-β  (Beta_LR)  independently  in  our  lab 
(Figure 2.5) using an entirely different approach (from ovary library) emphasized that 
the  observed  variation  in  the  sequences  were  genuine.  Thus,  what  emerged  as  a 
definite picture was the presence of novel isoform(s) very similar to SpARC1 (Figure 
2.7B).  
 
Careful analysis of the eleven clones revealed that they broadly segregated into two 
major groups (Figure 2.12). Group-II proteins shared only 85% identity with SpARC1, a 
Group-I  protein  and  thus  likely  constitute  a  novel  ARC  isoform.  Group-I  further 
segregated into two sub-groups, with one sub-set (clones 14, 17, 24, 1) being similar to 
SpARC1 and the other sub-set (clones 4 and 6) similar to Beta_LR. In summary, the 
set  of  eleven  clones  clearly  constituted  three  different  SpARC1-like  isoforms.  First, 
sequences similar to SpARC-β that was previously cloned by Galione’s group (Davis, 
et  al.,  2008),  but  independently  cloned  in  this  study  using  different  approaches. 
Second, sequences divergent enough to be classified as novel SpARC1-like isoform 88 
 
(Group-II);  clone  3  being  a  representative  (Figure  2.12).  Third,  clone  7,  possibly  a 
splice variant of Group-II isoforms, with exon 4 absent.  
 
The greatest challenge that emerged from the analysis of the clones was the extremely 
high levels of similarity between the sequences. Yet the sequences exhibited some 
differences  that  could  not  be  overlooked.  The  observed  differences  also  physically 
mapped to certain genomic contigs (Figure 2.9, 2.10 and 2.11), strengthening the idea 
that  they  were  real  differences  and  not  PCR  artefacts.  This  high  level  of  similarity 
between SpARC1-like sequences contradicts the fact that all ARCs discovered so far 
display only modest sequence similarity (Figure 2.13) even within an organism (30-
40%).  A  southern  blot  hybridisation  of  S.purpuratus  genomic  DNA,  using  SpARC1 
sequence  as  a  probe,  would  conclusively  prove  if  SpARC1  gene  exists  in  multiple 
copies. 
 
There is also a possibility that some of the SpARC1-like clones are splice variants, 
given the observed differences occur specifically in particular exons (Figure 2.9). This 
is obvious for clone 7 which lacks exon 4 (Figure 2.7A). This is unlikely to be a cloning 
error considering location of the deletion to an intron-exon boundary (Figure 2.7B). The 
observed alternate splice product for an ARC family member is not unique to this study. 
Previous investigations with human CD38 identified an alternatively spliced product: 
exon 3 was specifically spliced out, causing a shift of reading frame and eventually a 
premature stop codon (Nata, et al., 1997). Such alternate splicing was suggested as a 
possible mechanism for the transcriptional regulation of CD38.  
 
Davis  et  al  in  their  studies  used  antibodies  raised  against  SpARC-β  peptides 
FQLAIPNEMYAETC  and  CLYLQNFLMNMNFNV  (Davis,  et  al.,  2008).  This  peptide 
sequence is same in SpARC1 and SpARC-β (Figure 2.17). Therefore the antibodies 
should have revealed the presence of SpARC1 in ER. However, there could be several 89 
 
reasons for this discrepancy in localization. SpARC-β was isolated and localized using 
S.purpuratus  egg  (Davis,  et  al.,  2008),  while  SpARC1  was  isolated  from  the  ovary 
library  and  localization  determined  by  heterologous  expression  in  Xenopus  oocytes 
(Churamani, et al., 2007). There is the possibility that the expression and location of 
SpARC1  (isoforms)  is  developmentally  regulated  (as  will  be  further  investigated  in 
Chapter 6), such that SpARC1 may not be expressed in the egg. Careful analysis also 
revealed  that  the  peptide  sequence  used  to  raise  antibodies  against  SpARC-β  is 
different  in  the  newly  discovered  Group-II  isoforms  (Figure  2.17).  Therefore,  the 
antibodies employed in the study of Davis et al would not have recognised these novel 
SpARC1-like  isoforms.  Hence,  further  molecular  characterization  of  SpARC1-like 
isoform(s) (possibly clone 3), would shed light on the physiological and evolutionary 
relevance of such a duplicated gene.  
 
 
 
 
 
 
 
 
 
 
Although SpARC1-like proteins differ subtly from each other (Figure 2.7B), the amino 
acid  substitutions  observed  occur  in  crucial  positions.  Particularly,  amino  acids 
immediately adjacent to all three active site residues (Figure 2.7B - highlighted green 
for Glu and cyan for two Trp) are different in Groups I and II. These changes may be 
crucial in regulating the active site conformation and enzyme catalysis of the isoforms. 
Additionally, changes in amino acids at residues governing cyclase against hydrolase 
                  Peptide 1                                          Peptide 2 
          
SpARC-β    FQLAIPNEMYAETC          LYLQNFLMNMNFNV 
SpARC1     FQLAIPNEMYAETC          LYLQNFLMNMNFNV  
Clone3     FTLPIPNEMYAETC          LYLRNYLMNRNFNV 
 
 
Figure 2.17: Peptides used for design of antibodies in SpARC-β studies 
 
In their studies, Davis et al targeted SpARC-β by raising antibodies against two short peptides 
(Davis, et al., 2008). Shown above is the Clustal W amino acid sequence alignment of those two 
peptides of SpARC-β against corresponding regions of SpARC1 and Clone 3. 90 
 
activities are also observed (Figure 2.7B - highlighted grey). Group-II clones have an 
aspartate residue instead of Glu
126 in the “TLEDTL domain”. Although this seems a 
conservative  substitution,  Lee  and  colleagues  have  shown  that  site-directed 
mutagenesis of the corresponding Glu to Asp in CD38 resulted in the introduction of 
cyclase activity when compared to the wild-type (Graeff, et al., 2001). Moreover, in the 
same set of clones Ile
207 is also replaced by phenylalanine. Although this residue is not 
widely  conserved  in  SpARCs,  again  Lee  and  co-workers  have  highlighted  its 
significance in controlling the cyclase versus hydrolase reactions. Cyclase activity was 
introduced in CD38 by the replacement of the corresponding Thr to Phe, while Aplysia 
cyclase exhibited hydrolase activity in the converse experiment (Graeff, et al., 2009;Liu, 
et al., 2009). Also in analogy, mutation of this residue had significant implications for 
SpARC4  activity  as  detailed  in  Chapter  5.  Another  significant  difference  between 
Group-I and Group-II clones was the number of consensus sequences for potential N-
linked glycosylation sites. This could possibly influence the stability and activity of the 
isoforms (Yamamoto-Katayama, et al., 2001). 
 
Previous studies hinted on the existence of a fourth divergent ARC isoform in  sea 
urchins  (Patel,  unpublished).  In  this  study  SpARC4  was  cloned  from  S.purpuratus 
embryos (Figure 2.14). The exonic organization of SpARC4 was very similar to that of 
CD38. Intron 1 of SpARC4 spans ~7.5kb and is bigger than all other introns (Figure 
2.15).  This  possibly  suggests  that  the  intron-exon  architecture  of  ARCs  have  been 
conserved across phyla during evolution. There is also an absolute conservation of the 
active  site  residues  Trp
174  and  Glu
212  residues  (SpARC1  numbering)  in  SpARC4. 
Another active site amino acid Trp
103 which is strikingly different in Schistosoma NACE 
(Figure  5.8A)  is  conserved  in  SpARC1-like  proteins,  SpARC2  and  SpARC3.  This 
residue is replaced with a conservative substitution to a tyrosine in SpARC4 (Figure 
2.14 - red). The significance of such a deviation of an active site amino acid for the 
functional evolution of SpARC4 will be detailed in Chapter 5. 91 
 
CD38  and  CD157  are  likely  products  of  a  gene  duplication  event  (Ferrero  and 
Malavasi,  1997).  Malavasi  proposed  that  the  gene  duplication  episode  that  created 
CD38 and CD157 may not have been an isolated event (Ferrero and Malavasi, 1999). 
According to Doolittle’s hypothesis, there is a tendency for “duplication to beget more 
duplication”  (Doolittle,  1995).  This  would  suggest  that  a  relatively  small  number  of 
genes expanded by duplications  and/or modifications to give rise to a repertoire of 
proteins during the course of evolution. Thus, CD38 and CD157 were possibly only the 
first members to be identified, belonging to a much larger and diverse gene family. In 
this context, the discovery of a highly expanded collection of four different ADP-ribosyl 
cyclases and possibly more SpARC1-like isoforms in S.purpuratus is both interesting 
and timely. It is intriguing that mammals have only two ARC isoforms, whereas sea 
urchins possess such a large portfolio. Nevertheless, this is not the first instance of 
such duplications occurring in S.purpuratus genome. It recently came as a surprise 
when four greatly expanded subfamilies of rhodopsin-type GPCRs were identified in 
S.purpuratus. It was one of the largest molecular sensory repertoires reported in any 
organism (Raible, et al., 2006). Sea urchins also possess at least 222 Toll-like receptor 
(TLR) genes and 200 Nod-like receptor (NLR) genes similar to vertebrates (Rast, et al., 
2006). 
 
Since  S.purpuratus  possess  such  an  expanded  family  of  ARCs,  it  is  particularly 
important to know the evolutionary placement of SpARCs with respect to each other 
and also in relation to other ARCs. Therefore, to describe the evolutionary patterns of 
conservation and divergence in ARCs, a comprehensive sequence comparison and 
phylogenetic analysis of all known ARC sequences was carried out in this study (Figure 
2.17). Broadly two protein families with highly conserved signature motifs and distinct 
evolutionary  relationships  were  identified.  Group-I  consisted  of  invertebrate  ARC 
sequences while  Group-II was made of vertebrate  ARCs. Group-II could be further 
delineated as CD38 and CD157 molecules. The overall pattern of divergence was in 92 
 
line with the tree of life. All SpARCs except SpARC3 clustered into Group-I. SpARC1 
and SpARC2 were closer to each other sharing a common ancestor as also exhibited 
by their sequence similarity (Figure 2.13). SpARC4 diverged much earlier sharing a 
common ancestor with the clade of SpARC1 and SpARC2 and SmNACE. Surprisingly, 
SpARC3  was  clearly  divergent,  sharing  the  same  ancestors  as  vertebrate  CD38 
molecules.  This  disparity  is  also  reflected  by  fact  that  SpARC3  shares  the  lowest 
percent similarity with other members of the SpARC family (Figure 2.13). Whether this 
finding has any physiological implications, is not known at this point. However, this 
result has to be interpreted with caution since the boot-strap values for this clade is 
very low.  
 
The phylogenetic tree also reiterated the fact that the vertebrate CD38 and CD157 
molecules  have  arisen  by  an  ancient  duplication  event.  This  is  evident  from  their 
proximity and placement in the phylogenetic tree with respect to other ARC sequences 
(Figure  2.17).  The  phylogenetic  tree  also  suggested  that  ARC  molecules  have 
undergone selective expansion only in the sea urchins. This coupled with the evidence 
for existence of multiple SpARC1-like exons in S.purpuratus geneome bear significant 
implications on ARC evolution. The rather unusual divergence of ARC gene family in 
the sea urchin, which is a basal deuterostome, is very interesting. Sea urchins have an 
evolutionary niche, being the closest relative of chordates. Careful genomic analysis of 
ARCs from other deuterostomes could also provide further insights into the specific 
expansion patterns of ARC family in this particular lineage. 93 
 
Chapter 3: Localization and structural properties 
of sea urchin ADP-ribosyl cyclases 
 
3.1  Introduction  
 
ADP-ribosyl cyclases are remarkable enzymes involved in the production of calcium-
releasing second messengers cADPR and NAADP (Lee, 2001). All of the ARC family 
members harbour consensus sites for N-linked glycosylation (Lee, 1997). Mutagenesis 
studies  carried  out  by  Jingami’s  lab  suggested  that  N-glycosylation  of  CD157  was 
critical for the folding of the nascent polypeptide chain into a conformation conducive 
for intracellular trafficking and enzymatic activity (Yamamoto-Katayama, et al., 2001). 
Another report showed that N-linked glycosylation was crucial for the maintenance of 
structural  stability  of  human  CD38.  However,  it  was  not  a  pre-requisite  for  its 
localization to the plasma membrane (Gao and Mehta, 2007). Recent investigations on 
bovine CD38 established that glysosylation was not essential for the processing and 
secretion of the protein. Nevertheless the deglycosylated mutant exhibited significant 
alterations in thermo-stability and catalytic activity (Muller-Steffner, et al., 2010).  
 
CD38 and CD157 are predominantly located on the plasma membrane of different cell 
types (Jackson and Bell, 1990;Itoh, et al., 1994). Even before the discovery of ARCs, a 
bovine  NAD  glycohydrolase  (later  confirmed  as  CD38)  was  localized  to  the  cell 
membrane and the implication of its transverse topology argued (Muller and Schuber, 
1980). Yet, after three decades of exploration, it is still an enigma as to why an enzyme 
whose substrates and products that are active in the cytosol should after all be located 
on the cell surface. To justify the observed “Topology Paradox” (De Flora A., et al., 
1997b) many theories have been proposed and some indirect experimental proof has 94 
 
also been gathered, yet there is no conclusive evidence for the rationalisation of this 
mystery. 
 
However, CD38 has also been shown to be expressed in various organelles. CD38 
was  detected  in  mitochondria  of  rat  liver  preparations  and  proposed to  function  by 
sensing the metabolic state of the cell through perceiving NADH levels (Liang, et al., 
1999).  The  presence  of  CD38  was  also  revealed  in  the  nuclear  envelope.  CD38 
mediated calcium  signalling  was proposed to influence nuclear activation and gene 
expression  in  hepatocyte  nucleus  (Khoo,  et  al.,  2000)  and  was  also  implicated  in 
nuclear calcium homeostasis (Adebanjo, et al., 1999). Trubiani et al showed that CD38 
was  constitutively  expressed  in  the  nucleus  and  was  independent  of  the  plasma 
membrane  pool  (Orciani,  et  al.,  2008).  In  another  study,  CD38  was  detected  at 
interchromatin regions linked to nuclear scaffold, micronuclei and cajal bodies and also 
co-localized  with  coilin  suggesting  a  role  for  ARCs  in  nuclear  processes  like 
transcription, replication, repairing and splicing (Trubiani, et al., 2008). 
 
CD38 has also been widely detected in endosomes. Zocchi et al demonstrated the 
internalization of CD38 into endocytic vesicles in response to externally added NAD 
(Zocchi, et al., 1996). Malavasi’s lab illustrated that the CD38 expressed on the plasma 
membrane entered a specific endocytic pathway upon stimulation and clustered during 
the  formation  of  immunological  synapse  (Munoz,  et  al.,  2008).  Khoo  and  Chang 
observed  domain  specific  expression  pattern  in  plasma  membrane  of  hepatocytes 
suggesting the clustering of CD38 as a possible way of regulation (Khoo and Chang, 
2000). Contradictory to these reports, Lund and co-workers demonstrated that CD38 
expression was only detectable at the level of plasma membrane and not within the cell 
in B lymphocytes (Moreno-Garcia, et al., 2005). 
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Aplysia  cyclase  has  a  very  short  hydrophobic  signal  peptide  sequence  at  its  N-
terminus. It is a soluble protein and present in the granules of ova-testis (Glick, et al., 
1991).  Recently  it  was  demonstrated  to  be  redistributed  to  the  nucleus  upon 
depolarization (Bezin, et al., 2008). CD38 has a slightly longer hydrophobic N-terminus 
that acts as a transmembrane domain, through which it is tethered to the cell surface 
(Jackson  and  Bell,  1990),  while  CD157  and  SmNACE  are  attached  to  the  plasma 
membrane by a C-terminal GPI-anchor (Itoh, et al., 1994; Lee, 1997; Goodrich, et al., 
2005). GPI-anchors  endow  the attached protein with a stable membrane anchoring 
device, resistant to most extracellular proteases and lipases. However, they can be 
released  from  the  plasma  membrane  specifically  by  the  action  of  the  enzyme, 
phosphoionisitol  specific  phospholipase  C  (PI-PLC)  and  phosphoionisitol  specific 
phospholipase D (PI-PLD) (Low and Saltiel, 1988). Such cleavages of the GPI-anchor 
from  its  associated  protein  has  been  suggested  as  a  mechanism  for  the  selective 
regulation  without  involving  transcriptional  control  and  may  thus  lead  to  efficient 
recycling of the active biomolecule (Low, 1989). In studies carried out by Chini’s group, 
PI-PLC  released  novel  ARC  activity  from  the  plasma  membrane  but  not  from  the 
mitochondrial membranes of rat liver (Liang, et al., 1999). 
 
As  discussed  in  section  1.6.1,  at  least  in  some  mammalian  cell  types,  transport 
mechanisms for NAD/NADP/cADPR have been reported (Guida, et al., 2002;Bruzzone, 
et al., 2001;Billington, et al., 2006). Recently, a sea urchin ARC, SpARC1 located in the 
lumen of endoplasmic reticulum was shown to easily access its substrates and form 
products (Churamani, et al., 2007). Another study suggested that SpARC-β localized to 
the  cortical  granules  of  the  egg  (Davis,  et  al.,  2008).  These  studies  indicated  the 
existence  of  transport  systems  for  NAD  and/or  cADPR  in  the  sea  urchins  as  well. 
Similar ER localization has been registered previously for CD38 (Yamada, et al., 1997). 
Figure 3.1 schematically depicts the sub-cellular distribution observed for some known 
ARCs. 96 
 
In this Chapter, SpARC2, SpARC3 and SpARC4 have been heterologously expressed 
in  Xenopus  embryos  and  HEK  cells  and  their  post-translational  modifications,  sub-
cellular localization and mode of membrane attachment established. 
 
 
 
3.2  Materials and Methods  
 
3.2.1  Structural predictions for SpARCs 
 
General protein bio-physical parameters were calculated using ExPasy ProtParam tool 
(Gasteiger  E.,  2005).  Signal  peptides/anchors  were  determined  using  Signal-P  3.0 
Figure 3.1: Sub-cellular distribution of ARCs 
 
Schematic representation of the sub-cellular localization of various members of the ARC family. 
The mode of anchorage to the membrane is also depicted. SA= signal anchor; GPI= Glycosyl 
phosphatidyl inositol anchoring sequence. N and C terminus are indicated for CD38 and CD157. 97 
 
(Bendtsen, et al., 2004). GPI modification sites were identified using big-PI predictor 
(Eisenhaber,  et  al.,  1999)  and  GPI-SOM  (http://gpi.unibe.ch).  Hydrophobicity  was 
calculated by the Kyte-Doolittle method (Kyte and Doolittle, 1982), DAS-TM filter server  
and TMHMM 2.0 (http:// www.cbs.dtu.dk/services/TMHMM). N-Glycosylation sites were 
predicted using NetNGlyc 1.0 (http://www.cbs.dtu.dk/services/NetNGlyc).  
 
3.2.2  Cloning of SpARCs into pCS2+ vectors 
 
SpARC2 and SpARC3 were cloned from the testes library of S.purpuratus by Sandip 
Patel (Churamani, et al., 2007). SpARC2-Myc was generated in two consecutive steps 
again  by  Sandip  Patel.  First  the  signal  peptide  sequence  corresponding  to  first  23 
amino acids was cloned at the BamHI/ClaI site of pCS2+ MT vector (Roth, et al., 1991) 
(http://sitemaker.umich.edu/dlturner.vectors/home). This construct is here after named 
pCS2
+-SP-MT. Following that, the remaining C-terminal sequences corresponding to 
amino  acids  from  24  to  332  were  amplified  and  cloned  into  pCS2+-SP-MT  at  the 
EcoRI/XbaI sites. 
 
The  primers  used  in  this  chapter  are  listed  in  Table  3.1.  SpARC3-Myc  was  also 
constructed in two steps. First the N-terminal putative signal anchor sequence alone 
(corresponding to amino acids 1 to 27) was amplified using primers SpARC3-3F and 
SpARC3-NMyc-1R and cloned into pCS2+-MT vector at the BamHI/ClaI sites, such 
that the 6-Myc tags were introduced after the signal anchor. In the subsequent step, 
the  remaining  C-terminal  sequences  corresponding  to  amino  acids  28  to  355  were 
amplified using primers SpARC3-NMyc-1F and SpARC3-7R and cloned into the above 
vector at the EcoRI/XbaI sites.  
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Primers were designed with restriction sites incorporated, to amplify from start to stop 
codon, the SpARC4 gene, from its TOPO-TA clone (section 2.2.3). Similar to SpARC2-
Myc, SpARC4-Myc was generated by using primers SpARC4-NMyc-1F and SpARC4-
6R to amplify sequences corresponding to amino acids 38 to 343 and cloned at the 
EcoRI/XbaI sites of pCS2+-SP-MT.  
 
SpARC2-ΔC-Myc, SpARC3-ΔC-Myc and SpARC4-ΔC-Myc were constructed using the 
same 5’ primer as used in full length constructs and new 3’ primers bearing a stop 
codon at the end: SpARC2-CT-Trun-1R, SpARC3-CT-Trun-1R and SpARC4-CT-Trun-
1R. This resulted in the deletion of the last 37 amino acids of SpARC2, 23 amino acids 
of SpARC3 and 17 amino acids of SpARC4. 
 
All constructs were verified by DNA sequencing.  
 
 
3.2.3  In vitro transcription 
 
SpARC2  constructs  were  linearised  at  the  BstXI  site,  while  SpARC3  and  SpARC4 
constructs  were  linearised  at  the  NotI  site  and  purified  on  QIA  prep  spin  columns 
(Qiagen).  Capped  mRNA  was  synthesised  from  the  SP6  promoter  using  the 
mMessage  mMachine  Kit  (Ambion)  from  the  linearized  construct  according  to 
manufacturer’s  instructions.  The  reaction  was  terminated  by  DNaseI  treatment  and 
mRNA purified using RNeasy spin column (Qiagen) as per manufacturer’s instructions. 
The RNA quality and yield were estimated by A260 and A280 measurements using UV 
spectrophotometer. The RNA was aliquoted and stored at -80°C until further use. 99 
 
Figure 3.2: Flow-chart for heterologous expression of SpARC isoforms 
  
The above chart explains the various processes involved in over-expression of SpARC proteins. 
Each step is detailed in further sections of materials and methods.  
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  Primer name  Primer sequence (5’→3’) 
1  SpARC3-3F  CACCGGATCCAT GCCATA CACTGCCTATATACGA 
2  SpARC3-NMyc-1R  ACCCAATCGATGGTTTTCAATAACCGTCATTACGA 
3  SpARC3-NMyc-1F  CACCGAATTCAGCGAGTACGATGATGACGA 
4  SpARC3-7R  GCTCTAGATTACGTGTCGTGTAAGACACGG 
5  SpARC4-NMyc-1F  CACCGAATTCATTCGGCGATACGGACGAT 
6  SpARC4-6R  GCTCTAGATCAATTAACAGAAAGGAATGATATGA 
7  SpARC2-CT-Trun-1R  GCTCTAGAGTCATTCCTGCCTGCTGTATGG 
8  SpARC3-CT-Trun-1R  GCTCTAGATTAGGCGTTATGAGTTCTCGATG 
9  SpARC4-CT-Trun-1R  GCTCTAGAGTCACGAGCCGAAAGTCGCG 
 Table 3.1: List of all primers used in this chapter 
 
3.2.4  Microinjection of Xenopus laevis embryos 
 
Xenopus embryos at 2-4 cell stage were injected with 0.8 ng of mRNA per blastomere 
and incubated in 5% normal amphibian medium (Sive, et al., 2000) at 14-17°C, until 
late  blastula/early  gastrula  stage.  Only  healthy  embryos  were  then  collected.  For 
immunohistochemistry experiments, a only a single blastomere at 2-4 cell stage was 
injected in order to induce a mosaic pattern of expression. All the Xenopus embryo 
injections were done by Dr. Leslie Dale, Dept. of Cell and Developmental Biology, UCL. 
 
For western blotting experiments, the Xenopus embryos were homogenised in 20 µl 
per  embryo  of  homogenisation  buffer  (20  mM  Tris,  pH  7.2,  50  mM  NaCl,  10  mM 
MgAcetate, 1% TX-100), supplemented with complete
TM EDTA free protease inhibitors 
and incubated on ice for 30 min. The homogenates were then centrifuged at 21000 g at 
4°C for 1 min to remove any particulate matter. For deglycosylation experiments, the 101 
 
homogenates (half embryo equivalents) were denatured and treated with PNGase F 
enzyme (NEB) or water (negative controls) at 37°C for 1 h according to manufacturer’s 
instructions. 
 
3.2.5  Transfection of HEK cells 
 
Human  Embryonic  Kidney  (HEK)  cells  were  grown  and  maintained  in  Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal bovine serum and antibiotics 
penicillin (100 U/ml) plus streptomycin (100 µg/ml) at 37°C in a humidified 5% CO2 
chamber.  The  cells  were  transferred  to  an  antibiotic  free  medium  one  day  before 
transfection  and  seeded  onto  either  a  6-well  plate  (for  western  blotting/secretion 
assays)  or  poly-L-Lysine  (20  µg/ml)  coated  1  cm  cover  slips  (for  immuno 
cytochemistry). Upon reaching 90% confluency, the cells were transiently transfected 
with  4  µg/  0.8  µg  plasmid  DNA  using  Lipofectamine™  2000  transfection  reagent 
(Invitrogen) according to manufacturer’s instructions. The cells were then allowed to 
grow for at least 17 h post transfection.  
 
For  the  preparation  of  homogenates,  the  cells  were  resuspended  into  100  µl 
homogenisation  buffer,  rotated  at  4°C  for  1h  and  spun  at  100,000  g  for  1  h.  The 
supernatants were collected and frozen at -20°C. 
 
3.2.6  Western blot analysis 
 
Either 0.33 Xenopus embryo equivalents or 25-50 µg of HEK cell homogenates and 
media equivalents (see section 3.2.11 and 3.2.12 for details) per well were mixed with 
gel loading dye (Invitrogen), reduced and denatured with 100 mM DTT at 90°C for 10 
min and loaded onto NuPAGE 4–12% Bis-Tris gels (Invitrogen). The gel was run with 102 
 
MOPS running buffer (Invitrogen) for 50 min. The protein bands were then transferred 
to nitrocellulose membrane (Applied Biosystems) at 15 V for 35 min. The blots were 
then blocked with 5% dried skimmed milk powder in 1X TBS-T (25 mM Tris, 137 mM 
NaCl, 2.7 mM KCl, pH 7.4, 0.1% Tween-20) overnight at 4°C. The blot was washed 
three times with 1X TBS-T, and incubated with 1:1000 dilution of the primary antibody 
(mouse anti-myc monoclonal antibody, clone 9e10, Insight Biotechnology) for 1 h at 
25°C. Again following 3 washes with TBS-T, the blot was treated with 1:1000 dilution of 
the secondary antibody (anti-mouse IgG conjugated to Horse Radish Peroxidase) for 1 
h at 25°C. All the incubations and washing were done with gentle rocking. Finally the 
blots were developed either with Pierce ECL substrate (Thermo Scientific) or ECL™ 
Advanced System (GE Healthcare) according to manufacturer’s guidelines. 
 
3.2.7  Immunohistochemistry in Xenopus embryos 
 
The Xenopus embryos expressing SpARCs were collected at blastula stage and fixed 
and stored at 4°C in 4% PFA-PBS. Before initiation of antibody staining, the embryos 
were washed twice with 1X TBS containing 0.1% Triton X-100 for 30 min each. This 
was followed by three washes of 1X TBS-T for 30 min each. The Xenopus embryos 
were then blocked in a solution containing 1X TBS-T and 20% goat serum for 1 h. 
Embryos were further incubated with 1:100 dilution of the anti-myc primary antibody 
overnight at 4°C in the blocking solution. The following day the embryos were washed 
four times with 1X TBS-T containing 2 mg/ml BSA and additionally blocked in a solution 
containing 1X TBS-T supplemented with 2 mg/ml BSA and 20% goat serum for 1h. 
Subsequently, the embryos were treated with 1:100 dilution of the secondary antibody 
(Goat polyclonal anti-mouse IgG conjugated with Cy-3 [Zymed]) overnight at 4°C in the 
same blocking solution. The embryos were finally washed four times with 1X TBS-T 103 
 
containing 2 mg/ml BSA for 30 min each. The embryos were mounted on a cover slip 
of a chamber and imaged using a confocal microscope.  
 
3.2.8  Immunocytochemistry in HEK cells  
 
In the HEK cell expression system, two different approaches were used to study the 
localization  of  SpARC  proteins.  In  the  first  approach  the  cells  were  fixed  and 
permeabilised prior to antibody incubation, while in the second method live HEK cells 
were labelled with the primary antibody before fixation. 
 
Permeabilised cells: The HEK cells were fixed in 4% PFA-PBS for 10 min at 25°C, 17 h 
post-transfection. This was followed by three washes with PBS at 25°C. The cells were 
permeabilised  with  PBS  containing  0.1%  TX-100  for  10  min  at  25°C  with  gentle 
agitation.  The  cells  were  again  washed  three  times  with  PBS  and  incubated  with 
blocking solution (5% FBS and 1% BSA in PBS) for 1 h at 25°C with gentle agitation. 
The cover slips were incubated with 1:100 dilution of the anti-myc primary antibody in 
blocking solution at 37°C for 1 h, followed by 3 washes with PBS + 0.1% Tween-20. 
Subsequently, the cover slips were incubated with 1:100 dilution of secondary antibody 
in the same blocking solution at 37°C for 1 h. This was followed by three washes with 
PBS-Tween. The cover slips were finally mounted on glass slides with DABCO, air 
dried and sealed with nail varnish. 
 
 
Live Cells: In this method, HEK cells were pre-treated with or without the enzyme PI-
PLC  (see  3.2.11  for  details).  The  cells  expressing  Myc-tagged  SpARCs  were  then 
incubated with 1:100 diluted primary antibody in HBS for 1 h at 4°C, washed three 
times with PBS followed by fixation in 4% PFA-PBS for 10 min at 25°C. Following a 104 
 
further three PBS washes, the HEK cells were incubated sequentially with blocking 
solution, primary and secondary antibodies, as described above.  
 
3.2.9  Confocal microscopy 
 
Fluorescence images of Xenopus embryos and HEK cells over-expressing SpARC2-
Myc, SpARC3-Myc or SpARC4-Myc were captured using a Zeiss LSM 510 confocal 
microscope equipped with either a 20X or 63X oil immersion lens. The wavelengths for 
excitation and emission for Cy3 were 543 nm and 560–615 nm respectively. For eGFP, 
the wavelengths used were 488 nm for excitation and 505-550 nm for emission.  
 
3.2.10  PI-PLC treatment of transfected HEK cells  
 
17 h post-transfection of HEK cells, media was removed and the adherent cells were 
incubated either in presence or absence of 1 U/ml bacterial PI-PLC (sigma) in HBS 
(156 mM NaCl, 3 mM KCl, 2 mM MgSO4, 1.25 mM KH2PO4, 10 mM D-Glucose, 2 mM 
CaCl2, 10  mM HEPES), pH 7.4 at 37°C for 1 h. The HBS was then collected and 
concentrated 10 fold using Amicon® Ultra 4 centrifugal filter (10 kDa cut-off). The cells 
were homogenized as described in section 3.2.6.  
 
 
3.2.11  Assay for secretion of C-terminal truncated SpARCs 
 
For the study of protein secretion, HEK cells were transfected with plasmids encoding 
SpARC2-Myc, SpARC3-Myc  or  SpARC4-Myc  and in parallel with SpARC2-ΔC-Myc, 
SpARC3-ΔC-Myc  and SpARC4-ΔC-Myc  respectively.  The media were replaced 5  h 
post-transfection, with serum free media. The cells were allowed to grow for further 12-105 
 
15 h, before the collection and processing of media and cells as described in section 
3.2.10.  
 
 
3.3  Results 
 
3.3.1  Topology predictions for SpARCs  
 
The  molecular  properties  of  SpARC1  were  extensively  characterized  previously 
(Churamani,  et  al.,  2007).  In  this  chapter,  the  molecular  properties  of  SpARC2, 
SpARC3 and SpARC4 were investigated. SpARC2, SpARC3 and SpARC4 sequences 
were  analysed  using  various  bio-informatics  programs  to  predict  their  structural 
properties.  All  isoforms  were  predicted  to  be  glycoproteins.  SpARC2  had  five 
consensus  sequences  for  N-linked  glycosylations.  SpARC3  had  eight  sites  while 
SpARC4  had  only  two  sites.  SpARC2  and  SpARC4  had  putative  signal  peptide 
sequences at their N-termini. However SpARC3 was predicted with a potential signal 
anchoring  domain  at its  amino terminus.  All three proteins also possessed  putative 
GPI-anchoring motifs at their C-termini. Thus, as per the predicted topology, all three 
proteins  would  be  anchored  to  the  cell/  organelle  membrane  with  their  active  sites 
exposed to the extra cellular/ luminal surface. The predicted structures of SpARC2, 
SpARC3 and SpARC4 are schematically depicted in Figure 3.3. 106 
 
 
Figure 3.3: Predicted structure of SpARC isoforms 
  
 SpARC2 (A)  and  SpARC4  (C) are  predicted  to  harbour  signal  peptides,  SP (dotted  lines).  (B) 
SpARC3  is  predicted  a  putative  signal  anchor,  SA  (cyan).  All  three  are  predicted  to  be 
glycoproteins (Y represents glycosylation) and possibly anchored to the membrane through C-
terminal GPI-anchoring sequences (brown).  
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3.3.2  Generation of expression constructs for SpARCs  
 
Successful expression and characterization of SpARC1 by heterologous expression in 
Xenopus  embryos  and  HEK  cells  has  been  reported  (Churamani,  et  al.,  2007). 
Therefore,  Xenopus  embryos  and  HEK  cells  were  again  chosen  for  analysis  of 
SpARC2,  SpARC3  and  SpARC4.  To  achieve  this,  the  constructs  schematically 
depicted in Figure 3.4 were generated.   
 
 
 
3.3.3  Expression and glycosylation of SpARCs 
 
SpARC1 has previously been shown to be a glycoprotein (Churamani, et al., 2007). 
SpARC2,  SpARC3  and  SpARC4  also  harbour  consensus  sites  for  N-linked 
glycosylations (Figure 3.3). Therefore to determine if the other SpARC isoforms were 
also  glycoproteins,  SpARC2-Myc,  SpARC3-Myc  and  SpARC4-Myc  were 
A 
B 
C 
D 
E 
F 
Figure 3.4: Schematic representation of constructs used in Chapter 3 
 
Schematic  representation  of  the  various  constructs  used  in  this  chapter.  SP=signal  peptide; 
SA=signal  anchor;  GPI=Glycosyl  phosphatidyl  inositol  anchoring sequence.  Red bars  indicate 
position of the 6 Myc tags. 
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heterologously expressed in Xenopus embryos and HEK cells. The Xenopus and HEK 
cell  homogenates  were  treated  with  PNGase  F,  an  enzyme  that  removes  sugar 
residues  from  N-glycosylated  proteins.  Western  blot  analysis  of  Xenopus  embryo 
homogenates  expressing  SpARC2-Myc  revealed  a  broad,  diffuse  band  ranging 
between ~60 to 65 kDa (Figure 3.5A, left), while the predicted molecular weight was 47 
kDa. In contrast, SpARC2-Myc expressed in HEK cells displayed a single prominent 
band  at  ~60  kDa.  PNGase  F  treatment  of  the  HEK  cell  homogenate  expressing 
SpARC2-Myc caused a shift of the major band to ~50 kDa (Figure 3.5A, right). 
 
The western blots of SpARC3-Myc expressed in Xenopus embryo exposed multiple 
bands of sizes ranging from ~48 to 100 kDa, (Figure 3.5B, left) while the expected size 
was 50 kDa. Multiple bands were also observed on the western blots with SpARC3-
Myc expressed in HEK cells. However the size of the bands ranged from ~40 to 70 kDa 
only.  Action of the enzyme PNGase F on Xenopus embryo homogenates expressing 
SpARC3 produced a single broad hazy band of ~54 kDa (Figure 3.5B, left). The blots 
of Xenopus embryo homogenates expressing SpARC3-Myc were consistently fuzzy in 
spite  of  several  repeats.  PNGase  F  treated  SpARC3-Myc  expressing  HEK  cell 
homogenates again revealed the convergence of the multiple bands into two bands of 
sizes ~47 and 44 kDa (Figure 3.5B, right).  
 
Finally, the western blots of Xenopus embryo homogenates expressing SpARC4-Myc 
indicated a prominent band of ~52 kDa, while the expected molecular weight was 46 
kDa (Figure 3.5C, left). Similarly a prominent band of ~52 kDa was also evident in HEK 
cells  expressing  SpARC4-Myc  (Figure  3.5C,  right),  along  with  an  additional  lower 
molecular weight band of ~44 kDa. PNGase F treated Xenopus embryo homogenates 
expressing SpARC4-NMyc revealed a major band of ~50 kDa (Figure 3.5C, left). While 
in case of PNGase F treated HEK cell homogenates, two major bands of ~49 and 44 
kDa were observed (Figure 3.5C, right). 109 
 
20 
37 
50 
75 
120 
25 
37 
50 
75 
100 
25 
37 
50 
75 
100 
25 
37 
50 
75 
100 
A  B  C 
HEK cells  Xenopus  HEK cells  Xenopus  HEK cells  Xenopus 
N
o
t
 
t
r
e
a
t
e
d
 
M
o
c
k
 
t
r
e
a
t
e
d
 
P
N
G
a
s
e
F
 
t
r
e
a
t
e
d
 
N
o
t
 
t
r
e
a
t
e
d
 
M
o
c
k
 
t
r
e
a
t
e
d
 
P
N
G
a
s
e
F
 
t
r
e
a
t
e
d
 
N
o
t
 
t
r
e
a
t
e
d
 
M
o
c
k
 
t
r
e
a
t
e
d
 
P
N
G
a
s
e
F
 
t
r
e
a
t
e
d
 
N
o
t
 
t
r
e
a
t
e
d
 
M
o
c
k
 
t
r
e
a
t
e
d
 
P
N
G
a
s
e
F
 
t
r
e
a
t
e
d
 
N
o
t
 
t
r
e
a
t
e
d
 
M
o
c
k
 
t
r
e
a
t
e
d
 
P
N
G
a
s
e
F
 
t
r
e
a
t
e
d
 
N
o
t
 
t
r
e
a
t
e
d
 
SpARC3  SpARC4  SpARC2 
Figure 3.5: SpARCs are glycoproteins 
 
Heterologous  expression  of  SpARC2-Myc  (A),  SpARC3-Myc  (B) and  SpARC4-Myc  (C) in  Xenopus  and  HEK  cells.  Western  blots with  anti-myc  antibodies of 
homogenates prepared from Xenopus embryos (left) or HEK cells (right) expressing the indicated construct. The samples were either not treated, mock treated or 
PNGase F treated prior to SDS-PAGE. Migration of the standard protein molecular weight markers is indicated to the left of the blots. 110 
 
The observed molecular weights of all three SpARC isoforms were higher than their 
calculated  theoretical molecular  weights.  However  the molecular  sizes  of the major 
bands obtained after the action of PNGase F enzyme were in reasonable agreement 
with the predicted sizes of the mature SpARCs. Taken together, these data suggest 
that  SpARC2,  SpARC3  and  SpARC4  are  all  glycoproteins,  consistent  with  the 
predictions made by the presence of consensus N-glycosylation sites.  
 
 
3.3.4  Localization of SpARCs  
 
Immunohistochemical analysis in conjunction with confocal microscopy was carried out 
to establish the sub-cellular distribution of SpARCs. Figure 3.6 shows the distribution of 
SpARC2-Myc, SpARC3-Myc and SpARC4-Myc heterologously expressed in Xenopus 
embryos. Since only a single blastomere of a four cell stage embryo was injected with 
SpARC mRNA, a mosaic pattern of expression was created. Indeed, cells which did 
not express SpARCs were identifiable and served as negative controls for background 
fluorescence (Figure 3.6A, asterisks). Clear cell surface staining was observed with all 
three  isoforms  (Figures  3.6A,  3.6B  and  3.6C).  In  case  of  SpARC3  and  SpARC4, 
punctuate intracellular distribution (mostly towards the periphery of the cells) was also 
observed in some cells (Figures 3.6B and 3.6C). With SpARC4, occasional punctuate 
staining  was  evident  often  at  the  junction  of  two  or  more  cells  (Figure  3.6C, 
arrowheads).  
 
The sub-cellular distribution of SpARC isoforms was also determined in HEK cells. In 
permeabilised HEK cells, SpARC2-Myc, SpARC3-Myc and SpARC4-Myc localized to 
the  plasma  membrane,  although  diffuse  intracellular  labelling  was  often  observed 
(Figure 3.7, top panel).  111 
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Figure 3.6: Localization of SpARCs in Xenopus embryos 
 
Immunohistochemistry  with  anti-myc  antibodies  followed  by  confocal  imaging  of  Xenopus 
embryos  over-expressing  SpARC2-Myc  (A),  SpARC3-Myc  (B)  or  SpARC4-Myc  (C).  Asterisks 
indicate cells that did not express SpARCs. Arrowheads shows punctuate staining at the junction 
of two or more cells. Scale bar represents 10 µm. n=3 independent batch of embryos. 
* 
*  * 112 
 
In another approach, further localization studies were performed by treating live HEK 
cells  with  primary  antibody,  followed  by  fixation  without  permeabilisation.  In  this 
procedure, the antibodies would not enter the cell to label intracellular structures. Using 
this  protocol,  exclusive  cell  surface  staining  was  seen  (Figure  3.7,  bottom  panel), 
confirming the plasma membrane localization of SpARC2, SpARC3 and SpARC4. 
 
 
 
3.3.5  Mode of membrane attachment in SpARCs  
 
The  presence  of  GPI-anchor  for  a  protein  can  be  easily  tested  by  the  action  the 
enzyme, PI-PLC which releases GPI-anchored proteins from the membrane. HEK cells 
expressing SpARC2-Myc, SpARC3-Myc or SpARC4-Myc were treated with or without 
the  enzyme  PI-PLC.  Following  that  the  western  blot  analysis  of  both  the  cell 
homogenates and the media fractions with anti-myc antibodies revealed that indeed 
SpARC2-Myc,  SpARC3-Myc  and  SpARC4-Myc  were  all  released  into  the  medium 
following the treatment (Figures 3.8A, 3.8B and 3.8C). These data suggest that all the 
three isoforms are likely to be attached to the plasma membrane via a GPI-anchor. 
 
In a second and parallel approach, immuncytochemistry experiments were conducted 
to examine the cell surface expression of SpARC2-Myc, SpARC3-Myc and SpARC4-
Myc in live HEK cells, prior to or after PI-PLC treatment. Confocal microscopy revealed 
that the PI-PLC action led to a reduction in SpARC immunoreactivity (bottom panels - 
Figures 3.9A, 3.9B and 3.9C), compared to the untreated samples (top panels). This 
decreased detection of SpARCs after PI-PLC treatment, again likely reflects the loss of 
the protein through the cleavage of GPI-anchor. A plasma membrane marker protein 
hRFC (human Reduced Folate Carrier), which is not attached through a GPI-anchor, 
but  tethered  through  transmembrane  domain,  was  employed  as  a  control.  In  this 
regard, HEK cells transfected with hRFC did not reveal any change in the surface  113 
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Figure 3.7: Localization of SpARCs in HEK cells 
 
Immunocytochemistry with anti-myc antibodies followed by confocal imaging of HEK cells over-expressing SpARC2-Myc (A), SpARC3-Myc (B) or SpARC4-
Myc (C). Top panel shows cell staining following permeabilisation with 0.1% TX-100. The lower panel indicates antibody staining of non-permeabilised HEK 
cells expressing SpARCs. Scale bar represents 5 µm. 
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Figure 3.8: Release of SpARCs following PI-PLC treatment 
 
Western blots with anti-myc antibodies of cells (left) or media equivalents (right) from HEK cells transiently transfected with SpARC2-Myc (A), SpARC3-Myc (B) 
and SpARC4-Myc (C). The HEK cells were either not treated (-) or treated with the enzyme PI-PLC (+) prior to homogenate preparation and media collection. 
Migration  of  the  standard  protein  molecular  weight  markers  is  shown  on  the  left.  Arrow  indicates  migration  of  protein  bands  in  the  concentrated  media 
equivalents. 
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expression upon PI-PLC treatment (Figure 3.9D), thus confirming the specificity of PI-
PLC action. 
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B 
Figure 3.9: Decrease in immuno-flourescence following PI-PLC treatment 
 
Immunocytochemistry with anti-myc antibodies either before (top panel) or after PI-PLC treatment 
(bottom  panel)  followed  by  confocal  imaging  of  HEK  cells  over-expressing  SpARC2-Myc  (A), 
SpARC3-Myc (B) or SpARC4-Myc (C). (D) Parallel treatment of HEK cells transfected with hRFC, a 
non-GPI-anchored,  plasma  membrane  protein  was  also  carried  out,  as  a  control.  Scale  bar 
represents 50 µm. 
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Finally, in the third and independent approach, the C terminal region harbouring the 
putative GPI-anchoring domains of SpARC2, SpARC3 and SpARC4 were deleted as 
detailed in the section 3.2.2 (Figure 3.4). With the loss of membrane anchoring motif, 
the possibility of the secretion of SpARCs was studied. Western blot of the proteins 
resolved  from  both the cells  and  the  media  fractions  of  HEK  cells  transfected  with 
SpARC2-Myc,  SpARC3-Myc  or  SpARC4-Myc  in  parallel  with  SpARC2-∆C-Myc, 
SpARC3-∆C-Myc or SpARC4-∆C-Myc were carried out with anti-myc antibodies.  
 
Prominent bands of ~59 and 56 kDa were observed from the HEK cells transfected 
with SpARC2-Myc and SpARC2-∆C-Myc respectively (Figure 3.10A, left). A band of 
~61  kDa  was  detected  from  the  concentrated  media  fractions  of  SpARC2-∆C-Myc 
transfected HEK cells (Figure 3.10A, right). However negligible amounts were found in 
the corresponding media fraction of SpARC2-Myc transfected cells, thus revealing that 
SpARC2-∆C-Myc was secreted in the media while SpARC2-Myc was not.  
 
Similarly cells expressing SpARC3-Myc expressed a range of bands from ~48 to 80 
kDa, while cells transfected with SpARC3-∆C-Myc revealed bands from ~46 to 60 kDa 
(Figure 3.10B, left). The media fractions of SpARC3-∆C-Myc had a prominent band of 
~88 kDa, which was absent from media of cells transfected with SpARC3-Myc (Figure 
3.10B, right). 
 
Analogous results were observed with SpARC4. A band corresponding to ~52 kDa was 
detected  corresponding  to  the  SpARC4-Myc,  while  in  SpARC4-∆C-Myc,  the  major 
band was ~49 kDa (Figure 3.10C, left). In the media fractions from SpARC4-∆CT, a 
~56  kDa  band  was  identified,  but  was  less  prominent  in  the  media  fractions  from 
SpARC4 Myc (Figure 3.10C, right). 117 
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Figure 3.10: Secretion of SpARCs lacking GPI-anchoring motif 
 
Western blots with anti-myc antibodies of cells (left) or media equivalents (right) from HEK cells transiently transfected with 6-Myc tagged constructs of either full 
length (FL) or C-terminal truncated (∆C) constructs of SpARC2 (A), SpARC3 (B) and SpARC4 (C). Migration of the standard protein molecular weight markers is 
shown on the left. Arrow indicates migration of protein bands in the concentrated media equivalents. 
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In all cases, the intensities of the bands obtained from the cellular fractions indicated 
that both the full length and the C-terminal truncated constructs were expressed in 
equivalent  levels.  Taken  together,  the  above  data  further  confirms  that  SpARC2, 
SpARC3 and SpARC4 are indeed tethered to the plasma membrane through a GPI-
anchor at their C termini. 
 
 
3.4  Discussion  
 
The  structure  and  location  of  a  protein  is  crucial  for  its  effective  functioning.  It  is 
absolutely essential to obtain an in depth knowledge of where SpARCs are located in 
the cells, especially considering that there are several isoforms. To follow on, it is also 
important to identify the different molecular motifs that are responsible for targeting of 
SpARCs to the concerned locations. In this regard, various bio-informatics programs 
were used to identify the characteristic structural motifs/domains of SpARC2, SpARC3 
and SpARC4 (Figure 3.3). The predictions indicated that all three isoforms would be 
plasma membrane glycoproteins attached through GPI-anchor. 
 
To  test  these  predictions,  SpARC2-Myc,  SpARC3-Myc  and  SpARC4-Myc  were 
heterologously expressed in Xenopus embryos and HEK cells. These systems have 
been  effectively  used  previously  for  the  functional  characterization  of  SpARC1 
(Churamani, et al., 2007). All three SpARC isoforms were expressed in both Xenopus 
embryos and the HEK cells (Figure 3.5). In each case, the observed molecular weight 
of  SpARC  was  higher  than  the  predicted  molecular  mass  (based  on  the  primary 
sequence), as observed by western blotting. This could be due to the addition of glycan 
sugar moieties to the protein. To test the prediction that SpARCs are glycoproteins, the 
Xenopus and HEK cell homogenates were treated with PNGase F, an enzyme that 119 
 
removes N-linked glycosylation from glycoproteins. The results (Figure 3.5) indicated 
that  the  apparent  molecular  weight  of  the  all  three  SpARCs  indeed  reduced  upon 
PNGase  F  treatment,  consistent  with  them  bearing  consensus  sites  for  N-linked 
glycosylation.  
 
There were multiple bands observed with SpARC3-Myc expressed in Xenopus (Figure 
3.5B,  left).  All  these  bands  were  PNGase  F  sensitive,  indicating  the  existence  of 
differentially glycosylated pools of the protein in the cell. SpARC3-Myc expressed in 
Xenopus revealed additional higher molecular weight band(s) than SpARC3 expressed 
in HEK cells (Figure 3.5B, right), indicating either a better or aberrant glycosylation 
pattern occurring in Xenopus embryos. For SpARC3-Myc and SpARC4-Myc expressed 
in HEK cells, an additional low molecular weight band that was PNGase F insensitive 
was also observed (Figure 3.5B and 3.5C, right). The molecular weight of this smaller 
band was lower than the predicted molecular weight of SpARC3 and SpARC4. The 
identity  of  these  latter  band(s)  has  not  been  determined  and  may  correspond  to 
unprocessed/truncated SpARC3 and SpARC4. Nevertheless, the overall reduction in 
the apparent molecular weights of SpARC2-Myc, SpARC3-Myc and SpARC4-Myc after 
PNGase  F  treatment  observed  in  this  study  confirms  that  they  enter  the  secretory 
pathway and undergo N-glycosylation(s).  
 
The  importance  of  glycosylation  for  ARC  activity  is  debatable.  Many  groups  have 
functionally expressed ARCs mutated for consensus N-glycosylation sites in different 
expression  systems  (Munshi  and  Lee,  1997;  Munshi,  et  al.,  1997)  while  others 
preferred to retain the sites (Goodrich, et al., 2005; Churamani, et al., 2007). In this 
context, Dousa’s group demonstrated that novel ARC activity from membranes of rat 
vascular smooth muscle cells (VSMC) unlike CD38 was sensitive to inactivation by N-
glycosidase F (de Toledo, et al., 2000). It is therefore possible that glycosylation may 
be important for the structural stability and catalytic activity of some but not all ARCs. 120 
 
In this study, two independent heterologous cell systems were used to determine the 
sub-cellular  distribution  of  SpARCs.  In  Xenopus  embryos,  predominant  plasma 
membrane localization was observed for all three SpARCs (Figure 3.6). This is in stark 
contrast to SpARC1, which is an intracellular ADP-ribosyl cyclase (Churamani, et al., 
2007).  SpARC3  and  SpARC4  occasionally  also  exhibited  an  intense  intracellular 
punctuate  staining,  especially  towards  the  periphery  of  the  cells  (Figure  3.6B  and 
3.6C). Analogous dual locations for ARCs have been observed in previous studies. 
Malavasi’s lab reported the existence of two distinct pools of CD38 molecules, one at 
the cell surface while the other on recycling endosomes (Munoz, et al., 2008). Trubiani 
et al demonstrated that internalization of CD38 into endosomes was a reproducible 
event  and  involved  only  a  fraction  of  the  surface  expressed  molecules.  CD38  was 
found  in  both  early  and  late  endosomes  (Trubiani,  et  al.,  2004).  But  whether  the 
observed  punctuate  staining  was  due  to  the  internalization  of  the  SpARC3  and 
SpARC4  into  vesicles  similar  to  those  observed  with  CD38  (Zocchi,  et  al.,  1996) 
remains to be established.  
 
The  HEK  cell  expression  of  SpARCs  revealed  predominant  plasma  membrane 
localization,  and  some  intracellular  labelling  in  permeabilised  cells  (Figure  3.7,  top 
panel). To explore this pattern further, non-permeabilised “live” HEK cells were used, in 
which typical plasma membrane staining was observed (Figure 3.7, bottom panel). This 
further asserted that SpARCs were expressed on the outer cell surface (at least in case 
of HEK cells) and also confirmed that the epitopes were indeed extracellular. Recently 
Churchill  and  colleagues  identified  a  novel  NAADP  synthesizing  activity  from  the 
plasma membrane of intact sea urchin sperm (Vasudevan, et al., 2008). Whether the 
activity corresponds to SpARC2, SpARC3 or SpARC4 will be discussed in the next 
chapter.  
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The cell surface expression of SpARC2, SpARC3 and SpARC4 would again impose 
topological  constraints  in  terms  of  the  availability  of  the  substrates  and  release  of 
products  from  and  to  cytosol.  Having  said  that,  in  spite  of  its  luminal  localization, 
SpARC1 was active and could gain access to its cytosolic substrates (Churamani, et 
al., 2007). Work from Galione’s lab also suggests that transport mechanisms for the 
substrates and products were present and functional in S.purpuratus egg (Davis, et al., 
2008). Although results from this group confirmed the plasma membrane location of 
SpARC2, it contradicted with the localization of SpARC1 (Churamani, et al., 2007) and 
SpARC3 observed in this chapter. SpARC-β and SpARC-γ have been localized to the 
cortical  granules  of  S.purpuratus  egg  (Davis,  et  al.,  2008).  More  evidence  and 
arguments of why such a location is less likely will be presented in Chapter 6.  
 
Given the varied residences of ARCs, an important question is which of these locations 
would make the enzyme active/inactive? There is no strong and clear-cut experimental 
evidence to exclusively  prove/rule-out activity arising from either the cell surface or 
intracellular  locations.  It  can  certainly  be  hypothesized  that  the  plasma  membrane 
presented  CD38  is  involved  in  cyclisation  reaction  by  scavenging  any  available 
extracellular NAD. However for the base-exchange reaction to occur, the enzyme may 
need to be internalized, to provide a localized acidic pH and concentrated source of 
nicotinic acid.  In this context, it is particularly interesting to note that CD38 has been 
detected in acidic organelles like the endosomes. Discovery of multiple locations for a 
multifunctional  enzyme  rationalizes  the  differential  regulation  of  the  enzyme  with 
respect  to  substrate  availability  and  pH  requirements  and  the  need  of  the  cell  to 
synthesise either cADPR and/or NAADP. 
 
Finally, to test the bio-informatics predictions for the presence of C-terminal GPI-anchor 
in all three SpARC isoforms again the HEK cell expression system was used. The 
release of all three SpARCs following PI-PLC treatment was evident as observed by 122 
 
both western blotting (Figure 3.8) and immunocytochemistry (Figure 3.9). Even if the 
release  of  SpARC2  and  SpARC4  was  expected,  the  release  of  SpARC3  was 
perplexing. This was because SpARC3 was predicted to be double anchored with a 
signal anchor at its N-terminus (Figure 3.3B). If true, PI-PLC should not have released 
SpARC3. The results with PI-PLC release experiments were further confirmed using a 
third independent approach. The C-terminal deleted constructs of all three SpARCs 
were secreted when compared to their respective full length constructs (Figure 3.10). 
Taken  together,  SpARC3  most  likely  harboured  a  signal  peptide  and  not  a  signal 
anchor at its N-terminus. The western blots also suggested that the secreted form of 
the SpARCs had higher molecular weights than their corresponding cellular pools. This 
could be  due to increased glycosylation of the secreted proteins compared to their 
membrane bound counterparts or an incomplete glycosylation of the cellular pool due 
to over-expression. The specificity of PI-PLC activity was however ascertained by the 
use of a non-GPI plasma membrane protein, as a control (Figure 3.9D). 
 
GPI-anchored proteins have also been shown to be extensively associated with the 
endocytic  system  in  mammalian  cells  (Mayor,  et  al.,  1998;Keller,  et  al.,  1992). 
Presence of GPI acts as a signal sorter for the targeting of GPI-anchored proteins into 
novel internalization routes that are distinct from the caveolae and clathrin-mediated 
pathways.  In  fact,  at  very  early  times  of  internalization,  GPI-anchored  proteins  are 
found enriched in compartments termed GPI-AP-enriched endosomal compartments 
(GEECs) (Chatterjee and Mayor, 2001). In this regard, lipid microdomains/rafts play an 
important role in the targeting, recycling and regulation of GPI-anchored proteins (Fujita 
and Jigami, 2008). Independently, Trubiani et al in fact suggested that specialized raft 
sphingolipid  microdomains  in  the  plasma  membrane  might  be  involved  in  CD38 
translocation (Trubiani, et al., 2004). Release of GPI-anchored proteins by the action of 
endogenous phospholipases has been suggested as a mechanism of regulating the 
expression  levels  of  these  proteins.  At  the  same  time,  the  products  released  from 123 
 
phospholipase cleavage, such as inositol phospholipids, may be involved in generating 
further signal transduction (Low, 1989). It has been demonstrated that an endogenous 
PI-PLC  release  of  a  76  kDa  GPI-anchored  serine  protease  was  essential  for  the 
enzyme activation in Plasmodium falciparum (Braun-Breton, et al., 1988). Additionally, 
cancer marker CEA was released into the extracellular medium of colonic epithelial 
cells  by  the  action  of  endogenous  PI-PLC,  by  the  cleavage  of  its  GPI-anchor 
(Kinugasa, et al., 1994). Particularly with SpARC4, rare punctuate staining was also 
observed, often at the junction of two or more cells (Figure 3.6C). Thus, SpARC4 might 
analogously be transported/ released from GPI-anchor into the extracellular space.  
 
The bioinformatics predictions for  N-linked glycosylations and the presence of  GPI-
anchoring domains in SpARCs have been tested and confirmed in this study. SpARC 
isoforms predominantly localized to the plasma membrane although intense punctuate 
intracellular  staining  was  also  observed  with  SpARC3  and  SpARC4.  SpARC2  and 
SpARC4 harboured signal peptides as predicted, while surprisingly SpARC3 was not 
dual anchored. The hydrophobic domain at the N-terminus of SpARC3 is more likely a 
signal peptide than a signal anchor. Thus the bio-informatics predictions were accurate 
in case of SpARC2 and SpARC4, but incorrect with SpARC3. Similar discrepancy has 
also  been  encountered  during  the  characterization  of  SpARC1  (Churamani,  et  al., 
2007). 124 
 
Chapter 4:  Enzymatic activities of sea urchin 
ADP-ribosyl cyclases 
 
 
4.1  Introduction  
 
 
The most astonishing characteristic of ARC enzymes is their multi-functionality. They 
are capable of using several substrates to produce structurally varied products (Lee, 
2000). ADP-ribosyl cyclases can either cyclise NAD to cADPR or hydrolyse it to ADPR 
at  neutral  pH.  ARCs  can  also  carry  out  a  base-exchange  reaction  at  acidic  pH  to 
produce NAADP from NADP (Lee, 1997). Two different theories have been suggested 
to explain the nature of ARC catalysis. The initial mechanism proposed by Lee et al 
was the sequential model. According to this theory, the first step in catalysis was the 
formation  of  an  ADP-ribosylated  enzyme  intermediate.  Further,  an  intra-molecular 
attack by N-1 of adenine resulted in cyclisation and formation of cADPR. Then cADPR 
could  either  be  released  or  remain  bound to the  enzyme  in  an  activated  state.  An 
additional  assault  by  water  resulted  in  the  hydrolysis  of  the  activated  cADPR  and 
formation of ADPR. The former  step was predominant in  Aplysia  cyclase while the 
latter in CD38 (Lee, et al., 1995).  
 
Lee and colleagues also suggested a partitioning mechanism for ARC catalysis. In this 
theory,  an  oxo-carbenium  ion  is  formed  during  the  enzyme  intermediate  state. 
Subsequent intra-molecular attack resulted in the formation of cADPR (or cADPRP if 
NADP  was  substrate).  Alternatively,  in  the  presence  of  high  concentrations  of  a 
nucleophile like nicotinic acid, the activated intermediate produced NAAD (or NAADP) 
instead. The above principles have been applied to enzymatically synthesise a variety 
of NAADP analogs (Lee, et al., 1997; Lee and Aarhus, 1998). The active site of ARC 125 
 
was suggested to allow free rotation of N-7 bond of guanine, when NGD was used as a 
surrogate substrate. CD38 produced predominantly ADPR, as its active site was more 
accessible  to  water  than  Aplysia  cyclase  (Lee,  1997).  Also,  in  Aplysia  cyclase,  the 
intra-molecular cyclisation was a kinetically faster step while in CD38 the intermolecular 
reaction  with  water  was  more  rapid  (Cakir-Kiefer,  et  al.,  2000).  Recently,  using 
nicotinamide 2-fluoroadenine dinucleotide (a fluorinated analogue of NAD that cannot 
be cyclised), Schuber and colleagues unmasked the glycohydrolase activity of Aplysia 
cyclase (Zhang, et al., 2007). A single reactive intermediate being responsible for both 
the cyclisation and the base-exchange activities of the ARCs was also postulated by 
many other groups (Kim, et al., 1993b; Muller-Steffner, et al., 1996; Sauve, et al., 1998; 
Berthelier,  et  al.,  1998).  In  fact  the  kinetic  mechanisms  and  involvement  of  oxo-
carbenium intermediate, pH dependence and product inhibition by nicotinamide and 
ADPR were all elucidated in a calf spleen glycohydrolase (now re-classified as CD38), 
almost three decades ago (Schuber, et al., 1976; Schuber, et al., 1979; Travo, et al., 
1979).  
 
The  structural  basis  of  multiple  reaction  catalysis  by  CD38  has  recently  been 
elucidated by Lee and co-workers.  The active site comprises of Trp
125, Trp
189, Glu
146, 
Asp
155, and Glu
226 while the substrate recognition requires Arg
127, Ser
126, Thr
221, Phe
222, 
Trp
125, and Glu
226. The oxo-carbenium ion intermediate was stabilized by both Glu
226 
and Ser
193 (Liu, et al., 2006). The release of nicotinamide forced the folding back of the 
adenine ring guided by Asp
155, Glu
146 and Trp
189. Glu
226 was critical in driving cADPR to 
the  catalytic  site.  The  binding  of  cADPR  (or  cGDPR)  to  the  active  site  induced 
structural  rearrangements  in  the  dipeptide  Glu
146-Asp
147.  This  was  the  first  direct 
evidence for  any conformational change occurring at  the active site of  ARC during 
catalysis.  Earlier  studies  revealed  indirect  evidence  for  conformational  changes 
occurring in CD38 upon ligand binding (Berthelier, et al., 2000; Lacapere, et al., 2003). 
More  recently,  calcium-induced  closure  of  the  active  site  of  CD38  has  also  been 126 
 
reported  (Liu,  et  al.,  2008).  Both  the  cyclisation  and  hydrolysis  reactions  involved 
similar catalysis (Liu, et al., 2007a). The above studies unravelled the importance of 
several amino acid residues in ARC catalysis.  
 
As  discussed  in  section  1.5.5,  the  reactions  catalysed  by  ARCs  are  very  much 
dependent upon the pH of the surrounding medium. In general it has been reported 
that cyclisation of NAD and NGD by Aplysia cyclase, CD38 and SmNACE occurred 
optimally at neutral pH, while the base-exchange reaction was favoured at acidic pH  
(Aarhus, et al., 1995; Lee, 1997; Graeff, et al., 1998; Graeff, et al., 2006; Goodrich, et 
al., 2005). The acidic dependence of base-exchange reaction was probably due to the 
charge neutralization of active site and/or nicotinic acid (Lee, 1997). Therefore, whether 
an ARC would act as a preferential cyclase or base-exchanger would be depend on the 
pH and availability of substrates (NAD versus NADP) in its sub-cellular location.  
 
In this chapter, the cyclase/hydrolase activities of SpARC2, SpARC3 and SpARC4 with 
substrates  NAD  and  NGD  were  characterized,  along  with  their  base-exchange 
activities. The effect of pH on SpARC activities was also examined. 
 
 
4.2  Materials and Methods 
 
4.2.1  Generation of expression constructs for SpARCs  
 
The  cloning  of  SpARC2-Myc,  SpARC3-Myc  and  SpARC4-Myc  were  described  in 
section 3.2.2 (Figures 3.3A, 3.3C and 3.3E). The untagged versions of SpARC3 and 
SpARC4 were generated in this chapter. The full length coding sequence of SpARC3 
and  SpARC4  were  amplified  by  PCR  using  primers  SpARC3-7F/SpARC3-7R  and 127 
 
SpARC4-7F/SpARC4-6R, respectively. The products were cloned at the EcoRI/XbaI 
sites  of  pCS2+  to  produce  constructs  coding  for  untagged  SpARC3  and  SpARC4 
respectively. The list of all primers used in this Chapter is detailed in Table 4.1. 
 
  PRIMER NAME  PRIMER SEQUENCE (5’→3’) 
1  SpARC3-7F  CACCGAATTCAATGCCATACACTGCCTATATACGA 
2  SpARC3-7R 
GCTCTAGATTACGTGTCGTGTAAGACACGG 
3  SpARC4-7F  CACCGAATTCAATGCATTCCCTCTACGGTTT 
4  SpARC4-6R  GCTCTAGATCAATTAACAGAAAGGAATGATATGA 
5  SpARC3-6-Myc-1F  CACCGAATTCAGCGAGTACGATGATGACGA 
6  SpARC3-CT-Trun-1R  GCTCTAGATTAGGCGTTATGAGTTCTCGATG 
7  C190-sense  GGGTTCGCTAAAGGGGCCGCTGATGCGTGCTG 
8  C190-antisense  CAGCACGCATCAGCGGCCCCTTTAGCGAACCC 
Table 4.1: List of all primers used in this chapter 
 
 
Additional  SpARC3  constructs  were  also  generated.  S2-SP-SpARC3-Myc  contained 
the  signal  peptide  of  SpARC2  in  place  of  the  signal  anchor/peptide  sequence  of 
SpARC3.  Nucleotides  corresponding  to  amino  acids  28  to  355  of  SpARC3  were 
amplified using primers SpARC3-6-Myc-1F and SpARC3-7R and cloned into pCS2+ - 
SP-MT (see 3.2.2) at the EcoRI/XbaI sites, to generate S2-SP-SpARC3-Myc. Similarly 
SpARC3-soluble-Myc (without GPI and signal anchor/peptide) was constructed using 
primers  SpARC3-6-Myc-1F  and  SpARC3-CT-Trun-1R  to  amplify  nucleotides 
corresponding to amino acids 28 to 332 and cloned into vector pCS2+-SP-MT at the 
EcoRI/XbaI sites. 
 128 
 
Finally, a 6-Myc tagged version of SpARC3, in which Cys
190 was substituted with Ala 
(SpARC3-C190A-Myc),  was  generated.  Quick  change  site-directed  mutagenesis  kit 
(Stratagene) was used as per manufacturer’s guidelines, with template SpARC3-Myc 
and HPLC purified primers C190A_sense/C190A_antisense. A 50 μl PCR reaction was 
made with 1X PCR buffer, 0.2 mM dNTPs, 0.5 U Turbo Pfu DNA polymerase enzyme 
(Stratagene), 0.2 mM of each of HPLC purified primers and 10 ng of template. PCR 
conditions  were  initial  2  min  denaturation  at  95°C,  followed  by  16  cycles  of  20  s 
denaturation at 95°C, 20 s annealing at 55°C and 150 s extension at 72°C. The PCR 
mix was then treated with restriction enzyme DpnI to remove any methylated wild-type 
DNA  and  transformed  into  XL-10  gold  competent  cells.  The  positives  clones  were 
verified by sequencing. A schematic representation of all the constructs used in this 
chapter is shown in Figure 4.1. 
 
4.2.2  Preparation of Xenopus embryo homogenates 
 
In  vitro  transcription  for  the  synthesis  of  capped  mRNAs  and  their  injection  into 
Xenopus embryos at 2-cell stage were carried out as described in sections 3.2.3 and 
3.2.4.  For  enzyme  activity  measurements,  the  embryos  were  homogenized  in  a 
hypotonic  buffer  (20  mM  HEPES,  pH  7.2  with  complete
TM  EDTA  free  protease 
inhibitors),  followed  by  3X5  s  bursts  of  sonication  at  4°C.  The  homogenates  were 
aliquoted for single use and frozen at -20°C. In some experiments with SpARC3, the 
homogenates were used immediately for activity measurements, while in others the 
homogenates were prepared with or without protease inhibitors, 100 µM EGTA, or 1 
mM DTT. 
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4.2.3  Enzyme activity measurements 
 
For the cyclase activity measurements, 50 µl of homogenate was diluted 5 times in a 
reaction mix comprising 20 mM HEPES, pH 7.2 and 1 mM NAD/NGD. For the base-
exchange activity measurements, typically 50 µl of homogenate was diluted 5 times in 
a reaction mix containing 1 mM NADP and 50 mM nicotinic acid, pH 4.8. The reactions 
were allowed to proceed from 45 min to 22 h. To stop the reaction, the samples were 
diluted 10 fold with water and heated at 60°C for 5 min. The mix was then centrifuged 
for  1  min  at  21000  g  to  remove  any  particulate  matter  and  the  supernatants  were 
frozen  at  -20°C  until  HPLC  analysis.  In  some  experiments,  SpARC3  homogenates 
were treated with or without 1 U/ml of PI-PLC enzyme for 1h, prior to the start of activity 
assays. 
G 
H 
D 
E 
F 
A 
B 
C 
Figure 4.1: Schematic representation of constructs used in chapter 4 
 
Schematic representation of the different constructs of SpARC2 (A), SpARC3 (B-F) and SpARC4 
(G-H) used in this chapter. SP=signal peptide; SA=signal anchor; GPI=Glycosyl phosphatidyl 
inositol anchoring sequence. Red bars indicate position of the 6-Myc tags. 
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4.2.4  Activity measurements at different pH 
 
The enzyme activities were carried out as described in section 4.2.3, except that, for 
the  cyclase  activity  measurements,  50  µl  of  homogenate  was  diluted  5  times  in  a 
reaction mix made of 20 mM Na acetate, pH 4.5 or 20 mM Tris, pH 8.1 along with 1 
mM NAD/NGD. For base-exchange reactions, 50 µl of homogenate was diluted 5 times 
in a reaction mix made of 1 mM NADP and 50 mM nicotinic acid, 20 mM Na HEPES, 
pH 7 or 20 mM Tris, pH 8.1. The reactions were allowed to proceed for 0 to 4 h.   
 
4.2.5  HPLC analysis 
 
The supernatants were  injected onto  an AG  MP1  (Bio-Rad) anion exchange HPLC 
column  (3X150  mm).  A  flow  rate  of  1  ml/min  along  with  a  concave-up  gradient  of 
trifluoroacetic  acid  (Churamani,  et  al.,  2007)  was  used  for  elution  of  the  bound 
nucleotides.  Thus,  the  more  negatively  charged  compounds  eluted  later  from  the 
column.  The  optical  density  values  were  recorded  at  254  nm  using  a  UV 
spectrophotometer and the areas of the resolved peaks were calculated using Breeze 
software (Waters). A standard mix of substrates and products were co-injected each 
time to identify the retention time of the eluants. 
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4.3  Results 
 
4.3.1  SpARCs are multifunctional 
 
4.3.1.1  NAD utilisation by SpARCs 
 
SpARC1-Myc  was  previously  shown  to  be  catalytically  active  when  heterologously 
expressed in Xenopus embryos (Churamani, et al., 2007). In chapter 3, SpARC2-Myc, 
SpARC3-Myc  and  SpARC4-Myc  were  successfully  expressed  in  this  system  and 
shown  to  undergo  post-translational  modifications  (Figure  3.5).  In  this  chapter,  the 
enzymatic activities of SpARC2, SpARC3 and SpARC4 were investigated. In the first 
set of experiments, homogenates expressing SpARCs were incubated with NAD as a 
substrate  at  pH  7.2.  As  seen  in  the  HPLC  chromatograms  of  control  uninjected 
Xenopus embryo homogenates incubated with NAD in Figure 4.2A, even after 22 h 
incubation, there was no production of either cADPR (retention time = 17.3 ± 0.1 min) 
or  ADPR  (retention  time  =  25.8  ±  0.2  min).  In  SpARC2-Myc  expressing  embryo 
homogenates, the substrate NAD was converted to a product with a retention time of 
17.7 ± 0.14 min, corresponding to that of cADPR, albeit at low levels, at the end of 4 h 
incubation.  However, ADPR production was not detectable (Figure 4.2B). Figure 4.2C 
revealed that SpARC3-Myc embryo homogenates did not catalyse the production of 
either cADPR or ADPR. In contrast, as seen in the HPLC chromatograms of SpARC4-
Myc  expressing  homogenates  in  Figure  4.2D,  substantial  cADPR  production  was 
observed, after a 3 h incubation period.  
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Homogenates  prepared  from  Xenopus  embryos  of  uninjected  controls  (A)  or  expressing 
SpARC2-Myc (B) SpARC3-Myc (C) SpARC4-Myc (D) were incubated with 1 mM NAD, pH 7.2 for 
indicated time periods. The reaction products were separated by HPLC using anion exchange 
column.  Typical  chromatograms  at  the  start  (black  traces)  and  end  (red  traces)  of  the 
reactions are shown. Insets show zoomed product peaks. 
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Figure 4.2: NAD utilisation by SpARCs 
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4.3.1.2  NADP utilisation by SpARCs 
 
In the second set of experiments, the ability of SpARCs to generate NAADP by the 
base-exchange reaction was tested. This was done by incubating homogenates with 
NADP and nicotinic acid under acidic conditions (pH 4.8). As seen in Figure 4.3A, the 
uninjected homogenates showed no production of NAADP (retention time = 31.3 ± 0.03 
min) at the end of a 22 h incubation. In contrast, SpARC2-Myc expressing Xenopus 
embryo  homogenates  after  an  incubation  of  4  h  were  able  to  convert  NADP  to  a 
product with retention time 31.4 ± 0.04 min, similar to that of NAADP (Figure 4.3B). 
However, SpARC3-Myc homogenates exhibited no detectable levels of base-exchange 
activity  even  after  an  incubation  of  22  h  (Figure  4.3C).  Meanwhile,  SpARC4-Myc 
expressing Xenopus embryo homogenates also displayed a significant production of 
NAADP after 3 h incubation (Figure 4.3D). 
 
 
4.3.1.3  NGD utilisation by SpARCs 
 
NGD, the commonly used surrogate substrate for NAD, was also employed to test the 
cyclase  activities  of  SpARC2,  SpARC3  and  SpARC4.  When  uninjected  Xenopus 
homogenates were incubated with NGD, neither cGDPR (retention time = 19.8 ± 0.21 
min)  nor  GDPR  (retention  time  =  33.9  ±  0.1  min)  were  detectable  even  after  an 
incubation of 22 h (Figure 4.4A). SpARC2-Myc homogenates produced extremely low 
levels of cGDPR, but only after an incubation for 22 h (Figure 4.4B), while SpARC3-
Myc homogenates produced no detectable levels of either cGDPR or GDPR (Figure 
4.4C). SpARC4 also produced no cGDPR under similar conditions. However, a small 
GDPR peak was indentified (Figure 4.4D). 134 
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Figure 4.3: NADP utilisation by SpARCs 
  
 
Homogenates  prepared  from  Xenopus  embryos  of  uninjected  controls  (A)  or  expressing 
SpARC2-Myc (B) SpARC3-Myc (C) SpARC4-Myc (D) were incubated with 1 mM NADP and 50 
mM nicotinic acid, pH 4.8 for indicated time periods. The reaction products are separated by 
HPLC using anion exchange column. Typical chromatograms at the start (black traces) and end 
(blue traces) of the reactions are shown. Insets show zoomed product peaks. 
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Figure 4.4: NGD utilisation by SpARCs 
 
 
Homogenates  prepared  from  Xenopus  embryos  of  uninjected  controls  (A)  or  expressing 
SpARC2-Myc (B) SpARC3-Myc (C) SpARC4-Myc (D) were incubated with 1 mM NGD, pH 7.2 for 
indicated  time  periods.  The  reaction  products  are  separated  by  HPLC  using  anion  exchange 
column. Typical chromatograms at the start (black traces) and end (green traces) of the reactions 
are shown.  
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4.3.2  Differences in catalytic activities of SpARCs 
 
4.3.2.1  cADPR and NAADP production by SpARCs 
 
Time courses for cADPR and NAADP production by SpARC2-Myc and SpARC4-Myc 
are  shown  in  Figures  4.5A  and  4.5B.  SpARC2-Myc  produced  more  NAADP  than 
cADPR while strikingly SpARC4-Myc synthesised more cADPR than NAADP (Figure 
4.5B). The pooled initial rates of cADPR and NAADP production for both SpARC2-Myc 
and SpARC4-Myc are shown in Figure 4.5C. Since the initial rates of reaction varied 
considerably between different Xenopus embryo batches (depending on their quality 
and survival), the activities were also calculated as cyclisation: base-exchange ratios. 
This  measure  would  be  independent  of  variations  in  expression  between  embryo 
batches. The cyclisation: base-exchange ratio of SpARC4-Myc was at least 25 times 
higher than SpARC2-Myc (Figure 4.5D). 
 
Introduction of tags at an inappropriate domain of an enzyme may distort its catalytic 
properties. Therefore all activities obtained from SpARC4-Myc were compared against 
activities from SpARC4-untag expressed in the same embryo batch. The results show 
that  SpARC4-untag  (Figure  4.1H)  also  produced  more  cADPR  than  NAADP.  The 
cyclisation: base-exchange ratio for SpARC4-untag was very similar to SpARC4-Myc 
(Figure 4.5D) indicating that this peculiar catalytic activity associated with SpARC4 was 
not a consequence of introducing a tag and/or the presence of a signal peptide from 
SpARC2. 
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Figure 4.5: SpARC2 and SpARC4 are multifunctional 
 
Time courses for cADPR production via cyclisation of NAD (red circles) and NAADP production 
via  base-exchange  of  NADP  (blue  squares)  by  Xenopus  embryo  homogenates  expressing 
SpARC2-Myc (A) and SpARC4-Myc (B). (C) Pooled initial rates for cADPR and NAADP production 
by  SpARC2  (n=6)  and  SpARC4  (n=9).  (D)  Cyclisation:  Base-exchange  ratio  for  SpARC2-Myc 
against SpARC4-Myc and SpARC4-untag (n=3).  
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4.3.2.2  ADPR production by SpARCs  
 
As shown in Figure 2.2, under the conditions for the cyclisation assay using NAD as 
substrate, ADPR formation was not routinely detected. This was consistently the case 
for  SpARC2-Myc,  which  produced  negligible  amounts  of  ADPR  (Figure  4.6A).  
However, in case of SpARC4, ADPR production was occasionally detected but only 
when high levels of cADPR production was observed (Figure 4.6B). However, in most 
experiments, cyclisation: hydrolysis ratio of SpARC4 was approximately 8-10 (Figure 
4.6A), indicating again that SpARC4 was a poor hydrolase. 
 
 
 
 
 
cADPR and ADPR production by SpARCs 
Figure 4.6: Hydrolase activity of SpARCs 
 
(A) Pooled data for cADPR and ADPR production by SpARC2-Myc (n=6) and SpARC4-Myc (n=9). 
(B) ADPR production plotted against cADPR production for SpARC4 (Myc-tagged and untagged).  
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4.3.3  pH profile of SpARCs 
 
The  activity  of  SpARC2-Myc  and  SpARC4-Myc  was  analysed  at  different  pH,  by 
carrying out the enzymatic assays at acidic (4.5/4.8), neutral (7/7.2) or alkaline (8.1) 
pH. Whilst, the base-exchange activity of SpARC2-Myc was reduced significantly at 
neutral and alkaline pH, the cyclase activity was relatively independent of pH (Figure 
4.7A). More remarkable was the pH profile of SpARC4-Myc, as both the cyclase and 
base-exchange activities were broadly unaffected by pH, although NAADP production 
was  decreased  modestly  at  alkaline  pH  (Figure  4.7B). Thus,  SpARCs were  unique 
enzymes capable of catalysing enzymatic reactions over a very wide pH range. 
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Figure 4.7: Effect of pH on catalytic activities of SpARCs 
 
Cyclisation and base-exchange reactions were carried out at indicated pH, assayed with Xenopus 
embryo homogenates expressing SpARC2-Myc (A) and SpARC4-Myc (B). Initial rate of cADPR 
(red) and NAADP (blue) production are shown. n=3 Xenopus expressions. 
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4.3.4  SpARC3 (in)activity  
 
Results  from  sections  4.3.1  and  4.3.2  suggested  that  SpARC3-Myc  was  unable  to 
produce  either  cADPR/ADPR  or  NAADP  (Figures  4.2C  and  4.3C)  under  the  same 
conditions  where  SpARC2-Myc  and  SpARC4-Myc  were  shown  to  be  active.  Since 
tagging of a protein could potentially lead to loss of its enzymatic activity, SpARC3-
untag  was  also  analysed.  The  homogenates  prepared  from  Xenopus  embryos 
expressing  SpARC3-untag  (Figure  4.1C)  however  were  unable  to  produce 
cADPR/ADPR, NAADP or cGDPR. Thus, SpARC3-untag was also inactive (data not 
shown; n=5).  
 
Xenopus  embryo  homogenates  are  normally  stored  frozen  without  loss  of  activity 
(Churamani, et al., 2007). Considering the possibility that freeze-thaw could selectively 
inactivate  SpARC3,  cyclisation  and  base-exchange  reactions  were  performed  using 
freshly  prepared  Xenopus  embryo  homogenates  expressing  SpARC3.  Again 
cADPR/ADPR  or  NAADP  production  was  not  detected  (data  not  shown;  n=2). 
Cyclisation  and  base-exchange  reactions  were  also  carried  out  at  different  pH 
conditions. Acidic (pH 4.5 as in endo-lysosomes) or alkaline (pH 8.1, as in sea water) 
were  used  for  cyclisation  reactions,  while  for  base-exchange,  neutral  pH  (7  as  in 
cytosol) and alkaline pH (8.1, as in sea water) were chosen. In spite of the change in 
pH conditions, neither cADPR/ADPR nor NAADP production could be detected (data 
not shown; n=2). 
 
Recently a NAADP synthase from sea urchin sperm was shown to be regulated by 
calcium  (Vasudevan,  et  al.,  2008).  Therefore,  to  determine  if  calcium  regulated 
SpARC3 activity, Xenopus homogenates were prepared in the presence (or absence) 
of  EGTA,  a  calcium  chelating  agent.  cADPR/NAADP  production  however  was  not 
detected (data not shown; n=2). Additionally, considering the possibility that SpARC3 141 
 
could  be  proteolytically  activated,  SpARC3-Myc  expressing  Xenopus  embryo 
homogenates  were  prepared  in  absence  of  protease  inhibitors.  cADPR  or  NAADP 
production was again not detectable (data not shown; n=2). 
 
All  ARCs  characterized  previously  have  an  even  number  of  cysteine  residues. 
However, SpARC3 was unusual as it possesses an odd number of cysteine residues 
(Figure 4.8A – highlighted red). The presence of an unpaired cysteine could potentially 
interfere  with  correct  disulphide  bond  formation  and  eventually  lead  to  protein 
misfolding and loss of enzyme activity. To address this issue, two different approaches 
were employed. In the first approach, the Xenopus embryo homogenates expressing 
SpARC3-Myc and SpARC3-untag were prepared in the presence (or absence) of a 
reducing agent, DTT. In the second approach, site-directed mutagenesis was used to 
substitute  Cys
190  for  Ala.  This  construct,  SpARC3-C190A-Myc  (Figure  4.1D)  was 
readily  expressed  in  Xenopus  as  shown  in  Figure  4.8B.  Results  from  activity 
measurements  show  that  the  Xenopus  embryo  homogenates  expressing  either 
SpARC3-Myc (in presence of DTT) or SpARC3-C190A-Myc were not able to produce 
either cADPR or NAADP (data not shown; n=2 each). 
 
In  Chapter  3,  a  possible  dual  anchoring  was  predicted  for  SpARC3  (Figure  3.3B). 
Considering  the  possibility  that  GPI-anchoring  may  affect  the  enzymatic  catalysis, 
SpARC3-Myc homogenates were treated with (or without) PI-PLC, prior to incubation 
with the substrates NAD and NADP. Again no product formation was detectable either 
from  the  membrane  bound  or  soluble  fractions  containing  SpARC3-Myc  (data  not 
shown;  n=2). To further address the issue of ambiguity at  the N-terminal region of 
SpARC3, two additional constructs of SpARC3 were generated. Firstly, the sequences 
coding for putative signal anchor/peptide were deleted and replaced with the signal 
peptide sequence of SpARC2 (Figure 4.1E). Secondly, a soluble construct lacking both 142 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N and C-terminal hydrophobic domains of SpARC3 was produced (Figure 4.1F).  Both 
S2-SP-SpARC3-Myc  (Figure  4.4C)  and  SpARC3-soluble-Myc  (Figure  4.4D)  were 
readily expressed in Xenopus embryos. However, neither of the constructs produced 
either cADPR or NAADP (data not shown; n=2 each).  
 
The  above  data  suggests  that  in  spite  of  using  different  constructs  and  various 
experimental strategies, SpARC3 did not exhibit enzymatic activity.  
SpARC1 CPNNTKAA--FWARASKMLATQAVGDVYVVLNAQRAGGAFNNG-SIFATIEAPNLNQDVVTNVAIYLIPDFQLAIPNEMYAETC 
SpARC2 CSNNTFAT--FWDRVSELFTRQATGEVYLVLNAQRDRGAYHLE-STFARVEVPALDPTKVTNVAIYLIPDFTLPTPNDKVRETC 
SpARC3 CGFAKGCADAFWAEASINFAKQAKGQVRVFFDSNREGGAFHNNNSYFAQYELINMDPDVVENVNIYLVTELETKSG-----DNC 
SpARC4 CENDTQDA--FWKKSSQRFAGQASGDVTVILDGSRADGAYRPT-SFFRLQEVANLDPAKVTSLTAYVVHSLNGDVT-----EKC 
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Figure 4.8: Expression of SpARC3 mutants 
 
(A)  Clustal  W  amino  acid  sequence  alignment  of  SpARC  family  members.  Highly  conserved 
cysteine residues present in all ARC members is highlighted yellow. Highly conserved active site 
residues,  Trp  and  Glu  are  highlighted  cyan  and  green.  An  odd,  unpaired  cysteine  residue  in 
SpARC3  is  highlighted  red.  Western  blot  with  anti-myc  antibodies  of  Xenopus  embryo 
homogenates expressing SpARC3-C190A-Myc (B), SA-SP-SpARC3-Myc (C) and SpARC3-soluble-
Myc (D). 
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4.4  Discussion  
 
ADP-ribosyl cyclases synthesise different molecules like cADPR/ADPR and NAADP 
that are involved in calcium mobilization. However, the factors governing messenger 
production in vivo are not fully understood. Either the various activities of the same 
enzyme may be differentially regulated or different isoforms of ARCs may be entrusted 
with distinct activities. Sea urchins possess an expanded repertoire of ARC molecules 
(Figures  2.7B  and  2.14).  Previous  studies  have  suggested  that  SpARC1  was 
functionally active (Churamani, et al., 2007). In this study, SpARC2 (Figures 4.2B and 
4.3B) and SpARC4 (Figures 4.2D and 4.3D) are also shown to be enzymatically active 
when heterologously expressed in Xenopus embryos. The three isoforms are therefore 
bona fide multifunctional ADP-ribosyl cyclases capable of both cyclisation of NAD to 
produce cADPR and base-exchange of NADP to form NAADP. Strikingly SpARC4-Myc 
produced more cADPR (Figure 4.5C) than SpARC1-Myc (Churamani, et al., 2007) and 
SpARC2-Myc  (Figure  4.2B),  both  of  which  preferentially  produced  NAADP  (Figure 
4.3B).  
 
Although ARC family members share several common structural features, they often 
differ  functionally,  especially  with  respect  to  substrate  specificity  (Lee,  2000).  For 
example, Aplysia cyclase generates more cADPR than ADPR while the reverse is true 
for  CD38  (Lee,  1997).  In  the  past,  studies  on  ARCs  have  focused  on  cyclase: 
hydrolase activities (Graeff, et al., 2001), but not on cyclase: base-exchange ratios. 
Therefore, besides the pH and availability of substrates, the ability of the active site 
residues to control the cyclisation relative to the base-exchange pathway could also be 
critical in deciding which calcium signalling pathway would take precedence in the cell, 
at a particular time. 
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NGD is often used as a surrogate substrate instead of NAD to measure the cyclase 
activity, because its conversion is more efficient than the natural substrate and the 
product  cGDPR is more resistant to hydrolysis compared to cADPR  (Graeff,  et al., 
1994). The site of cyclisation of cADPR and cGDPR are different (Kim, 1993a; Graeff, 
et  al.,  1996)  and  therefore  the  underlying  kinetic  mechanisms  and  the  active  site 
residues involved could shed light on the multi-functionality of ARCs. Although NGD 
was a good substrate for SpARC1-Myc (Churamani, et al., 2007), SpARC2-Myc was 
only  able  to  cyclise  NGD  very  poorly  (Figure    4.4B).  Surprisingly  SpARC4-Myc  a 
preferential  cyclase  with  respect  to  cADPR  production  was  unable  to  synthesise 
cGDPR  (Figure  4.4D).    Lund  and  co-workers  established  that  GDP-ribosyl  cyclase 
activity of an enzyme is not always equivalent to its ADP-ribosyl cyclase activity (Lund, 
et  al.,  2005).  The  same  group  also  demonstrated  that  SmNACE  favoured  NGD 
cyclisation over NAD (Goodrich, et al., 2005). ARCs that do not cyclise NGD have 
previously been characterized from Jurkat T lymphocytes (Guse, et al., 1999), human 
peripheral blood mononuclear cells (Bruzzone, et al., 2003) and brain of CD38 knock-
out mice (Ceni, et al., 2003).  
 
The untagged constructs of SpARCs served as controls to check that tagging did not 
alter the catalytic properties of the protein (Figure 4.5D). The production of ADPR by 
SpARCs was not routinely noticed, at least with the HPLC method of detection. As 
shown in Figure 4.6A, SpARC2-Myc produced almost no ADPR while SpARC4-Myc 
exhibited  occasional  hydrolase  activity.  ADPR  synthesis  often  became  pronounced 
under  high  levels  of  expression  and/or cADPR  production  by  SpARC4-Myc  (Figure 
4.6B). Similar observations were made by Schuber and colleagues. They suggested 
that in the presence of high concentrations of the enzyme Aplysia cyclase, which was 
considered  an  exclusive  cyclase,  cADPR  could  eventually  be  hydrolysed  to  ADPR 
(Cakir-Kiefer, et al., 2000). Regardless, SpARC4 was a predominant cyclase and the 
hydrolase activity was most often negligible (Figure 6A).  145 
 
All homologues of ARCs display marked pH dependence, favouring cADPR formation 
at neutral/alkaline pH and NAADP production at acidic pH (Lee, 2000). However, this 
was not so obvious in case of SpARC2 and SpARC4. The cADPR synthesis by both 
SpARC2-Myc and SpARC4-Myc were broadly insensitive over a wide pH range (from 
4.5-8.1).  SpARC2-Myc  carried  out  optimal  base-exchange  at  acidic  pH,  which  was 
reduced  to  a  fourth  at  neutral  and  alkaline  pH  (Figure  4.7A),  whilst  SpARC4-Myc 
produced NAADP with equal efficiency at both acidic and neutral pH (Figure 4.7B). 
SpARCs are unique enzymes to display such a broad range of pH tolerance. Davis et 
al  reported  that  SpARC-ʱ  (similar  to  SpARC2)  carried  out  better  cADPR/ADPR 
synthesis at acidic pH than neutral pH (Davis, et al., 2008). There could be various 
reasons for this observed discrepancy. In their studies, Davis et al have expressed a 
soluble form of SpARC-ʱ (amino acids 19 to 300), with the deletion of N and C-terminal 
hydrophobic regions and used yeast heterologous expression system (Davis, et al., 
2008). In this chapter, however, a full length SpARC2 was heterologously expressed in 
Xenopus embryos. Therefore the results obtained from both the studies are not directly 
comparable. 
 
Interestingly, the NAADP synthase characterized from sea urchin sperm also displayed 
an  optimal  activity  at  pH  5,  which  was  reduced  25%  at  neutral  and  alkaline  pH 
(Vasudevan, et al., 2008). Both NAADP synthase and SpARC2 are plasma membrane 
localized,  both  are  predominant  base-exchangers  and  both  have  very  similar  pH 
profile. The only difference being that SpARC2 produced small amounts of cADPR 
(which was very low compared to NAADP) and negligible amounts of cGDPR, while 
neither products were detectable (with the techniques employed) in case of NAADP 
synthase. However, the sperm enzyme generated small amounts of ADPR and was 
regulated  by  calcium  (Vasudevan,  et  al.,  2008).  The  effect  of  calcium  on  SpARC2 
activity has not been tested, but it is very much possible that the molecular correlate of 
sea urchin sperm NAADP synthase is SpARC2.  146 
 
The  most  disappointing  result  of  this  study  was  the  inactive  nature  of  SpARC3. 
SpARC3  (including  untagged  version)  was  unable  to  produce  cADPR/ADPR, 
cGDPR/GDPR or NAADP at acidic, neutral or alkaline pH (Figures 4.2C, 4.3C and 
4.4C). Even freshly prepared embryo homogenates of SpARC3 displayed no signs of 
enzymatic activity whilst frozen homogenates of other SpARC isoforms were active 
(Figures  4.2B,  4.2D,  4.3B,  and  4.3D).  Considering  the  possibility  of  regulation  by 
divalent  cations  like  calcium,  SpARC3  homogenates  were  prepared  in  presence  of 
EGTA. However this did not reveal activity. The requirement of a protease cleavage to 
activate/mature  SpARC3  was  also  investigated.  Homogenates  made  in  absence  of 
protease inhibitors however were also inactive. 
 
SpARC3  had  odd  number  of  cysteine  residues  (Figure  4.8A).  Due  to  this,  protein 
folding  might  be  compromised  under  the  highly  oxidizing  environment  of  the  cell, 
especially under conditions of over-expression. To address the issue of oxidation of the 
unpaired  cysteine,  two  approaches  were  taken.  First,  SpARC3  homogenates  were 
prepared and tested in presence of DTT, a reducing agent. Chini et al demonstrated 
the  importance  of  disulphide  bonds  by  use  of  DTT  to  show  that  cADPR  induced 
calcium release mechanism(s) were inhibited by thiol group modification (Chini, et al., 
1998). SpARC3-Myc was inactive even in presence of DTT. Second, SpARC3-C190A-
Myc, a point mutant was constructed to abolish the unpaired cysteine. This construct 
should address the issue better than the external addition of DTT. However, SpARC3-
C190A-Myc (Figure 4.8B) was also inactive.  
 
SpARC3  was  predicted  dual  anchoring  both  at  N  and  C-termini  (Figure  3.3B). 
However, results from the previous chapter (Figure 3.10B) indicated that SpARC3 was 
most likely anchored only through its C-terminal GPI-anchoring sequence. Therefore, 
release  of  the  C-terminal  GPI-anchor  was  postulated  to  make  SpARC3  active. 
SpARC3-Myc homogenates were thus treated with PI-PLC before enzymatic assays. In 147 
 
spite of that, neither the membrane bound nor the released fractions of SpARC3-Myc 
were  active.  Due  to  the  perplexing  nature  of  SpARC3  N-terminus,  two  additional 
constructs were also generated. First, the putative signal anchor/peptide sequence of 
SpARC3 was replaced with the signal peptide sequence of SpARC2 (Figure 4.1C and 
4.5D). Second, a soluble construct of SpARC3 was generated by the deletion of both N 
and C-terminal hydrophobic domains (Figure 4.1D and 4.5C). Frustratingly, none of the 
above constructs were active. 
   
Although a wide array of conditions have been employed to assay SpARC3 activity, it 
may not be exhaustive. It is possible that SpARC3 catalysis is regulated by certain 
divalent  cations  such  as  magnesium,  zinc  etc,  or  certain  metabolites  like  ATP 
(Kukimoto, et al., 1996; Takasawa, et al., 1993b) or other factors not considered in this 
chapter. Alternatively, SpARC3 might have poor catalytic efficiency similar to CD157. 
Therefore,  the  HPLC  assay  may  not  be  sensitive  enough  for  the  detection  of  low 
amounts of products formed. To address this, more sensitive assays like the radio-
receptor assay and/or cycling assay could be employed (Graeff and Lee, 2002b; Graeff 
and Lee,  2002a). The extremely  low  levels of cADPR produced by  SmNACE  were 
initially not evident by conventional assays but were detected using a cycling assay 
(Goodrich,  et  al.,  2005).  In  summary,  the  enzymatic  activity  SpARC3  could  not  be 
established  in  this  chapter.  Intriguingly,  the  studies  of  Galione  and  co-workers  that 
demonstrated the catalytic properties of SpARC-ʱ and SpARC-β had no reference to 
whether SpARC-γ was active (Davis, et al., 2008). 
 
Finally, there could be other reasons for SpARC3’s inactivity. To begin with, SpARC3 
may not be an ARC after all. The percent sequence identity between SpARCs (Figure 
2.13) and the phylogenetic analysis (Figure 2.16) revealed that SpARC3 was the most 
divergent isoform. Whether this is of evolutionary significance is not known at this point 
of time. It is possible that SpARC3, in spite of sharing many common features with 148 
 
other  ARCs,  might  just  be  lacking  one  or  more  (yet  uncharacterized)  residues  or 
domains that are critical for its enzymatic activity. Almost 98 amino acid residues that 
are conserved between SpARC1 and SpARC2 are different in SpARC3. In this context, 
pseudo-kinases are of relevance. These proteins have a kinase domain but lack one or 
more conserved amino acids in the kinase domain that are critical for phosphorylation. 
Nevertheless, they are involved in the regulation of the activity of functional kinases 
and other cell signalling events (Boudeau, et al., 2006). In analogy, SpARC3 could be a 
catalytically inactive protein, but endowed with some other physiological role, which is 
unknown at this moment. 
 
SpARC1, SpARC2 and SpARC4 all produce the same second messenger molecules, 
but  at  different  rates.  These  kinetically  and  catalytically  distinguishable  features  of 
SpARCs  (along  with  their  sub  cellular  localization)  are  significant,  considering  that 
there are so many ARC isoforms in S.purpuratus. Understanding the molecular and 
structural basis for such catalytic differences could lead to better understanding the 
physiological functions of these enzymes.  149 
 
Chapter  5:  Molecular  determinants  governing 
catalytic  activities  of  sea  urchin  ADP-ribosyl 
cyclases 
 
5.1 Introduction  
 
Although ARCs share common evolutionary ancestry, their enzymatic functions have 
diverged.  As  a  result  of  mounting  X-ray  crystallographic  data  and  site-directed 
mutagenesis studies, the roles played by key invariant amino acid residues in dictating 
the  substrate  specificities,  are  beginning  to  be  unravelled.  Initial  site-directed 
mutagenesis  studies  were  performed  by  Tohgo  et  al  using  CD38,  which  is  a  poor 
cyclase compared to Aplysia cyclase. They mutated the extra pair of cysteines found in 
CD38  but  not  Aplysia  cyclase  and  found  that  cyclisation  activity  was  increased  in 
C119K/C201E double mutant. Conversely introduction of an additional disulfide bond in 
Aplysia cyclase at residues 95 and 170 corresponding to cysteines 119 and 201 in 
CD38 introduced cADPR hydrolase activity. These data indicate that cysteine residues 
play crucial role in the synthesis and hydrolysis of cADPR (Tohgo, et al., 1994). The 
same  group  also  showed  that  mutations  in  Lys
129  of  CD38  abolished  its  cADPR 
hydrolase  activity,  suggesting  the  involvement  of  this  residue  in  cADPR  binding 
(Tohgo, et al., 1997). 
 
Lund et al also performed mutagenesis on CD38, abolishing the extra disulphide bond 
(Lund, et al., 1999). The mutant was shown to produce more cADPR than wild-type 
CD38.  They  also  mutated  the  acidic  glutamate  and  aspartate  residues  of  the  well 
conserved  “TLEDTL domain”. Replacement of the  acidic residues with basic amino 
acids  conferred  cyclisation  activity.  However,  substitution  of  the  acidic  residues  to 
neutral amino acids dramatically reduced all enzyme activities (Lund, et al., 1999). 150 
 
Subsequently, Graeff et al showed that Glu
146 residue (of the TLEDTL domain) was in 
fact an important part of the active site of CD38 and uniquely controlled cyclase versus 
hydrolase activities. Again a series of site-directed mutants were generated, wherein 
Glu was substituted by Phe, Ala, Asn, Gly, Asp and Leu. Mutants in which Glu
146 was 
substituted with neutral amino acids produced up to 3-fold more cADPR than ADPR. 
Glu
146 was also proposed to be involved in regulating the entry of water molecules at 
the active site (Graeff, et al., 2001). From structural studies, it became obvious that 
Glu
146  formed direct hydrogen bonds with cADPR to facilitate  its recruitment at the 
active site  (Liu,  et  al., 2007b). The dipeptide Glu
146-  Asp
147  was shown to  undergo 
structural rearrangement upon cADPR binding. It was proposed that the replacement of 
a charged glutamate to a small neutral residue in the mutants could alleviate the strain 
on the dipeptide, thus enhancing the cyclisation process (Liu, et al., 2007a).  
 
Substitution of Glu
146 of CD38 (or the equivalent Glu
98 of Aplysia cyclase) to neutral 
residues like Ala and Gly also relieved the acidic pH dependence of the base-exchange 
reaction allowing NAADP production to occur at neutral or alkaline pH (Graeff, et al., 
2006). Structural characterizations indicated that the electrostatic repulsion between 
Glu
146 and the substrates that were negatively charged at neutral pH prohibited their 
binding and were thus unfavourable for base-exchange to proceed. Asp
155 replaced 
with either Asn or Gln also eliminated pH dependency of NAADP synthesis.  However, 
substitution  of  the  neighbouring  residue,  Asp
147  with  Val  did  not  affect  the  acidic 
dependency of NAADP production, highlighting specificity (Graeff, et al., 2006).  
 
Although  Glu
146  was  a  critical  residue  in  catalysis,  its  mutation  did  not  eliminate 
enzymatic  activities  completely  but  only  altered  the  preference  of  the  reactions 
favoured by ARCs. Mutation of adjacent Asp
147 (again a part of the TLEDTL domain) to 
Val  caused  a  7%  decrease  in  NADase  activity.  However  with  a  double  mutation 
E146L/D147V, a complete loss of enzyme activity was evident (Graeff, et al., 2001), as 151 
 
also noticed by Lund et al earlier (Lund, et al., 1999). Intriguingly, in CD157, Glu
146 is 
replaced by Ser
130.  
 
Apart from the two tryptophan residues known previously to be involved in substrate 
moulding (Munshi, et al., 2000), it was later suggested that Phe
174 of Aplysia cyclase 
was also important in the folding of the linear substrate so that the two ends of NAD 
could  be  cyclised.  Structural  studies  revealed  that  the  phenyl  ring  of  the  Phe
174 
interacted with Trp
140 and rotated 10° during binding of substrate to promote folding of 
the adenine moiety of NAD (Graeff, et al., 2009). Therefore replacement of Phe
174 with 
a less bulky residue would decrease the cyclisation activity of the enzyme. In CD38, 
the  presence  of  a  less  hydrophobic  Thr
221  at  the  similar  position  might  thus  be 
responsible for its high hydrolytic activity. Site-directed mutagenesis of Phe
174 to Ala, 
Gly, Ser, or Thr conferred hydrolase activity on Aplysia cyclase to varying degrees. In 
F174T  mutant,  43%  of  the  product  was  ADPR,  thus  converting  Aplysia  cyclase  to 
CD38-like enzyme. In contrast and as a specificity control, mutation of neighbouring 
Phe
175  did  not  bestow  any  NADase  activity  (Graeff,  et  al.,  2009).  Mutation  of  the 
equivalent residue T221F in CD38 led to increased cADPR production, while a double 
mutation T221F/E146A converted CD38 to an Aplysia cyclase-like enzyme (Liu, et al., 
2009). The effects of mutations observed were specific since cGDPR production was 
not altered. The cyclisation site in cGDPR is different from cADPR (Figure 1.5). Hence 
the folding of NGD as a substrate might involve different residue(s). 
 
The active site of Schistosoma cyclase, SmNACE harbours a His residue at position 
103 instead of a well conserved Trp residue found in all other known ARCs. SmNACE 
produced  negligible  amounts  of  cADPR  from  NAD,  yet  cyclised  NGD  to  cGDPR 
(Goodrich,  et al., 2005).  However,  H103W mutant  restored cADPR production from 
NAD (Kuhn, et al., 2006). It is again important to note here that although SmNACE 152 
 
evolved a non-conserved residue at its active site, the overall catalytic activity of the 
enzyme was not affected while the cyclase activity alone was hugely impacted. 
 
These  structural  and  site-directed  mutagenesis  studies  have  provided  insight  into 
underlying mechanisms for substrate preferences displayed by ARCs.  However, we 
are far from  understanding the principles that govern the ratio of cADPR to ADPR 
production  by  ARCs.  Moreover,  the  structural  determinants  that  are  critical  for 
controlling  cADPR  versus  NAADP  production  have  not  been  deciphered  yet.  This 
important area of research needs more thrust, given that the products are involved in 
calcium mobilization by varied modes of action.  
 
In  this  chapter, the  molecular  analysis  of  SpARC2  and  SpARC4  was  performed  to 
dissect  the  roles  played  by  some  critical  amino  acid  residues  in  determining  the 
functional uniqueness of each isoform. 
 
 
5.2  Materials and Methods 
 
5.2.1  Site-directed mutagenesis 
 
SpARC2-G126E-Myc  and  SpARC2-W103Y-Myc  were  constructed  using  the  quick 
change  site-directed  mutagenesis  kit  (Stratagene)  as  per  manufacturer’s  guidelines 
and  SpARC2-Myc  as  template.  HPLC  purified  primers  G126E_sense/ 
G126E_antisense and W103Y_sense/ W103Y_antisense were used, respectively. The 
list  of  all  the  primers  used  in  this  Chapter  are  summarised  in  Table  5.1.  Similarly, 
SpARC4-F238T-Myc, SpARC4-R52/53A-Myc, SpARC4-F123Y-Myc, SpARC4-Y142W-
Myc and SpARC4-Y142H-Myc were generated using SpARC4-Myc as template. The 153 
 
HPLC  purified  primers  used  were  F238T_sense/F238T_antisense,  R52/53A_sense/ 
R52/53A_antisense,  F123Y_sense/F123Y_antisense,  Y142W_sense/Y142W_anti 
sense, Y142H_sense/Y142H_antisense, respectively. The protocol for PCR conditions 
and cloning of the mutated constructs are same as described in section 4.2.1. 
 
  PRIMER NAME  PRIMER SEQUENCE (5’→3’) 
1  SpARC2-G126-SENSE  GGAGTACATTGTCCTAGAAGAGACCTTTCCCGGAT 
2  G126-ANTISENSE  ATCCGGGAAAGGTCTCTTCTAGGACAATGTACTCC 
3  SpARC2-W103Y-SENSE  ACCAAACCCGGAACGACAATTTTTTATACCGGTGTCAGTG 
4  W103Y-ANTISENSE  CACTGACACCGGTATAAAAAATTGTCGTTCCGGGTTTGGT 
5  SpARC4-F238T-SENSE  CGTATCGACCAACAAGCACCTTTCGACTCCAGGAGG 
6  F238T-ANTISENSE  CCTCCTGGAGTCGAAAGGTGCTTGTTGGTCGATACG 
7  SpARC4-R52/53A-SENSE  ATGATGATGCTGGTAGTCGCGTTGCGGCAGCGGACGGAAA 
 
8  R52/53A-ANTISENSE  TTTCCGTCCGCTGCCGCAACGCGACTACCAGCATCATCAT 
 
9  SpARC4-F123Y-SENSE  AACAGCGTGCCAGAGGACTATGATGACTATGCTAACATGG 
10  F123Y-ANTISENSE  CCATGTTAGCATAGTCATCATAGTCCTCTGGCACGCTGTT 
11  SpARC4-Y142W-SENSE  CTCACCAATGACCAGACACTATTCTGGTCAGGAATGTATAGCATG 
12  Y142W-ANTISENSE  CATGCTATACATTCCTGACCAGAATAGTGTCTGGTCATTGGTGAG 
13  SpARC4-Y142H-SENSE  CCAATGACCAGACACTATTCCATTCAGGAATGTATAGCATG 
14  Y142H-ANTISENSE  CATGCTATACATTCCTGAATGGAATAGTGTCTGGTCATTGG 
15  SpARC4-NMyc-2F  CACCGAATTCAGGAAACAACATGACCACGG 
16  SpARC4-6R  GCTCTAGATCAATTAACAGAAAGGAATGATATGA 
Table 5.1:  List of all primers used in this chapter. Residues highlighted in 
red indicate site of introduced mutation. 154 
 
5.2.2  Generation of SpARC4-ΔN-Myc  
 
SpARC4-ΔN-Myc (in which the first 17 amino acids of mature SpARC4 were deleted) 
was  constructed  using  primers  SpARC4-NMyc-2F  and  SpARC4-6R.  Nucleotides 
corresponding  to  amino  acids  56  to  343  were  amplified  using  SpARC4-Myc  as 
template  and cloned  into SP-pCS2+-MT (see 3.2.2)  at the EcoRI/XbaI sites as per 
standard protocols. All constructs were sequenced to ensure PCR fidelity. Figure 5.1 
schematically depicts all the constructs used in this Chapter.  
 
 
Figure 5.1: Schematic representation of constructs used in chapter 5 
 
SpARC2-Myc  (A)  was  used  to  generate  point  mutants  (B)  and  (C)  by  site-directed 
mutagenesis. Similarly SpARC4-Myc (D) was used to generate point mutants (E), (F), 
(H),  (I)  and  (J)  as  described  in  methods.  The  relative  position  of  the  mutation  is 
indicated by asterisks. In SpARC4-∆N-Myc (G), the first 17 amino acids of the mature 
SpARC4 harbouring the acidic-basic cluster (yellow) was deleted. 
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Pro-protease cleavage site was identified by ProP 1.0 server (Duckert, et al., 2004). 
Rest of the methodologies were same as described in previous Chapters.  
 
 
5.3  Results 
 
5.3.1    Determinants  dictating  preferential  cyclase  over  hydrolase 
activity 
 
Whilst CD38 and SmNACE possess robust hydrolase activities, results from chapter 4 
indicated that both SpARCs displayed negligible hydrolase activities (Figure 4.6). In 
this chapter, the critical molecular components that suppress the hydrolase activities of 
SpARCs were examined. 
 
5.3.1.1  Role of non-conserved “TLEDTL domain” in SpARC2 catalysis 
 
It is now established that Glu of the “TLEDTL signature domain” of ARCs regulates its 
preferential  cyclase  versus  hydrolase  activities  (Graeff,  et  al.,  2001).  Amino  acid 
sequence alignment of ARCs indicated that the Glu residue of the TLEDTL domain is 
highly conserved in Aplysia cyclase, CD38, SpARC1, SpARC3 and SpARC4. However, 
it is replaced by a non-conserved Gly residue in SpARC2 (Figure 5.2A - red) and Ser in 
CD157. Hence, it was hypothesised that the substitution of Glu with Gly in SpARC2 
was responsible for the lack of hydrolase activity.  
 
To  test  the  role  of  this  non-conserved  Gly  residue  in  governing  SpARC2  catalytic 
activity, a mutant SpARC2-G126E-Myc was generated (Figure 5.1B). SpARC2-G126E-
Myc expressed at levels equivalent to SpARC2-Myc in Xenopus embryos (Figure 5.2B) 
and  HEK  cells  (Figure  5.2C)  as  revealed  by  the  western  blot  analysis.  SpARC2-156 
 
G126E-Myc also localized to the plasma membrane (Figure 5.2D) and was PI-PLC 
sensitive similar to SpARC2-Myc (Figure 5.2E).  
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SpARC2-G126E-Myc  -PIPLC  +PIPLC 
Figure 5.2: Expression of SpARC2-G126E-Myc 
 
(A) Clustal W amino acid sequence alignment of ARCs around the TLEDTL domain.  The non-
conserved residue in SpARC2 is highlighted red. Western blot analysis with anti-myc antibodies 
of Xenopus embryo homogenates (B) and HEK cell homogenates (C) expressing SpARC2-Myc 
and SpARC2-G126E-Myc. (D) Confocal images of the sub-cellular localization of SpARC2-G126E-
Myc carried out by immunocytochemistry, in HEK cells. Scale bar = 5 µm. (E) Confocal images of 
HEK  cells  showing  cell  surface  expression  of  SpARC2-G126E-Myc  before  and  after  PI-PLC 
treatment. Scale bar = 50 µm.  
AcARC    ---ITLEDTLPGYMLNSLVWC 
HsCD38   ---FTLEDTLLGYLADDLTWC 
HsCD157  ---MPLSDVLYGRVADFLSWC 
SpARC1   ---SVLEETFPGYMAGNLSWC 
SpARC2   ---TVLGETFPGYMALNLSFC 
SpARC3   ---WSLEYTLMGYLINNLKFC 
SpARC4   ---TNIELTMLGGLVNGITFC 
SmNACE   GVCRSLETTFPGYLFDELNWC 
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Enzyme activity measurements were performed with Xenopus embryo homogenates 
expressing  SpARC2-G126E-Myc  in  parallel  with  embryos  expressing  SpARC2-Myc. 
The results indicated that cADPR production was not grossly affected by the mutation, 
although the base-exchange reaction almost doubled (Figure 5.3A). More striking was 
the  finding  that  the  mutation  introduced  huge  amounts  of  hydrolase  activity  as 
measured  by  ADPR  production  when  NAD  was  used  as  substrate  (Figure  5.3A). 
ADPRP production was not significantly increased (data not shown).   
 
When NGD was used as a substrate, cGDPR production of SpARC2-G126E-Myc was 
similar to SpARC2-Myc (Figure 5.3C) at extremely low levels, whilst GDPR production 
increased slightly over the 22 h incubation period (Figure 5.3D).   
 
Results from the previous chapter indicated that SpARC2 exhibited extraordinary pH 
tolerance for enzyme catalysis (Figure 4.7). The Glu of the “TLEDTL domain” of ARCs 
is also implicated in the acidic dependence of NAADP synthesis in CD38 and Aplysia 
cyclase (Graeff, et al., 2006). Therefore in SpARC2, the effect of substitution of Gly
126 
with Glu, on the pH dependence for NAADP production was also studied. The base-
exchange  activity  of  SpARC2-G126E-Myc  was  reduced  by  90%  at  neutral  pH 
compared to 75% for SpARC2-Myc. At pH 8.1, the mutant was completely unable to 
synthesise NAADP, unlike the wild-type (Figure 5.3B).  
 
Thus, the non-conservation of the Glu of the TLEDTL domain was responsible for poor 
hydrolase activity in SpARC2. This substitution was also critical for SpARC2’s ability to 
carry out the base-exchange reaction over wider pH conditions.  158 
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Figure 5.3: Role of Glu
126 in SpARC2 catalysis 
 
(A)  Initial  rates  of  cADPR/ADPR/NAADP  production  by  SpARC2-Myc  and  SpARC2-G126E-Myc  heterologously 
expressed  in  Xenopus  embryos.  n=3  Xenopus  expressions  for  both  constructs.  (B)  NAADP  production  by 
SpARC2-Myc  and  SpARC2-G126E-Myc  at  acidic,  neutral  and  alkaline  pH.  Xenopus  embryos  homogenates 
expressing SpARC2-Myc (C) and SpARC2-G126E-Myc (D) were incubated with 1 mM NGD, pH 7.2 for indicated 
time periods. The reaction products were separated by HPLC. Typical chromatograms after a 0.1 h (black traces) 
at the start of the reaction and 22 h (green traces), at the end of incubation are shown.  
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5.3.1.2  Role of Phe
238 in SpARC4 catalysis 
 
As previously demonstrated, SpARC4 like SpARC2 is a poor hydrolase (Figure 4.6). 
Results from section 5.3.1 implicated a role for the non-conserved Gly residue of the 
“TLEDTL  domain”  for  the  lack  of  SpARC2  hydrolase  activity.  However,  analysis  of 
SpARC4 sequence revealed that the Glu of “TLEDTL domain” was conserved (Figure 
5.2A).  Certain  other  residues  have  also  been  implicated  in  the  control  of  cyclase 
against hydrolase activities of Aplysia cyclase and CD38. Phe
174 in Aplysia cyclase was 
responsible  for  its  major  cyclase  activity  while  the  corresponding  Thr
221  in  CD38 
governed  its  predominant  hydrolase  activity  (Graeff,  et  al.,  2009;  Liu,  et  al.,  2009). 
Alignment of amino acid sequences of various ARCs revealed that SpARC4 had a Phe 
at the corresponding position, similar to Aplysia cyclase (Figure 5.4A). Therefore, it was 
hypothesised that the presence of Phe
238 was responsible for the major cyclase activity 
of SpARC4 and its substitution with Thr would introduce hydrolase activity. To test this 
hypothesis, a point mutant, SpARC4-F238T-Myc was generated (Figure 5.1E). 
 
Western  blot  analysis  indicated  that  SpARC4-F238T-Myc  and  SpARC4-Myc  were 
expressed in equivalent levels in both Xenopus embryos (Figure 5.4B) and HEK cells 
(Figure 5.4C). SpARC4-F238T-Myc localized to plasma membrane (Figure 5.4D) and 
was  PI-PLC  sensitive  (Figure  5.4E)  when  expressed  in  HEK  cells.  Interestingly, 
enzyme  activity  measurements  with  Xenopus  embryo  homogenates  expressing 
SpARC4-F238T-Myc indicated major knockdown of the cyclase activity (Figure 5.4F). 
However, no ADPR production was detectable. The base-exchange activity was also 
significantly lowered (Figure 5.4F). When NGD was used as a substrate, again there 
was no detectable cGDPR or GDPR production even after an incubation of 22h (data 
not shown). Thus, Phe
238 was critical in controlling the overall catalysis of SpARC4, the 
mutation of which caused major loss of SpARC4 enzymatic activities. 160 
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AcARC    PKVPAYRPDSFFGKYELPNL 
HsCD38   SK--IFDKNSTFGSVEVHNL 
HsCD157  PTG-AYPIKGFFADYEIPNL 
SpARC1   AGG-AFNNGSIFATIEAPNL 
SpARC2   DRG-AYHLESTFARVEVPAL 
SpARC3   EGGAFHNNNSYFAQYELINM 
SpARC4   ADG-AYRPTSFFRLQEVANL 
SmNACE   KAP--FNENKTFGKIELPLL 
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Figure 5.4: Role of Phe
238 in controlling enzymatic activities of SpARC4 
 
(A) Clustal W amino acid sequence alignment of ARCs around the residues implicated in cyclase 
versus hydrolase reactions in Aplysia cyclase (Phe
174) and CD38 (Thr
221). SpARC4 harbours Phe 
at corresponding position (highlighted red).  Western blot analysis with anti-myc  antibodies of 
Xenopus embryo homogenates (B) and HEK cell homogenates (C) expressing SpARC4-Myc and 
SpARC4-F238T-Myc. (D) Confocal images of the sub-cellular localization of SpARC4-F238T-Myc 
carried out by immunocytochemistry, in HEK cells. Scale bar = 5 µm. (E) Confocal images of HEK 
cells showing cell surface expression of SpARC4-F238T-Myc before and after PI-PLC treatment. 
Scale  bar  =  50  µm.  (F)  Initial  rates  of  cADPR  and  NAADP  production  by  SpARC4-Myc  and 
SpARC4-F238T-Myc heterologously expressed in Xenopus embryos. n=3 Xenopus expressions. 
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5.3.2    Determinants  dictating  preferential  cyclisation  over  base-
exchange activity  
 
Results  from  the  previous  chapter  indicated  that  SpARC4  had  an  exceptional 
preference for cyclisation over base-exchange (Figure 4.5B). This was in contrast to 
enzymatic activities of SpARC1 (Churamani, et al., 2007) and SpARC2 (Figure 4.5A), 
both  of  which  were  preferential  base-exchangers.  In  the  following  sections,  the 
potential  molecular  determinants  involved  in  influencing  SpARC4’s  cyclase  activity 
were investigated.  
 
 
 
5.3.2.1  Role of the N-terminus in SpARC4 catalysis 
 
SpARCs are most divergent at their N and C-terminal sequences (Figure 2.14). Careful 
scanning of the amino acid sequences of SpARCs revealed the presence of a cluster 
of acidic amino acids followed by basic residues present at the N-terminus of SpARC4, 
but absent in other SpARC isoforms (Figure 5.5A - yellow). To investigate the potential 
functional role of this acidic-basic cluster, an N-terminal deletion construct (SpARC4-
ΔN-Myc), lacking the first 17 amino acids of mature SpARC4 was generated (Figure 
5.1F). Further inspection of this region also resulted in the identification of a consensus 
sequence,  R-X-X-R  (Figure  5.5A  -  red)  for  cleavage  by  pro-convertase  enzymes, 
hinting at a possibility that SpARC4 might be proteolytically (de)activated. To address 
the cleavage issue more specifically, a mutant construct in which Arg
52 and Arg
53 were 
replaced with alanines (SpARC4-R52/53A-Myc), was also generated (Figure 5.1G). 
 
The two mutant  constructs  expressed  in  Xenopus  embryos (Figure 5.5B)  and HEK 
cells (Figure 5.5C) at levels similar to SpARC4-Myc. Immunocytochemical analysis in 
HEK cells indicated that the mutants were targeted to the plasma membrane (Figure 162 
 
5.5D and 5.5E) and were PI-PLC sensitive (Figure 5.5F and 5.5G). Since 6-Myc tags 
were added to SpARC4-Myc downstream of the pro-convertase consensus site, any 
cleavage would result in the loss of the tag to a smaller fragment (~15 kDa) (Figure 
5.5H, red arrow) while the larger fragment containing the SpARC4 catalytic domain 
would be undetectable by western blotting probed with anti-myc antibodies. However 
such a putative N-terminal cleavage product was undetectable even when SDS gels 
were  run  under  conditions  to  optimally  resolve  small  polypeptides  and  the  blots 
overexposed  (Figure  5.5H).  Thus  it  is  unlikely  that  SpARC4  underwent  proteolytic 
cleavage by pro-convertase enzymes. 
 
Xenopus embryos were injected in parallel with SpARC4-Myc, SpARC4-ΔN-Myc and 
SpARC4-R52/53A-Myc  mRNAs  and  enzyme  activity  assays  carried  out  with  the 
homogenates.  Measurement  of  cADPR  and  NAADP  production  from  the  three 
constructs did not reveal any significant differences between them (Figures 5.6A, 5.6B 
and  5.6C).  Although  the  cyclisation:  base-exchange  ratio  of  SpARC4-R52/53A-Myc 
was slightly lower than the other two (Figure 5.6C), this was not statistically significant 
for paired experiments (p=0.12). There were also no differences in NGD utilisation or 
pH sensitivity of SpARC4-ΔN-Myc and SpARC4-R52/53A-Myc compared to SpARC4-
Myc (data not shown). 
 
The  above  data  suggested  that  neither  the  N-terminal  acidic-basic  cluster  nor  the 
putative pro-convertase consensus sequence influenced SpARC4 activity. 
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AcARC    ---------------------MSPVAIIACVCLAVTLT----------------------------SISPSEAIVP 
HsCD38   MANCEFSPVSGDKPCCRLSRRAQLCLGVSILVLILVVVL---------------------AVVVPRWRQQWSGPGT 
HsCD157  ------MAAQG----CAASRLLQLLLQLLLLLLLLAAG---------------------------GARARWRAEGT 
SpARC1   ---------------------MGIYTIFTYLSPILAVT----------------------------VAYNNKGPGA 
SpARC2   --------------------MMNLLRTSLFLSSILAAT----------------------------VAYTLPGPGT 
SpARC3   ---MPYTAYIRRRIFGVLAATIVVMTVIENASTMMTTR----------------------ATMTTLPPVLYSDNGT 
SpARC4   -----MHSLYGLSPSAPAYINKAFVLVIVAASLVVNSSGRLLPFGDTDDDDAGSRVRRADGNNMTTELPLNLGDGT 
SmNACE   ---------------------MMNVILFLTLSNIFVFN---------------------------------SAQHQ 
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Figure 5.5: Expression of SpARC4-∆N-Myc and SpARC4-R52/53A-Myc 
 
(A)  Clustal  W  amino  acid  sequence  alignment  of  the  N-terminal  regions  of  different  ARCs. 
SpARC4  possessed a  unique  stretch  of  acidic-basic  residues  (highlighted  yellow) which  also 
harboured  the  consensus  sequence  (RXXR)  for  recognition  by  pro-convertase  enzymes 
(highlighted  red).  Western  blot  analysis  of  Xenopus  embryo  homogenates  (B)  and  HEK  cell 
homogenates  (C)  expressing  SpARC4-Myc,  SpARC4-∆N-Myc  and  SpARC4-R52/53A-Myc. 
Confocal images of the sub-cellular localization of SpARC4-∆N-Myc (D) and SpARC4-R52/53A-
Myc (E) carried out by immunocytochemistry, in HEK cells. Scale bar = 5 µm. Confocal images of 
HEK cells showing cell surface expression of SpARC4-∆N-Myc (F) and SpARC4-R52/53A-Myc (G) 
before and after PI-PLC treatment. Scale bar = 50 µm. (H) Western blot analysis of SpARC4-Myc 
and SpARC4-R52/53A-Myc (run under conditions to better resolve the lower molecular weight 
bands  and  deliberately  over-exposed).  Red  arrow  indicates  the  approximate  position  of  the 
expected cleavage product of SpARC4-Myc.  
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Figure 5.6: Effect of acidic-basic cluster and pro-convertase consensus 
sequence on SpARC4 activity 
 
Time course for cADPR and NAADP production by  SpARC4-Myc (A), SpARC4-∆N-Myc (B) and 
SpARC4-R52/53A-Myc  (C)  heterologously  expressed  in  Xenopus  embryos.  (D)  Pooled  data  for 
cyclase: base-exchange activities of SpARC4-Myc against untagged SpARC4, SpARC4-∆N-Myc 
and SpARC4-R52/53A-Myc.  n=3 Xenopus expressions for all constructs. 
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5.3.2.2  Role of Phe
123 in SpARC4 catalysis 
 
The  acidic-basic  cluster  or  putative  pro-convertase  consensus  sequence  did  not 
influence SpARC4’s cyclisation activity majorly (Figure 5.6). Subsequent inspection of 
the amino acid sequence alignments of the SpARCs identified a Phe at position 123 in 
SpARC4, in place of a highly conserved Tyr at corresponding position in other ARC 
isoforms  (Figure  5.7A  -  red).  Intriguingly,  SmNACE  also  possessed  a  Phe  at  the 
corresponding position. To investigate the role of this non-conserved Phe residue in 
enzymatic catalysis of SpARC4, a point mutant SpARC4-F123Y-Myc was generated 
(Figure 5.1H). 
 
SpARC4-F123Y-Myc was expressed at similar levels to SpARC4-Myc in both Xenopus 
embryos (Figure 5.7B) and HEK cells  (Figure 5.7C). The construct  localized to the 
plasma  membrane  (Figure  5.7D)  and  was  PI-PLC  sensitive  (Figure  5.7E)  when 
expressed in HEK cells. Interestingly, the enzymatic assays with the Xenopus embryo 
homogenates heterologously expressing SpARC4-F123Y-Myc revealed that there was 
a  complete  loss  of  both  cyclase  and  base-exchange  activities  when  compared  to 
SpARC4-Myc  (Figure  5.7F). When  NGD  was  used  as  substrate,  there  was  neither 
cGDPR nor GDPR production (data not shown). These data suggested that Phe
123 was 
critical for the overall enzymatic catalysis of SpARC4, but did not specifically dictate its 
preferential cyclase activity. 
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Figure 5.7: Role of Phe
123 in controlling SpARC4 activity 
 
(A)  Clustal  W  amino  acid  sequence  alignment  of  ARCs  around  a  tyrosine  residue  absolutely 
conserved  in  all  ARCs  except  SmNACE.  This  residue  is  substituted  by  Phe  in  SpARC4 
(highlighted  red).  Western  blot  analysis  of  Xenopus  embryo  homogenates  (B)  and  HEK  cell 
homogenates (C) expressing SpARC4-Myc and SpARC4-F123Y-Myc. (D) Confocal images of the 
sub-cellular  localization  of SpARC4-F123Y  carried  out by  immunocytochemistry,  in  HEK  cells. 
Scale bar = 5 µm. (E) Confocal images of HEK cells showing cell surface expression of SpARC4-
F123Y-Myc before and after PI-PLC treatment.  Scale bar = 50 µm. (F) Initial rates of cADPR and 
NAADP  production  by  SpARC4-Myc  and  SpARC4-F123Y-Myc  heterologously  expressed  in 
Xenopus embryos. n=3 Xenopus expressions. 
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5.3.2.3  Role of non-canonical active site in SpARC4 catalysis  
 
Since the search for a molecular motif responsible for the remarkable cyclase activity of 
SpARC4 was unsuccessful, SpARC4 sequence was further critically analysed. ARC 
family members share low percent similarity. However, their active site residues are 
highly conserved. A critical glutamate residue is involved in ADP-ribosylation during 
catalysis while two tryptophan residues lining the triad of the active site are essential 
for the moulding of the linear substrate (Munshi, et al., 1999; Liu, et al., 2007b). One of 
the active site residues, Trp
103 is not conserved in SmNACE and replaced with His 
(Goodrich, et al., 2005). Intriguingly, amino acid sequence alignment indicated that the 
corresponding residue was also not conserved in SpARC4, being substituted with a Tyr 
residue (Figure 5.8A-red). This non-canonical active site of SpARC4 is intriguing and 
may have both evolutionary and functional significance.  
 
To investigate the importance of this substitution, point mutants in which the Tyr
142 was 
replaced either with a Trp (as in other ARCs), SpARC4-Y142W-Myc, or with a His (as 
in SmNACE), SpARC4-Y142H-Myc, were generated (Figure 5.1I and 5.1J). The mutant 
constructs SpARC4-Y142W-Myc and SpARC4-Y142H-Myc expressed both in Xenopus 
embryos (Figure 5.8B) and HEK cells (Figure 5.8C) at levels similar to SpARC4-Myc. 
Furthermore, the point mutants localized to the plasma membrane (Figures 5.8D and 
5.8E) and displayed PI-PLC sensitivity (Figure 5.8F and 5.8G).  
 
Although the mutants expressed and targeted similar to the wild-type, quantification of 
cADPR and NAADP production revealed that they were functionally very different from 
SpARC4-Myc. Whilst SpARC4-Myc preferentially produced more cADPR than NAADP 
(Figure 5.9A), SpARC4-Y142W-Myc produced similar levels of both the messengers 
(Figure  5.9B).  Even  though  the  overall  activity  of  SpARC4-Y142W-Myc  was  lower 
compared  to  SpARC4-Myc,  it  was  still  higher  than  those  observed  for 168 
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Figure 5.8: Expression of SpARC4-Y142W-Myc and SpARC4-Y142H-Myc 
 
(A) Clustal W amino acid sequence alignment of ARC sequences around the tryptophan active 
residue. Substitution of the highly conserved Trp by Tyr in SpARC4 is highlighted red. Western 
blot analysis of Xenopus embryo homogenates (B) and HEK cell homogenates (C) expressing 
SpARC4-Myc, SpARC4-Y142W-Myc and SpARC4-Y142H-Myc. Confocal images of the sub cellular 
localization  of  SpARC4-Y142W-Myc  (D)  and  SpARC4-Y142H-Myc  (E)  carried  out  by 
immunocytochemistry, in HEK cells. Scale bar = 5 µm. Confocal images of HEK cells showing cell 
surface expression of SpARC4-Y142W-Myc (F) and SpARC4-Y142H-Myc (G) before and after PI-
PLC treatment. Scale bar = 50 µm.  
 
SpARC4-Y142W-Myc  SpARC4-Y142H-Myc 
D 
S
p
A
R
C
4
-
M
y
c
 
S
p
A
R
C
4
-
Y
1
4
2
W
-
M
y
c
 
A 169 
 
 
 
 
 
B  A 
0
0.3
0.6
0 1 2 3
Time (h)
 
P
r
o
d
u
c
t
i
o
n
 
(
n
m
o
l
/
e
m
b
r
y
o
)
NAADP
cADPR
SpARC4-Y142W-Myc
C  D 
Figure 5.9: Role of the non-canonical active site in dictating cyclase: 
base-exchange activities of SpARC4 
 
Time course for cADPR and NAADP production by SpARC4-Myc (A) SpARC4-Y142W-Myc (B) and 
SpARC4-Y142H-Myc  (C)  heterologously  expressed  in  Xenopus  embryos.  (D)  Pooled  data  of 
cyclase:  base-exchange  activities  of  SpARC4-Y142W-Myc  and  SpARC4-Y142H-Myc  against 
SpARC4-Myc and SpARC2-Myc.  n=3 Xenopus expressions. 
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SpARC1 (Churamani, et al., 2007) and SpARC2 (Figure 4.5A). The kinetics displayed 
by SpARC4-Y142H-Myc was even more remarkable. The point mutation completely 
reversed the preference for the cyclisation and now the mutant preferentially produced 
more NAADP (Figure 5.9C). The cyclisation: base-exchange activity ratio of SpARC4-
Y142W-Myc and SpARC4-Y142H-Myc were drastically different from each other and 
from  that  of  SpARC4-Myc  (Figure  5.9D).  NGD  utilisation  by  the  mutants  was  not 
significantly different from that of SpARC4-Myc (data not shown).  
 
These  data  demonstrated  that  the  non  conserved  Tyr  residue  at  the  active  site  of 
SpARC4 was responsible for controlling its preferential cyclisation reaction. 
 
 
5.3.2.4  Engineering a non-canonical active site in SpARC2 
 
SpARC2 has been shown to be a preferential base-exchanger (Figure 4.5A), while 
SpARC4  favoured  cyclisation  (Figure  4.5B).  Results  from  the  previous  section 
demonstrated that the presence of a non-conserved tyrosine residue at the active site 
of  SpARC4  was  responsible  for  its  unusual  catalytic  activity.  Consequently,  it  was 
hypothesized that the replacement of the active site residue of SpARC2 from Trp
103 to 
Tyr would conversely increase its cyclase activity.  
 
A point mutant, SpARC2-W103Y-Myc was therefore generated (Figure 5.1C). Western 
blot  analysis revealed that SpARC2-W103Y-Myc was expressed at  levels similar to 
SpARC2-Myc, in both Xenopus embryos (Figure 5.10A) and HEK cells (Figure 5.10B). 
In addition, SpARC2-W103Y-Myc targeted to the plasma membrane in the HEK cells, 
as revealed by the confocal images (Figure 5.10C) and was PI-PLC sensitive (Figure 
5.10D). Enzymatic analysis of the Xenopus embryo homogenates heterelogously 171 
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Figure 5.10: Role of conserved active site residue Trp
103 in SpARC2 
catalysis 
 
Western  blot  analysis  of  Xenopus  embryo  homogenates  (A)  and  HEK  cell  homogenates  (B) 
expressing  SpARC2-Myc  and  SpARC2-W103Y-Myc.  (C)  Confocal  images  of  sub-cellular 
localization of SpARC2-W103Y-Myc carried out by immunocytochemistry, in HEK cells. Scale bar 
= 5 µm. (D) Confocal images of HEK cells showing cell surface expression of SpARC2-W103Y-Myc 
before  and  after  PI-PLC  treatment.  Scale  bar  =  50  µm.  (E)  Initial  rates  of  cADPR  and  NAADP 
production  by  SpARC2-Myc  and  SpARC2-W103Y-Myc  heterologously  expressed  in  Xenopus 
embryos. n=3 Xenopus expressions. Xenopus embryos homogenates expressing SpARC2-Myc 
(F)  and  SpARC2-W103Y-Myc  (G)  were  incubated  with  1  mM  NGD,  pH  7.2  for  indicated  time 
periods. HPLC chromatograms of the reaction mix after a 0.1 h (black traces) at the start of the 
reaction and 22 h (green traces), at the end of incubation are shown.  
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expressing SpARC2-W103Y-Myc or SpARC2-Myc revealed no significant differences 
in NAADP production (Figure 5.10E). However, surprisingly cADPR production was not 
detectable  in  SpARC2-W103Y-Myc  (Figure  5.10E).  When  NGD  was  used  as  a 
substrate SpARC2-W103Y-Myc produced neither cGDPR nor GDPR (Figure 5.10G), 
unlike SpARC2-Myc which produces very low levels of cGDPR (Figure 5.10F) over 22 
h incubation. 
 
The  above  data  suggests  that  the  active  site  residue  Trp  was  critical  for  SpARC2 
catalysis and its replacement with Tyr selectively abolished all the cyclisation activity.  
 
 
5.4  Discussion  
 
Results  from  Chapter  4  indicated  that  SpARCs  were  poor  hydrolases  (Figure  4.6). 
When  NAD  was  provided  as  a  substrate,  both  SpARC2  and  SpARC4  converted  it 
predominantly  to  cADPR  (Figure  4.2B  and  4.2D).  ADPR  production  was  modest, 
especially for SpARC2 (Figure 4.6A). In addition, the data also revealed that SpARC2 
was  a  preferential  base-exchanger  (Figure  4.5A)  whereas  SpARC4  favoured 
cyclisation  (Figure  4.5B).  Understanding  the  structural  basis  for  such  catalytic 
differences is vital for deciphering the physiological functions of SpARCs. Certain key 
residues/motifs were identified and their significance in governing such extra-ordinary 
catalytic activities of SpARC2 and SpARC4 were investigated in this Chapter.  
 
Firstly, the critical residues that could be responsible for the poor hydrolase activity of 
SpARCs were examined. Earlier studies suggest that Aplysia cyclase is a preferential 
cyclase  while  CD38  a  better  hydrolase  (Lee,  2000).  Glutamate
  of  the  “TLEDTL 
signature domain” is by far the best studied residue shown to be involved in control of 173 
 
synthesis and hydrolysis of cADPR (Graeff, et al., 2001). Careful analysis of amino acid 
sequence  alignments  of  SpARC  isoforms  revealed  that  the  highly  conserved  Glu 
residue of the TLEDTL domain was in fact replaced by a Gly in SpARC2 (Figure 5.2A, 
red). Therefore, to study the importance of this Gly substitution for SpARC2 catalysis, a 
site  direct  mutant,  SpARC2-G126E-Myc  was  generated  (Figure  5.1B).  Xenopus 
embryo  homogenates  expressing  SpARC2-G126E-Myc  displayed  a  significant 
increase in ADPR production compared to SpARC2-Myc (Figure 5.3A). However, the 
cyclase activity of the mutant was relatively unaffected. There was also a pronounced 
increase  in  base-exchange  activity  of  SpARC2-G126E-Myc  (Figure  5.3A).  cGDPR 
production was unaltered in SpARC2-G126E-Myc although a slight increase in GDPR 
production was evident over 22 h incubation (Figure 5.3D). These results suggested 
that  this  particular  residue  of  the  “TLEDTL  domain”  indeed  controlled  the  relative 
cyclase versus hydrolase activities of ARCs. 
 
 Lee and colleagues carried out site-directed mutagenesis studies on CD38, generating 
E146G  mutant  (Graeff,  et  al.,  2001)  almost  six  years  before  SpARC2  was  cloned 
(Churamani, et al., 2007), an ARC in which such a mutation has been selected by 
nature. In the E146G mutant of CD38, the observed effects on activity were the reverse 
of those observed in this chapter (Figure 5.3A). The E146G mutant led to increased 
cyclase against hydrolase activity and also decreased base-exchange. However, there 
was no change in cGDPR production (Graeff, et al., 2001). The substitution of Glu with 
Gly at the TLEDTL domain probably reflects the evolutionary pressure on SpARC2 to 
remain  a  cyclase  and  not  change  to  a  hydrolase.  Analogously,  it  would  be  quiet 
interesting to study the consequence of converting the corresponding Glu of “TLEDTL 
domain”  to  Gly  in  SpARC4.  In  this  context  it  is  noteworthy  that  the  new  family  of 
SpARC1-like isoforms (Group-II) also bear a different amino acid at the corresponding 
position (Asp
126 instead of Glu
126 of SpARC1) (Figure 2.7B). In CD38, E146D, although 
a conservative substitution, displayed a cyclase: hydrolase ratio of unity (Graeff, et al., 174 
 
2001). Even though Glu of “TLEDTL domain” is critical, substitutions at this residue are 
probably  more  tolerable,  perhaps  to  select  for  variants  with  differing  cADPR/ADPR 
synthesizing capabilities. 
 
Another  intriguing  result  from  chapter  4  was  the  broad  pH  sensitivity  displayed  by 
SpARCs (Figure 4.7). ARCs characterized previously, were able to carry out base-
exchange reaction only at acidic pH with zero activity at alkaline pH (Graeff, et al., 
2006). This acidic dependency of NAADP synthesis has again been associated with 
the  Glu  residue  of  the  “TLEDTL  domain”  (Graeff,  et  al.,  2006).  Although  SpARC2 
carried out base-exchange reaction optimally at acidic pH, the activity was still quiet 
significant at neutral and alkaline pH (Figure 5.3B). However, in the case of SpARC2-
G126E-Myc, the drop in the base-exchange activity was more pronounced at neutral 
pH. Furthermore, at alkaline pH there was absolutely no NAADP production (Figure 
5.3B).  Thus,  the  acidic  dependence  of  NAADP  production  was  also  restored  with 
SpARC2-G126E-Myc. E146G mutant of CD38 (or E98G of Aplysia cyclase) conversely 
abolished  the  acidic  dependence  of  NAADP  synthesis  and  rendered  the  mutant 
enzyme active at alkaline pH, compared to the wild-type enzyme (Graeff, et al., 2006).  
 
Recent  studies  from  Lee  and  co-workers  specified  the  role  of  another  amino  acid 
residue in controlling cyclase versus hydrolase activities. Phe
174 of Aplysia cyclase and 
the corresponding Thr
221 of CD38 were implicated to play key roles in governing the 
prevalence of cyclase and hydrolase activities, respectively. The studies culminated in 
the  effective  inter-conversion  of  Aplysia  ARC  to  CD38-like  and  vice-versa  by  the 
exchange  of  analogous  residues  (Graeff,  et  al.,  2009;  Liu,  et  al.,  2009).  Multiple 
sequence  alignment  of  ARCs  confirmed  that  this  particular  residue  was  not  well 
conserved,  especially  in  SpARCs  (Figure  5.4A),  with  all  four  isoforms  harbouring 
different amino acids. SpARC4 carried a Phe at the corresponding position similar to 
Aplysia cyclase (Figure 5.4A). Since SpARC4 exhibited low hydrolase activity, it was 175 
 
postulated that Phe
238 could play a critical role, the mutation of which could increase 
ADPR production. But on the contrary, there was a complete loss of cyclase activity 
and  no  ADPR  production  in  SpARC4-F238T-Myc  (Figure  5.4F).  There  was  also  a 
substantial reduction in NAADP synthesis (Figure 5.4F). Thus, Phe
238 played a critical 
role in SpARC4 catalysis. In Aplysia cyclase, this residue was postulated to be involved 
in substrate moulding (Liu, et al., 2009). At least for SpARC4, Phe
238 could be more 
critical than just controlling the cyclase versus hydrolase activities. The newly cloned 
Group-II,  SpARC1-like  isoforms  also  harbour  differences  at  this  particular  residue 
(Figure 2.7B). It will therefore be interesting to study the role of this amino acid on the 
enzyme activity of SpARC1-like isoforms. 
 
A unique feature of SpARC4 catalysis is its ability for preferential cyclisation over base-
exchange reaction (Figure 4.5B). SpARC4 is by far the best cyclase among SpARC 
isoforms. The structural element(s) of SpARC4 that dictate the ratio of cADPR versus 
NAADP production are important in committing the cell to a particular calcium signalling 
pathway.  In  the  past,  many  groups  have  focused  exclusively  on  the  determinants 
regulating the cyclase  versus  hydrolase activities of ARCs, however, little  is known 
about residues/domains that control the relative production of cADPR versus NAADP. 
This  is  a  critical  aspect  in  the  study  of  ARCs  considering  the fact that  the  second 
messengers  produced  target  different  calcium  channels  located  on  distinct  stores, 
regulating calcium signalling both spatially and temporally. With this endeavour, various 
conspicuous domains/residues of SpARC4 were investigated.  
 
Firstly,  the  unique  acidic-basic  cluster  at  the  N-terminus  of  SpARC4  (Figure  5.5A-
yellow), that was absent in all other ARCs including SpARCs, was proposed to regulate 
SpARC4 catalysis. The region also harboured an R-X-X-R consensus (Figure 4A -red) 
for cleavage by pro-convertases (Roebroek, et al., 1994). Cleavage at such sites are 
pre-requisites for either the activation of proteins like tolloid metalloproteases (Leighton 176 
 
and Kadler, 2003) and insect vittelogenins (Tufail and Takeda, 2008) or inactivation of 
other proteins like matrix metalloproteinase-2 (Cao, et al., 2005) and endothelial lipase 
(Jin, et al., 2005).  Proprotein convertase sites are also found in S.purpuratus BMP2/4 
proteins (Angerer, et al., 2000). Xenopus expression systems are excellent for studying 
this type of proteolytic cleavage and have been used with great success in the past 
(Birsoy,  et  al.,  2005;  Nelsen,  et  al.,  2005).  Similar  processing  of  SpARC4  could 
potentially regulate its enzymatic activity and/or localization. Two parallel approaches 
were employed to address this cleavage issue. Mutant construct lacking the acidic-
basic cluster (SpARC4-∆N-Myc) and more specifically, a site-directed mutant, in which 
arginines at positions 52 and 53 were replaced with alanines (SpARC4-R52/53A-Myc), 
were employed. However, there were no significant differences either in the catalytic 
activity (Figures 5.6B and 5.6C) or localization (Figures 5.5D and 5.5E) with either the 
deletion of the N-terminal acidic-basic cluster or the abolition of the putative cleavage 
consensus. More importantly, cleavage of SpARC4-Myc was not detectable, at least 
with  the  techniques  employed  in  this  study  (Figure  5.5H).  Hence,  the  functional 
significance of this unique N-terminal region of SpARC4 remains to be determined. It is 
noteworthy  that  the  deletion  of  N-terminal  cytoplasmic  domain  and  transmembrane 
domain  of  CD38  changed  the  localization  of  the  mutant  proteins  mainly  to 
mitochondria, but had no effect on its activity, in NIH3T3 cells (Sun, et al., 2002). 
 
Careful analysis of SpARC alignments also revealed that Tyr
84 (SpARC1 numbering) 
that  was  absolutely  conserved  in  SpARC1,  SpARC2,  SpARC3,  CD38  and  Aplysia 
cyclase  was  substituted  by  a  Phe  at  the  corresponding  position  in  SpARC4.  As  a 
second potential candidate for directing the predominant cyclase activity of SpARC4, 
the role of this non-conserved Phe residue was explored by use of a point mutant 
SpARC4-F123Y-Myc. Surprisingly, all activities of the mutant enzyme were completely 
lost  (Figure  5.7F),  in  spite  of  it  localizing  similar  to  SpARC4-Myc  (Figure  5.7D). 
Schuber and Lee’s labs demonstrated similar results with E146L/D147V double mutant 177 
 
of CD38, which led to a complete loss of all activities (Lund, et al., 1999). Thus Phe
123 
was  a  critical  residue  for  the  overall  catalysis  of  SpARC4.  Although  this  particular 
residue is highly conserved in ARCs (Figure 5.7A), its significance has not yet been 
reported in the literature. It would be interesting to locate this residue by 3-D homology 
modelling of SpARC4 using CD38 and Aplysia cyclase as templates. It’s interaction 
with  neighbouring  residues  in  the  protein  tertiary  structure  could  shed  light  on  any 
structural role for this residue. 
 
The active site of an enzyme is critical for the catalysis and is therefore conserved 
across the phyla over the course of evolution. A Trp residue at the active site of Aplysia 
cyclase is crucial for the folding of the linear substrate NAD  (Munshi, et al., 1999). 
Careful analysis of SpARC4 sequence revealed that it had a non-canonical active site 
(Figure 5.8A, red). SpARC4 harboured a Tyr
142 in place of the highly conserved Trp 
residue. Such a deviation was also observed in SmNACE, at a corresponding active 
site residue, but substituted by a positively charged histidine instead (Goodrich, et al., 
2005).  In  SmNACE,  the  restoration  of  tryptophan  instead  of  histidine  increased  its 
cyclase activity (Kuhn, et al., 2006). Therefore the non-canonical active site of SpARC4 
was proposed as the third potential determinant of its extra-ordinary catalytic activity. 
Two  point  mutants,  SpARC4-Y142W-Myc  and  SpARC4-Y142H-Myc  were  used  to 
dissect the role of Tyr
142 in SpARC4 catalysis. 
 
Results from Kuhn et al and Lee’s group suggested that the presence of tryptophan at 
the active site of ARC was essential for the cyclisation of NAD (Kuhn, et al., 2006; 
Munshi, et al., 1999). However, in contrast, the results obtained in this chapter with 
SpARC4-Y142W-Myc  and  SpARC4-Y142H-Myc  indicated  that  tyrosine  but  not 
tryptophan was vital for SpARC4’s preferential cyclase activity. SpARC4-Y142W-Myc 
produced almost equivalent levels of both messengers (Figure 5.9B); while in SpARC4-
Y142H-Myc there was a complete switch resulting in preferential NAADP production 178 
 
(Figure  5.9C).  In  fact  SpARC4-Y142H-Myc  displayed  a  cyclisation:  base-exchange 
ratio similar to SpARC2-Myc (Figure 5.9D). Therefore this active site Tyr residue was 
important in controlling the cyclisation: base-exchange activities of the enzyme. Again 
evolution has provided leniency in some ARC homologs, for substitutions at this critical 
residue that forms a part of the active site. Thus, the tyrosine residue at the active site 
of SpARC4 dictated the choice between cADPR and NAADP production.  
 
By  mutation  of  a  single  SpARC4  residue,  its  preferential  cyclase  activity  could  be 
reversed (Figure 5.9D). Therefore the converse experiment with the replacement of the 
active site Trp
103 of SpARC2 with Tyr was carried out. The hypothesis was that it would 
increase cADPR production. But in contradiction, such a substitution (SpARC2-W103Y-
Myc) led to a complete loss of the cyclase activity of the mutant, although the base-
exchange activity was not significantly affected (Figure 5.10E). It is interesting to note 
that in CD38, site-directed mutagenesis of corresponding Trp
125 to Tyr led to drastic 
reductions  in  all  activities,  in  spite  of  the  conservative  nature  of  the  substitution 
(Munshi,  et  al.,  2000).  Therefore  it  again  emphasizes  the  functional  significance  of 
active site residues specifically retained/substituted during the course of evolution in 
certain homologues. Thus, Trp was ideal for SpARC2, CD38 and Aplysia cyclase, while 
its replacement to Tyr in SpARC4 was arguably for preferential cADPR production. 
Although  the  presence  of  His  at  the  corresponding  position  rendered  SmNACE 
incapable of any cADPR production, it was proposed to be vital for the scavenging of 
the  extra-cellular  NAD,  thus  regulating  host-parasite  interactions  (Goodrich,  et  al., 
2005).  
 
By  employing  site-directed  mutagenesis  described  here,  it  may  be  possible  to  use 
metabolically  redesigned  SpARC4  to  alter  cADPR/NAADP  synthesis  in  vivo.  For 
example,  engineered  SpARC4  point  mutants  could  be  employed  to  study  the 
consequence  of  altering  the  ratio  of  calcium  second  messengers,  on  sea  urchin 179 
 
physiology and development. It could also shed light on the absolute necessities or 
redundancies of calcium signalling pathways operating  during critical developmental 
events. Finally, these mutants could also be used to probe whether the ratios of second 
messenger production in vivo could be regulated by factors like substrate availability, 
pH and other physiological parameters. 
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Chapter  6:  Role  of ADP-ribosyl  cyclases  in  sea 
urchin embryogenesis 
 
 
6.1  Introduction  
 
Calcium signals regulate fertilization and embryonic development in most organisms 
(Whitaker, 2006a; Whitaker, 2006b). As previous discussed in section 1.11, calcium 
signalling is critical for the egg activation by sperm (Steinhardt and Epel, 1974). A wave 
of calcium spreads across the egg from the point of sperm entry, triggering massive 
cortical exocytosis (Parrington, et al., 2007). Additional calcium signals are generated 
during mitosis (Busa and Nuccitelli, 1985)    and  control  various processes  including 
membrane  fusion,  microtubule/actin  cytoskeleton,  nuclear  envelope  breakdown 
(Steinhardt  and  Alderton,  1988),  chromosome  segregation  and  formation  of  the 
cleavage furrow (Groigno and Whitaker, 1998). Calcium is best suited for regulating the 
spatio-temporal cellular processes during development  (Whitaker, 2008).  Calcium is 
involved in  varied developmental events  such as  axis determination  (Creton,  et al., 
2000;  Westfall,  et  al.,  2003),  gastrulation  (Webb  and  Miller,  2006),  convergent 
extension  of  the  notochord  (Wallingford,  et  al.,  2001),    induction  of  neural  tissue 
(Moreau,  et  al.,  2008),  neurotransmission  in  the  neural  plate,  cell  migration  and 
development  of  the  body  plan  (Freisinger,  et  al.,  2008).  In  spite  of  the  knowledge 
acquired about the calcium dynamics during fertilization (Parrington, et al., 2007), little 
is known regarding the molecular repertoire of calcium signalling molecules involved in 
the regulation of subsequent developmental events. 
 
The sea urchin is a free-living, motile marine invertebrate that is important for sub tidal 
marine ecology. Urchins have been used extensively to study gene expression, cellular 181 
 
interactions and more recently for the description of the gene regulatory networks that 
govern  embryonic  development  (Davidson,  2006).  The  recent  completion  of  the 
genomic  sequencing  of  S.purpuratus  is  a  major  milestone  in  sea  urchin  biology 
(Sodergren, et al., 2006b). The sea urchin as a model system also led to discovery of 
the cell cycle regulatory proteins “cyclins” by Timothy Hunt (Evans, et al., 1983), for 
which he was awarded the Nobel Prize in 2001. 
 
Sea urchins are easily available and can be maintained in the laboratory throughout the 
year. The sea urchin has been extensively used as a model system for the study of 
calcium  signalling.  The  importance  of  divalent  cations  in  the  egg  activation  during 
fertilization  was  first  realised  in  the  sea  urchin  (Azarnia  and  Chambers,  1976).  In 
particular increases in cytosolic calcium during fertilization were first recorded in the 
sea urchin egg (Steinhardt et al., 1977). Sea urchin as a model system was crucial in 
the discovery of two new calcium  messenger molecules,  cADPR and NAADP (Lee 
1987).  Several  studies  employed  either  eggs  (Lee,  1996;  Galione,  et  al.,  2000)  or 
sperm (Chini, et al., 1997; Billington, et al., 2002; Churchill, et al., 2003) to unravel 
calcium signalling mechanisms. In early studies, the calcium ionophore A23187 was 
used to parthenogenetically activate development (Brandriff, et al., 1975). In addition, 
microinjection of calcium induced entry into mitosis while injection of calcium chelators 
blocked mitosis in urchin embryos (Steinhardt and Alderton, 1988; Twigg, et al., 1988). 
Changes in free calcium levels were also observed with different stages of the cell 
division cycle (Poenie, et al., 1985). Further, local peri-nuclear calcium signals were 
found to be associated with mitosis entry and nuclear envelope breakdown in early sea 
urchin embryos (Wilding, et al., 1996). A functional genomic and proteomic perspective 
of the “calcium toolkit” operating during the fertilization in sea urchins has also recently 
been detailed (Roux, et al., 2006).  
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Sea urchins have also been used as a model for the study of development. Embryo 
development  is  very  rapid  and  highly  synchronous.  The gametes  and embryos  are 
optically translucent and hence easy to trace and distinguish (Davidson, et al., 1982). 
Immediately  after  fertilization  (within  2  min)  a  membrane  called  the  fertilization 
envelope is formed to physically prevent poly-spermy. The first cell division occurs at 
about 2 h after fertilization (in case of S.purpuratus grown at 15°C). Around 15-16 h, a 
protease is secreted by the embryo to dissolve the fertilization envelope resulting in the 
hatching  of  the  embryo.  The  freely  swimming  blastula  is  made  of  a  hollow  ball  of 
ciliated cells. Following this, the primary mesenchymal cells migrate into the blastocoel 
cavity. Later (around 46 h), thickening of cells around the vegetal pole occurs, forming 
the site for subsequent invagination (anus), leading to gastrulation and formation of the 
archenteron.  Further  morphogenesis  causes  the  gut  tube  to  bend  towards  the 
blastocoel and contact the embryo wall resulting in the formation of the mouth. A pair of 
tri-partite spicules is also formed along the blastocoel walls. Finally, during the pluteus 
stage, the embryo elongates while the stomach region differentiates into three visible 
zones and four arms grow anteriorly. The larva can now feed by itself and exists as a 
free living organism, by 70 h. Most research on the sea urchin embryos have focused 
on the stages between fertilization and the pluteus. The sea urchin undergoes indirect 
development. The early embryogenesis is separated from adult body plan formation 
(Davidson, et al., 1982). Additionally, the embryos have a bilateral symmetry while the 
adults  have  a  radial  body  plan.  The  important  stages  in  the  early  embryonic 
development of the sea urchin are schematically depicted in Figure 6.1. 
 
As discussed in detail in section 1.11.1, studies on endogenous ARC activity in the sea 
urchin egg homogenates demonstrated regulation by cGMP (Galione, et al., 1993) and 
nitric  oxide  (Willmott,  et  al.,  1996).  Further  reports  from  two  independent  groups, 
revealed the presence of two types of ARCs: soluble and membrane bound. However, 
there were discrepancies with respect to their regulation by cAMP and cGMP (Wilson 183 
 
and Galione, 1998; Graeff, et al., 1998). There are few reports in the literature, on the 
involvement  and/or  regulation  of  ARCs  during  embryogenesis.  Expression  of  the 
Schsitosoma cyclase was shown to be regulated during the course of the development 
of the worm (Goodrich, et al., 2005). Ceni et al studied CD38-dependent ARC activity 
from developing mouse brains but found no difference between embryonic day 15 and 
post-natal day 1, though the levels were higher in the adult brain (Ceni, et al., 2002).  
ARC activities from other tissues however were not examined. 
 
 
 
 
In this Chapter, the relative expression pattern of SpARCs was determined and the 
endogenous  ARC  activity  quantified  during  early  embryonic  development  of 
S.purpuratus.  The  effect  of  modulating  SpARC4  expression  levels  on  S.purpuratus 
embryogenesis was also examined.  
 
Figure 6.1: Embryonic developmental stages in S.purpuratus 
 
Important  stages  during  early  embryonic  development  of  S.purpuratus  are  schematically 
depicted. Approximate times (post-fertilization) corresponding to embryo development at 12°C is 
also indicated. Modified from www.stanford.edu 184 
 
6.2  Materials and Methods 
 
6.2.1  Semi-quantitative RT-PCR  
 
S.purpuratus  eggs  were  fertilized  and  embryos  developed  as  0.5%  suspensions  in 
filtered sea water (FSW) at 16°C. The embryos were then collected at various time 
points (egg, 2, 3, 10, 21, 27.5, 33.5, 46, 58 and 63h post-fertilization) according to 
standard protocols (Ettensohn, et al., 2004). The suspensions were gently centrifuged 
and the FSW aspirated. The egg/embryos (~ 250 µL packed volume of cells) were 
flash frozen and stored at  -80°C. This was kindly performed by Victor D Vacquier, 
Scripps Institute of Oceanography, La Jolla, USA.   
 
 
Total  RNA  was  isolated  from  the  frozen  egg/embryo  samples  using  RNeasy  kit, 
according to manufacturer’s instructions. The samples were treated with on-column 
DNase  to  eliminate  genomic  DNA  contamination.  The  RNA  concentration  was 
quantified and the samples were checked for purity by measuring the absorbance at 
230, 260 and 280 nm, using a UV absorbance spectrophotometer. Only samples with 
A260/280 and A260/230 > 2 were used. cDNA was synthesised from 2 µg of RNA from each 
embryo sample with oligo-dT primers, in the presence of RNasin, using the ImProm-II 
kit (Promega) according to manufacturer’s instructions. Water was added instead of 
reverse transcriptase in –RT control reactions. cDNA synthesis conditions were same 
as described in section 2.2.2.  
 
A minimum of 3 sets of primers were designed for each of SpARC1, SpARC2, SpARC3 
and SpARC4 genes, such that they flanked at least one or more introns identified from 
their  genomic  sequence,  using  the  sea  urchin  genome  resources 
(http://www.ncbi.nlm.nih.gov/genome/guide/sea-urchin).  This  was  to  ensure  that  the 
amplicons  from  cDNA  and  genomic  DNA  (if  any)  would  be  distinguishable.  PCR 185 
 
conditions  were  standardized  using  various  primer  combinations  and  a  gradient  of 
annealing  temperatures  (45°  to  60°C).  PCR  was  also  carried  out  at  various  cycle 
numbers (27-37) to optimize the cycle number empirically for each gene, such that the 
amplification was in the exponential phase. Ubiquitin gene was used as an internal 
standard.  
 
Typically, a 25 µl PCR reaction was made with 1X PCR buffer, 0.75 mM MgCl2, 0.2 mM 
dNTPs, 0.2 mM of each primer, 1 µl of the cDNA template and 0.2 U of Platinum Taq 
Polymerase  (Invitrogen).  PCR  conditions  were  2  min  initial  denaturation  at  94°C, 
followed by the specified number of cycles comprising 30 s denaturation at 94°C, 30 s 
annealing at 50°C and 60 s extension at 72°C. The final extension was carried out for 5 
min at 72°C. The number of PCR cycles used was 35 for SpARC1, 27 for SpARC2, 33 
for SpARC3, 35 for SpARC4 and 27 for ubiquitin. The primers used in this chapter are 
listed in Table 6.1. SpARC1-qPCR-7F and SpARC1-qPCR-7R were used for SpARC1 
analysis;  ARC-3F  and  SpARC2-qPCR-2R  for  SpARC2  analysis;  SpARC3-5F  and 
SpARC3-1R for SpARC3 analysis; SpARC4-1F and SpARC4-1R for SpARC4 analysis. 
The PCR products were resolved on 1% agarose gels, stained with ethidium bromide 
(5 µg/ml), visualized on a UV transilluminator and images captured using Image Quant 
software (GE Healthcare). 
 
6.2.2  Endogenous ARC activity measurement 
 
For enzyme activity measurements, the flash frozen embryo samples were thawed and 
homogenized in a hypotonic homogenization buffer containing 20 mM HEPES, pH 7.2 
(with complete
TM EDTA free protease inhibitors) followed by 5X5 s bursts of sonication 
at 4°C, to form a 25% v/v homogenate. For cyclase activity measurements, 25 µl of the 
egg/embryo homogenate was diluted 10 times in a reaction mix made of 20 mM 186 
 
  PRIMER NAME  PRIMER SEQUENCE (5’→3’) 
1  SpARC1-qPCR-7F  ATGGGCATCTACACCATATTCA 
2  SpARC1-qPCR-7R  TAGGGTAGTAGATATTGTATTCCAACC 
3  ARC-3F  GCGATGTCAACTGTGATGCT 
4  SpARC2-qPCR-2R  CTCACAAGTGTTGCTGAGACC 
5  SpARC3-5F  CACCGGATCCCCGCTGTATTCATCGTACCG 
6  SpARC3-1R  ACCCTTTAGCGAACCCACAT 
7  SpARC4-1F  ACAACTGTTCGGGTCTGTGG 
8  SpARC4-1R  CAACTGTCGAACGTCGGA 
9  SpUQ-1F  CCAGATGAACCCACTTCTTCCC 
10  SpUQ-1R  TTTGCCCCTGCATCCCATCAACT 
11  mCherry-1F  CACCATCGATTTATGGTGAGCAAGGGCGAG 
12  mCherry-1R  TGAATTCAACTTGTACAGCTCGTCCATGC 
Table 6.1:  List of all primers used in this chapter 
 
HEPES, pH 7.2 and 1 mM NAD. For base-exchange activity measurements, a reaction 
mix made of 1 mM NADP and 50 mM nicotinic acid at pH 4.8 was used. The reactions 
were allowed to proceed for up to 2.25 h for cyclisation and 3 h for base-exchange. To 
terminate the reaction, the samples were diluted 10 fold with water and heated at 60°C 
for 5 min. The mix was then centrifuged for 3 min at 21000 g to remove any particulate 
matter.  The  products  in  the  supernatants  were  resolved  on  an  AG  MP1  anion 
exchange HPLC column as described in section 4.2.4. The protein concentrations of 
the embryo homogenates were measured using the bicinchoninic acid protein assay kit 
(Pierce) according to manufacturer’s instructions, using bovine serum albumin as the 
standard. 187 
 
6.2.3  Assay for endogenous GPI-anchored ARC activity 
 
The 25% v/v egg homogenates were diluted two-fold and treated with or without 1 U/ml 
PI-PLC for 2 h at 25°C. The homogenates were then centrifuged at 100,000 g for 1 h at 
4°C to separate the membrane bound and soluble fractions. The membranes were 
further resuspended in the original volume with homogenization buffer and equivalent 
volumes of membranes and supernatant fractions were assayed for base-exchange 
activities.  
 
6.2.4  Generation of mCherry-SpARC4 
 
mCherry  was  amplified  from  the  source  vectors  using  primers  mCherry-1F  and 
mCherry-1R. The PCR products were cloned at the ClaI/EcoRI sites of SpARC4-Myc 
(Figure 3.4E) to generate a plasmid encoding for SpARC4 tagged with mCherry (Figure 
6.7A). 
 
6.2.5  In vitro transcription 
 
Capped mRNA was generated from SpARC4-mCherry as described in section 3.2.3. 
The  quality  and  quantity  of  RNA  were  determined  by  0.8%  agarose  gel  and  UV 
spectrophotometer, respectively. The RNA was resuspended to a final concentration of 
2 mg/ml in RNase free water.  
 
6.2.6  Design of MASO for SpARC4 
 
A 25-mer morpholino anti-sense oligonucleotide (MASO), 5’  ATAAACCGTAGAGGG 
AATGCATGAC  3’,  was  designed  against  the  translational  start  region  of  SpARC4 
(Figure 6.2) and ordered from Gene Tools, LLC. A 1 mM stock solution (in water) of 188 
 
SpARC4-MASO was prepared and stored at -20°C. A working concentration of 500µM 
was prepared in 120 mM KCl prior to injections. 
 
 
 
 
6.2.7  Sea urchin fertilization and microinjection 
 
The following procedures were carried out at the Scripps Institution of Oceanography, 
La Jolla, USA. Recycled gravid S.purpuratus male and female adults were collected 
and injected with ~300 µl of 0.55 M KCl to induce spawning. The sperm was collected 
dry and stored dry at 4°C. The eggs were collected in a beaker containing FSW as per 
standard protocols (Ettensohn, et al., 2004). The eggs were filtered through a 120 µm 
nylon mesh to remove any debris and washed three times with FSW. For dejellying, the 
eggs were treated with acidic sea water (pH 5) twice with constant swirling, for 5-10 
min each. Finally the eggs were washed twice with FSW for 5-10 min each. The eggs 
were arranged in rows on protamine sulfate (1% w/v) coated dishes filled with FSW 
supplemented with 4 mM para amino benzoic acid. The rowing of eggs was kindly 
performed by Dr. Kevin Ulingher. The eggs were then fertilized with freshly activated 
sperm (dry sperm diluted with FSW when required). The embryos were immediately 
microinjected with SpARC mRNA (2 mg/ml) or MASO (500 µM) according to standard 
protocols (Ettensohn, et al., 2004). The microinjections were kindly performed by Dr. 
5’----TTCGTACGCTCTCCCCAAACAGACGTCATGCATTCCCTCTACGGTTTATCCCCTA---- 3’ 
                           3’ CAGTACGTAAGGGAGATGCCAAATA 5’                               
 
5’ UTR  Coding sequence 
Figure 6.2: Design of MASO against SpARC4 
 
A 25-mer MASO (highlighted red) was designed complementary to the translational initiation site 
of SpARC4. The initiation codon is highlighted green. The 5’UTR sequence is highlighted grey.  189 
 
Amro  Hamdoun.  Some  dishes  with  rowed  eggs  were  fertilized  in  parallel  but  not 
injected and used as controls. Following microinjection, the dishes with embryos were 
gently  washed  ten  times  with  FSW,  to  remove  PABA.  The  embryos  were  further 
incubated in humid chambers at 12°C for at least 15 h before investigation. In some 
experiments, the embryos (15-16 h post fertilization) were counterstained with Hoechst 
(Sigma) -10 µM final concentration  and FM-1-43 (Invitrogen) -1 µM final concentration, 
for 15-20 min, prior to microscopy (Terasaki and Jaffe, 2004). 
 
6.2.8  Confocal Microscopy 
 
Fluorescence  images  of  S.purpuratus  embryos  expressing  SpARC4-mCherry  were 
captured  using  a  Zeiss  LSM  700  confocal  microscope  with  variable  dichroic  filters, 
equipped with a 20X, 40X water or 63X water immersion lens. The wavelengths for 
excitation  for  Hoechst,  FM-1-43  and  mCherry  were  405nm,  488nm  and  555nm 
respectively. Both bright field and Differential Interference Contrast (DIC) mode were 
used to capture images of whole embryos. A cooling chamber maintained at 12°C was 
used on the stage. After hatching, the free floating embryos were gently trapped on a 
clean glass slide using a cover slip and clay feet.  
 
 
6.3  Results 
 
6.3.1    Differential  expression  of  SpARCs  during  early  embryonic 
development  
 
Sea urchin eggs have long been used as a model system to study calcium signalling. 
In previous studies, transcripts of SpARC-ʱ, β and γ have been detected in sea urchin 
eggs (Davis, et al., 2008). cDNA prepared from S. purpuratus egg samples was used 190 
 
initially to check for the expression of the four SpARC isoforms described in this study. 
Amplicons of the expected size (972 bp for SpARC1, 638 bp for SpARC2 and 619 bp 
for SpARC3, 298 bp for SpARC4) were detectable in the egg (Figure 6.3, left panel). 
The results indicated that SpARCs were maternally expressed, possibly indicating a 
role for these enzymes during oocyte maturation and/or fertilization.  
 
Following the detection of SpARC isoforms in the egg, the relative expression patterns 
of  SpARC1,  SpARC2,  SpARC3  and  SpARC4  were  analysed  through  the  early 
embryonic development of  S. purpuratus  (from 0 to 58  h). Oligo-dT primed cDNAs 
prepared from critical developmental time points were analysed by semi-quantitative 
RT-PCR analysis. Ubiquitin (SpUQ), a standard housekeeping gene was used as an 
internal reference (215 bp amplicon). Ubiquitin levels did not vary significantly during 
the time course analysed (Figure 6.3A). The -RT negative controls were blank for all 
genes and at all time points (Figure 6.3). Transcript levels for SpARC1 (detected using 
primers that would not discriminate between SpARC1-like isoforms) (Figure 6.3B) were 
low  in  egg  and  early  embryos  but  increased  from  27.5  h  post-fertilization 
(corresponding to gastrula transition). Conversely, SpARC2 levels (Figure 6.3C) were 
high in egg and early embryos,  and the levels  started  decreasing  during the same 
gastrula transition, from 27.5 h post-fertilization embryos. For SpARC3, the transcript 
levels in the egg were low, decreasing further to almost negligible levels by 10 h. But 
again  at  21  h  (corresponding  to  late  blastula  stage),  SpARC3  was  massively  up-
regulated to relatively high levels (Figure 6.3D). Finally, for SpARC4, the expression 
was low in the egg and early embryos but increased significantly from 27.5 h post-
fertilization, again corresponding to gastrula transition (Figure 6.3E).  
 
The above results suggest that each SpARC isoform is uniquely regulated during sea 
urchin embryogenesis. 191 
 
Figure 6.3: SpARCs are differentially regulated during development 
 
Semi-quantitative RT-PCR analysis for Ubiquitin (A), SpARC1 (B), SpARC2 (C), SpARC3 (D) and 
SpARC4  (E) was performed using oligo-dT primed cDNA synthesised from S.purpuratus egg and 
embryos (at the indicated time post-fertilization) either in the absence (top lanes) or presence 
(bottom lanes) of reverse transcriptase. Size of the molecular weight markers are indicated to the 
right. Displayed above are results from a single fertilization. Similar results were obtained using 2 
other independent fertilizations. Embryos were developed at 16°C. 
 
A 
E 
Egg  2  3  10  21  27.5  33.5  46  58 h 
- 
- 
- 
+ 
+ 
- 
+ 
+ 
+ 
SpUQ 
SpARC3 
SpARC4 
SpARC2 
SpARC1 
Post-fertilization 
B 
C 
D 
200 bp 
200 bp 
1000 bp 
1000 bp 
650 bp 
650 bp 
650 bp 
650 bp 
300 bp 
300 bp 
- 192 
 
6.3.2  Endogenous ARC activity in S.purpuratus eggs 
Calcium  signalling  is  important  during  the  fertilization  event  of  many  organisms, 
including  the sea  urchins  (Whitaker,  2006a).  In  fact,  the calcium  mobilizing  second 
messengers,  cADPR  and  NAADP  were  both  discovered  in  the  sea  urchin  eggs 
(Clapper, et al., 1987). Having detected the presence of all four isoforms in the egg 
(Figure 6.3, left panels), the endogenous ARC activity was determined in S. purpuratus 
egg homogenates.  
 
 
6.3.2.1  Endogenous cyclisation and base-exchange activities 
 
A time-course for cyclisation reaction using NAD as a substrate was performed with 
S.purpuratus egg homogenates. An increase in cADPR production by the cyclisation of 
NAD was observed with time (Figure 6.4A). Similarly, a time-course for base-exchange 
reaction  using  NADP  and  nicotinic  acid  as  substrates  was  also  performed  with 
S.purpuratus  egg  homogenates.  NAADP  production  was  readily  observed  that 
increased linearly with time of incubation (Figure 6.4B) 
 
 
 
6.3.2.2  Endogenous GPI-anchored ARC activity  
 
Results from chapter 3 suggested that heterologously expressed SpARCs were GPI-
anchored (Figures 3.7, 3.8 and 3.9). To test if GPI-anchored ARC activity was indeed 
detectable  in  vivo,  S.purpuratus  egg  homogenates  were  again  used.  The  most 
abundant ARC isoform in the egg was likely SpARC2 (Figure 6.3), a preferential base-
exchanger  (Figure  4.5A).  For  that  reason,  S.purpuratus  egg  homogenates  were 
fractionated  by  ultracentrifugation  and  base-exchange  activity  measurements  were 
performed using the soluble and membrane bound components. Figure 6.5A indicated 193 
 
that  the  majority  of  total  NAADP  synthesis  of  the  egg  homogenate  was  from  the 
membrane fraction although significant activity was also present in the soluble fraction. 
However, PI-PLC treatment of the egg homogenates prior to fractionation revealed a 
significant reduction in membrane bound activity and a corresponding increase in the 
activity  of  the  soluble  fraction  (Figure  6.5B).  Pooled  data  using  egg  homogenates 
prepared from different animals is shown in Figure 6.5C. 
 
The  above  data  suggested  that  majority  of  ARC  activity  in  S.purpuratus  egg 
homogenate was indeed GPI-anchored. 
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Figure 6.4: Endogenous ARC activity in S.purpuratus eggs 
 
Time course for cyclisation (A) and base-exchange (B) activities by measurement of cADPR and 
NAADP production, respectively, in S.purpuratus egg homogenates. Cyclisation was carried out 
using NAD as a substrate at pH 7.2, while base-exchange was performed with NADP as substrate 
in presence of excess nicotinic acid at pH 4.8. 
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Figure 6.5: Endogenous GPI-anchored base-exchange activity in S.purpuratus egg 
 
Time course for NAADP production by total, membrane or soluble fractions prepared from mock treated (− PI-PLC) (A) or PI-PLC treated (B) S.purpuratus egg 
homogenates. (C) Pooled data from independent animals, quantifying the initial rate of NAADP production in the indicated preparations (n=3 animals). 195 
 
6.3.3    Endogenous  ARC  activity  during  S.purpuratus  early 
embryonic development 
 
Previous  studies  have  identified  ARC  activities  in  the  sea  urchin  egg  (Wilson  and 
Galione,  1998;  Graeff,  et  al.,  1998).  Results  from  previous  section  confirmed  this 
finding (Figure 6.4) and in addition also demonstrated that majority of the endogenous 
ARC activity from S.purpuratus egg homogenates was PI-PLC releasable (Figure 6.5). 
However, little is known regarding ARC activities in the developing sea urchin embryos. 
In  this  section  the  endogenous  ARC  activities  were  further  characterized  during 
S.purpuratus embryogenesis.   
 
 
6.3.3.1  Cyclisation activity during early development  
 
Cyclisation reactions from the egg and the embryo samples using NAD as a substrate 
were performed at pH 7.2. cADPR production was observed at all the developmental 
time  points  tested,  but  the  amount  produced  varied  throughout  the  development 
(Figure 6.6A). cADPR produced in the egg was at moderate levels, which fluctuated 
until the advanced prism stages (53 h). Then the production increased through the 
complete skeleton/pluteus (68 h) stage. At this point the production of  cADPR  was 
approximately two fold higher than the egg sample (Figure 6.6A).  
 
 
6.3.3.2  Base-exchange activity during early development  
 
Base-exchange reactions from the egg and the embryo samples were carried out at pH 
4.8 in presence of excess nicotinic acid, conditions under which NADP is converted to 
NAADP. NAADP was produced at all the developmental time points analysed, and like 
cADPR,  the  amount  varied  throughout  the  course  of  embryo  development  (Figure 196 
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Figure 6.6: Endogenous ARC activity during early development of S.purpuratus 
 
cADPR (A) and NAADP (B) production from the egg and embryo homogenates were quantified by cyclisation reaction using 1 mM NAD at pH 7.2 or base-exchange 
using 1 mM NADP and 50 mM nicotinic acid at pH 4.8, respectively. The products were analysed by HPLC; the areas of resolved NAADP peaks calculated using breeze 
software and normalized against protein concentration of the homogenates. (C) Cyclisation: Base-exchange ratio of the egg and embryo homogenates plotted against 
developmental time points. n=3 independent fertilizations. The embryos were developed at 16°C. 
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6.6B). NAADP production was high in the egg, which decreased until blastula stage (27 
h) and fluctuated through gastrula (33 h), prism (46 h), and the advanced prism stages 
(53  h)  stages.  However,  NAADP  production  again  increased  through  complete 
skeleton/pluteus (68 h) stage. At this stage however, the production of NAADP was 
lower than that of the egg sample (Figure 6.6B).  
 
 
6.3.3.3  Switch in cyclisation: base-exchange ratio during development  
 
Results  from  chapter  4  (Figure  4.5D)  indicated  that  different  SpARC  isoforms  had 
distinct  cyclisation:  base-exchange  ratios.  Therefore,  to  gain  insight  into  possible 
correlation of endogenous ARC activities to SpARC isoforms, the cyclisation: base-
exchange ratio was calculated for all the embryo samples through development. The 
results indicated that the ratio fluctuated from egg samples up to 46 h post-fertilization 
embryos (Figure 6.6C). However, the ratio increased in the pluteus (63 h).  
 
 
6.3.4    Consequences  of  modulating  SpARC  expression  during 
S.purpuratus embryogenesis 
 
Results from sections 6.3.1 and 6.3.3 indicated that SpARC isoforms possibly played 
an  important  role  in  the  early  embryogenesis  of  S.purpuratus,  especially  during 
blastula-gastrula transition. The expression profile of SpARC1 (Figure 6.3B) was the 
combination  of  both  SpARC1  and  SpARC1-like  isoforms  (Figure  1.7B).  Therefore 
SpARC1  was  not  chosen  for  gene  expression  modulation.  The  RT-PCR  data  of 
SpARC2 (Figure 6.3C) indicated that it was maternally expressed and down-regulated 
during  embryogenesis.  Therefore  it  would  be  difficult  to  manipulate  SpARC2 
expression levels during development.  SpARC3 and SpARC4 were both zygotically 198 
 
expressed (Figures 6.3D and 6.3E). Since the enzymatic activity of SpARC3 could not 
be established (section 4.3.4), it was not considered for expression modulation studies. 
Meanwhile, SpARC4 displayed both an interesting up-regulation during embryogenesis 
(Figure 6.3E) and unique catalytic properties (Figure 4.5D). Therefore SpARC4 was 
chosen  for  analysis.  To  investigate  its  role  during  early  embryonic  development, 
SpARC4  was  tagged  with  mCherry  as  described  in  section  6.2.4  (Figure  6.7A),  to 
enable live cell imaging.  
 
6.3.4.1  Localization of SpARC4-mCherry in S.purpuratus embryos 
 
Capped  mRNA  synthesised  from  SpARC4-mcherry  was  microinjected  into  fertilized 
S.purpuratus  eggs  and  the  embryos  were  developed  at  12°C.  SpARC4-mCherry 
fluorescence was detectable in the injected embryos from 15 h post-fertilization (Figure 
6.7B). There was a significant increase in SpARC4-mCherry expression between 15-18 
h (Figure 6.7C). The majority of the SpARC4 fluorescence was observed initially in 
vesicles towards the apical surface (white arrows, Figure 6.7B) of the embryonic cells 
that collated to form larger vesicles which again trafficked to the apical side of the 
embryo (white arrows, Figure 6.7C).  
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However, from 20 h onwards, SpARC4 segregated to smaller vesicles (Figure 6.8). 
Counterstaining  of  the  embryo  with  Hoechst  and  FM-1-43  indicated  that  SpARC4 
expression was peri-nuclear and not on the cell surface (Figure 6.8A and 6.8B). The 
vesicles were <1 µm (Figure 6.8C) and smaller than the acidic vesicles stained by 
lysotracker red (Figure 6.8D).  
Figure 6.7: Increase in SpARC4-mCherry expression before hatching 
 
(A)  Schematic  representation  of  SpARC4-mCherry  used  for  live  cell  imaging.  Fluorescence 
images of an S.purpuratus embryo over-expressing SpARC4-mCherry, captured at 15 h (B) and 18 
h (C) post-fertilization. Three different planes of focus: surface view (left panel), mid-plane view 
(middle panel) and equatorial view (right panel) are shown. White arrow heads indicate vesicular 
staining of SpARC4. Green arrow heads show invasion of blastocoel by cells. 
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Figure 6.8: Localization of SpARC4-mCherry in S.purpuratus embryo 
 
Confocal images of SpARC4-mCherry (bottom left - red) expressing embryos at 20 h post-fertilization, counter-stained with Hoechst for nucleic acids (top left - 
blue) and FM-1-43 for membranes (top right - green). Bottom right indicates merged images of the three channels. Outer/surface (A) and equatorial (B) views of 
the meschenchymal blastula stage embryo are shown. Scale bar= 20 µm. (C) Zoomed image of the embryo showing vesicular staining of SpARC4. Scale bar=1 
µm.  (D)  S.purpuratus  embryo  at  the  same  stage  (parallel  processing)  stained  for  acidic  vesicles  with  lysotracker  red.  Scale  bar  =  1  µm.  n=2  independent 
fertilizations. 
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6.3.4.2    Phenotypic  consequences  of  SpARC4  over-expression  on 
S.purpuratus development 
 
The  development  of  S.purpuratus  embryos  over-expressing  SpARC4-mcherry  was 
compared with the development of control uninjected embryos from the same batch. 
The control embryos developed as expected. Ciliated blastula staged embryos with 
intact fertilization envelopes were observed 15 h post-fertilization (Figure 6.9A). The 
embryos hatched between 20-21 h. The freely swimming embryos initiated gastrulation 
after 46 h (Figure 6.9B). The archenteron was fully developed and a pair of tri-radiate 
spicules was seen at the end of 3 d. By 5 d, the pluteus stage of the elongated larva 
with arms and tri-partitioned stomach was visible (Figure 6.9C).  
 
S.purpuratus embryos were observed under a confocal microscope from 14 h post-
fertilization. SpARC4-mcherry was expressed in the injected embryos from 14 h to at 
least 6 days of development, as indicated by the fluorescence (purple) in the images in 
Figure 6.9. However, SpARC4-mCherry expressing embryos developed similar to the 
uninjected control embryos only until the ciliated blastula stage (Figure 6.9A). In some 
embryos  the  blastocoel  was  invaded  by  cells  (green  arrow  heads,  Figure  6.7A). 
Following  that,  SpARC4-mCherry  expressing  embryos  failed  to  gastrulate  (Figure 
6.9B). SpARC4-mcherry expressing embryos were however still viable, at least for 8 d 
post-fertilization, but did not undergo differentiation similar to the controls (Figure 6.9C). 
 
Some  embryos  underwent  delayed  but  abnormal  gastrulation,  such  that  the 
archenteron was curved (Figure 6.10, white arrowhead) and fused at a wrong angle to 
the embryo wall. In other embryos abnormal spicules were also evident (Figure 6.10, 
yellow arrowhead).  202 
 
 
48.5 h 
Figure 6.9: Over-expression of SpARC4 in S.purpuratus embryos 
 
Fertilized S.purpuratus eggs were either uninjected (controls – left panel) or micro-injected with 
SpARC4-mCherry mRNA (right panel) and allowed to develop at 12°C.  Embryos were analysed 
for morphology and fluorescence at the following stages: blastula (A), gastrula (B), prism/pluteus 
(C), at indicated time points post-fertilization. Scale bar = 20 µm. Purple colour indicates regions 
of embryo with SpARC4 expression. n=2 independent fertilizations. 
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6.3.4.3    Phenotypic  consequences  of  SpARC4  knock-down  on 
S.purpuratus development 
 
To  further  examine  the  significance  of  SpARC4  in  embryogenesis,  S.purpuratus 
embryos were injected with MASO designed to block the translation of SpARC4 mRNA 
(Figure 6.2). The development and morphologies of the morpholino-injected embryos 
were  compared  to  control  embryos  from  the  same  batch  of  fertilization.  Control 
uninjected embryos developed normally. The cells divided and differentiated regularly; 
a ring of cells forming the mesenchymal blastula stage was observed by 15 h and 
hatching  occurred  at  20  h  post-fertilization.  Gastrulation,  by  the  invagination  of  the 
archenteron was evident by the end of the second day (Figure 6.11B). Pluteus stage 
was observed at 5 d (Figure 6.11C). 
 
Embryos  injected  with  SpARC4-MASO  appeared  relatively  normal  until  the 
mesenchymal blastula stage (data not shown). However, later the blastocoel was filled 
with abnormal cells (Figure 6.11A, white arrowheads). The SpARC4-MASO injected 
embryos did not gastrulate similar to the controls (Figure 6.11B). The abnormal larvae 
had no digestive tract (Figure 6.11C) and swam slower than the controls. The knock-
out  of  SpARC4  was  however  not  lethal  (at  least  up  to  8  d  of  observations).
SpARC4-mCherry 
Figure 6.10: SpARC4 over-expression causes 
abnormal  phenotype  in  S.purpuratus 
embryos  
 
Over-expression  of  SpARC4-mCherry  during  S.purpuratus 
embryogenesis  leads  to  either  absence  (Figure  6.9B)  or 
delayed/abnormal  gastrulation.  White  arrow  head  indicates 
curved archenteron. Yellow arrow head points to abnormal 
spicule. 
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Figure 6.11: Knock-down of SpARC4 expression in S.purpuratus embryo 
 
Fertilized S.purpuratus eggs were either uninjected (controls – left panel) or micro-injected with 
SpARC4-MASO  (right  panel)  and  allowed  to  develop  at  12°C.    Embryos  were  analysed  for 
morphology  at  approximately  the  following  stages:  early  gastrula  (A),  late  gastrula  (B)  and 
pluteus (C) stages, at indicated time points post-fertilization. Scale bar= 20 µm. n=2 independent 
fertilizations. 
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 In some embryos, gastrulation was delayed with the development of stunted, curled or 
everted archenteron (Figure 6.12A). The archenteron sometimes fused at the wrong 
side of the embryo wall (Figure 6.12B).  
 
 
 
 
Thus,  both  over-expression  and  knock-down  of  SpARC4  interfered  with  normal 
gastrulation of S.purpuratus. 
 
 
 
6.4  Discussion 
 
The sea urchin has proven an excellent model system for the study of both calcium 
homeostasis and early development (Whitaker, 2006a). It is only apt therefore to study 
the molecules involved in calcium messenger production, namely the ARCs during the 
development of S.purpuratus. In this Chapter, the SpARC isoforms were shown to be 
SpARC4 - MASO 
B
  
A
  
Figure 6.12: SpARC4-MASO generates abnormal phenotypes in 
S.purpuratus embryos  
 
Knock-down  of  SpARC4  during  S.purpuratus  embryogenesis  leads  to  either  absence  (Figure 
6.11B)  or  delayed/abnormal  gastrulation.  White  arrow  indicates  curved  archenteron  (A).  The 
archenteron sometimes fuses at the wrong side of the embryo (B) - red arrow.  
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differentially expressed during embryogenesis. The majority of the endogenous base-
exchange activity in the egg homogenates was found to be GPI-anchored. Additionally, 
both cADPR production by cyclisation and NAADP production by base-exchange were 
modulated  throughout  the  early  embryonic  development.  Whilst,  SpARC4-mCherry 
localized to small vesicles in the blastomeres, both over-expression and knock-down of 
SpARC4 interfered with normal gastrulation. These data strongly suggest a role for 
SpARCs, especially SpARC4 during S.purpuratus embryogenesis. 
 
SpARC1,  SpARC2,  SpARC3  and  SpARC4  transcripts  were  all  detectable  in 
S.purpuratus  egg  (Figure  6.3,  left  panel).  S.purpuratus  embryos  at  major  stages of 
early  development  were  analysed  by  semi  quantitative  RT-PCR  for  changes  in  the 
expression levels of individual SpARC isoforms. The analysis suggested that all four 
SpARCs were differentially regulated throughout early embryonic development (Figure 
6.3). Caution was exercised in the primer design for these experiments, such that the 
primer  pair  flanked  at  least  one  intron-exon  boundary.  The  cycle  number  for 
amplification was also empirically determined for each gene to obtain amplification in 
an exponential phase. This was to ensure that any differences in expression levels 
would be reflected as intensity changes of the PCR products. The expression levels of 
ubiquitin, a standard housekeeping gene did not vary significantly during the course of 
development (Figure 6.3A). 
 
SpARC1 was expressed at low levels in the egg and early embryos but the expression 
increased from gastrula stage embryos (Figure 6.3B). The primers for the SpARC1 
transcript  amplification  were  designed  in  the  common  region  of  all  SpARC1-like 
isoforms.  The  expression  profile  for  SpARC1  thus  represented  the  sum  total  of 
expressions of all SpARC1-like isoforms. Therefore it is difficult to draw insight into 
individual expression patterns of each SpARC1-like isoform, at this stage.  207 
 
In contrast, the expression of SpARC2 (Figure 6.3C) was higher in the egg and early 
embryos. The expression then decreased around gastrula transition, i.e. 27.5 h post-
fertilization. SpARC2 was possibly the predominant isoform in the egg (Figure 6.3, left 
panel). This was due to the fact that SpARC2 consistently required lower number of 
PCR amplification cycles to reach exponential phase. Whilst only 27 PCR cycles were 
employed for SpARC2 similar to ubiquitin, other SpARC isoforms required at least 33 
cycles of amplification. This was observed with two additional primer pairs tested for all 
SpARC isoforms. Also intriguingly, SpARC2 was the only isoform whose expression 
was down regulated during early development (Figure 6.3C). Therefore, it is possible 
that SpARC2 plays a major role during oocyte maturation and/or fertilization processes. 
 
SpARC3 had a unique expression profile (Figure 6.3D). SpARC3 was expressed at 
extremely  low  levels  in  the  egg  and  was  almost  undetectable  (by  the  methods 
employed) by 10 h post-fertilization. However from 21 h onwards, very high levels of 
expression were observed (Figure 6.3D). Therefore it is possible that SpARC3 plays a 
crucial role during hatching/entry into gastrulation. 
 
Finally, the expression of SpARC4 was very low in the egg and early embryos but 
increased significantly from 27.5 h post-fertilization, again corresponding to gastrula 
transition (Figure 6.3E). The fact that the maternal expression of SpARC4 was low 
could be the reason for the failure to obtain full-length SpARC4 from the ovary library 
(see  section  2.3.2)  that  were  used  to  clone  SpARC1,  SpARC2  and  SpARC3 
(Churamani,  et  al.,  2007).  Of  all  SpARC  isoforms,  SpARC4  had  a  phenomenal 
enzymatic  activity  (Figure  4.5B). Therefore  it  is  highly  likely  that  SpARC4  plays  an 
important role during S.purpuratus embryogenesis. 
 
Thus,  SpARC1/SpARC3/SpARC4  and  SpARC2  exhibited  reciprocal  pattern  of 
expression (Figures 6.3B, 6.3E and 6.3C). Whilst SpARC1 and SpARC4 (Figure 6.3B 208 
 
and 6.3E) were both up regulated during mid-blastula, SpARC2 was down-regulated 
during the same period (Figure 6.3C).  The increase in transcript levels of SpARC1, 
SpARC3  and  SpARC4  during  blastula  to  gastrula  transition  indicated  that 
cADPR/NAADP mediated calcium signalling may be important for the embryo’s entry 
into  gastrulation.  Vacquier  and  colleagues  reported  similar  up-regulation  of  plasma 
membrane and sarco/ endoplasmic reticulum Ca
2+-ATPases during late blastula stage 
of S.purpuratus embryos (Jayantha and Vacquier, 2007). Previous studies indicated 
that during sea urchin embryogenesis, zygotic gene expression takes over maternal 
gene expression and more than 80% of the regulatory genes are fully expressed by 
gastrulation (Howard-Ashby, et al., 2006).  
 
Wei et al have created a database of mRNA expression patterns for the sea urchin 
embryo (Wei, et al., 2006). The temporal expression profiles obtained in their study 
indicated  that  only  5%  of  all  mRNAs  were  maternally  expressed  while  24%  were 
exclusively zygotically transcribed. Furthermore, they observed that during the course 
of  S.purpuratus  embryonic  development,  more  than  80%  of  mRNA  levels  were 
modulated by a factor of three (Wei, et al., 2006). The nucleotide sequences of the 
amplicons  of  SpARC  isoforms  were  analysed  using  the  above  mRNA  database. 
Typical expression profiles of 60 bp long probes corresponding to SpARC amplicons 
are shown in Figure 6.13. The predicted expression profiles for SpARC1 consisted of 
two  different  patterns  (Figures  6.13A  and  6.13B).  The  first  pattern  showed  little 
changes in expression levels through early embryogenesis (Figure 6.13A). The 60 bp 
probe  for  this  pattern  had  a  100%  complementarity  with  SpARC1  sequence.  The 
second pattern displayed an increase in the levels of expression during early embryo 
development (6.13B), similar to those observed in this chapter (Figure 6.3B). However 
the probe had a few mismatches with both SpARC1 and SpARC1-like isoforms. This 
could  possibly  be  due  to  polymorphisms.  Thus,  the  variations  of  SpARC1  exons 209 
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Figure 6.13: Predicted expression 
profiles for SpARC isoforms  
 
The  nucleotide  sequence  of  SpARC  amplicons 
were analysed using the mRNA database  (Wei, et 
al., 2006). Typical expression profiles of 60 bp long 
probes  corresponding  to  SpARC  amplicon 
sequences  are  shown  above.  Probes 
corresponding to SpARC1 displayed two different 
patterns (A and B) of expression. However, probes 
corresponding  to  SpARC2  (C),  SpARC3  (D)  and 
SpARC4  (E)  displayed  a  single  pattern  of 
expression.  The  red  bar  on  top  of  each  figure 
represents expression levels (not normalised). The 
numbers on top of bars indicate the approximate 
number  of  mRNA  molecules  per  embryo.  In  this 
report,  it  was  assumed  that  2  h  post-fertilization 
embryo samples were equivalent to egg samples. 
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observed in chapter 2 (Figure 2.3A and 2.7A), was evident also during this database 
analysis. SpARC2, SpARC3 and SpARC4 expression data obtained in this chapter by 
semi-quantitative RT-PCR method (Figures 6.3C, 6.3D and 6.3E), conformed fully to 
the pattern predicted in the database (Figures 6.13C, 6.13D and 6.13E). It was evident 
from the analysis that while SpARC2 was down-regulated, both SpARC3 and SpARC4 
were  up-regulated  during  embryogenesis.  In  conclusion,  the  expression  of  all  four 
SpARC isoforms was altered during early embryogenesis, especially during blastula-
gastrula transition. 
 
cADPR  and  NAADP  were  first  identified  using  the  sea  urchin  egg  homogenates 
(Clapper, et al., 1987). Therefore in this chapter, ARC activity was measured in the egg 
homogenates by the quantification of cADPR production via cyclisation and NAADP 
production  through  base-exchange  activities.  In  S.purpuratus  egg  homogenates,  a 
higher  base-exchange  activity  was  observed  (Figure  6.4B)  compared  to  cyclisation 
activity  (Figure  6.4A).  This  could  be  due  to  the  fact  that  SpARC2,  possibly  the 
predominant isoform in the egg (Figure 6.3C and 6.13C), was also a preferential base-
exchanger.  
 
In chapter 3, SpARC2 (also SpARC3 and SpARC4) was predicted (Figure 3.3) and 
proven  by  heterologous  expression  studies  to  be  GPI-anchored  to  the  membrane 
(Figure  3.10).  The  existence  of  GPI-type  of  anchorage  was  further  verified  in  the 
endogenous  system  using  S.purpuratus  egg  homogenates.  Fractionated  egg 
homogenate  was  assayed for  total  base-exchange  activity  before  and  after  PI-PLC 
treatment. The results suggested that the majority of base-exchange activity was in the 
membrane  fraction  (Figure  6.5A).  However,  following  the  action  of  bacterial 
phospholipase  C,  majority  of  the  membrane-bound  activity  was  released  to  soluble 
fraction (Figure 6.5B). These data indicate the presence of GPI-anchored ARC activity 
in  S.purpuratus  egg.  Previous  studies  have  identified  predominant  base-exchange 211 
 
activity in membrane fractions of sea urchin eggs homogenates (Graeff, et al., 1998). 
The  data  obtained  in  this  chapter  independently  confirms  this  observation  and 
additionally demonstrates that the majority of the ARC activity could be released by PI-
PLC  treatment  (Figures  6.5B  and  6.5C).  Although  SpARC2  was  possibly  the  main 
isoform involved, contributions from SpARC3 and SpARC4 or other unknown ARCs 
cannot be ruled out. The presence of ARC activity in the soluble fractions of the mock-
treated  homogenates  suggests  the  possibility  for  the  presence  of  yet  unidentified 
soluble  ARC  in  S.purpuratus,  perhaps  similar  to  Aplysia  cyclase.  Moreover,  the 
residual activity retained  in the membranous fractions,  even after PI-PLC treatment 
hints at the existence of additional membrane bound (but not GPI-anchored) ARC(s). 
Earlier studies from Galione’s lab reported a cAMP-sensitive membrane bound ARC 
isoform (Wilson and Galione, 1998). However, the molecular correlate of this ARC has 
not yet been identified.  
 
Following  the  detection  of  ARC  activity  in  S.purpuratus  egg  homogenates,  ARC 
activities were also measured in the developing embryos. Time-courses for cADPR 
production  through  cyclisation  of  NAD  at  pH  7.2  and  NAADP  production  by  base-
exchange  activity  at  pH  4.8  were  carried  out  using  embryo  homogenates  at  major 
developmental  stages.  The  initial  rate  of  cADPR  production  was  low  compared  to 
NAADP production, in the egg (Figures 6.4A and 6.6A). This could be due to the fact 
that  the  predominant  isoform  found  in  the  egg,  SpARC2,  does  not  exhibit  robust 
cyclisation activity (Figure 4.5A). The cADPR production fluctuated up to prism stage 
but increased at the pluteus stage (Figure 6.6A). Thus the cyclisation activity increased 
during early development.  Intriguingly, SpARC4, the major cyclase of S.purpuratus (as 
of now), was also up-regulated during early development (Figure 6.3E).  
 
NAADP production was also modulated throughout early embryogenesis (Figure 6.6B). 
Relative to cADPR production, NAADP production was high in the egg. This could be a 212 
 
contribution from SpARC2, the only maternally expressed isoform and a preferential 
base-exchanger. Further, NAADP production decreased initially until blastula stage and 
again fluctuated up to prism stage. Finally, NAADP production again increased through 
pluteus  stage.  However,  the  levels  in  pluteus  were  still  lower  than  the egg (Figure 
6.6B). The initial decrease in NAADP production could possibly be attributed to the 
down regulation of SpARC2 (Figure 6.3C). However the final rise in NAADP production 
could be due to the increased expression of SpARC4 through embryogenesis (Figure 
6.3E).  Although  a  preferential  cyclase  (Figure  4.5B),  SpARC4  produces  NAADP  in 
levels similar to SpARC2 (Figure 4.5A). 
 
Finally,  the  cyclisation:  base-exchange  ratios  were  calculated  for  all  the  embryo 
samples. The ratio was found to increase during the course of development (Figure 
6.6C). Interestingly, SpARC4 possesses the highest cyclisation: base-exchange activity 
ratio (Figure 4.5D). SpARC4 is also up regulated during the same course of time during 
development (Figure 6.3E). Therefore it is highly possible that SpARC4 is responsible 
for the increase in cADPR production observed during early embryonic development. 
Having  said  that,  the  above  results  must  be  interpreted  with  caution,  as  the  total 
cADPR/NAADP production observed is a sum total of contributions from all SpARCs 
(including SpARC3 and SpARC1-like proteins whose activities are not established yet) 
and  any  other  unknown  ARC  activity.  The  physiological  factors  that  regulate  the 
activities of the different isoforms in vivo are also not known and hence may not directly 
correlate to the catalytic activities obtained by heterologous expressions (Figures 4.5A 
and  4.5B).  Nevertheless,  the  changes  in  the  levels  of  both  cADPR  and  NAADP 
production  observed  during  embryogenesis,  suggests  a  role  for  these  second 
messengers during embryonic development. 
 
The sea urchin embryo provides a simple and tractable system for  analyzing early 
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ablated in this model system, to explore their physiological functions (Davidson, et al., 
2002).  Similarly,  over  expression  and  knock-down  of  SpARCs  in  the  developing 
S.purpuratus  embryos  could  shed  light  on  the  physiological  relevance  of  these 
enzymes and specifically on the necessity for so many ARC isoforms by S.purpuratus. 
The expression profile of SpARC1 was a combination of both SpARC1 and SpARC1-
like  proteins  (Figure  6.3B).  SpARC2  was  maternally  expressed  and  physiologically 
down  regulated  during  embryo  development  (Figure  6.3C).  Although  SpARC3  was 
zygotically  expressed,  its  enzymatic  activity  could  not  be  established  in  this  study 
(section  4.3.4).  Therefore  SpARC1,  SpARC2  and  SpARC3  were  not  chosen  for 
modulation  of  expressions  in  the  embryo.  SpARC4  was  up  regulated  during  early 
embryogenesis (Figure 6.3E) and also displayed unique catalytic activity (Figure 4.5B). 
Hence SpARC4 was the ideal candidate for embryonic over-expression and knock-
down studies.  
 
mRNA  synthesised  from  SpARC4-mCherry  was  microinjected  into  S.purpuratus 
embryos  immediately  after  fertilization  and  allowed  to  develop  at  12°C.  SpARC4-
mCherry expression was followed in S.purpuratus embryos from 14 h (Figure 6.7A). 
SpARC4-mCherry was massively up-regulated between 15 - 18 h (Figure 6.7B). The 
localization  of  SpARC4-mcherry  in  S.purpuratus  embryos  was  predominantly  peri-
nuclear and vesicular (Figures 6.7 and 6.8). Real time imaging indicated the trafficking 
of SpARC4 to the apical surface of the blastomeres (Figure 6.7C). However, in chapter 
3, heterologous expression studies of SpARC4 in Xenopus embryos and HEK cells 
described  a  predominant  plasma  membrane  with  occasional  intracellular  vesicular 
localization (Figures 3.5C and 3.6C). Previous studies have identified dual sub-cellular 
locations for ARCs. Apart from the conventional plasma membrane localization, ARCs 
were  also  found  in  acidic  vesicles  like  the  recycling  endosomes  (Zocchi,  et  al., 
1996;Munoz, et al., 2008). In addition, GPI-anchored proteins are often known to be 
targeted to the apical membrane in  polarized cells. The GPI-anchor  has also been 214 
 
proposed to act as an apical targeting signal (Schuck and Simons, 2006). Localization 
of ARCs to vesicles like endosomes could provide a micro-environment with lower pH 
and  high  concentration  of  nicotinic  acid,  required  for  base-exchange  reactions. 
Endosomes are smaller in size and less acidic than the lysosomes. The vesicles that 
SpARC4  localized  were  also  different  and  smaller  (Figure  6.8C)  than  the  vesicles 
stained  by  lysotracker  red  (Figure  6.8D).  Therefore,  it  is  quiet  likely  that  the  small 
vesicles to which SpARC4 is trafficked to, are endosomes. Earlier studies have also 
described a number of other types of intracellular vesicles and granules in the sea 
urchin eggs and embryos (Lee and Epel, 1983;Sardet, 1984). Apart from the cortical 
granules  and  yolk  platelets,  clear  granules  which  are  also  acidic  are  distributed  at 
random in the egg (Lee and Epel, 1983). Therefore, as an alternate possibility the 
vesicles to which SpARC4 localizes could be clear granules. The exact identity of the 
vesicles and SpARC4 localization remains to be established. Moreover, the localization 
of SpARC4 obtained here pertains to the blastula stage of the embryo. It is possible 
that  SpARC4  distribution  changes  with  developmental  stage.  Hence,  the  exact 
endogenous  distribution  of  SpARC4  in  S.purpuratus  egg,  sperm  and  development 
stages like gastrula and pluteus also needs to be thoroughly investigated.  
 
SpARC4  over-expressing  embryos  developed  normally  only  until  the  blastula  stage 
(Figure  6.9A).  Often,  the  blastocoel  was  filled  with  cells  (Figure  6.7,  white  arrow). 
These  embryos  either  did  not  subsequently  gastrulate  (Figures  6.9B  and  6.9C)  or 
underwent abnormal gastrulation (Figure 6.10). In embryos where gastrulation ensued, 
it was at least 48h delayed compared to control embryos. However, the archenteron 
was  curved  (Figure  6.10)  and  fused  at  a  wrong  point  in  the  blastula  wall.  Such 
phenotypes  involving  abnormal  gastrulation  are  often  observed  when  sea  urchin 
embryos  are  subjected  to  gene  manipulation  studies.  In  previous  studies,  similar 
phenotypes  have  been  observed  when  developing  S.droebachiensis  embryos  were 
exposed to UVB light (Adams and Shick, 2001). Over-expression of SpARC4 however 215 
 
was not instantly lethal to the developing embryo (Figure 6.9C). These results further 
suggest  that  SpARC4  and  cADPR/NAADP  mediated  signalling  is  important  for 
S.purpuratus embryo’s entry into gastrulation. However, the above experiments have to 
be validated to fully ascertain the effect of SpARC4 over-expression on development. 
The following controls could be included in the study: 1) mock-injection of the control 
embryos, 2) testing of various mRNA concentrations, 3) employment of ARC inhibitors 
to  check  for  the  reversal  of  over-expression  phenotypes,  4)  enzyme  activity 
measurements with SpARC4 over-expressing embryos.  
 
Over-expression  of  SpARC4  interfered  with  the  normal  embryonic  development  of 
S.purpuratus  (Figure  6.9).  Therefore  the  converse  experiments  with  knock-down 
studies  using  SpARC4-MASO  was  also  performed.  Morpholino  oligonucleotides  are 
highly stable DNA analogs that are not susceptible to enzymatic degradation (Hudziak, 
et al., 1996). Genes expressed during organogenesis have been successfully knocked-
down by injection of MASO into the fertilized S.purpuratus egg (Corey and Abrams, 
2001;Coffman,  et  al.,  2004).  The  introduction  of  MASO  would  prevent  the  zygotic 
translation  of  full-length  SpARC4  protein  from  endogenous  mRNA  (Figure  6.2). 
SpARC4-MASO  injected  embryos  developed  abnormally  compared  to  the  controls 
(Figure  6.11).  The  SpARC4  knock-out  embryos  again  failed  to  gastrulate  (Figures 
6.11B and 6.11C). Even after 6 d post-fertilization, the gut was not differentiated and 
the prism stage not attained (Figure 6.11C), compared to the control embryos. If and 
when  gastrulation  occurred,  it  was  both  delayed  and  abnormal.  The  archenteron 
curved  (Figure  6.12A)  and  fused  to  the  wrong  end  of  the  embryo  (Figure  6.12B). 
Spicules were either absent or malformed in the knock-out embryos. These results 
once  again  demonstrate  a  role  for  SpARC4  and  cADPR/NAADP-mediated  calcium 
signalling during gastrulation of S.purpuratus embryos.   
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Again,  additional controls have to be performed before validating the effects of the 
MASO. A control or sequence scrambled MASO could be employed. Additionally, the 
degree  of  depletion  of  the  endogenous  mRNA  would  depend  on  many  other 
parameters  like  the  morpholino  concentration,  the  amount  and  stability  of  the 
endogenous  protein,  the  localization  of  the  targeted  mRNA  and  the  rate  of  new 
transcription (Corey and Abrams, 2001). There is also an absolute need to substantiate 
the data with RT-PCR quantification to check the levels of mRNA of the modulated 
SpARC isoform in over-expressed embryos. In case of the MASO study, the phenotype 
rescue should be attempted by the co-injection of SpARC4-mCherry. It may also be 
helpful  to  raise  antibodies  against  the  endogenous  SpARC  isoforms,  so  that  the 
antibodies  can  be  applied  to  check  the  endogenous  protein  levels  by  western  blot 
analysis and immunocytochemistry in the developing embryos.  
 
In conclusion, SpARCs, in particular, SpARC4 and cADPR/NAADP-mediated calcium 
signalling possibly play important role(s) during the embryogenesis of S.purpuratus. 
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Chapter  7:  General  Discussion  and  Future 
directions 
 
The sea urchin has been used extensively in the past as a model system for the study 
of  both  calcium  signalling  and  embryonic  development  (Whitaker,  2006a).  Although 
cADPR and NAADP were both first discovered in the sea urchin egg homogenates 
(Clapper, et al., 1987), the enzyme responsible for their synthesis, namely ARCs had 
not been characterized from this important model organism. Recently, three different 
isoforms of ARCs, namely SpARC1, SpARC2 and SpARC3 were cloned (Churamani, 
et al., 2007).  
 
In chapter 2, a family of novel SpARC1-like isoforms (Figure 2.7B) and SpARC4, a 
fourth divergent isoform (Figure 2.14) were cloned from S.purpuratus, highlighting the 
further expansion and diversification of ARCs in this particular lineage. It is intriguing 
that ARC family has undergone expansion in this lineage. While most ARC sequences 
identified until now are divergent (30-40%), SpARC1-like isoforms are very similar to 
each other (88-90%). The results from chapter 2 also indicated the possible existence 
of further novel SpARC1-like exons in S.purpuratus genome, given the identification of 
variant sequences corresponding to exon 3 that harbours active site residues (section 
2.3.1.1).  The  new  SpARC1-like  isoforms  were  cloned  from  cDNAs  prepared  from 
pluteus  stage  embryos.  Results  from  chapter  6  suggested  changes  in  SpARC 
expression  during  the  blastula-gastrula  transition  (Figure  6.2).  Therefore,  RT-PCR 
analysis  of  cDNAs  prepared  from  embryos  at  important  developmental  stages  like 
blastula  and  gastrula  could  possibly  reveal  additional  novel  SpARC1-like  isoforms. 
Various techniques have been applied with success, for the molecular characterization 
of SpARC2, SpARC3 and SpARC4 in chapters 3, 4, 5 and 6. Similar heterologous 
expression of the new SpARC1-like isoforms, in parallel  with SpARC1, in  Xenopus 218 
 
embryos and HEK cells would indicate if the new SpARC1-like isoforms also localize to 
the ER lumen. Further, any differences in the catalytic activities of the isoforms would 
be revealed. Amino acid sequence analysis (Figure 2.7B) already points to differences 
in the amino acid residues implicated in hydrolase activity of ARCs in the new isoforms. 
Therefore, it would be interesting to see if SpARC1-like isoforms produce more ADPR 
than SpARC1.  
 
Heterologous  expression  studies  in  Xenopus  embryos  and  HEK  cells  in  chapter  3 
demonstrated that SpARC2,  SpARC3 and SpARC4 were glycoproteins (Figure 3.5) 
that were expressed predominantly at the plasma membrane (Figures 3.6 and 3.7) via 
C-terminal  GPI-anchoring  sequence  (Figure  3.10).  However,  occasional  punctuate 
intracellular vesicular staining was also evident (Figure 3.6). The localization results in 
this thesis were obtained by over-expression. It would be informative to raise specific 
antibodies  against  individual  SpARC  isoforms  and  use  them  for  the  detection  of 
endogenous proteins. In this context, Davis et al developed antibodies against SpARC-
β,  SpARC-ʱ  and  SpARC-γ  and  established  the  localization  of  the  isoforms  in 
S.purpuratus eggs (Davis, et al., 2008). There were discrepancies between the location 
of SpARC1 (Churamani, et al., 2007) and SpARC-β (Davis, et al., 2008). SpARC1 was 
shown to be an ER luminal protein while SpARC-β was suggested to be expressed in 
the cortical granules of S.purpuratus egg. Results from chapter 6 suggest that although 
SpARC1  was  maternally  expressed,  the  expression  increased  in  the  developing 
embryo (Figure 6.2). However, the cortical granules disappear after fertilization and 
therefore  not  present  in  the  embryos.  Moreover  as  discussed  in  chapter  2,  the 
antibodies employed by Davis et al against SpARC-β would not have recognised the 
novel SpARC1-like isoforms. Considering the existence of additional novel SpARC1-
like isoforms, it is possible that the different isoforms are expressed at different sub-
cellular locations. Therefore both ER and cortical granule locations could be true for 
SpARC1.  There  are  mixed  reports  in  the  literature  about  the  importance  of 219 
 
glycosylation  for  ARC  activity  (Yamamoto-Katayama,  et  al.,  2001;Gao  and  Mehta, 
2007;Muller-Steffner,  et  al.,  2010).  Therefore,  it  will  be  informative  to  abolish  the 
glycosylation  sites  of  SpARCs  and  study  their  effect  on  activity,  stability  and 
localization. 
 
In chapter 4, SpARC2 and SpARC4 were shown to be multi-functional and able to 
synthesise  both  cADPR  by  cyclisation  and  NAADP  by  base-exchange  reactions 
(Figures 4.5A and 4.5B) over a wide pH range (Figure 4.7). This wide pH tolerance is a 
unique  characteristic  of  SpARCs.  Broad  pH  tolerance  along  with  dual  locations 
identified, could mean that SpARCs are functionally active possibly at more than one 
sub-cellular location. Both SpARC2 and SpARC4 were poor hydrolases (Figure 5.6A). 
This  suggests  that  SpARCs  are  functionally  similar  to  Aplysia  cyclase  in  their 
preferential production of cADPR over ADPR. In addition, SpARC2 and SpARC4 were 
unable to cyclise NGD to cGDPR (Figures 4.4B and 4.4D). Although NGD is widely 
used as a surrogate substrate for NAD (Graeff, et al., 1994), there are many reports in 
the literature about ARCs that do not utilise NGD as a substrate (Lund, et al., 2005).  
Distinct amino acid residues are possibly involved in the cyclisation of NAD and NGD. 
It would be interesting to investigate the molecular mechanisms as to why NGD was a 
poor  substrate  for  SpARC2  and  SpARC4.  This  could  shed  more  light  on  the 
mechanistic details of ARC multi-functionality, in general.  
 
Although SpARC2 and SpARC4 shared many similarities as described above, there 
was a striking catalytic difference between them. Whilst SpARC2 was a predominant 
base-exchanger (Figure 4.5A), SpARC4 was a preferential cyclase (Figure 4.5B). This 
simple  catalytic  difference  could  however  dictate  the  activation  of  distinct  calcium 
signalling  pathways  and  lead  to  physiologically  varied  outcomes.  Disappointingly, 
SpARC3’s  enzymatic  activity  could  not  be  established  in  this  study  (section  4.3.4). 
Whether  SpARC3  was  truly  an  inactive  protein  or  possessed  low  levels  of  activity 220 
 
(similar to CD157) that could not be detected by the limits of experimental design is not 
known. 
 
Although  the  enzymatic  assays  performed  with  Xenopus  embryo  homogenates 
expressing SpARCs revealed functional differences between the isoforms, the material 
that  was  available  for  analysis  was  limiting.  This  did  not  allow  rigorous  kinetic 
characterization including determination of Km and Vmax values. Alternate expression 
systems  therefore  need  to  be  established.  In  this  context,  bacterial  and  yeast 
expression systems have been used in the past for heterologous expression of CD38 
(Fryxell,  et  al.,  1995).  Expression  of  SpARC3  in  such  systems  could  yield  large 
quantities  of  the  recombinant  protein  enabling  various  assays  at  higher  protein 
concentrations, to determine its functional activity. Efforts were already focussed in this 
direction  although  without  fruitful  results.  Soluble  domains  of  SpARC3,  along  with 
SpARC2  as  a  control,  were  targeted for  expression  in  E.coli  periplasm,  a  site  that 
would aid proper formation of disulphide bridges. But unfortunately, in spite of high 
levels of protein expressions, the majority of the synthesised proteins accumulated in 
inclusion  bodies  (data  not  shown).  In  addition,  the  small  fraction  of  SpARC2  and 
SpARC3 purified from the periplasmic fractions was not catalytically active (data not 
shown).  Nevertheless,  future  efforts  could  focus  on  optimising  targeting  and/or 
retrieving SpARC activity from inclusion bodies. Another expression system, yeast, is 
often used for the study of ARCs (Goodrich, et al., 2005). In addition to the ease of 
cultivation  and  purification  of  proteins,  yeast  would  mediate  any  necessary  post-
translational  modifications  including  glycosylation.  Soluble  domains  of  CD38  and 
CD157 (Hussain, et al., 1998) and more recently SpARC-ʱ and SpARC-β (Davis, et al., 
2008) have been functionally expressed in yeast. For this reason, soluble domains of 
codon optimized SpARC2 and SpARC3 genes retaining their native N-glycosylation 
sites were expressed in Pichia pastoris in collaboration with Dr. Helene Muller-Steffner 
and Prof. Francis Schuber, Strasbourg, France. However both SpARC2 and SpARC3 221 
 
were  inactive  and  the  majority  of  the  protein  was  degraded  during  the  purification 
process (data not shown). Nonetheless, in future, improvements could be made to the 
protein purification protocols to prevent degradation. SpARC3 was also heterelogously 
expressed in SKBR3, a breast cancer cell line that was recently used for the functional 
expression of the sea urchin two-pore channels (Brailoiu, et al., 2010). SpARC3 was 
again catalytically inactive in this system (data not shown). 
 
In  chapter  5,  various  candidate  molecular  motifs  of  SpARC2  and  SpARC4  were 
analysed to investigate their roles in enzyme catalysis. Whilst the mutation of some 
residues had no effect on SpARC4 activity (Figure 5.6), others completely abolished all 
SpARC4 activities (Figures 5.4 and 5.7). A single non-conserved glycine residue at the 
“TLEDTL  domain”  of  SpARC2  was  shown  to  be  responsible  for  its  poor  hydrolase 
activity  (Figure  5.3).  Similarly,  a  single  non-canonical  active  site  tyrosine  residue 
controlled the cyclisation: base-exchange activity ratios of SpARC4 (Figure 5.9). These 
site-directed mutagenesis studies could be extended for dissecting the role of other 
conserved and non-conserved residues of SpARCs. In particular, the Glu residue of 
TLEDTL  domain  of  SpARC4  could  be  substituted  for  Gly  and  its  effect  on  activity 
established.  Mutation  of  adjacent  residues  could  also  be  carried  out  to  ascertain 
specificity. The point mutants, SpARC2-G126E that introduced new hydrolase activity 
in SpARC2 and SpARC4-Y142H that completely reversed the catalytic preferences of 
SpARC4 could be employed in the metabolic engineering of S.purpuratus.  Parallel 
over-expressions of SpARC2 versus SpARC2-G126E and SpARC4 versus SpARC4-
Y142H  could  be  carried  out  during  the  early  development  of  S.purpuratus.  Any 
phenotypic differences arising between the mutants could be  attributed to the roles 
played by cADPR/ADPR/NAADP-mediated calcium signalling during embryogenesis. 
 
In chapter 6, SpARC isoforms were found to be differentially expressed during the early 
development of S.purpuratus (Figure 6.2). The primers used for SpARC1 amplification 222 
 
were  designed  in  the  common  region  of  all  SpARC1-like  isoforms.  Therefore,  the 
profile obtained for SpARC1 was a mix of both SpARC1 and SpARC1-like isoforms. In 
future, specific primers could be designed for the amplification of individual isoforms. 
Even though the technique of semi-quantitative RT-PCR analysis indicated changes in 
expression  patterns  for  all  four  isoforms  analysed,  real-time  PCR  would  provide 
quantitative  information  regarding  levels  of  expression  of  SpARCs  during 
embryogenesis.  Initial  efforts  were  focussed  in  this  direction.  However  due  to  high 
polymorphisms,  it  was  difficult  to  design  specific  primers  for  individual  isoforms. 
Polymorphisms in the primer region could comprise the binding efficiency of the primer 
to the template and hence the amplification. Although the RT-PCR reaction would still 
be internally controlled, it would be inappropriate to compare the data across isoforms.  
 
In chapter 6, the endogenous ARC activity measured by cADPR production through 
cyclisation  and  NAADP  synthesis  via  base-exchange  was  shown  to  be  modulated 
through early embryogenesis (Figure 6.5). In addition, majority of endogenous ARC 
activity of the egg was found to be GPI-anchored (Figure 6.4). This validates the results 
obtained in chapter 3, where SpARC2, SpARC3 and SpARC4 were shown to be GPI-
anchored (Figure 3.10). The actual cADPR and NAADP content of the embryo could 
also  be  measured  during  different  developmental  stages.  Such  values  could  be 
compared to the total ARC activities observed in this study. 
 
Homologous over-expression of SpARC4 in the sea urchin resulted in its localization to 
small vesicles (<1 µm) in the blastomeres of S.purpuratus (Figure 6.7). This was similar 
to the punctuate staining observed for SpARC4 in Xenopus embryos (Figure 3.6C). 
However, a thorough localization study should be performed in the gametes and also at 
the  different  embryonic  stages  of  S.purpuratus.  Additionally,  in-situ  hybridisation  of 
embryos  at  different  developmental  stages  using  fluorescent  probes  could  prove 
informative. 223 
 
 
Finally both over-expression (Figure 6.9) and knock-down (Figure 6.11) of SpARC4 
during the embryo development resulted in either absence or abnormal gastrulation 
(Figures  6.10  and  6.12).  However  these  experiments  need  to  be  repeated  with 
additional independent fertilizations, employing all appropriate controls as suggested in 
chapter 6. Similar over-expression and knock-down of other SpARC isoforms would 
also be informative. Due to the possible redundancies that may be operational during 
the calcium signalling mediated by SpARC isoforms, double or triple knock-outs could 
also  prove  useful.  In  general  for  the  embryology  experiments,  time  and  resources 
permitting,  it  would  be  helpful  to  obtain  more  embryo  samples  within  shorter  time 
intervals. This is to ensure that any important physiological changes are not missed 
due  to  the  limited  number  of  developmental  time  points  analysed.  Using  the  gene 
knock-outs for the individual SpARC isoforms, the down-stream target proteins that are 
involved  the  cADPR/NAADP  signal  cascade  can  be  worked  out  similar  to  the 
construction of the gene regulatory networks. 
  
Taken together, the data and analysis from this thesis has provided new insights into 
the  molecular  properties  of  ADP-ribosyl  cyclases  from  S.purpuratus.  The  ARC 
repertoire is massively expanded in this basal deuterostome and each isoform possibly 
plays  a  unique  role  in  maintaining  the  calcium  homeostasis  during  S.purpuratus 
embryogenesis. Given the involvement of ARC homologs in varied patho-physiological 
conditions in humans including but not limiting to diabetes, autism, obesity, Parkinson’s 
disease  and  also  for  the  progression  of  illnesses  such  as  AIDS,  lymphomas  and 
myelomas; it is only apt to suggest that the work presented in this thesis will go a long 
way in furthering our knowledge in understanding the molecular mechanisms of ARCs. 
This  could  culminate  in  the  discovery  of  novel  drugs  to  cure  these  conditions,  in 
decades to come.  224 
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